Ministry of Health and Family Welfare

Government of India

INDIA TB REPORT 2022

Coming Together
to End TB Altogether
This publication can be obtained from:

Central TB Division
Ministry of Health and Family Welfare,
3, Sansad Marg, Janpath, New Delhi – 110001
http://www.tbcindia.gov.in
March 2022

© Central TB Division, Ministry of Health and Family Welfare

PB i
ii iii
 *The data is as of 03rd January 2022.

iv v
vi vii
viii ix
x xi
 Table of Contents
07 Patient Support Systems ........ 65
Executive Summary

08 Partnerships for the Private ........ 71

01 TB Disease ........ 03 Sector Engagement
Burden in India

09 Advocacy, Communication and ........ 111

02 TB Diagnostic Services and ........ 13 Community Engagement
Active Case Finding

10 Best Practices and ........ 121

03 Treatment Services ........ 23 Success Stories

11 Research and Innovations ........ 133

04 TB Prevention ........ 35

12 Health Financing ........ 139

05 TB Comorbidities and ........ 43

Special Situations

Annexures ........ 147

06 Supervision and Monitoring ........ 57
 for First-Line LPA, and out of these, 61 are all the States/UTs in India since 2017. A
additionally certified for Second-Line LPA. special campaign was introduced in January

EXECUTIVE The momentum to improve TB diagnostic

services does not end here. The programme
2021 for active case finding among risk
groups: diabetes, chronic kidney and liver

SUMMARY division has developed an Annotation tool for

LPA result interpretation through Machine
disease, patients on immunosuppressants,
etc. In addition, to mitigate the impact of
COVID-19 on TB services, a special ACF drive
Learning (ML). Moreover, besides the 19
was launched to screen influenza-like illness
laboratories NABL accredited till 2021 under
While the world was still reeling with the unsparing effects of the COVID-19 pandemic in (ILI) and severe acute respiratory infections
the NTEP, in 2022, 15 additional laboratories
2020-ravaging lives, uprooting livelihoods, crippling national economies, and debilitating health (SARI) cases for TB. Accordingly, in 2021, 34
have been accredited with the NABL.
infrastructure, the pandemic continued wreaking its havoc in 2021. Admittedly, the fight against States/UTs have conducted ACF activities/
Early identification of people with a high campaigns at the state and district level,
Tuberculosis (TB) encountered setbacks in decades of gains. However, the pandemic also forged
probability of having active TB is crucial for leading to the screening of 2.23 crore people,
pathways to ingenious solutions, health-system strengthening, and the ever-expanding reach of
breaking the chain of transmission. To achieve out of which 17,52,903 samples were tested
the public health programme delivery.
that, it is imperative to reach the unreached for TB, and 73,772 additional TB patients
and targeted groups through Active case were identified. The NTEP has made 81
◄ TB DISEASE BURDEN IN INDIA
finding (ACF) for early detection of TB cases Mobile TB Diagnostic Vans available to the
Despite the brief decline in TB notifications for Elimination of Tuberculosis (NSP 2017- and initiating treatment promptly. ACF States for conducting ACF in remote and
observed around the months corresponding 25) permeated to state and district levels has been systematically conducted across hard-to-reach areas.
to India’s two major COVID-19 waves, the yet again to encompass more objectives.
National Tuberculosis Elimination Programme Eighteen States have committed to Ending ◄ TREATMENT SERVICES
(NTEP) reclaimed these numbers. Accordingly, TB by 2025 by formally implementing State-
2021 witnessed a 19% increase from the specific Strategic Plans and have gone a step The NTEP has been agile in adopting and Further, the NTEP has been unwavering in
previous year in TB patients’ notification—the ahead to devise a District-specific Strategic adapting newer drugs and treatment curtailing the impediments in managing
total number of incident TB patients (new and Plan, which shall serve as a guiding tool for the modalities. In recent years, the country drug-resistant TB (DR-TB) patients. To offer
relapse) notified during 2021 were 19,33,381 programme managers and staff at the district has made far-reaching progress in the the last-mile service delivery for better access
as opposed to that of 16,28,161 in 2020. In and sub-district level towards the elimination management of TB. For example, an injection- and quality care to TB patients, including
2021, the vision of the National Strategic Plan of Tuberculosis. free treatment regimen for Drug-sensitive DRTB patients and their close contacts, the
TB (DS-TB) was implemented across the programme has decentralised TB services to
◄ TB DIAGNOSTIC SERVICES AND ACTIVE CASE FINDING country. Similarly, the programme introduced the Ayushman Bharat – Health and Wellness
a comprehensive package for differentiated Centres (AB-HWC). The “Guidelines for
Free of cost laboratory services to patients by the end of 2021, 80 laboratories are care of TB patients to identify the patients Programmatic Management of Drug-resistant
attending public health facilities and those equipped to support liquid culture system, requiring referral or hospitalisation to reduce TB (PMDT) in India - 2021” were also released.
referred from the private sector has been the of which 60 are certified for First-Line TB mortality and rapidly reduce preventable Moreover, a Shorter oral Bedaquiline
programmatic ethos since its inception. Over Liquid Culture Drug Susceptibility Testing mortality among TB patients. In terms of (Bdq)-containing MDR/RR-TB regimen was
the years, the programme has evinced one (FL LCDST), and 49 are certified for Second- DS-TB treatment performance, in 2021, among introduced and scaled up across the country.
of the most extensive TB diagnostic networks Line Liquid Culture Drug Susceptibility Testing 21,35,830 patients diagnosed, 20,30,509 (95%) Likewise, access to drugs, including newer
globally, spanning all health system tiers. (SL LCDST). Moreover, Liquid culture-based patients were put on treatment. While the drugs, to patients seeking care in the private
Staying true to its history of ever-increasing DST has been expanded to include Linezolid disaggregated treatment success rate of sector is free. Regarding DR-TB treatment
spread in both public and private sector and and Pyrazinamide. Concerning Line Probe patients notified from the public and private performance, in 2021, 48,232 MDR/RR-TB
up-gradation to newer diagnostic technologies, Assay (LPA), 74 Laboratories are certified sectors are 83% and 82%, respectively. patients were diagnosed and 43,380 (90%)

xiv xv
were put on treatment. 8455 Pre-XDR-TB, initiated on a shorter oral Bdq-containing Acknowledging the consequences of of sputum samples in COVID containment
376 XDR-TB and 13724 H mono/poly patients MDR/RR-TB regimen, 23,889 on longer alcoholism and tobacco smoking among zones; and establishing linkages for diagnosis
were diagnosed and 7562 (89%), 333 (89%) M/XDR-TB regimen, and 25,235 patients were TB patients, the programme offers services and management for TB at all COVID-19 Care
and 12008 (87%) were put on treatment initiated on the shorter injection-containing like counselling, linkages to de-addiction Centres, and dedicated COVID-19 Health
respectively. A total of 1939 patients were MDR-TB regimen. centres, and social support systems to people Centres and Hospitals. Furthermore, in line
struggling with alcoholism. In 2021, the with the new scientific evidence, the NTEP
◄ TB PREVENTION data was captured for 72% of total notified recognises TB as a comorbidity for COVID-19
patients, out of which 7% admitted to alcohol and its impacts on the progression and severity
‘Prevent’ is one of the four critical pillars three months of weekly Rifapentine and
usage. Similarly, out of the 74% of the known of the disease and has foreseen measures to
(Detect – Treat – Prevent – Build) of India’s Isoniazid (3HP) has been recommended as an
tobacco usage among all TB patients, 12% of ensure early detection and timely detection
National Strategic Plan for Elimination of alternative to six months of daily life Isoniazid
TB patients were reported to be tobacco users. effective management of TB and COVID-19.
Tuberculosis (NSP 2017-25) that focuses regimen (6H). These policy decisions and
Among those screened, 30% were linked to For example, screening for TB will also be
on preventing the emergence of TB in a their implementation are summated with the
tobacco cessation services. conducted among post-COVID patients at six-
vulnerable population. The program has release of The Guidelines for Programmatic
monthly intervals for two years.
offered TB Preventive Therapy (TPT) for more Management of TB Preventive Treatment Provider Initiated Testing and Counselling
than a decade, albeit limitedly to children (PMTPT) in India. In 2021, more than 2 lakh (PITC) initiative continued making headways In India, childhood Tuberculosis remains
below the age of six years and People living PLHIV on active care and 1.20 lakh HHC of for early detection of HIV among presumptive a staggering problem, contributing to
with HIV/AIDS (PLHIV) for the past few years. pulmonary bacteriologically confirmed TB TB patients. In 2021, 95% of the notified TB approximately 31% of the global burden.
However, to reinforce the goal of Ending TB by patients were initiated on TB Preventive patients knew their HIV status, while more Over the last decade, consistently, children
2025 by accelerating preventive measures like Treatment. Furthermore, the programme has than 2,5 lakhs PLHIV were given access to constitute 6-7% of all the patients treated
the TPT, the NTEP has taken a monumental introduced TPT in contacts of DR-TB patients in rapid molecular testing via CBNAAT/TrueNat under NTEP annually, pointing to a gap
leap in 2021 by expanding the policy to offer 12 States (Andhra Pradesh, Telangana, Delhi, for TB diagnosis. Likewise, single-window of 4-5% in total notification against the
TPT to all household contacts (HHC) of index Gujarat, Himachal Pradesh, Karnataka, Kerala, TB and HIV services are being implemented estimated incidence. To that end, inter-
pulmonary TB patients irrespective of their Maharashtra, Meghalaya, Odisha, Punjab, and through existing ART centres. More than 96% sectoral coordination is critical for ensuring
age, and other risk groups. Moreover, to Assam) to gain programmatic evidence and of PLHIV visiting the ART centres every month wide-reach of the programme to remedy this
overcome the challenges a long treatment experience for further scale-up. are screened for TB symptoms. gap. To establish pathways of early detection
entails, a new shorter TPT regimen with of children with TB symptoms and track them
Similarly, the programme has been steadfast
for early diagnosis and treatment initiation,
in adapting its strategy to address the
◄ TB COMORBIDITIES AND SPECIAL SITUATIONS the programme, in collaboration with the
pandemic. The country-wide implementation
Rashtriya Bal Swasthya Karyakram (RBSK) and
Comorbidities like malnutrition, diabetes, collaborated with the Ministry of Women and of bidirectional screening of TB and
Rashtriya Kishor Swasthya Karyakram (RKSK),
HIV, tobacco smoking, and alcohol impact a Child Development (MoWCD). To support COVID-19, i.e., COVID-19 screening for all
launched the “Collaborative Framework to
person with TB in predisposition and severity. the NTEP’s objective of successful treatment diagnosed TB patients and TB screening
Address the Burden of Tuberculosis among
To combat these, the programme brought in a and improved nutritional status among TB for all suspected and confirmed COVID-19
Children and Adolescents.” This integrated
multitude of initiatives. patients, the programme and the MoWCD patients, expanded its reach. In addition to
framework endeavours to enhance community
have ensured the holistic development of repurposing the resources from then ongoing
Cognizant of the bidirectional relationship awareness on childhood TB, generate demand,
women and children by providing additional National TB Prevalence survey and Nikshay
of TB and undernutrition, in addition to and promote disease prevention and early
nutrition support to TB patients. In addition, Sampark (national TB call centre) to serve
the Nutrition-TB App (N-TB App) that health-seeking.
TB awareness generation also became a as COVID-19 helpline, the programme also
facilitates the implementation of the technical
part of the annual ‘Poshan Mah’ to address provides services like symptomatic screening The programme has child-friendly formulations
aspects of the nutritional assessment and
malnutrition at the population level. for TB and inclusion during surveillance in of drugs to manage paediatric drug-sensitive
appropriate supplementation, the programme
the community; home sample collection TB and procures child-friendly formulations

xvi xvii
for DR-TB. Similarly, the programme has the Communities, Human Rights and Gender Two districts (each with high and low TB one’s health records enabling interoperability
mandated upfront molecular diagnostics Tools. This year, the programme started Index scores) were selected from each State/ within the digital health ecosystem. Moreover,
for all paediatric TB samples to address the gearing up the programme managers to UT for the JSSM. The team provided extensive the TB Aarogya Sathi application has been
common diagnostic challenges in paediatric acquire skills for gender-responsive analysis recommendations to the state officials for released for people with TB with multi-
TB, including DR-TB. Lastly, Bedaquiline has and interventions along the Detect-Treat- solidifying TB response. Furthermore, the language support, TB screening tool, self-
been approved for use in children above five Prevent-Build continuum by designing a programme division is strengthening the reporting bank account, and treatment
years of age, offering a shorter and safer training module. A national-level Training of Nikshay portal by incorporating advanced adherence feature. In addition, new modules
treatment regimen. Trainers of facilitators has been conducted, and analytical tools to provide regular feedback to like Diagnostic, Sample Tracking, and Drug
regional-level training has been scheduled to the States on important indicators, which will Dispensation have been incorporated into
In 2020, through its National Framework for
enable the stakeholders to implement gender- help them take necessary and timely actions. Nikshay. Similarly, the Adverse Event Module
A Gender-Responsive Approach to TB, India
sensitive approaches across differentiated TB is available to record adverse events for
became one of the first countries to adopt In 2021, Ayushman Bharat Health Account was
patient care. patients, add causality, and declare outcomes
enabled within Nikshay to uniquely identify
for events.
◄ ADVOCACY, COMMUNICATION, AND COMMUNITY ENGAGEMENT persons, authenticate them and digitally share

Since its inception, Advocacy, Communication, Northern, Western and Eastern States have ◄ PATIENT SUPPORT SYSTEMS
and Community Engagement (ACSM) have been completed. Moreover, a certificate course
been bolstering the programme’s foundation titled “Self-learning course for TB Champions” The significant burden of TB in India is Effecting new patient-supportive pathways
by solidifying the measures across all aspects has been developed and hosted on multiple compounded by the dual existence of food in the aftermath of COVID-19 pandemic-
of TB care. 2021 was punctuated by the e-platforms to empower TB survivors with the insecurity and undernutrition, signifying the led challenges, the programme brought
highest political commitment towards TB basic knowledge on TB and the provision of necessity of facilitating nutritional support about flexibility to provide the DBT benefit
Mukt Bharat Abhiyaan by Hon’ble Governors various services offered by the NTEP. to TB patients. Direct Benefit Transfer (DBT) through the existing bank account of a
at the 51st Conference of Governors chaired into the beneficiary’s bank account under the blood relative of a TB patient to ensure that
Also, a strategy document to incorporate
by the President of India—a first of its kind NTEP continued its exemplary reach in 2021. all patients can avail themselves of the NPY
stigma reduction across all TB interventions,
and juxtaposed with the lowest administrative Approximately INR 1488 crores have been paid scheme. The programme is in the process
develop a comprehensive communication
unit—exemplified by the inclusion of the to 57.33 lakh TB patients under Nikshay Poshan of operationalisation of e-RUPI vouchers for
strategy, and actively engage the TB affected
TB module in the Gram Pradhans induction Yojana (NPY) from April 2018 to February 2022. DBT schemes.
community to foster non-stigmatising and
for mobilising TB Free Panchayats. Also,
non-discriminatory behaviours in the society—
a “Guidance Document on Community ◄ PARTNERSHIPS FOR THE PRIVATE SECTOR ENGAGEMENT
”Strategy on Addressing Stigma Associated
Engagement” has been developed to guide
with Tuberculosis” was released in 2021. Despite the disruption and turmoil of Units have been formed in nine high priority
the States/ UTs in planning, designing, and
Entwining all the ACSM strategies together, a the COVID-19 pandemic, private sector States, contributing to more than 75% of
monitoring the activities under community
360-degree mass media campaign has been commitments and undertaking of the pre- National TB notifications. Not only the existing
engagement. While, national Training of
ongoing across the country under TB Mukt COVID era endured. Several partners and partnerships across the States have been
Trainers on Community Engagement for
Bharat Abhiyaan. varied stakeholders have been threaded on a systematically mapped, thereby providing
single strand of India’s fight to eliminate TB, a clear need-based road map for the future,
◄ SUPERVISION AND MONITORING
bringing numerous innovative approaches engagement of interphase agencies in the
and diverse strategies. The programme has form of Patient-Provider Support Agency
Field-level supervision exercises over the past administrative challenges faced by the States/
established a National Technical Support (PPSA) to promote private sector engagement
two years have been significantly impacted UTs and provide course-correction, a nation-
Unit at the central level to strengthen the has also been scaled up to more than
in the wake of the COVID-19 pandemic. wide Joint Supportive Supervision Mission
private sector and inter-sectoral engagement. 170 districts.
Consequently, to identify the technical and (JSSM) was conducted across 34 States/UTs.
Likewise, Multi-disciplinary Technical Support

xviii xix
For accelerated action towards TB elimination M/o Rural Development, M/o Consumer Affairs, ◄ HEALTH FINANCING
in the mission mode, a Multisectoral response M/o of Statistics and Program Implementation,
has been given utmost priority to ensure M/o of Electronics & Information Technology, The Programme Implementation Plan with the general health services, expansion of
meaningful engagement of key stakeholders, M/o Road Transport & Highways, (PIP) of NTEP is an integral part of the diagnostics services, amplifying the Nikshay
including Ministries/ Departments both at the M/o Panchyati Raj, M/o of Heavy Industries, M/o NHM. It is the most crucial instrument by ecosystem, provision of DBT, employing
central and state-level, industries of public Small, Micro & Medium Enterprises, M/o Youth which States submit their costed plans and newer treatment modalities, scaling up of
and private sectors, corporate, and business Affairs & Sports, M/o Labour & Employment, propose strategies and activities, to receive DRTB management and last-mile support,
associations. A ‘National Inter-Ministerial North Eastern Council, to name a few, resources under the NHM. The NTEP PIP and TPT, catering bidirectional screening of
Task Force on Tuberculosis (NIMTF-TB)’ has for strengthening inter-ministerial support to States/UTs—aligned with the TB and COVID-19, providing single-window
been proposed by the MoHFW to engage collaboration. Lastly, 138 corporates joined NHM PIP template, has been developed and service for TB-HIV cases, strategizing
with 23 key line Ministries of the GoI of India Corporate TB Pledge (CTP), including 10 disseminated. For 2020-21, about Rs 2516.82 national TB prevalence survey, synthesising
for policy and programme convergence. The Business Associations.   crores had been recommended, while an integration across sectors and ministries,
programme coordinated with ministries like additional Rs 25.48 crores were recommended bridging the divide of the public and private
in the Supplementary PIP for four States. sector, collaborating with corporates and
◄ TB RESEARCH & INNOVATIONS national institutes, facilitating research of new
The NTEP has constantly been evolving,
tools, and anticipating various dimensions of
buttressing innovations, and reinforcing
Drawing from the third pillar of the NSP and tuberculosis pandemics in Brazil, Russia, health systems challenges—both unfinished
strategies at all levels—mandatory notification
2017-25 on research & innovations, the NTEP India and South Africa” (IMPAC19TB). The and emerging.
of all TB cases, integration of the programme
is collaborating with various national entities project aims to understand the impact of
towards augmenting the development of COVID-19 and related response measures on
new tools, reinforcing not only the rapid the epidemiology and provision of healthcare
uptake of available tools and products but services for TB and develop innovative and
also to expedite our battle to end TB. To that pragmatic solutions to overcome the adverse
end, a multi-state validation study of C-Tb consequences. Furthermore, capitalising
skin test to detect TB infection has been on Artificial Intelligence (AI) for improving
completed with the support of Indian Council healthcare delivery, increasing diagnostic
of Medical Research - Department of Health accuracy, and screening for disease, an AI
Research (ICMR-DHR). Likewise, India is solution is being developed to screen for
participating and contributing to the BRICS TB from cough sounds and voices with the
multi-country project on “Epidemiological support of WIAI.
impact and intersection of the COVID-19

◄ BEST PRACTICES & SUCCESS STORIES

The NTEP has consistently boosted its levels of healthcare delivery, whether as a
capacity to address TB. The programme has response to a particular health outcome
encapsulated best practices and success or addressing a programmatic dimension
stories designed and implemented at various required for improved performance.

xx xxi
Meaningful
health
information TB DISEASE
to inform
TB policy BURDEN IN INDIA

1 INDIA TB REPORT 2022

01 INDIA TB REPORT 2022 2
 prevalence of disease), mortality surveys, inventory studies of under-reporting of detected TB,
in-depth analysis of surveillance and other data, expert opinion and consultations with countries1.

Incidence Estimation Methods Mortality Estimation Methods

Incidence estimates are derived from one of Mortality estimates are obtained from the
the following four methods: either of the following two methods:

• Results from TB prevalence surveys, • National vital registration systems of

mortality surveys,
• Notifications in high-income countries
adjusted by a standard factor to account • Indirectly derived from incidence and case
for under-reporting and underdiagnosis, fatality ratio.

• National inventory studies,

• Patient notification data combined with

expert opinion about case detection gaps.

However, for the 2021 estimations, methodology was modified considering the impact of
disruptions due to pandemic across various countries worldwide. The updates in the methodology
adopted were as follows:

◄ WHO developed dynamic country- Reductions in TB patient notifications in

specific models for 16 countries (Angola, 2020 relative to the expected number-
Bangladesh, Brazil, China, India, Indonesia, based on extrapolation of pre-2020 trends,
Kenya, Myanmar, Pakistan, Peru, were attributable to delays in diagnosis of
Philippines, Russian Federation, South TB and initiation of TB treatment.
Africa, Uganda, Ukraine and Vietnam),
◄ A 50% reduction (uncertainty interval,
which contributed to a 93% drop in the
25–75%) in TB transmission during periods

TB Disease notifications between 2019 and 2020.

◄ The key assumptions based on which

of lockdown,country-specific based on the
data on duration of lockdown availability.

Burden in India the model was built were as follows:

TB Burden in India
TB Incidence 19,33,381 which was 19% higher than that
Estimation of TB Burden of 2020 (16,28,161). The programme had
Scientific evidence is key to improving thus requiring complex methodologies to As per the Global TB Report 2021, been able to catch-up with the dip in TB
global public health, because National and derive estimates. Estimates of the burden the estimated incidence of all forms of notifications that was observed around the
International health policies should be of disease caused by TB measured in terms TB in India for the year 2020 was months when the two major covid waves
based on accurate and meaningful health of incidence, prevalence and mortality are 188 per 100,000 population (129-257 per happened in India. Though factors such as
information and this requires the generation of produced annually by WHO using information 100,000 population). changes in the health seeking behaviour
valid scientific evidence. However, health data gathered through surveillance systems The total number of incident TB patients of patients with chest symptoms (patient-
from epidemiological studies may have limited (patient notifications and death registrations), (new & relapse) notified during 2021 was related) as well as diversion of the human
scope or only convey information partially, special studies (including surveys of the

Glaziou P, Dodd PJ, Dean A, Floyd K. Methods used by WHO to estimate the global burden of TB disease. Geneva: World Health Organization; 2020 (https://www.
1

who.int/tb/publications/global_ report/TB20_Technical_Appendix_20201014.pdf)

3 INDIA TB REPORT 2022 INDIA TB REPORT 2022 4

 Estimated incidence of all forms of TB in India as per global TB report 80000 3000000
(Per lakh population)
500 70000
2500000
456
450 437
420 60000
404
400 2000000
50000 56569
350
350 328
47284 1500000
303
286
40000
300 276 266
42505 43380
247 257
250 241 234 228 223 30000 35950
217 211 204 199
32914 1000000
193 188
200 20000 26966
24073
21093 500000
150
10000 2182 14117
135 136 134 132
100 124 128 129
3378
102 102 102 102
0 0
50
2010 2011 2012 2013 2014 2015 1016 2017 2018 2019 2020 2021
0
2010 2011 2012 2013 2014 2015 1016 2017 2018 2019 2020 Notified MD/RR-TB cases No. of MDR/RR_TB cases put on treatment
Target as per Global TB report Notified TB cases
Incidence of all forms of TB Higher interval Lower interval

and material resources (provider-related) Measuring presumptive TB examination rate 2019. In 2020 and 2021, there was a reduction high-level meeting and National Strategic Plan
were seen across the country, NTEP has (number tested per lakh population) is an of 14% and 9% in the number MDR patients for Elimination of Tuberculosis (NSP 2017-25).
been resilient in regaining the momentum important measure of effort to find all cases put on treatment as compared to the Innovative strategies such as, provision of
of finding the missing TB patients by in the community. As the gap between cases estimated numbers. rapid molecular diagnostics of TB to everyone
introducing bidirectional screening for found and the estimates reduces, the number or to high-risk patients upfront (accessibility)
Similarly, higher reductions were also seen in
TB-Covid, doorstep delivery of services as needed to get one case TB will increase. Both and an integrated health-system approach for
the number of XDR-TB patients being started
well as earned gains on the behaviour change passive and active case finding efforts will service delivery with the other components
on treatment in 2020 and 2021 as compared
of people in terms of respiratory etiquette, contribute to achieving the target of 2025. including counselling in the general health
to the previous years, and also against the
which in the long run is expected to have system (availability) need to be explored
estimated numbers. Reversals in progress
an impact on reducing the transmission and implemented for early diagnosis and
in the number of people enrolled on MDR/
of TB as well as other respiratory infections decentralized delivery of DR-TB services.
XDR-TB treatment means that the gaps have
within the community. widened to reach the targets set at the UN

Drug-Resistance TB in India, 2021 Resilience of NTEP During the COVID-19 Pandemic

There are five categories of drug-resistant plus at least one of the drugs, bedaquiline
The programme has been able to catch-up with country, NTEP has been resilient in regaining
TB used by the national health programmes and linezolid.
the dip in TB notifications that was observed the momentum of finding the missing
at present: isoniazid (INH)-resistant TB, RR-
The estimated number of MDR and XDR-TB around the months when the two major covid TB patients by introducing bidirectional
TB and MDR-TB (RR and INH resistant), plus
cases to have been put on treatment as per waves happened in India. Though factors screening for TB-Covid as well as earn gains
pre-extensively drug-resistant TB (pre-XDR-
the global TB report 2021 was 4 per 100,000 such as major change in the health seeking on the behaviour change of people in terms
TB) and XDR-TB. Pre-XDR-TB is TB that is
and 1 per 100,000 population, respectively. behaviour of patients with chest symptoms of respiratory hygiene which on a long run
resistant to rifampicin (MDR/RR-TB) and any
During the pandemic, a significant reduction as well as diversion of the human as well as is expected to reduce the transmission of TB
fluoroquinolone (a class of second-line anti-TB
was observed in the total number of DR-TB material resources were seen across the infection in the community.
drug). XDR-TB is TB that is resistant to rifampicin
patients started on treatment as compared to
(MDR/RR-TB), plus any fluoroquinolone,

5 INDIA TB REPORT 2022 INDIA TB REPORT 2022 6

 The reported mortality among the different sub-groups of DR-TB patients is as given below:
DSTB NOTIFICATION
250000 205139 TYPE OF DRUG-RESISTANCE REPORTED DEATH RATE
19... 176082
200000 H-MONO/POLY DR-TB (2020 COHORT) 5%
150000 177153
MDR/RR ON SHORTER INJECTABLE REGIMEN
100000 11%
80807 89803 (2020 COHORT)
50000
MDR/RR ON ALL ORAL LONGER REGIMEN
0 14%
(2019 COHORT)
y

ry

ch

r il

ay

ne

ly

er

r
us

be

be

be
ar

Ju
ua

XDR (2019 COHORT) 21%

Ap

ob
M
ar

Ju

g
nu

em

em

m
M

Au
br

ct

ce
Ja

O
pt

ov
Fe

De
Se

N
2019 2020 2021
Estimates of Catastrophic Costs due to TB
Mortality due To TB Poverty is both a risk factor and a consequence related “catastrophic costs” that includes
of TB, and it disproportionately affects the indirect costs because of accessing TB-
Estimated death vs reported Death (age and 13% higher that of the year 2019 estimate.
households with low socio-economic status related services has been incorporated. As
sex): The estimated mortality rate among all As per Nikshay, the total number of reported
causing a financial burden on them, thereby per the definition if the total costs incurred
forms of TB was 37 per 100,000 population deaths among DS-TB patients notified in 2020
resulting in detrimental outcomes like delayed by a TB-affected household exceeds 20%
(34-40 per 100,000 population) in 2020, as per was 76002 (4.3% of the total notifications of
care seeking, increased default rates and poor of household annual income, the costs are
the Global TB Report 2021. There has been a 2020) which is 15.4% of the estimate for the
treatment outcomes. One of the reasons for classified as catastrophic. To date, there has
slight increase in the mortality rate due to all country, thus emphasising the importance
poor compliance to the treatment thereby been no nationally representative study of
forms of TB between 2019 and 2020 by 11% of establishing a “TB Death Surveillance and
leading to low success rate to treatment is the catastrophic costs for TB in India. A recent
in the country. In absolute numbers, the total Response” system in line with the maternal
cost that the disease imposes on individuals systematic review (2020) estimating the direct
number of estimated deaths from all forms mortality surveillance to improve the coverage
and families affected. Such costs could lead and indirect patient costs of drug-sensitive
of TB excluding HIV, for 2020 was 4.93 lakhs and real time resolution of lacunae including
to financial catastrophe, and in India, around and drug-resistant TB care in India reports that
(4.53-5.36 lakhs) in the country, which was the system related factors.
18% of the general population experience 7 to 32 percent of among DS-TB patients and
such catastrophic healthcare expenditure2. 68% of DR-TB were experiencing catastrophic
To address this, the End TB Strategy of WHO costs for TB care in India3.
Trend in estimated mortality (all forms) as per Global TB and the National Strategic Plan (NSP) for TB
The pandemic had affected the measures of
report: 2010-2020 in India have set a target to eliminate the
TB control programmes globally and more
catastrophic cost due to tuberculosis care by
55 so in the high burden countries impacting
the year 2020.
50 care-seeking, treatment services, household
50 48
47 End TB Strategy as well as the NSP measures income and cost incurred to the affected
45 44
43 the out-of-pocket expenditure through the household. The global civil society survey
43
42 40 concept of “catastrophic costs,” which is had reported the impact of pandemic and
40 40 38 37 37
39 37
36
35 different from “catastrophic expenditures,” its response affecting the services for TB
38 38 36 35
35 37 34 an indicator that is used to measure progress in India such as fear of contracting COVID
35 33
34 33 34 towards universal health coverage (UHC). by accessing facilities, closure of public
30 32 32
31
30 While guaranteeing UHC is essential, it will facilities for accessing TB care etc4. Hence,
25 not be sufficient to end the epidemic. Hence to plan, advocate and implement strategic
2010 2011 2012 2013 2014 2015 1016 2017 2018 2019 2020 instead of “catastrophic expenditure” which interventions, which are evidence-based there
Estimated Mortality rate all forms Low bound High bound focuses on direct medical costs only, TB- is a need for a cost survey either separately

2
National Health Systems Resource Centre, Ministry of Health and Family Welfare, Government of India. Healthcare Utilization & Expenditure in India: State Fact Sheets,
62. (Available from: http://nhsrcindia.org/sites/default/files/ State%20Fact%20Sheets_Health%20care%20Utilization% 20and%20Expenditure%20in%20India.pdf)
3
Chandra, Ankit & Kumar, Rakesh & Kant, Shashi & Parthasarathy, Raghavan & Krishnan, Anand. (2020). Direct and indirect patient costs of tuberculosis care in India.
Tropical Medicine & International Health. 25. 10.1111/tmi.13402.
4
Global Civil Society, TB Affected Community Led Survey, 2020. The Impact of COVID-19 on the TB Epidemic: A Community Perspective 2020. Geneva, Switzerland: Stop TB Partnership.

7 INDIA TB REPORT 2022 INDIA TB REPORT 2022 8

or combined with health surveys at national aiding in tracking the progress towards the On the lines of the National Strategic Plan, December 31, 2021, 18 states have committed
and state level to understand the new baseline goal of achieving zero catastrophic cost due states were motivated to prepare a State to elimination of TB by formally implementing
burden in the affected households, thereby to TB. Strategic Plan. Multiple platforms have been their State-specific Strategic Plans and have
utilised for guiding the states in preparation gone a step ahead to devise District-specific

TB Burden Estimation at Sub-National Levels of the state plan and in October 2021, a two- Strategic Plan which shall serve as a guiding
day National workshop was conducted for the tool for the program managers and staff at
To propel the country towards the goal of conducted the Sub-National Certification same at New Delhi under the Chairpersonship the district and sub-district level towards
TB Elimination, it is essential that states exercise for 2020 in January & February of of Honourable Health and Family Welfare elimination of Tuberculosis.
and districts estimate the TB burden and 2021. There were 67 district-level claims and Minister, Government of India. As of
customise their strategic plans to address the two UT-level claims for reduction in incidence.
determinants and reduce the burden. Similarly for the year of 2021, the sub-national LIST OF STATE WITH STATE STRATEGIC PLANS (As on December 31, 2021)
certification exercise is being conducted in
There is a need to measure TB burden more
February 2022 with 201 district-level claims Andaman Dadra and Kerala Madhya Puducherry Tamil Nadu
accurately, frequently (annually) and at least
and 10 State/UT-level claims for reduction & Nicobar Nagar Haveli Pradesh
up to the district-level if not sub-district. For
in incidence. Islands and Daman
this a robust system is required to monitor and Diu
the control at the district level in terms of the The National TB Prevalence Survey is another
Chhattisgarh Himachal Ladakh Manipur Punjab Uttar Pradesh
performance of the program. District level important exercise to assess the prevalence
Pradesh
annual survey (DLAS) uses an innovative of TB using standardised methodologies.
survey technique and is proposed as an Additionally, it will also enable the calculation Gujarat Karnataka Lakshadweep Meghalaya Sikkim West Bengal
important component for strengthening the of the TB incidence at the national and state
monitoring of TB elimination under NTEP. levels. The survey has been completed and the
Subnational Certification is an extension of the results are expected to help the country assess
Strategies in Pipeline for Burden Estimation
DLAS which helps to assess the TB incidence as the impact of COVID-19 on the TB prevalence ◄ Development of customised mathematical and prepare for developing their TB end
well as incentivise the efforts of districts and in the country as well as help in making the models to adjust for various assumptions game strategies.
states for reduction of incidence each year required changes in the strategies towards and supporting data from recently
◄ The burden estimation exercise could be
in comparison to the baseline of 2015. The TB Free India. Similarly, State TB prevalence concluded national prevalence surveys
made as an annual event for re-calibrating
Central TB Division supported by the World surveys have been conducted by few states to could be done to prepare the roadmap for
the strategies of the states and districts.
Health Organisation, ICMR - National Institute estimate the prevalence of TB at district levels. elimination and its milestones.
of Epidemiology (NIE) and Indian Association ◄ Newer burden estimates such as annual
◄ Also, similar to models for country specific
of Social & Preventive Medicine (IAPSM) episodes per lakh population could be
estimates, similar assumptions and state/
developed and the techniques to derive
district-specific information (studies,
Devising Strategic Plan for Elimination district prevalence surveys and district-level
at the same could be developed to better
understand the transmission patterns
of Tuberculosis annual surveys) could be fitted for deriving
across the country.
burden estimates for districts and states.
The National Strategic Plan for Elimination of The focus is on early diagnosis of all the TB This could help them strategically plan
Tuberculosis 2017-25 was approved on the patients, prompt treatment with the right
8th of May 2017 and has been operational drugs and regimens along with suitable
since then in the entire country with the goal patient support systems including financial
of Ending TB by 2025. This NSP addresses and nutritional support. This is supplemented
requirements for achieving the SDG and by prevention strategies including TB vaccines
End TB targets for India and is driven by the and TB Preventive Treatment.
DETECT - TREAT - PREVENT - BUILD approach.

9 INDIA TB REPORT 2022 INDIA TB REPORT 2022 10

Laboratory
services are
being provided TB DIAGNOSTIC
free of cost
SERVICES AND
ACTIVE CASE FINDING

02
 National Policy for Diagnosis

◄ Drug-Sensitive TB (DS TB)

▼ Patients with Pulmonary TB are ▼ Response to DS TB treatment

diagnosed using sputum smear is monitored using sputum
microscopy/ Chest- X ray and NAAT smear microscopy.
(Nucleic Acid Amplification Tests).
Smear replacement by NAAT and offer
of upfront NAAT for diagnosis of TB has
been prioritized by the Programme.

◄ Drug-Resistant TB (DR TB)

▼ Microbiologically confirmed TB patients (H) resistant TB patients. Liquid Culture

are offered NAAT for determining (LC) & DST is performed for determining
resistance to Rifampicin. amplification of resistance to drugs
used for managing DR TB.
▼ Line Probe Assay (LPA – First Line) is
offered to patients with Rifampicin ▼ LC is used for monitoring response to
Sensitive (RS) TB. DR TB treatment.

▼ First and Second Line LPA is offered to

Rifampicin-resistant (RR) and Isoniazid

TB Diagnostic Services
◄ Case finding strategies

and Active Case Finding Passive Case Finding Intensified Case Finding Active Case Finding

Patients with symptoms This is a provider-initiated Actively searching for

of TB voluntarily screening of outpatient TB patients among
seek health care. clinic/hospital attendees for poulation at higher risk
Introduction symptoms of TB. of TB in the community.

National TB Elimination Programme (NTEP) manner with introduction of newer diagnostic The Medical Officer follows TB screening  for patients
has the largest network of TB diagnostic technologies. Laboratory services are provided diagnostic algorithm for attending health facilities
laboratories globally spanning all levels in free of costs to patients attending public health for evaluating TB patients. with comorbidities.
the health system. Laboratory network has facilities as well as for those referred from the
been scaled up over the years in phased private sector.

13 INDIA TB REPORT 2022 INDIA TB REPORT 2022 14

Implementation Arrangement Quality Assurance
NTEP laboratory network is organised in a three-tier system with National level Reference An in-built routine system has been designed for conducting External Quality Assessment (EQA)
Laboratories (NRLs), State level Intermediate Reference Laboratories (IRLs), Culture and including all elements of internal quality control, on-site evaluation and external quality control.
Drug Susceptibility Testing (C-DST) laboratories in public & private sector and peripheral level EQA for the NRLs is conducted in through WHO Supra National Reference Laboratories (SNRL),
laboratories as Nucleic Acid Amplification Testing (NAAT), Designated Microscopy Centres (DMCs) NIRT, Chennai and the coordinating SNRL Antwerp, Belgium.
[Figure 1].

◄ External Quality Assessment (EQA) for:

TB Laboratory Network in NTEP in 2021
▼ Sputum smear microscopy includes On-site Evaluation, Panel Testing and Random Blinded
Re-Checking (RBRC).
Level of facility in the Testing modalities available
health system ▼ NAAT is conducted using Dried Tube Specimen (DTS) for public as well as private sector
laboratories.
▪ EQA for GeneXpert is conducted annually by NTI, Bangalore by providing a panel of DTS
National Reference Microscopy
Laboratory 6 NAAT to the participating laboratory. Complete coverage of EQA to all GeneXpert machines
LPA under the Programme was achieved in 2020. Instrument and technical performance of
Liquid Culture
Intermediate Reference the staff are assessed. Appropriate corrective measures are undertaken by respective
Laboratory (State Level) 34 LCDST
IRL and NRL (Figure 2).
C&DST Laboratory ▪ Pilot testing the expanded use of DTS panel for EQA in Truenat is ongoing.
Microscopy, NAAT, LPA,
(in Medical Colleges 58 Liquid Culture, LCDST
& Private Sector)
▼ o Phenotypic DST (Liquid Culture) and LPA is through structured panel testing and retesting
▪ Microscopy exercises. Proficiency Testing (PT) exercise is conducted annually for laboratories in all
District &
3760 - NAAT ▪ Rapid Molecular Test technologies used for determination of drug resistance.
Sub District Level (NAAT)-
Peripheral ▪ CBNAAT
Sub District 21820 - DMCs ▪ TrueNat Schematic representation of Quality Assurance mechanism for GeneXpert MTB/RIF testing using DTS
Level
NAAT‐ Nucelic Acid Amplification Test; LPA‐ Line Probe Assay; LC DST‐ Liquid Culture Drug Susceptibility Testing
EQA for Gene Xpert MTB/RIF Testing using DTS

NRLs, IRLs and C-DST laboratories are equipped to perform DST by various technologies such as
Rehydrate the dried tube Tighten caps and shake Incubate samples at room
Liquid Culture and molecular tests such as LPA and NAAT. specimen (DTS) samples vigorously 10-20 times temperature for 15 minutes
with transfer pipette
◄ 80 Laboratories are equipped to support Pyrazinamide. NRL- NIRT, Chennai and
liquid culture system, among them, 60 NITRD, New Delhi are certified for DST to
are certified for FL LC DST and 49 are Bedaquiline Delamanid and Clofazimine. SR
certified for SL LCDST. Solid culture & DST List of certified laboratories is provided in
is discontinued (PMDT guidelines 2021). Annexure. Aspirate rehydrate sample up to mark
on pipette provided with xpert®
◄ 74 Laboratories are certified for FL LPA and ◄ NRLs and IRLs conducts training, MTB/RIF assay kit and add sample to port
After 10 minutes has elapsed
Test immediately in the xpert® MTB/RIF catridge
among which 61 are additionally certified handholding, monitoring and evaluation shake sample again 10-20 times

for SL LPA for their respective State /district/ block

level facilities/ laboratories.
◄ In 2021, Liquid culture-based DST is
expanded to include Linezolid and

DeGruy et al. 2012. ASLM 1st International Conference

15 INDIA TB REPORT 2022 INDIA TB REPORT 2022 16

 Second Line LPA (2021)
Human Resource Development
No. of tests MTB FQ & SLI FQ SLI Low level XDR TB
In the current year, the following hands-on trainings were conducted to build capacity of staff in conducted Detected Sensitive Resistant Resistant Kanamycin (FQ + SLI
C&DST laboratory: resistant Resistance)

National level training programs for laboratory personnel organized for: 58,255 53,788 32,988 15,285 649 538 2,550
(92.3%) (61.3%) (28.4%) (1.2%) (1.0%) (4.7%)
◄ LPA (first and second line), liquid culture and DST, Truenat as well as EQA for CBNAAT.

◄ Hands-on training on SOP to staff at the five Whole Genome Sequencing facilities Liquid culture – 3,07,550 culture tests were performed during the year 2021.

◄ Induction training for Biomedical Engineers at National Reference Laboratories Second line LC-DST (2021)

◄ Training programme on DST to newer drugs used in the management of Drug Resistant TB SL DST No. of valid No. of FQ & No. of MDR + No. of MDR + No. of XDR
conducted test SLI Sensitive FQ resistance SLI resistance detected
◄ Logistics management in LIMS was developed, installed in 57 Laboratories and hands-on
detected detected (FQ + SLI
training provided.
Resistance)
◄ Induction and refresher training module designed and developed to promote self/ assisted
14,886 12,242 4,876 2,178 490 567
E- learning platforms. (84.2%) (39.8%) (17.8%) (4.0%) (4.6%)

State wise details of NAAT, LPA and LC DST conducted in 2021 are provided in Annexure.
Performance by the Laboratory Network (2021) Newer Initiatives
In 2021, of the 82,79,066 patients were offered Smear Microscopy through 21820 DMCs, and
▼ Module for real time tracking of patient sample from time of collection till reporting has
5,64,097 (6.8%) patients were diagnosed as TB.
been developed under STRIDES partnership and pilot study initiated. Diagnostic module in
NAAT facilities in the country were increased from 3147 in 2020 to 3760 in 2021. The details of the NIKSHAY is enhanced by creating simpler workflows.
tests conducted in 2021 are given below:
▼ Programme Division with technical support from Wadhwani Institute for Artificial
Intelligence, has developed an Annotation tool for LPA result interpretation through
NAAT (2021)
Machine Learning (ML). Results obtained Annotation tool is being compared with the
NAAT No. of tests MTB detected R Resistant results from panel of expert microbiologists.
conducted
▼ Nineteen laboratories under NTEP had obtained NABL accreditation till 2021 and in 2022,
CBNAAT 14,34,124 4,23,421 (29.5%) 43,493 (10.3%) fifteen additional laboratories have been taken up for NABL accreditation:

Truenat 21,97,757 4,50,304 ( 20.5%) 21,927 (4.8%) ▼ IRLs- AIIMS New Delhi; Trivandrum, Madurai, Jamnagar, Patiala, Dharampur, Agra, Indore
and Bhopal.
First Line LPA (2021)
▼ C&DST laboratories -NIRTH, Jabalpur, GRMC Gwalior, GMC Kozhikode and GMC Surat.
No. of tests MTB H&R H mono R mono MDR TB (H&R ▼ Supervisory visit (EQA-OSE) formats used by NRLs and IRLs were revised and are piloted
conducted Detected Sensitive Resistance Resistance Resistance)
in coordination with NRLs- National Tuberculosis Institute (NTI) Bangalore and National
3,28,715 3,11,399 2,57,996 19,710 4,818 22,205 Institute for Research in Tuberculosis (NIRT) Chennai.
(94.7%) (82.8%) (6.3%) (1.5%) (7.1%)

Way Forward
Undertaking sentinel surveillance for drug resistant TB using Whole Genome Sequencing (WGS).
Protocol for the surveillance has been developed by SNRL- NIRT, Chennai, in coordination with
CTD, UNION, FMR and WHO. Approvals from SAC and Institutional Ethics Committee has been
obtained. To be initiated in 2022.

17 INDIA TB REPORT 2022 INDIA TB REPORT 2022 18

Active Case Finding One of the key challenges identified in ACF has been the access to X-rays and NAAT. The program
envisions making available hand-held X-ray devices equipped with Artificial Intelligence to aid
Active Case Finding (ACF) has been systematically conducted across all states in India since 2017 automated reading which would improve access in hard-to reach areas. Additionally, ensuring
based on the National Strategic Plan 2017-25. availability of molecular testing platform at the block levels will improve the yield during ACF.

Active case finding among risk groups as defined in the National ACF guidelines which includes
diabetes, chronic kidney and liver disease, patients on immunosuppressants, etc., was conducted
in January 2021. TB services were largely affected due to COVID -19 and to detect the missing
cases, a special ACF drive (from 2nd September 2021 to 1st November 2021) was launched by the
Hon’ble Minister for Health & Family Welfare, GoI.

In 2021, a total of 2.23 crore persons were screened, 17,52,903 samples tested for TB and 73,772
additional TB patients identified through Active Case Finding. A total of 81 Mobile TB Diagnostic
Vans has been provided to the states for conducting ACF in remote, hard-to-reach areas. From
January to December 2021, 34 states/UTs have conducted ACF activities/campaigns at state and
district levels, at different time-periods. State wise details of ACF conducted in 2021 are provided
in Annexure.

2238.8

19 INDIA TB REPORT 2022 INDIA TB REPORT 2022 20

Managing TB
with world TREATMENT
class treatment SERVICES
solutions

03
 ◄ Shorter oral Bedaquiline (Bdq)-containing ◄ Difficult-to-treat TB clinic establishment at
MDR/RR-TB regimen introduced and national and state levels.
expanded across the country.
◄ As part of corporate sector involvement,
◄ Use of Bdq expanded to children from DR-TB Centre established in Medanta
five years of age onwards and weighing Hospital, Gurugram, Haryana.
15 kg and above, pregnant women, in
◄ Guidance on mandatory establishment of
select patients beyond six months and its
DR-TB centres in all the medical colleges.
combined use with Delamanid introduced.

◄ Access to free drugs including newer drugs

to patients seeking care in the private
sector.

Policy Statement and Implementation Arrangements

Treatment of drug-sensitive TB and drug-resistant TB

All diagnosed TB patients are to be put on standard first-line anti-TB regimen in the form of Fixed
Dosage Combination (FDC) after ruling out at least rifampicin resistant status (when biological
sample available) and to be initiated on treatment within three days of diagnosis. The flow of
patients from diagnosis to treatment initiation and follow-up till final treatment outcome is
depicted in the flowcharts below:

Treatment A – Flow of DS-TB patients

Services
A
At the HF
Presumptive TB New Episode
S-LPA
Lab

Lfx/Mfx(h)
detected
Modified

Introduction R resistance
detected
DR-TBC
Regimen

Microscopy
At the HF Need support
/NAAT
Treatment services are provided free of cost under the programme. Treatment for drug-sensitive DS-TB Detected

and drug-resistant TB are aligned with global guidelines by national experts. The NTEP has been
CHO/MO-HF/PP
agile in adopting and adapting newer drugs and treatment modalities. In recent years, the country Expert decision

has made considerable progress in the management of TB. Key highlights on treatment are
given below:
Adherence

◄ Injection-free treatment regimen for DS-TB mile service delivery for better access and Treatment Start DS-TB regimen
Outcome
was implemented across the country. quality care to TB, DR-TB patients, and their
New Episode
Post treatment
close contacts. Follow up
Treatment
◄ Introduction of differentiated TB care DS-TB Patient
Contact Tracing &
TPT after ruling
Supporter
Patient Support
package of services to reduce mortality. ◄ Guidelines for Programmatic Management & their
contacts
out active TB
Nikshay
Sampark Toll
of Drug-resistant TB (PMDT) in India - 2021 Free Helpline
◄ Engagement of Ayushman Bharat – Health 1800-11-6666
released by Hon’ble Union Health Minister.
and Wellness Centres (AB-HWC) in last

23 INDIA TB REPORT 2022 INDIA TB REPORT 2022 24

B – Flow of H mono/poly DR-TB patients D - Flow of patients on longer oral M/XDR-TB regimen

B Nikshay

Repeat
At the HF Sampark Toll
Free Helpline
D
NAAT At the HF 1800-11-6666
At the N/DDR-TBC
New
DS-TB patient Episode Longer Oral Regimen
New Episode DR-TBC
Follow up Positive/ DR-TB patient
Failure/Clinical Non S-LPA
responder Lab
Treatment Initiation
Lfx/Mfx(h) Eligible for Longer oral regimen
R resistance not
detected MO-HF/CHO/PP
Modified
detected Regimen
NAAT
DR-TBC
F-LPA Lab Need support
H Resistance At the HF Continue treatment
Detected

Z & Mfx(h) can’t be used

CHO/MO-HF/PP R resistance detected
Expert decision
Management of
Nikshay severe adverse

Z or Mfx(h) can’t be used

NDR-TBC

Lzd can’t be used

Replacement events & replacement
Sampark Toll Adverse Events Counsellor
Free Helpline
Extension
1800-11-6666 Any two of Lzd Cfz Replacement
or Cs and R E Z
NDR-TBC Longer Oral DR-TB
Adherence Extension New
Start H Mono/ Counsellor Treatment Episode
Patient Counselling

Lfx Resistant
Cfz Cs R E Z Supporter
Treatment Poly DR-TB regimen Adherence
Outcome
New Episode

Rif Resistant
Lzd R E Z
Treatment Treatment Modified
Post treatment Contact Tracing & Supporter Outcome
Regimen
Follow up TPT after ruling out Mfxh R E Z
Nikshay
H Mono/Poly active TB Post treatment
Patient & their Shorter Oral or Follow up
Sampark Toll
Patient Support
contacts Patient and Family All Oral Longer Free Helpline
Family & patient 1800-11-6666
counselling Patient Support

Those patients advised to take medicine from treatment supporters identified and trained by the
health centers located close to the residence as per convenience of the patient.
C – Flow of patients on shorter oral Bedaquiline-containing MDR/RR-TB regimen
Comprehensive Package for Differentiated Care of TB patients
At the HF At the C
N/DDR-TBC Most of the deaths occurring during TB (a) assessment criteria of patients with active
Shorter oral
regimen initiated
treatment can occur either due to extensive pulmonary TB, (b) risk stratification of patients
DS-TB patient
TB with complications or due to serious co- for referrals, (c) criteria to refer TB patients for
Nikshay
Sampark Toll
morbidities. The programme introduced a in-patient care, (d) in-patient care package, (e)
Free Helpline DR-TBC
1800-11-6666
Continue shorter comprehensive package for differentiated care parameters for follow-up examinations of TB
NAAT oral regimen
Manage
adverse of TB patients with the intention to identify the patients, (f) mechanism to ensure follow up.
events
At the HF patients requiring referral or hospitalization The package also outlines the essential and
NDR-TBC to reduce TB mortality and with the objective desirable diagnostics and therapeutics for a
Counsellor
R resistance detected
AND/OR

Serious of rapid reduction of preventable mortality health facility design, budget, and building
adverse events
F-LPA lab
Sm+/Culture+ Change among TB patients. This document covers capacity to implement the package.
at 6 months of regimen
New
Episode
Adherence Patient
FQ resistance
Decentralized DR-TB treatment
AND/OR

MO-HF/CHO/PP counselling Inh A + Kat G

Only Inh A/ Treatment mutation New
only Kat G mutation Outcome Episode
With the aim to bring drug-resistant TB DR-TB centres were functional, which include
S-LPA lab Follow-up
Treatment Evaluations Nikshay treatment closer to patients’ residence, DR- 162 Nodal DR-TB centres. This empowers
Supporter Sampark Toll
Patient Support
Free Helpline TB treatment services were decentralized to districts to implement the “test and treat
1800-11-6666
Post treatment
follow-up
district DR-TB centers. By the end of 2021, 776 approach” to minimize the gap between
Family & patient
No SLD resistance counselling

25 INDIA TB REPORT 2022 INDIA TB REPORT 2022 26

diagnosis and treatment initiation, reduce India) made it mandatory to have a facility for Facilitators of the National ToT National ToT photo with participants

cost of travel, and expedite early care of MDR/ the management of MDR-TB in every medical
RR-TB patients within their respective district. college by the time of 3rd renewal (admission
of 4th batch of MBBS students). By the end of
To strengthen the involvement of medical
2021, 290/565 (51%) of medical colleges are
colleges in DR-TB care, National Medical
providing services to DR-TB patients.
Commission (NMC erstwhile Medical Council of

National Training of Trainers (ToT) in Guidelines for PMDT in India – 2021

Owing to the current pandemic restrictions, Following this, states have started cascade
a virtual training course was planned and trainings of district and sub-district levels staff
conducted on WHO India’s Swasth e-Gurukul using standard training materials developed
platform on a webinar mode with in-build by CTD. The Swasth e-Gurukul provided
assessments. Total of 442 participants from assessment platform for the trainings planned
all states/UTs across the country were physically/ virtually on webinar mode. Total Injection-free, oral regimen for all types of DR-TB patients
enrolled (average participation 369 per day 18 states/ UTs used the Swasth e-Gurukul
for all five days). Out of them, 361 (82%) had platform to conduct and assess the state-level In 2021, shorter oral Bdq-containing MDR/RR- Pradesh, Karnataka, Maharashtra, Punjab,
successfully completed the training (scored cascade trainings. TB regimen was introduced to replace shorter Telangana) in 3rd quarter of 2021 and gradually
>60% in post-test) and auto-generated their injection-containing MDR-TB regimen (the it was expanded to other states. By the end of
training certificate. only injection-containing regimen in the entire 2021, 1939 (7%) patients were put on shorter
TB care cascade) in a phased manner with the oral Bdq-containing MDR/RR-TB regimen. A
Launch of self-learning module on Guidelines for PMDT in India – 2021 aim to complete the transition by April 2022. series of review meetings for assessment of
Initially, it was started in eight states (namely preparedness of rest of the states and UTs
Using the video recordings of National ToT, on Swasth e-Gurukul platform and launched
Andhra Pradesh, Delhi, Gujarat, Himachal have been completed in January 2022.
self- learning module for the medical officers, by the Hon’ble Union Health Minister in
private practitioners, and others with the October 2021. More than 1100 participants
aim to allow participants to learn at their enrolled for the self-learning module on the
own convenience and pace was developed Swasth e-Gurukul.

Launch of self-learning module on “Guidelines for PMDT in India – 2021” on WHO’s Swasth e-Gurukul platform

27 INDIA TB REPORT 2022 INDIA TB REPORT 2022 28

Release of “Comprehensive Clinical Management Protocol of Tuberculosis” Cumulative performance since roll out

MDR/RR TB patient detected 3147 3760

Cumulative performance since roll 4,00,683 1180
1180
As per the programme guidelines, there developed by the programme and released by out MDR/RR TB patient detected
651
RR/MDR TB Patients initiated
are management protocols in the form of the Hon’ble Union Health Minister in October 1600000 on Rx
3,51,385 628 66255 70000
121
algorithm available for DS-TB, DR-TB, and TB 2021. This will serve as a ready reckoner 1400000 80 58347
60000
infection. With the aim to simplify and integrate for the clinical management of TB by 40
1200000 18
49679 48232
50000
these algorithms, a “Comprehensive Clinical the health care providers, both in the public 46569
1000000 38605
Management Protocol of Tuberculosis” was and the private sector, respectively. 34016
42505 48232 40000
800000 35950

1383282
29057 32958
25727 30000
600000 23148 27104

1047441
24113

916262
Release of “Comprehensive Clinical Management Protocol of Tuberculosis” by Hon’ble Union Health Minister,
17274 21144 20000

794320
400000

734247
14107
Dr Mansukh Mandaviya in Oct 2021

9002
200000 10000

395
105998

182235

200007
2724 7562
2127 2475 2666 1918
1268 993 333
0 0
2007 2008 2009 2010 2011 2012 1013 1014 2015 2016 2017 2018 2019 2020 2021

No. of presumptive DR TB patients No. of MDR RR TB patient detected

No. of MDR RR TB patients initiated on treatment Pre-XDR TB patients initiated on Rx
XDR TB patients initiated on Rx No. of H mono/poly patient initiated on treatment
NAAT sites

The cohort of DR-TB patients initiated on treatment in 2019 reported 57% treatment success
rate (34,535/60,873). This includes 39,358 of patients on shorter MDR-TB regimen (inj-containing)
with 59% treatment success rate and 1280 of patient on longer oral regimen with 70% treatment
success rate. This cohort also includes 11,791 patients put on old conventional MDR-TB regimen
that has reported 49% treatment success rate.

Trend in treatment sucess rate

100%

National Performance 90% 81% 82% 82%

80%
DS-TB performance analysis of 2021 DR-TB performance analysis of 2021 69% 83%
70% 76% 78%
57%
In 2021, among 21,35,830 patients diagnosed, In 2021, 48,232 MDR/RR-TB patients were 60% 52%
49%
20,30,509 (95%) patients were put on treatment. diagnosed and 43,380 (90%) were put on 50%
53%
61% were male and 39% were female among treatment. 8455 Pre-XDR-TB, 376 XDR-TB and 40%
45%
the patients put on treatment. Among the total 13724 H mono/poly patients were diagnosed
30% 36%
notification, 6% patients were in paediatric age and 7562 (89%), 333 (89%) and 12008 (87%)
20%
group. Among 17,51,437 TB patients notified were put on treatment respectively. A total of
in 2020, 83% were successfully treated while 1939 patients were initiated on shorter oral 10%

4% died during treatment. Disaggregated Bdq-containing MDR/RR-TB regimen, 23,889 0%

treatment success rate of patients notified on longer M/XDR-TB regimen and 25,235 2017 2018 2019 2020

from public and private sector are 83% and patients were initiated on shorter injection- DS-TB H mono-poly MDR-RR XDR-RR
82% respectively (Refer Annexure) containing MDR-TB regimen.
In the cohort of 2020, 30,985 patients initiated on shorter MDR-TB regimen (inj. containing)
reported treatment success rate of 55% and 11,525 H mono/poly resistant TB patients reported
treatment success rate of 83%.

29 INDIA TB REPORT 2022 INDIA TB REPORT 2022 30

Newer Interventions/ Additional Activities DR-TB Consortium under Corporate TB Pledge

DR-TB Consortium is providing a platform for corporate sector to deliberate the programme
Difficult-To-Treat TB Clinic need and support to be extended under corporate social responsibility. Three meetings of DR-TB
consortium members had been organized by The Union in 2021. Through DR-TB consortium, the
National Institute of Tuberculosis and managed through this mechanism. This was
following partnerships have been facilitated in DR-TB:
Respiratory Diseases (NITRD), New Delhi further decentralized in 2021 to 26 states/UTs
in collaboration with Central TB Division that have established State level – Difficult- ◄ Initiation of DR-TB clinic facilitated in ◄ Initiation of certification process of culture
and National Task Force (NTF) for Medical to-Treat TB Clinic (S-DT3C) in accordance with Medanta Hospital, Gurugram and a formal and DST of Pathkind lab, Gurugram
Colleges have initiated “Difficult to Treat TB the Guidelines for PMDT in India - 2021. Some MoU was established with support of WHO
◄ Active case finding through mobile X-Ray
Clinic (DT3C)” at National level. By the end case studies were discussed during periodic ◄ Pilot project in three districts of along with NAAT services in Rewari
of 2021, 47 difficult-to-treat TB patients were webinars conducted by these clinics. Maharashtra to improve access to newer
drugs for patients in the private sector
National DT3C webinar

Way Forward
◄ Improve coverage of universal drug DR-TB consortium meeting
susceptibility testing, including second line
DST

◄ Introduction of shorter oral effective and

safer DS-TB and pan DR-TB regimen

◄ Transition to Nikshay based paperless

recording and reporting system with
automated case finding report for drug-
resistant TB

◄ Expansion of digital adherence technology

like MERM and 99DOTS lite
Proposed establishment of 7 Centres of Excellence (CoE) in DR-TB care
◄ Establishment of DR-TB clinics in private
Initial site assessment visit to one of the CoE sites hospitals in major cities and towns with
To enhance quality of PMDT services, NTEP
hub and spoke model through technical
intends to upgrade some of the existing
support unit and PPSA across the country
Nodal DR-TB centres established in premier
institutes as CoE. A framework for assessment ◄ Monitor the establishment of DR-
of institutions was developed and a team of TB centres in all the medical colleges
national subject expert, CTD, The UNION and across the country through national task
WHO conducted initial site assessment visits force mechanism
to four institutions i.e, NITRD New Delhi,
RBI PMT New Delhi, J J Hospital Mumbai and
GHTM Tambaram.

31 INDIA TB REPORT 2022 INDIA TB REPORT 2022 32

Prevention at
the core of TB
management TB
PREVENTION

33 INDIA TB REPORT 2022

04 INDIA TB REPORT 2022 34
 TB Preventive Treatment (TPT) Policy
For more than a decade, NTEP has the of age and other risk groups such as patient
policy of providing TPT (erstwhile isoniazid with silicosis or undergoing dialysis, on
chemoprophylaxis) to the eligible children <6 immunosuppressant or anti-TNF treatment
years who are household contacts (HHC) of TB and patients proposed for organ transplant.
patients. The policy of providing TPT (erstwhile High TB transmission settings (such as health
isoniazid preventive therapy (IPT)) in People care workers, prisons, mines, slums, tribal,
living with HIV/AIDS (PLHIV) since 2017. migrant labourers etc.) are being prioritized
for TPT interventions guided by differential TB
In 2021, the eligibility for TPT has been
epidemiology by the State TPT Committee.
expanded to all HHC of pulmonary TB
(prioritizing in PBCT) patients irrespective

◄ TPT in PLHIV ◄ TPT expansion in household contact

of children less than five years,
TPT scale up has been taken up on mission
adolescent, adult and other risk
mode since 2020 as a collaborative effort
groups
by NACP and NTEP. As a result, India has
been able to counsel the majority of PLHIV The Central TB Division had issued a
on active care and offer them six months of policy guidance in June 2021 based on the
isoniazid based TPT. recommendations of NTEG for initiating
▼ 2
,10,171 PLHIV on active care were the preparations for expansion of TPT
offered TPT after ruling out active TB in coverage to the additional population.
the year 2021.

TB ◄ TPT in children less than five years

Prevention who are household contacts of

pulmonary TB patients

The health workers are conducting every

patient’s home visit within a week of TB
‘Prevent’ is one of the four critical pillars in next few years, NTEP has taken a huge leap notification. As per Nikshay reporting:
(Detect – Treat – Prevent – Build) in India’s in 2021 by expanding the policy to offer TPT
national strategic plan (2015-25) for ending to all household contacts of index pulmonary ▪ A home visit for contact investigation
TB by 2025 which aim towards preventing the TB (prioritize in pulmonary bacteriologically was conducted in 84% of PBCT patients.
emergence of TB in vulnerable population of confirmed TB [PBCT]) patients and other ▪ 48% of eligible children <5 years
 
India. It entails scale-up of air-borne infection risk groups beyond the existing policy for in contacts of PBCT patients were
control measures at health care facilities, PLHIV and HHC children <5 years. Also,
provided TPT.
treatment for TB infection and addressing the it has strengthened the air-borne infection
social determinant through an intersectoral control measures in N/DDR-TBC and
approach. To accelerate prevention and as a C&DST laboratories.
result, the anticipated decline of TB incidence

35 INDIA TB REPORT 2022 INDIA TB REPORT 2022 36

Release of the Guidelines for respectively; 290 (76%) participants who Review of the progress of states and
programmatic management of TB had launched the course completed the districts against the PMTPT scale up
preventive treatment (PMTPT) in India course successfully. An impressive 33% plans
increment in score between pre-test The Central TB division conducted virtual
National Task Force for guideline
and post-test was recorded. The same review with all the States/UTs between 6th
development prepared the guidelines of
methodology of virtual training through to 20th of January 2022 and assessed the
TPT as per the recommendation of National
WHO’s Swasth e-gurukul was extended for progressed in the implementation of their
Technical Working Group (NTEG) after a
state-level master trainers on request by PMTPT scale-up plans.
series of deliberations and review of global
states. All 36 states/UTs have completed
recommendations and in country evidence. The implementation of TPT in HHC
the training of state-level master trainers
The Guidelines of PMTPT in India (2021) >/=5years is in very nascent phase.
the training of national master trainers while cascade training at district levels and
were released by the Hon’ble Union Health
was conducted virtually. The challenge sub-district levels are ongoing.
Minister on 6th August 2021. ▪ 6% of eligible household contacts >5
of organising physical trainings was
Additionally, the entire national training years of PBCT patients were provided
overcome by cascading the virtual training.
was video recorded and converted into TPT in July to December 2021.
The training course was developed over
self-learning modules for Guidelines for Status of TPT initiation in the States are
WHO India’s Swasth e-gurukul knowledge
PMTPT for cascade trainings in support of placed in annexures.
platform. Of the 434 participants invited by
WHO country office for India.

PMTPT scale up plans ◄ TPT for DR-TB contacts:

The Central TB division with support of WHO
TPT for DR-TB contacts was introduced in 12
India introduced an excel based PMTPT tool
states (Andhra Pradesh, Telangana, Delhi,
to prepare district wise plans for PMTPT
Gujarat, Himachal Pradesh, Karnataka,
expansion to achieve national coverage
Kerala, Maharashtra, Meghalaya, Odisha,
up by mid-2022. The critical preparatory
Punjab and Assam) to gain programmatic
activities were listed (setting up of state
experience for further scale up.
level TPT committee; trainings of state,
Capacity building on Guidelines for PMTPT
appraisal on PMTPT to the state and district
in India on WHO’s Swasth e-gurukul ◄ e) Innovation and newer initiatives
administrators; district and subdistrict
knowledge platform CTD for the virtual webinar, 427 (98%) have
health officers and workers; linkages for
enrolled for the course in Swasth e-gurukul
Owing to the restrictions imposed due TBI testing and linkages for presumptive
and 382 (89%) launched the course.
to the prevailing COVID-19 pandemic, TB testing) with flexibility for timeline.
While the pre-test quiz of day 1 and 2,
District-wise projections of beneficiaries
and post-test of on day 3 were attempted
for TB screening, TBI testing and TPT were
by 90%, 87%, 82%, 79% participants,
also made based on TB notification and a
few assumptions. The district-level plans
from 770 districts were consolidated at
the national level. This plan would not only
be guiding the districts and the states for
taking up the critical preparatory activity
for PMTPT expansion but also be serving
as a reference for monitoring. The entire
exercise was carried out in latter half of 2021.

37 INDIA TB REPORT 2022 INDIA TB REPORT 2022 38

 ▼ Self-learning training module for ▼ C-TB skin test for TB infection: There is ◄ Global fund supported project Akshaya Plus and JEET 2.0:
PMTPT: Restrictions imposed by a need of an affordable, acceptable and
COVID-19 pandemic was causing delay available TBI testing alternative to IGRA. Non-government principal recipients
in cascading training at the same time ICMR has completed the C-TB feasibility (NGPR) WJCF, FIND and The UNION are
health care workers were involved study and results are encouraging and awarded with the projects titled JEET 2.0 and
in COVID-19 duty. To overcome the the same would be dedicated to the Akshaya Plus under Global fund grant for
challenge, the self-learning training country on World TB Day 2022. 2021-24 with TPT interventions. The project
module for PMTPT has been developed is implemented in 184 districts. TBI testing
▼ Community Engagement: As per initial
on WHO’s Swasth e-Gurukul platform through IGRA is supported by the project in
roll out experiences, hesitancy was
and launched by Hon’ble Union Health test & treat model districts. The TPT drugs
reported among the healthy contacts in
Minister in October 2021. More than will be facilitated by the programme. ~8,000
taking TPT course. Advocacy campaigns
2000 participants have enrolled in 3HP courses and ~15,000 6H courses are
and community engagement to address
the self-learning PMTPT module and being supported under the project. Both
the hesitancy in accepting PMTPT
already completed by >800 individuals. the projects under Global fund grant are
interventions in the community is being
expected to gain experience and generate
▼ Shorter TPT Regimen: To overcome developed.
local evidence to facilitate expansion.
the challenge, new shorter TPT regimen
▼ IMPAACT4TB Study: A multi-
with 3 months of weekly rifapentine
centric feasibility study is being
and isoniazid (3HP) is recommended as
undertaken through 6 ART centres
an alternative to 6H. While ~29500 3HP ◄ Workshop organized by Global Coalition for TB Activist titled ‘Advocacy
by NIRT, Chennai. The evidence will
courses have been supplied through Roadmap for TB preventive treatment through community engagement’
be available by the end of 2022.
WHO India to various states and research
organization, the programme division Dr. Rajendra Joshi (DDG-TB) delivered
has initiated the procurement of 3HP. keynote address in inaugural session.
The Brochure developed by GCTA and
partners, “How to protect ourselves from TB?

Support from Bilateral and Multilateral – about preventive TB therapy” was launched
at the workshop. The brochure is available
Partner Organization in eight language including English, Hindi
and Bangla.
◄ Donation of 3HP TPT courses by WHO-Country Office for India

WHO India office donated ~29,500 3HP

courses for programmatic implementation, Air-Borne Infection (Aic) Control Measures at Health
operational research and TPT in IGRA Care Facilities
positives during national TB
prevalence survey. This is the first ‘National Guidelines on Air-borne Infection Control in Healthcare and Other settings’ is being
ever introduction of 3HP in India. implemented at high-risk centres such as DR-TB centres, ART centres and C&DST laboratories.
The implementation policy includes availability of AIC committee and plan; baseline assessment;
resource planning and budgetary provisions; training of health care workers; implementation
of administrative, environmental and personal protection measures. Assessment of nodal and
district DR-TB centres for AIC compliance was conducted in 2021 through the district teams.
Number of N/DDR-TBC compliant with AIC varied in different states. As per the district reports,
432 N/DDR-TBC are AIC compliant out of total 785 N/DDR-TBC.

39 INDIA TB REPORT 2022 INDIA TB REPORT 2022 40

Comorbidities
are important
contributors TB COMORBIDITIES
to the TB AND SPECIAL
burden SITUATIONS

05
 As per the Global TB Report 2021, the TB case attributable risk factors are in order of alcohol,
diabetes, HIV infection, smoking, and under-nourishment at the global level while in India, the TB
attributable risk factors are as highlighted in the table below.

TB Attributable Risk Factors

1 Under-nourishment 609K (418K-836K)
2 Alcohol use disorder 254K (73K-547K)
3 Smoking 156K (28K-394K)
4 Diabetes 104K (29K-226K)
5 HIV 51K (21K-94K)

Therefore, integrating the NTEP with the other national programmes is of utmost importance for
addressing these comorbidities.

TB-Nutrition
Undernutrition and TB form a vicious successful treatment and improved &
cycle, where undernutrition predisposes better health/ nutritional status among
an individual to acquire TB, while TB could TB patients, the programme and the
exacerbate undernutrition. Nutritional Ministry of Women and Child Development
support to TB patients improves weight (MoWCD) have ensured the holistic
gain, adherence to therapy, muscle strength, development of women and children.
quality of life, and reduced mortality. It also In addition, the annual ‘Poshan Mah’ is
leads to a shorter time to sputum conversion observed in the month of September to
and a greater sustained microbiological cure, address malnutrition at population level.

TB Comorbidities
thereby decreasing relapse of TB disease.

Through Nikshay Poshan Yojna, the ◄ Nutrition-TB App (N-TB App)

and Special Government of India is committed to

supporting the nutritional requirement of all
In order to facilitate the implementation

Situations
of the technical aspects of the
TB patients through direct benefit transfer of
nutritional assessment and appropriate
INR 500/month into the bank account of the
supplementation, the Nutrition-TB App
beneficiary (TB patient) for the entire duration
(N-TB app) has been developed by the CTD
of TB treatment. “Guidance document
with the support of partners. The App is a
on nutritional care and support for patients
mobile-based application that simplifies
with TB in India” has been developed
Introduction and disseminated.
assessment, counselling, and support
for undernourished adult patients with
Comorbidities like malnutrition, diabetes, HIV, and important contributors to the TB burden
tuberculosis. It is available for free from
usage of tobacco-smoking and alcohol cause and poor TB treatment outcomes. Therefore,
◄ Collaboration of NTEP and Ministry Google and the iOS app stores. This tool for
weakening of the immune system and increase it is essential to identify these comorbidities
of Women and Child Development healthcare workers helps in:
the chances of an individual to progress from in people diagnosed with TB to improve co-
(MoWCD) ▪ Assessment and classification of
TB infection to TB disease within a shorter time management because TB and its treatment
and can also lead to an increase in severity of can complicate the management of some of nutritional status based on BMI
To support the NTEP’s objective of
TB illness. These conditions are risk factors these conditions and vice versa.

43 INDIA TB REPORT 2022 INDIA TB REPORT 2022 44

 ▪ Actions based on the nutritional status ▪ Provides tailored tips for dietary and being associated with increased rates of to screen TB cases using four-symptom
▪ Indicates desirable weight and counselling for TB patients death, failure, and relapse after completion complex. The TB symptoms identified at the
required weight gain depending on the ▪ Simplified information on all food of treatment. Long-term, poor, or inadequate NCD clinics are referred to the NTEP facilities
current weight groups, their caloric and protein content, glycaemic control appears to play a critical role for TB diagnosis and further management.
▪ Indicates recommended daily calorie focusing on locally available and cost- in the increased risk of TB and poor response Similarly, all TB patients are tested for blood
to treatment. sugar and, if found to be diabetic, are linked
and protein intake effective foods.
to the NCD clinic for management of diabetes.
On the other hand, TB is not a risk factor for the
TB and Alcohol Use Disorder development of DM, but it can cause “stress- As a result of TB-Diabetes collaborative
induced hyperglycemia,” unmasking those framework implementation, nearly 93% of the
An important risk factor for tuberculosis Under the NTEP, information on alcohol use
at risk of DM in the future. TB is associated TB Detection Centres have blood sugar testing
is alcohol consumption. The prevalence of by TB patients is being captured in Nikshay.
with glucose intolerance and hyperglycaemia, facilities. In 2021 of all the notified TB patients,
alcoholism among TB patients is between In 2021, the data of alcohol consumption was
which resolve automatically with TB treatment. 89% were screened for blood sugar, and out
20.3% to 31.5%. Studies have shown that captured for 72% of total notified patients,
In some studies, up to 50% of TB patients who of screened, 8% were found to have diabetes.
alcohol use significantly impairs the immune out of which 7% admitted to alcohol usage.
have high blood glucose levels at the time of Out of this, 62% of patients were referred to
response and increases susceptibility to Services for alcohol users include counselling,
diagnosis have normal levels by the end of TB the NCD clinics and linked to anti-diabetic
respiratory diseases such as tuberculosis linkages to de-addiction centres, and social
treatment. TB also impairs glycaemic control treatment. Among the NCD clinic attendees
and reactivation of tuberculosis infection support systems.
among patients with previously known DM. with diabetes, about 7% have been screened
to disease.
for tuberculosis and referred for TB testing.
To address TB and diabetes, intensified TB
TB and Tobacco case finding is conducted in the NCD clinics

Smokers have two times higher chances of Under the NTEP, in 2021, out of the 74% of the
getting infected with TB, progressing into known tobacco usage among all TB patients, TB and HIV
active disease, having recurrent TB, and death 12% of TB patients were reported to be
from TB compared to a non-smoker. Further, it tobacco users. Among those screened, 30% People living with PLHIV are 29 times (26–31) more likely to develop tuberculosis disease than
increases the risk of latent TB infection, culture were linked to tobacco cessation services. people without PLHIV and living in the same country. TB is a leading cause of hospitalization
conversion, cavitary disease, treatment delay, and death among adults and children living with HIV, accounting for one in five HIV-related
The TB Tobacco cessation service programme
treatment loss to follow up, poor treatment deaths globally.
is being implemented in all States/UTs of
outcomes, and disease transmission. Similarly,
the country. The collaboration between the Estimates of TB HIV Burden in India (Global TB Report 2021)
passive smoking or exposure to second-
two programmes is being strengthened HIV positive TB Incidence 53K (36K-72K) 3.8 (2.6-5.2) %
hand smoke is a risk factor for infection by
through regular review in the TB Comorbidity
mycobacterium tuberculosis and developing HIV positive TB mortality 11K (9.8-12K) 0.78 (0.71-0.84)/lac
Committee meeting at various levels.
TB disease. Smoking cessations is an effective
way to decrease treatment failure and
drug resistance. Following are the updates in the management of TB HIV co-infected patients as per the meetings
conducted by NACO in 2021.
TB and Diabetes Mellitus (DM)
◄ The 13th Technical Resource Group for ◄ The 16th Meeting of Technical Resource
The association between TB and DM has been by 2–3 times. TB may present atypically Antiretroviral Therapy (TRG) of Paediatrics Group updated the Antiretroviral Therapy
known for many years. Available evidence and with more frequent and severe symptoms has given updated recommendations to for Adults & Adolescents.
modelling studies indicate that nearly 20% and signs in those with diabetes. DM also NTEP for management of CLHIV.
of all TB cases in India may suffer from DM. adversely affects TB treatment outcomes by
Diabetes increases the risk of tuberculosis causing delays in microbiological conversion

45 INDIA TB REPORT 2022 INDIA TB REPORT 2022 46

Achievements The following are the key interventions might contribute to TB and other respiratory of TB notification in 2019, 2020, 2021. The dip
being undertaken to strengthen HIV- diseases in the household and the community. in 2020 and 2021 coincides with the 1st and
▼ For early detection of HIV among The graph below shows the month-wise trend 2nd waves of the COVID-19 pandemic.
TB Collaborative activities
presumptive TB patients, Provider
Initiated Testing and Counselling ▼ Intensified TB Case Finding (ICF) at ICTC:
(PITC) is being implemented across 7% of ICTC clients were screened for TB,
the country. out of which 5% were diagnosed with TB
▼ Of all the notified TB patients, ▼ Use of molecular diagnostic (CBNAAT
95% know their HIV status. (Public: 96%, or Truenat) for early diagnosis of TB
Private: 92%) and Rifampicin drug resistance among
▼ Nearly 95% of TB Detection People living with HIV Out of the PLHIV
Centres (TDCs) have co-located HIV tested for TB, 7% were diagnosed
testing facilities. with TB

▼ 2,51,675 PLHIV given access to rapid ▼ TB Preventive Therapy- TPT

molecular testing via CBNAAT for
TB diagnosis. Priority Areas for 2022
▼ Single window TB and HIV services are
▼ Improve linkages of NAAT testing facility
being implemented through existing
for PLHIV presumptive TB patients.
ART centers
▼ Notification of all TB cases diagnosed in ◄ Policy Statement ◄ Implementation Arrangement
▼ TB screening among ART center
ART centres including those diagnosed
attendees using ‘4 symptoms screening As an effort to mitigate the impact of Since the issuance of guidance on
by NAAT, in private, clinically diagnosed
tool’. Based on the evaluation, PLHIV Covid -19 Pandemic on the TB programme, bidirectional screening of TB and
by scan, histopathology, cytology.
is being offered TB treatment or the Joint Monitoring Group of the MoHFW, COVID-19 in 2020, its implementation was
TB preventive therapy by ART ▼ Implementation of 3HP for TPT. in its meeting held on 15th June 2020, started at varied points of time by the
medical officers. ▼ Sensitisation of ART MOs in PMDT recommended the following strategies: different States/UTs.
▼ More than 96% of PLHIV visiting the ART guidelines 2021 for management of drug ▼ Bi-directional screening for TB and The status of screening for COVID-19
centres every month are screened for resistance TB and PMTPT guidelines for COVID–19, i.e., COVID-19 screening for among TB notified patients as of 31st
existing TB symptoms. TB preventive therapy. all diagnosed TB patients and TB December 2021 is as follows: (Source:
▼ As per Nikshay data, the linkage ▼ Implementation of updated ART screening for all suspected and Nikshay)
of HIV-TB co-infected patients to guidelines for the management of confirmed COVID-19 patients.
Cotrimoxazole Preventive Therapy (CPT) PLHIV. ▼ Symptomatic screening for TB and
Indicators 2021
and Antiretroviral Therapy in 2021 were ▼ Introduction of newer diagnostics like inclusion during surveillance for ILI/
93% & 95%, respectively. TB-LAM for TB diagnosis among PLHIV SARI/COVID in the community. Total TB cases notified 2136418
with advanced disease. ▼ Home sample collection services Out of above, Tested for
1272728
COVID-19
of sputum samples in COVID-19

TB and COVID-19 containment zones. Percentage tested for COVID-19 60%

▼ Referral linkages for diagnosis and Out of those tested, TB

4996
Tuberculosis and COVID-19 are infectious The COVID-19 pandemic has brought along COVID-19 comorbid
management for TB at all COVID-19
diseases that primarily attack the lungs stigma and discriminatory behaviour, leading Percentage positive for TB
Care Centres, Dedicated Covid Health 0.4%
presenting with similar symptoms of cough, people to hide the symptoms and refrain from COVID-19
Centres, Dedicated Covid Hospitals.
fever, and difficulty in breathing. seeking health care. Such social behaviour

47 INDIA TB REPORT 2022 INDIA TB REPORT 2022 48

 airborne infection control measures will and COVID-19 complications is an area yet
play a pivotal role in ending TB by 2025. to be ventured into. Hence policy changes
around the following may help create solid
As far as the treatment outcomes in terms of success rates and percentage deaths are During this period, the NAAT machines
scientific evidence:
concerned, the national scenario shows the fatality rate in TB COVID comorbid patients in 2021 procured for COVID-19 diagnosis can be
was more than twice that of TB patients without COVID. utilized for strengthening diagnostics under ▪ Rollout of TB preventive treatment
the National TB programme hereafter. among COVID-19 positive patients
Additionally, hygienic practices like using with TB infection using test and
2021 (Jan-Oct)*
TB Patients a mask, practicing social distancing, not treat policy.
Success (%) Death (%) spitting in public have brought a window of
opportunity for the TB programme, as this ▪ Prioritization of TB patients during
COVID-19 Positive 2490/3045 (82) 284/3045 (9.33)
will prevent the spread of TB. COVID-19 vaccination.
COVID-19 Negative 273088/309802 (88) 10994/309802 (3.55)
Prevention of the development of TB disease
*For the year 2021 (January-October), the cohort considered is of patients notified in 2020 (January
to October) with known Covid status Childhood Tuberculosis
Way Forward Tuberculosis remains a major cause of However, over the last decade, consistently,
morbidity and death from infectious diseases children constitute 6-7% of all the patients
The newer scientific evidence available adult COVID-19 patients”, released by
for children of all ages globally, particularly treated under NTEP annually, pointing to
on TB and COVID-19 suggests that TB is a MoHFW on 14th January 2022, across
in young children. As per the Global TB a gap of 4-5% of total notification against
comorbidity for COVID-19 and impacts its the States/UTs to ensure the successful
Report 2021, about 3.06 lakh children (0-14 the estimated incidence. Inarguably,
progression and severity and vice versa. outcome of COVID-19 treatment and
years of age) are estimated to get TB every the case reporting across the states
Hence as an effort to ensure early detection early identification & management of
year, accounting for about 11 % of total varies and is attributed to differences in
and timely and effective management TB. While doing so, the following has
estimated TB cases reported to the NTEP. In the burden of disease, health-seeking
of TB and COVID-19, the following been recommended:
India, childhood Tuberculosis is a staggering behaviour, and accessibility to services.
recommendations have been approved
▪ COVID-19 patients with active TB to problem, contributing to approximately 31%
and are under process of being shared
be managed as per protocols of the global burden.
with the states in the form of a guidance
document on “TB & COVID-19 screening ◄ Paediatric Drug-Resistant Tuberculosis
▪ If cough persists after 2-3 weeks, to
and follow up.”
be tested for TB
▼ Screening patients with a history of TB The dearth of paediatric DR-TB data Transmission of DR-TB in children is mainly
in the past two years for COVID-19 at a ▪ Follow up COVID-19 patients’ remains a challenge both globally and from the close contact of a confirmed
six-monthly interval as post-treatment post-treatment and periodically nationally. Only 12,200 (11%) of the target
MDR-TB patient (usually an adult or
follow-up for two years. For COVID screen for TB of 1,15000 was achieved globally for the
adolescent) and less commonly through
testing, modalities like home-based pediatric age group.
previously inadequate TB treatment.
kits/ Rapid Antigen test/ RTPCR may While the COVID-19 pandemic has had an
MDR-TB in children reflects MDR-TB in
be utilized. adverse impact on the overall case finding
adults and, therefore, is common in settings
of TB, it also presented us with many
▼ Screening for TB among post COVID-19 where the MDR-TB pool exists in adults.
opportunities. Utilizing this opportunity
patients at six-monthly intervals for
in areas like lab strengthening – platform
two years.
technology, surveillance, strengthening
▼ Implementation of the protocol of currently existing treatment centres,
“Clinical guidance for management of further expansion of the network, and

49 INDIA TB REPORT 2022 INDIA TB REPORT 2022 50

▼ Trend of Paediatric TB Notification: childhood TB, generate demand, and centres are organised at National,
promote disease prevention and early Regional, State, and District levels. The
health-seeking. Active Screening for regional pCoE-TB has initiated coo
160000 100%
TB by Mobile Health Team (MHT) and
90% ▼ Partners Supporting Paediatric TB

151053
140000 verbal screening by the Counsellor
Management:

Proportion of Paediatric TB
80%

Notification Across All Age

at the Adolescent Friendly Health

129896
120000

Notification Among TB
SAATHII implemented Catalyzing
70%
TB Notification

Clinic (AFHC) is one of the pillars

118232
100000 Pediatric TB Innovations (CaP TB)

109678
60% of this inter-sectoral collaboration.

102489
during Oct 2017-Sep 2021, aiming to

Groups
80000 This will help early detection of
50% reduce morbidity and mortality due to
81482

children with TB symptoms and

76475
75083 40%
72307

60000 paediatric TB by enabling rapid scale-

track them for early diagnosis and
63884

30% treatment initiation.

up of paediatric TB services across
40000 the private health sector in 15 districts
20%
20000 ▪ Upcoming Collaborative Framework of Andhra Pradesh, Telangana, and
10%
7% 5% 6% 5% 5% 6% 6% 8% 6% 6% between NTEP and NRC Maharashtra. The project demonstrated
0 0% that integrating systematic screening
(Nutrition Rehabilitation Centres)
12
13
14
15
16
17
18
19
20
21
Collaborative Framework for for paediatric TB at private facilities
20
20
20
20
20
20
20
20
20
20
Management: is feasible. Further, it showed that
Paediatric TB Cases Notified % among Total TB Cases engaging paediatricians is essential
To improve timely detection of
to fill the gap in paediatric TB case
TB through a provider-initiated
finding in the 0-5 age group. At the
pathway, integrating TB screening
▼ Indian Academy of Paediatrics (IAP): Bedaquiline is approved for use in same time, multiple types of providers
algorithms in the clinical protocol
children above five years of age. NTEP must be engaged to identify cases
To build pediatricians’ capacity in the of facility-based management of
has acquired the 20mg dispersible tab among older children. The project has
public and private sectors, Continued children who are sick and have Severe
of Bedaquiline through the Japanese been transitioned to the NTEP and
Medical Education (CME) and training Acute Malnutrition (SAM) is critical
Grant of STOP TB Partnership. recommended allocating a dedicated
workshops are being conducted by IAP. for diagnosing and treating TB. The
To date, more than 4500 doctors have budget for paediatric TB activities in the
▼ Operationalization of Inter-Sectoral suggested collaboration points at an
been trained virtually/physically. private sector, establishing paediatric TB
Coordination: initial assessment at admission at an
sample collection hubs, and assigning
NRC facility and during the facility-
▼ Diagnostics, Regimen, Newer Drugs ▪ Collaborative Framework to paediatric TB targets for any private-
based follow-up have been shared
and Child-friendly Fixed Drug Address the Burden of Tuberculosis sector partnerships.
Combinations (FDCs): with the pertinent ministry.
among Children and Adolescents:

To address the common diagnostic The NTEP is collaborating with ▼ Paediatric Centre of Excellence:
challenges in paediatric TB, including Child Health and Adolescent Health The NTEP has established a network of
DR-TB, NTEP has mandated upfront programmes of the Ministry of Centre of Excellence (pCoE-TB). These
molecular diagnostics for all paediatric Health and Family Welfare (MoHFW),
TB samples. The programme has Rashtriya Bal Swasthya Karyakram
child-friendly formulations of drugs (RBSK), and Rashtriya Kishor
for the management of paediatric Swasthya Karyakram (RKSK). This
drug-sensitive TB and is procuring integrated framework endeavours to
child-friendly formulations for DR TB. enhance community awareness on

51 INDIA TB REPORT 2022 INDIA TB REPORT 2022 52

TB and Gender TB and Pregnancy
Gender differences in exposure, risks, poor access to healthcare services, competing While the burden of TB is higher in men in India, has developed a Collaborative Framework
vulnerability, and health-seeking behaviour for caretaking responsibilities, decision- the impact of TB in women is far-reaching, for Management of TB in Pregnant Women
are among the most significant determinants making power, and different clinical pictures. especially for women in the reproductive age to reduce morbidity and mortality due to TB
of health. Although the incidence of TB is higher Moreover, interacting with other factors that group (15-49 years). Due to common non- in pregnant women and new-borns through
in men in India due to various epidemiological determine a person’s social identity, such as specific symptoms in both TB and pregnancy, prevention, screening for early detection,
factors and an innate biological susceptibility age, caste, socioeconomic status, religion, diagnosing TB disease in pregnant women is and prompt management of TB in pregnant
in men, multiple studies indicate that women ethnicity, and sexual orientation, gender complex. TB in pregnancy has a wide spectrum women and achieve optimum maternal and
report fewer cases of TB when compared to interacts and adds another layer to these of short and long-term implications and could perinatal outcomes. This screening for TB
men. This could be attributed to causes such as health determinants. have sequential effects: repeated reproductive will be made an essential component of ANC
failure, fetal ill-health, preterm delivery, and services.  The National-level sensitisation
Age-Sex Pyramid
TB of the new-borns and infants, leading to workshop for all the state nodal officers of
In 2021, out of the total TB cases notified, 60.7% were men, 39.1% were women, and 0.04% were high maternal and perinatal morbidity and both the programmes has been conducted,
transgender. mortality. For example, there is a six-fold and the training will be cascaded.
increase in perinatal deaths and a two-fold
In 2021, the number of female patients
AGE-SEX PYRAMID FOR TB NOTIFICATION 2021 risk of premature birth and low birth weight in
screened for pregnancy was 47185, out
mothers with active TB disease.
of which 4048 were pregnant (Public - 3237,
Age_>64
The NTEP and the Maternal Health (MH) division Private - 811).
Age 55-64

Age_45-54

Age 35-44

Age_25-34

Age_20-24

Age_15-19

Age_10-14

Age_5-9

Age 0-4

3,00,000 2,50,000 2,00,000 1,50,000 1,00,000, 50,000 0 50,000 1,00,000 1,50,000 2,00,000 2,50,000

Female Male

The NTEP had launched a National Framework for Gender-Responsive approach to TB in India.
The programme has conducted several consultative sessions with the relevant stakeholders
and facilitated an orientation session for the CTD officials and consultants on the framework.
These sessions have yielded a training module that will be cascaded across districts.
Subject-matter experts across the country have been identified, national-level Training of Trainers
of facilitators has been conducted, and regional-level training is planned. This comprehensive
training would enable the stakeholders to translate gender-sensitive approaches across
differentiated TB patient care.

53 INDIA TB REPORT 2022 INDIA TB REPORT 2022 54

Enhancing
skills to create
a healthier SUPERVISION AND
tomorrow MONITORING

06
 TB Division along with the partner organization quantitative and qualitative performance of
decided to conduct the Joint Supportive the programme at district level.
Supervision with the objective assessing the

Joint Supportive Supervision Mission, 2021

The Covid-19 pandemic has affected most Mission (JSSM) was conducted across 34
of the field level supervision exercises over state/UTs within a span of 45 days. In total
the past two years. To identify the technical 17 teams were constituted whose members
as well as administrative challenges faced included Joint Secretary (NTEP), DDG-TB,
by the States/UTs as well as handhold them, Senior officers from Central TB Division,
a nation-wide Joint Supportive Supervision heads as well as consultants from various

Supervision and
Monitoring partner organizations.Two districts (one each with different stakeholders associated with
with high and low TB Index scores) were TB in the given district as well as interacted
selected from each State/UT. A standard with a selected sample of TB patients. The
Supervision is a systematic process for against an expected result. Monitoring is a daily supervision checklist was provided to the team provided extensive feedback and
increasing efficiency of the health personnel follow-up of activities to identify deviations teams and the teams visited various health recommendations to the state officials for
by enhancing their knowledge, skills, including and provide solutions and corrective actions facilities, discussed on persisting challenges necessary corrective actions.
soft skills for efficiently managing their tasks. to bring back to correct course.
Supervision is carried out in direct contact
with the health personnel. It is a two-way
communication between supervisors and Supervision
those being supervised. The NTEP emphasises
Supervision of the programme activities
its roles of supportive supervision and effective
is conducted at all levels by the Central TB
monitoring and evaluation of activities as a
Division (Central Internal Evaluations), State
learning exercise.
TB Office (State Internal Evaluations), Central
Monitoring is a continuous process of collecting Review Mission of the National Health Mission
and analysing information to compare on how as well as third-party supervision such as the
well a project or a programme is performing Joint Monitoring Mission. In 2021, the Central

57 INDIA TB REPORT 2022 INDIA TB REPORT 2022 58

A national debriefing meeting was held on 30th November at the Central TB Division to discuss
Monitoring
the findings of the JSSM and deliberate on the feasible solutions on the challenges identified in
each geography and drive the country towards ending TB by 2025. The salient findings of the JSS The program is continuously monitored at the The Central TB Division also releases quarterly,
Mission were: block, district, state, and national levels by the and bi-annual rankings of the states and
respective program managers, with the aid of districts based on the TB Score. This aids the
◄ States were advised to prepare ◄ Strengthening and capacity building of the the reports generated from Nikshay database states to identify the areas of lacunae, identify
District -specific Strategic Plans in lines with State Training and Demonstration Centres The NTEP is also part of all the important challenges and expedite their resolution on a
State/National Strategic Plan for Ending TB. (STDCs) and creating a network of STDCs to health review meetings held under the real-time basis. Nikshay Dashboard plays an
synergise training and other activities. chairpersonship of Elected representatives, important role in real-time monitoring of the
◄ Customised training materials on latest Principal Secretary (Health), Mission program performance.
updates in TB programme for all the ◄ Advocate for integration of the program Directors and District Magistrates/Collectors.
stakeholders involved in various thematic activities with the routine surveillance
areas of TB elimination. and patient care activities of the general
health system.
TB Score
◄ Emphasis of periodic sensitization as well
For continuous monitoring of the programme for the performance in each indicator. The
as ensuring active participation of PRIs ◄ Ensuring regular review of the program
performance at the national, state as well as individual indicators sum up to a total of 100.
and other elected members in all program under the chairpersonship of District
district level, a composite score calculated
related activities. Magistrates/Collectors.
from a selected list of key performance The TB index helps in objectively measuring
indicators from various thematic areas in the the performance of the state, identify areas
National Tuberculosis Elimination Programme. where guidance/resolution of challenges
National Consultative Workshop on Appropriate weightage has been given to each are necessary as well as promote a healthy
State Strategic Plans of these indicators and each state is scored competition towards ending TB.

A two-day national workshop under the The TB Index currently in usage consists of 9 indicators:

chairpersonship of Hon’ble Minister for S. No Parameter Indicator Score Allotted

Health & Family Welfare to guide the states Achievement of TB notification % of Target TB notification achieved
1 20
to formulate their state strategic plans as among the target identified (Source: Nikshay)
well fine tune the existing strategic plans was HIV testing/ screening of TB % of net TB notified patients with known HIV status
2 10
conducted on the 29th and 30th of October 2021. notified patients (Source: Nikshay)
The participants included Mission Directors UDST coverage among the TB % of net TB notified patients with UDST done
3 10
of NHM from the states, State TB Officers, notified patients (Source: Nikshay)
STDC Directors and WHO Consultants. The Treatment Success Rate of TB Treatment Success Rate for net TB patients
4 15
states were also motivated to conduct similar notified patients (Source: Nikshay)
consultative workshop at the State Level to Nikshay Poshan Yojana % of Eligible beneficiaries paid at least once under
5 10
handhold the districts in preparing the District implementation Nikshay Poshan Yojana (Source: Nikshay)

Strategic Plans for TB Elimination. The State DRTB treatment initiation among % of MDR/ RR patients initiated on treatment out of net
6 15
Strategic Plans have been received from 18 the diagnosed patients diagnosed (Source: PMDT Quarterly Reports )

state/UTs and many of the states have already 7 Utilisation of the allotted budget % of expenditure amongst ROP (Source: PFMS) 10
initiated the process of developing the District %
 of children <5/<6 years given chemoprophylaxis
Strategic Plans. against the total eligible children identified 5
8 Latent TB infection management (Source: Nikshay)

 % of PLHIV given IPT against total eligible PLHIV

5
(Source: NACP)

59 INDIA TB REPORT 2022 INDIA TB REPORT 2022 60

Feedback Mechanism & Engagement RANK STATES WITH STATES WITH
UNION
POPULATION POPULATION
with the field for Action (As per
TB score) <50 LAKHS >50 LAKHS
TERRITORIES

◄ The TB scores for the States as well as the assistance as well as advocacy. DO letters Dadra & Nagar Haveli
1 Sikkim Himachal Pradesh
Daman & Diu
districts are calculated by Central TB Division from Central TB Division at regular intervals
once monthly as well as quarterly. The are sent to the key officials of the state for Andaman & Nicobar
2 Goa Andhra Pradesh
Islands
quarterly scores are updated on the Nikshay the same.
portal as well as utilized for the review with 3 Tripura Odisha Lakshadweep
◄ In many parts of the country, the TB score
the states. The TB Score also promotes
is customized and utilized for the review
a healthy competition among the states 4 Meghalaya Gujarat Puducherry
of the program performance at the TB
and districts.
Unit level. 5 Mizoram Telangana Ladakh
◄ TB score helps the Central TB Division
◄ States as well as districts are encouraged
to identify indicators of concern for a
to perform Internal Evaluation activities
particular state or districts and accordingly TOP 5 ASPIRATIONAL
selecting districts as well as blocks with low RANK TOP 5 DISTRICTS TOP 5 TRIBAL DISTRICTS
DISTRICTS
guidance is provided in terms of technical (As per
TB scores.
TB score) DISTRICT STATE DISTRICT STATE DISTRICT STATE

State TB Score 2021 Himachal Himachal Himachal

1 Kinnaur Chamba Kinnaur
Pradesh Pradesh Pradesh
Andaman
Himachal
2 Chamba Koraput Odisha Nicobars & Nicobar
Pradesh
73 Islands
78
Himachal Himachal
3 Hamirpur-HP Dhenkanal Odisha Chamba
Pradesh Pradesh
92
67 West West
70 4 Alipurduar Gajapati Odisha Alipurduar
Bengal Bengal
75
71 83 69 5 Koraput Odisha Kalahandi Odisha Koraput Odisha
67 72
66 72
65 73
60 Way Forward
80 68 76 72
70 74
State TB Score 2021 ◄ Bi-Annual
 Joint Supportive Supervision ◄ S
trengthening the Nikshay portal and
73
84 Mission shall be planned to supervise the incorporating advances analytical tools to
85
78 states and districts, along with hand- provide regular feedback to the states on
92 holding towards the TB elimination. important indicators which shall help the
77 79
states/districts to do necessary course
◄ F
 ormation of Regional Review Committees
correction as and when required. This
by roping the Zonal Task Force mechanism
67 86 shall also help the Central TB Division is
to conduct monthly reviews at state/zonal
rationalization of resource allocation.
levels is planned.
81
78
78
74
60

61 INDIA TB REPORT 2022 INDIA TB REPORT 2022 62

 PATIENT SUPPORT
SYSTEMS

Creating
holistic patient
support systems

07
 Implementation Arrangements
To enable direct transfer of payments to the eligible beneficiaries, Nikshay has been integrated
with Public Financial Management System (PFMS). DBT payments can be processed to the eligible
beneficiaries via Nikshay.

Schemes Beneficiary Benefit Amount

• Confirmed TB Patients
Nikshay Poshan Yojana • DSTB & DRTB
Rs 500 per month
(NPY) • Public + Private Sector
Patients

Tribal Support Scheme Confirmed TB Patients residing Rs 750 (one time)

in Tribal TU

Patient Support Treatment Supporter

Honorarium
Treatment Supporter
•
•
Rs 1,000 for DS TB patients
Rs 5,000 for DR TB patients

Systems Private Health Facilities:

• Practitioner / Clinic etc. • Rs 500 as Informant or
Incentive for Notification
(Single) Notification Incentive
and Outcomes
• Hospital/ Clinic/ Nursing • Rs. 500 for Outcome
declaration
Introduction •
Home etc. (Multi)
Laboratories Chemists
Direct Benefit Transfer (DBT) to beneficiaries is a novel initiative by the Government of India,
enabling targeted delivery of benefits to citizens directly to the bank account(s), thus enhancing
efficiency, effectiveness, transparency, and accountability for each transaction.

Under the National TB Elimination Programme following schemes are currently ongoing: National Figures
◄ Nikshay Poshan Yojana (NPY) ◄ Honorarium for Treatment Supporters The following table provided the status of DBT Schemes
◄ Transport support for TB patients in notified ◄ Notification & Treatment Outcome
tribal areas Incentive for Private Sector Providers Scheme Beneficiaries Paid in No’s Amount Paid (in lacs)

Nikshay Poshan Yojana 13,26,306 28,544

The Government of India launched the Nikshay Poshan Yojna (NPY) scheme in April 2018, providing
Transport support for TB patients
financial incentives via DBT to all TB patients to support their nutritional requirements for the in notified tribal areas 1,00,581 752
duration of their treatment. Furthermore, under the Tribal Support Scheme, a one-time financial
incentive of Rs 750 is provided to the notified TB patients residing in tribal areas. In addition, Treatment Supporters’
honorarium 32,290 538
Treatment Supporters are provided an honorarium for supporting notified TB patients successfully
complete their treatment. Similarly, private providers are also provided financial Incentives for Private Sector
incentives for both notifying a TB patient as well as reporting their treatment outcome. Providers and Informants 12,060 1,216
The following are some details about these schemes are as under:

65 INDIA TB REPORT 2022 INDIA TB REPORT 2022 66

Novel Initiatives of Payment

◄ e-RUPI Payment Mechanism

It is one of the digital initiatives of the Government of India. Hon’ble Prime Minister launched
the e-RUPI, on 2nd August 2021. It is a person and purpose-specific digital payment solution
with limited touch points between the government and the beneficiary. The e-RUPI concept of
electronic voucher to the beneficiaries for need-based use takes forward this vision of good
Governance. NTEP, is in process of operationalization of e-RUPI voucher for DBT schemes.

◄ Other Initiatives

The year 2021 witnessed unprecedented challenges of the COVID-19 pandemic. This resulted
in the need to deploy diversified strategies to combat issues in private sector notification as
well as payment of incentives. Exceptional measures including providing doorstep services
were implemented post- lock down period to recover the ground. To overcome issues and
to ensure that TB patients are not denied of NPY benefit, flexibility has been given to provide
the benefit through existing bank account of a blood relative. Pilot project for opening bank
accounts through Indian Payments Postal Bank (IPPB) has also been successfully completed.
States have also been advised to facilitate opening of zero balance accounts for TB patients, if
necessary, under the Pradhan Mantri Jan Dhan Yojana (PMJDY).

67 INDIA TB REPORT 2022 INDIA TB REPORT 2022 68

Boosting
private sector
engagements
through active PARTNERSHIPS FOR
partnerships THE PRIVATE SECTOR
ENGAGEMENT

08
 IQVIA Consulting and Information Services India
Private Limited
In India, IQVIA has one of the largest public by the NTSU in collaboration with all
health practices with over two decades of the partners, for the five onboarded
service devoted to the public sector and STSU staff from Hindustan Latex Family
actively engaging with all aspects of the Planning Promotion Trust (HLFPPT),
healthcare ecosystem including TB.
Solidarity and Action Against the HIV
In 2021, IQVIA was part of the following key Infection in India (SAATHII), Society
initiatives and projects: for Promotion of Youth and Masses

◄ National Technical Support Unit (SPYM) and representatives from other

(NTSU) identified development partners. The

objective was to build their capacity
IQVIA was appointed as the National on direct benefit transfer, private
Technical Support Unit (NTSU) to the sector engagements, multi-sector
Central Tuberculosis Division for ensuring engagements, Nikshay, and other key
successful implementation of innovative areas which are linked with identified
interventions by supporting nine high
performance linked indicators and
priority states (viz. Uttar Pradesh,
essential for generating relevant
Maharashtra, Bihar, Rajasthan, Madhya
Partnerships for Pradesh, Karnataka, West Bengal, Assam,
and Tamil Nadu) and building their capacity
insights for next steps.
Orientation of five State Technical Support Units by

the Private Sector in areas such as strategic purchasing,

experts from CTD, WHO, USAID

Engagement
private sector engagements, Direct Benefit
Transfers, and multi-sectoral collaboration.
For this, State Technical Support Units
(STSUs) have been proposed in nine high
priority States under NTEP, through the
technical partner IQVIA.
Despite the nationwide accessibility of free comorbidity, drug resistance, and reduction
In the year 2021, five STSUs (Assam,
diagnostic and treatment care under the in out-of-pocket expenditures for the TB care
Bihar, Rajasthan, Madhya Pradesh,
national TB Elimination Programme (NTEP), in the private sector. More than twenty years
and Karnataka) have been set up. The
more than 50% of patients regardless of ago, in 2001 CTD developed the first guidelines
remaining four STSUs (Maharashtra, Tamil
their financial capability, seek TB care from on partnerships especially on engagement
Nadu, Uttar Pradesh, and West Bengal) are
the private sector and the private provider is of non-governmental organizations (NGO) ▼ Mapping of partners and partnerships
in the process of finalizing manpower and
their first point of contact. However, there are and private providers which subsequently options across India
they will be start focusing on respective
challenges in the private sector in the context underwent revisions in 2008, 2014 and 2019. An extensive district-wise mapping
deliverables from January 2022 onwards.
of notification, early diagnosis and treatment, Since then, NTEP has been engaging with
of over 100 partners working on
adherence, and patient support systems. various stakeholders in private sector to Key activities undertaken under NTSU:
eight partnerships options (as per
ensure that quality services are provided to ▼ Orientation and capacity building of
NTEP recognized this huge opportunity to the Partnerships guidance document
the TB patients. onboarded STSUs
engage with the private sector leading to 2019) across India was completed. In
decrease in the transmission of TB, mortality, An orientation workshop was organized addition, a line listing of more than 350

71 INDIA TB REPORT 2022 INDIA TB REPORT 2022 72

 non-governmental organizations for-profit organizations to orient, IQVIA hosted the Strengthening of STDCs Consultation Workshop on STDC Baseline Assessment under iDEFEAT TB Project with
all the stakeholders involved in the project
working in the TB domain in north, educate and train potential
south, east, and west zones along with organizations for increased private
the contact information was developed. sector engagement.

▼ PPSA Payment Tracker and Partnerships ▪ Onboarding and capacity

Landscape building of additional STSUs on
In most States, the private sector direct benefit transfer, private
engagement is done by implementation sector engagements, multi-sector
of Patient Provider Support Agency engagements, procurement, and
(PPSA) and engaging with private financial processes.
labs/NGOs/ agencies under various ▪ Support states on General
partnership options. To track the status Financial Rules (GFR) and contracting
of the above, two trackers, i) Partnership mechanisms to ensure timely payments
landscape and ii) PPSA Payment Tracker to the implementation agencies.
were developed. Both these trackers will
▪ Streamlining DBT related challenges of STDCs, engagement of private sector validated disease burden methodology
enable CTD and states to understand:
and clearance of back-log. This laboratories for TB diagnostic care and to provide empirical estimates of
▪ Initiation and progress of the various will ensure resolution of queries transforming conventional training TB disease burden and conducted
contracts on partnerships options and reduce the pendency in the approaches by building strategy and market analysis in the private sector.
▪ Status of payment to the DBT processes. institutional systems for e-learning. This methodology was developed by
implementing agencies. ▪ Support the MOUs for multi-sectoral integrating inputs of experts from
▼ TB Disease burden estimation
engagement to ensure participation Imperial College London, Central TB
This information will be linked to the
IQVIA supports estimation of TB patient
of ministries across India towards Division (Government of India), World
dashboard to give updates to program
load in the private sector by leveraging
TB elimination. Health Organization (WHO), and Bill &
managers and policy makers on contract
its proprietary data sets on TB drug
Melinda Gates Foundation (BMGF).
and payment related processes.
sales. IQVIA has develop a unique and
▼ The NTSU provided support to various ◄ iDEFEAT TB Project:
States for streamlining and expediting
IQVIA is one of the seven consortium
their procurement services Foundation for Innovative New Diagnostics (FIND)
partners of iDEFEAT TB Project -
▼ Going Forward
USAID India’s flagship TB project for FIND in partnership with the National TB Elimination Program (NTEP) continues to complement
Following actions will be undertaken drug Resistant TB and institutional Government of India’s efforts towards TB elimination. In 2021, FIND undertook the
with high priority: strengthening for TB and DR-TB care following activities:
led by The Union. In this project, IQVIA
▪ Designing dynamic contract
is providing support to the National Sustained Service Delivery;
management dashboard for states
Tuberculosis Elimination Program Enhanced capacity for DR –TB diagnosis
to provide real-time updates on
(NTEP) through technical assistance,
contract and payment to CTD, states Under Global Fund, FIND is establishing 13 laboratories. FIND supported 70 TB LC
capacity building, e-learning, bridging
and STSUs. 20 LC&DST laboratories across India. Seven TB DST labs, by providing required consumables
gaps with human resources, and
▪ National level workshops LC&DST laboratories were upgraded, validated and reagents and maintenance services for
other critical needs. Major activities
and handed over to the NTEP. Upgradation 18 different types of nearly 4,100 essential
with potential non-profit and supported by IQVIA are strengthening work is underway for the remaining lab equipment.

73 INDIA TB REPORT 2022 INDIA TB REPORT 2022 74

Scaling up CBNAAT EQA to all public maintenance, sample storage and bio medical include recommendations to optimize use India. The project, which was launched as
and private sites in India waste management, including a call centre of existing instruments, placement of new JEET 2.0, is following a two-pronged approach.
service to resolve issues. As of November diagnostic devices and design of integrated While, in a proportion of districts, ‘test and
NTI Bangalore and FIND are supporting 2021, 53 C&DST labs were actively using sample referral systems. treat’ modality will be piloted, most districts
NTEP in scaling up CBNAAT External Quality LIMS. A logistic module was developed and will follow a ‘treat only’ model. Contacts of
Assessment (EQA). FIND supported NTI to successfully tested. Through virtual trainings, all pulmonary TB patients from public and
JEET (Joint Effort for Elimination
develop in-country capacity to manufacture 241 microbiologists and laboratory staff from private patients are being targeted. The key
of TB)
large volumes of proficiency testing (PT) 64 C&DST laboratories were successfully activities include contact tracing, screening for
panels to enable CBNAAT EQA. trained. Further and based on feedback active TB, counselling, TPT initiation and follow
FIND is one of the three partners, implementing
NABL accreditation using customized NABL TB received on LIMS Version 1.8, a customised project JEET across six states - Andhra Pradesh, up. In September 2021, over 7000 household
SLMTA approach. version - LIMS 2.0 - was created and Telangana, Karnataka, Punjab & Chandigarh, contacts were screened and more than 2000
successfully tested at two NRLs, (NITRD, Delhi West Bengal & Himachal Pradesh - in 21 initiated on treatment.
FIND is strengthening Quality Management
and NIRT, Chennai). Subsequently, LIMS 2.0 PPSA & 80 PPSA lite districts. The project has
System (QMS) at six TB laboratories
was integrated into NIKSHAY and will now be catalyzed private sector engagement by
using a customized NABL-TB SLMTA Women Empowerment to End TB
deployed across all C&DST laboratories in India. deploying a Hub & Spoke model to engage
mentoring approach for NABL (ISO 15189) (WE END TB)
private health care providers, conduct CME
accreditation. Despite the challenges posed
Technical assistance to upgrade trainings, support sample transport & linkages “WE END TB” is a collaborative project being
by COVID-19, all six sites (NTI Bangalore,
C-DST Labs with DST facilities, and conduct active patient implemented by FIND India and Myrada
C&DST TB lab Raichur, IRL Bangalore, IRL
follow-ups, ensuring continuum of TB care. (NGO in Karnataka). It engages women-led,
Visakhapatnam, IRL Ahmedabad and KIMS FIND is providing technical assistance in
More than 37,000 patient notifications have Self-help Affinity Groups (SAGs) to increase
Hubli), achieved NABL accreditation in 2021. upgrading TB C&DST laboratories including
been facilitated in FIND project geographies access to TB services, treatment, linkages
procuring equipment in Maharashtra
(Jan – Sep 2021), and successful outcomes to micro-finance/skilling programs, and
Truenat EQA Pilot (GMC Miraj-Sangli, GTB Sewri- Mumbai
were reported for 84% of patients diagnosed. socio-economic schemes in rural Karnataka
and Kasturba Hospital-Mumbai), Tamil
NTEP has incorporated Truenat into its (Kalaburagi, Yadgir and Bellary).
Nadu (GHTM Tambaram-Chennai and
diagnostic algorithm to detect TB and JEET 2.0: Addressing latent TB Nearly, 25,415 presumptive TB cases have
KAPV GMC-Trichy), Himachal Pradesh
sequentially detect rifampicin resistance, in infection burden in India been identified and tested (22,872), resulting
(IGMC-Shimla and IRL-Dharampur)
DMCs at peripheral level. EQA, NTI, Bangalore in diagnosis of 1,645 TB patients, all of whom
and Madhya Pradesh (GRMC Gwalior).
and FIND under the overall guidance of NTEP FIND in partnership with William were linked with treatment. Till date, 1,275
conducted a pilot at 50 Truenat sites in 10 J Clinton Foundation and The Union is people have been linked to Nikshay Poshan
Networks for Optimized Diagnosis
states, using DTS panels. In 2021-22, FIND demonstrating and scaling-up models to Yojana (NPY), 492 with Pradhan Mantri Jeevan
to End TB (NODE-TB)
and NTEP plan to continue Truenat EQA for improve access to TPT to all contacts (children Jyoti Bima Yojana (PMJJBY) and three people
approximately 750 sites. FIND is facilitating NODE-TB in India, and adults) of TB cases across 21 states in with Income Generation Programs (IGP).
In addition, FIND will also support in the establishing a dataset to guide NTEP in network
scaling up of Truenat in India along with NTEP. planning, optimization – including optimal Global Coalition Against Tuberculosis (GCAT)
placement of existing and new diagnostic
technologies - and designing efficient sample The GCAT is a multi-partisan political forum discuss the challenges to TB elimination in the
Laboratory Information that has worked to raise the political discourse country and support the ministry in gathering
referral mechanisms. In 2021, FIND began
Management System (LIMS) on TB since 2012. Under the leadership of Dr independent expert guidance and galvanizing
implementing the project across ten states
including- Assam, Bihar, Karnataka, Uttar Dalbir Singh, the forum has brought together political support at all levels of governance, to
LIMS is designed to provide TB results, track
Pradesh (UP), Maharashtra, Madhya Pradesh, over 35 Members of Parliament (MPs) and 20 support the Government of India’s efforts of
samples, and test workflows inside the lab.
Odisha, Chhattisgarh, Andhra Pradesh and renowned public health experts to regularly eliminating TB.
Besides providing data analytics, it also
monitors HR availability, training, equipment Uttarakhand. The key outputs from the project

75 INDIA TB REPORT 2022 INDIA TB REPORT 2022 76

GCAT Expert Group Meetings Advisory Board Meetings Organizing a panel discussion at the 52nd Union Conference
GCAT along with Karnataka Health Promotion USAID, India; Professor Rajeev Gowda,
Given the precarious situation of public health GCAT organized a series of meetings with its
Trust (KHPT) led a session on “addressing Ex-Parliamentarian and Former Chair,
due to the COVID-19 pandemic, the Global Advisory Board members which consists of
gender and stigma barriers to TB Care” Centre for Public Policy, Indian Institute
Coalition Against TB organized a series of current and former Members of Parliament
to discuss the role of gender and stigma of Management, Bangalore; Dr Kirit
meetings with its Expert Group which consists in February and August to apprise them of
in affecting access to TB services and care. Premjibhai Solanki, Member of Lok Sabha;
of eminent public health experts to discuss the existing TB scenario, challenges faced
The co-chairs for the session were Dr Dalbir and Mr Bhubhneswar Kalita, Member of
the progress made by the TB program and by the NTEP in the second wave of COVID-19
Singh, President, Global Coalition Against TB, Rajya Sabha. The panel discussed the social
provide suggestions to improve access to TB pandemic, and the recommendations
and Dr Sudarshan Mandal, Deputy Director- consequences of the disease on women,
care. The Expert Group’s recommendations presented by the GCAT Expert Group in that
General, Central TB Division, India. The the need for building community structures,
were especially instrumental in providing regard. Several GCAT Advisory Board members
speakers included Mr H.L. Mohan, CEO, KHPT; political commitment at all levels and a
independent and expert guidance on the also provided supportive supervision to the TB
Ms Sangita Patel, Director- Health Office, patient-centric approach in policies.
necessary mitigation strategies, in the wake of program at the district levels, raised persisting
the second wave of the COVID-19 pandemic in challenges with State and district program and
India. The Expert Group also convened later in
the year to discuss the uptake of the strategies
ministry officials, and offered their support to
raise awareness about available services.
Karnataka Health Promotion Trust
put forth by the National Tuberculosis KHPT’s Community Engagement Approaches
Elimination Programme.
The involvement and ownership of KHPT’s engagement with community
communities and in particular vulnerable structures leverages the strengths of
Members of the GCAT Expert Group discuss update of Members of the GCAT Advisory Board discuss the
mitigation strategies during the second wave of COVID-19 recommendations put forward by the GCAT Expert Group communities is crucial to sustain a TB decentralized community networks such as
pandemic and provided suggestions to improve access to virtual meeting in August 2021 elimination response, according to the Self-Help Groups, Labour Unions and Youth
TB care National Strategic Plan (NSP). KHPT’s patient- Associations to increase awareness about TB,
centric community engagement approaches facilitate access to health services and create
are implemented in Assam, Bihar, Karnataka a supportive stigma-free environment for TB
and Telangana, under the USAID-funded patients. The engagement process includes
Breaking the Barriers (BTB) project. The mapping, training and periodical handholding
community structure engagement and patient of community structures. In all four BTB
support group (PSG) models developed by states, KHPT identified and engaged with 3980
KHPT involve a systematic process to create community structures and 7524 key leaders.
an enabling environment and improve TB This year, the engaged community structures
Presenting the findings to the Union President of GCAT, Dr Dalbir Singh and Member of notification and treatment outcomes. in four states have screened 5,61,925 persons
Parliament, Mr Bhubaneshwar Kalita met the Union Minister
Minister of Health and Family Welfare for TB, referred 13,497 presumptive, of whom
of Health and Family Welfare, Mr Mansukh Mandaviya
to share the recommendations put forward by the GCAT
11,716 have been tested and 1,142 have been
The President of GCAT, Dr Dalbir Singh Expert Group Community structure members support ACF activities at tea diagnosed with TB. Community structures
along with the Member of Parliament, Mr estate, Dibrugarh, Assam have supported state-level NTEP Jan Andolan
Bhubaneshwar Kalita, met and briefed the activities, Active Case Finding campaigns, and
Union Minister of Health and Family Welfare on taken initiative during the COVID19 pandemic
the recommendations for the TB programme to distribute food packets to needy TB patients.
as put forward by the GCAT Expert Group and
The PSGs, also known as care and support
deliberated over by the GCAT Advisory Board,
groups, are informal platform for patients
in November.
and caregivers to share their experiences and
interact with their healthcare providers in a safe
and non-judgemental space. The monthly PSG

77 INDIA TB REPORT 2022 INDIA TB REPORT 2022 78

meetings also facilitate linkages for patients to Groups have been established in four states, Policymakers’ Roundtable organized 45 hubs and worked with 2,121 spokes to
welfare schemes and other support mobilized and 7,679 TB patients have been benefited. at Union Conference 2021 generate 7,128 TB patient notifications in 2021
by community structures. 170 Patient Support through periodic in-person visits, CMEs and
To highlight the importance of addressing webinars. As a unique effort, during COVID19
A Patient Support Group meeting in Bengaluru gender and stigma barriers to TB care, lockdown, 5 patient webinars were conducted,
KHPT and USAID hosted a policy maker’s benefiting 196 private sector patients.
roundtable with the Global Coalition Against Over the project period, the increasing
TB (GCAT) and CTD, at the Union World Lung trend of private facilities notifying TB, is a
Health Conference on October 21. The co- milestone achievement.
chairs for the session were Dr. Sudarshan
KHPT-JEET executed a planned transition of
Mandal, Deputy Director General, NTEP, and
PPSA activities in the last two months of the
Dr. Dalbir Singh, President, GCAT. The speakers
project in collaboration with the State and
included Ms. Sangita Patel, Director - Health
District TB Offices. A transition workshop was
Office, USAID India, Mr. Mohan HL, CEO,
organised for all TU staff of the 3 districts
KHPT, Dr. Rajeev Gowda, Ex-Parliamentarian
on December 14-15. In the workshop, the
(Karnataka), Dr. Kirit P Solanki, MP
JEET team shared experiences and strategies
from Gujarat and Mr. Bhubaneswar Kalita,
for continuing private sector engagement
MP from Assam.
through different approaches for health
facilities, laboratories and pharmacies. A
Joint Effort for Elimination of Standard Operating Procedures document
Tuberculosis (JEET)- PPSA Project was developed and distributed. All the NTEP
participants were felicitated with certificate of
Since 2018, KHPT has been implementing appreciation and TB warrior badge.
GFATM – FIND funded JEET-PPSA project in 3
districts of Bengaluru. JEET had established
Endorsement of models and the way
forward
Mr Mohan HL, CEO, KHPT presenting a certificate of appreciation to Dr Nagesh, DTO, Bengaluru Rural at the transition
The KHPT’s community structures engagement and implementing partners were oriented on workshop

and PSG models were comprehensively community structures engagement and PSGs.
documented and endorsed in May 2021 Going forward, KHPT, in collaboration with the
by the Central TB Division (CTD). The CTD State and district NTEP, will support state-level
released and disseminated a guidance ToTs to operationalize the guidance document
document on community engagement in in all districts.
November to national partners and states
Dr N J Das, State TB Officer, Assam at the BTB
for implementation. KHPT facilitated sessions
state-level workshop
on community structure engagement and
PSGs at zonal level Training of Trainer (ToTs)
programmes conducted from September
onwards, in collaboration with CTD and REACH.
In December, KHPT, in collaboration with STC
Assam, organized a state-level workshop
on TB Elimination and Behaviour Change in
Assam. All the state DTOs, PPM coordinators

79 INDIA TB REPORT 2022 INDIA TB REPORT 2022 80

 follow-up form and adherence, and this initiative across allotted high priority
World Health Partners (WHP) DAT-related workflows. The Project districts under the guidance of National
conducts a comprehensive assessment TB Elimination Programme (NTEP). WHP
WHP, a non-profit Indian organization has ▼ Improving treatment outcomes
been providing operational, technical and with effective mental health and of TB patients’ quality of life (physical, is implementing PPSA project with the
analytical support to address the TB burden wellness interventions mental, social, and financial status) extensive government support in 11
through various projects in select districts of experiences and plans to develop districts of three states – Bihar, Punjab
6,453 patients were followed up for
Gujarat, Jharkhand, Bihar, Punjab and Odisha. a model to improve the patient and Odisha.
mental health assessment. Out of these
care experience by establishing the
11.4% patients were screened with mild Despite COVID-19 pandemic, travel
feedback mechanism.
Closing the Gaps in TB Care Cascade mental health disorders, 1.3% with restrictions and lockdown during the
(CGC) moderate and 0.65% were screened ▼ Centralised Control Center (CCC) year, all three PPSAs have achieved
with severe mental health disorders One of the key features of the WHP’s considerable notifications and engaged
CGC is a four-year (2020-2024) project funded
by the United States Agency for International who were referred for institutional people-centric care is to make key many new private sector doctors.
Development (USAID) care. Among these patients, 7% were health information and assistance As part of its interventions, “Closing
diagnosed with depression, and 7.3% available to all. An easy to remember the Gap in TB Care Cascade (CGC)”
In 2021, the CGC project focused on
were diagnosed with anxiety. The number enables general population and led by World Health Partners (WHP)
▼ Increasing case finding by engaging
project counselled mild MH disorder other individuals or family members and supported by USAID, provides
with private health care providers
patient with four counselling sessions. suffering from TB/COVID/Mental health counselling support to under treatment
(iSMART X-ray)
▼ Implementation of post-treatment to call for tele-consultation, counselling TB patients including mental health
The project engaged 1,098 (70% of total and referral services. This model is support and referral services.
follow-up
mapped) providers from 1,615 mapped particularly useful for populations that
44,139 TB patients were followed up To address the challenge, the CGC
in the intervention geographies. Out require aggressive follow-up over long
during Oct 2020 to Oct 2021 and the rate project administers a Patient Health
of 189 X-ray facilities engaged with 56 periods as in tuberculosis, mental health,
of recurrence found was 4% and fatality Questionnaire – 4 (PHQ-4) questionnaire
(30%) to provide free CXR. antenatal care etc. During the Year 2021,
rate 5%. to assess the mental health status of
▼ Improving adherence management with the CCC has provided its services to
TB patients. As part the strategy, CGC
Digital Adherence Technology (DAT) ▼ Contributions to the improvement of over 100,000 callers for tele-counselling
NTEP processes Care Coordinator meets the patient
and tele-consultations.
The team followed up with 9,610 TB and completes the process in four
patients, of which 7,263 (75.7%) used With successful demonstration and
different phases through home visits
99 DOTS, 394 (4%) were enrolled on learning the project transferred the
and provides them counselling on a
Medication Event Reminder Monitoring knowledge process to the State NTEP Cell
weekly. During the first phase, enable
(MERM) device and 1,953 (20.3%) to scale-up MERM devices in Jharkhand,
the patient to identify triggers and
patients used 99 DOTS Lite. trained NTEP staffs on post-treatment
coping skills. During the second phase,
treatment follow-up in 7 additional
pathways (social skills) are discussed.
states. Conceptualized and developed
Phase 3 of the counselling includes
the Nikshay Setu App that offers
behaviour-focused strategies (adapting
one-stop solutions to the public and
skills) and finally, during the fourth
private health staff to learn, manage
phase, Constructive thought pattern
and assess anti-TB processes. The
strategies [Relapse prevention Skills].
project supported CTD in developing the ▼ Patient Provider Support Agency (PPSA)
Adverse Event Module, TB Preventive
99 DOTS Lite 99 DOTS Lite MERM Patient Provider Support Agency (PPSA)
Therapy Module, post-treatment
project is being implemented to support

81 INDIA TB REPORT 2022 INDIA TB REPORT 2022 82

 Steering committee for decision making on AI
Achievement
A steering committee has been formed under A solution to predict lost to follow up (LTFU)
Bihar
the chairmanship of CTD, consisting of DG- using machine learning methods is another
Deliverable (8 dist.) Odisha
Punjab (2 dist.) NIC, USAID, WIAI and WHO with an objective solution which was prioritized and developed.
Bhojpur, Gaya, (1 dist.)
Nalanda, Patna, Amritsar and Patiala of assessment of proposals and to support Purpose of this solution is to stratify TB
Sambalpur
Bhagalpur, Katihar, decision making along with panel of experts. patients at risk of LFU and that would help
Munger and Saharsa
front line staff to make proactive decisions
Private Providers 1,290 1,083 46 for differentiated care for TB patients who
Engaged A solution to read, interpret and transmit at highest risk of LFU. Passive evaluation
results of Line Probe Assay (LPA) of ML solution algorithms completed on
TB Notifications 31,431 3,561 176
using AI/ML methods was prioritized data sets of 400k patients initiated on
HIV Test done 29,308 3,469 175 and Minimum Viable Product (MVP) has been treatment in 2019. The passive validation
developed. The AI solution aids in early diagnosis showed promising results. Further the model
Diabetic Test done 29,100 3,440 148 and appropriate treatment of DR-TB patients, was validated using the data sets of 600k
by reducing time and improving accuracy of patients initiated on treatment in 2020, which
UDST done 14,647 564 53 LPA test results. Field testing of the minimum showed the consistency in performance. The
Bank Details added (DBT) 27,139 2,879 169
viable product has been completed across 6 results has been shared with CTD and
laboratories. Passive evaluation of the MVP intervention states.
shows promising results and are shared with
So far, the CGC project has assessed over 4,500 TB patients across four districts of Gujarat and
CTD. Simultaneously, the Ground Truth Study by
Jharkhand as of September 2021 and 10% of these patients were found to be with mental health
the expert panel nominated by CTD is underway
issues. Seeing the relevance of mental health issues among TB patients, the project plans to
and the solution is ready for early deployment.
support NTEP to integrate the mental health domain in TB Care Cascade.

Wadhwani Institute for Artificial Intelligence The early deployment of the solution is
planned in 52 districts four intervention states
(Wadhwani AI) Maharashtra, Uttar Pradesh, West Bengal and
TRACE-TB Project: Transformative Research and Artificial Intelligence (AI) Capacity Karnataka by Mar’22.
for Elimination of TB and Responding to Infectious Diseases

TRACE-TB project supported by USAID AI-TSU at CTD The project is developing AI solution for
and implemented by Wadhwani AI, aims triaging of patients using cough, voice
to introduce AI solutions for TB, thereby A technical support unit (TSU) has been sounds. The solution will address the problem
contributing to strengthening the delivery established at CTD, with an objective to area of lack of objective, easy to use, highly
of TB cascade of care and facilitate build of create an institutional mechanism to sensitive, point of care triaging tool for TB
a enabling system for sustainable use of AI facilitate the process of proactively seeking and support the front-line staff in objectively
under the National TB Elimination Programme proposals for AI solutions and take it to the triage patients for further diagnosis. The
(NTEP), to accelerate the efforts to eliminate level of deployment. The AI-TSU consisting protocol for data collection and development
TB in India. The project achieved following of data scientists, system analysts, solution of proof of concept has been approved by
key accomplishments in 2021, in collaboration architects and program experts, is closely CTD and the data collection is expected to be
with Central TB Division (CTD). working with CTD to prioritize problem initiated across the country by Jan’2022.
areas that can be addressed through
AI-ML solutions and facilitate the
development of AI solutions to strengthen
the delivery of TB cascade of care.

83 INDIA TB REPORT 2022 INDIA TB REPORT 2022 84

In collaboration with WHO and ICMR, the project is developing an AI solution for improving the By June 2021, 758 patients (of the 1000 TAG members provide technical assistance
accuracy in interpretation of C-TB skin test for Early diagnosis of LTBI thus reducing the risk of enrolled) including 40% females and 10% to the project, with the vision to enable the
conversion of active TB patients. The data collection has been initiated across 6 sites in partnership children, were both cured and reported weight national TB program and to demonstrate
with WHO and ICMR. gain of 6 kgs or more. The outcomes were the value of evidence-based interventions in
verified by the NTEP staff in comparison to the eliminating the infectious disease. In addition,
NIKSHAY portal. they are also guiding impact and economic
The project in consultation with CTD, USAID, WHO and NIC has developed blueprint of AI evaluation of the project currently being
USAID, as the outcome funder paid around
solutions that can be potentially used under NTEP. The blueprint will be useful to call out the undertaken by the PGIMER, Chandigarh.
Rs.95 lakhs ($128,000) to ChildFund to achieve
need of AI solutions under NTEP. Innovators can pick up the potential problem and solve it with
the complete outcomes for 758 patients. Based
AI solution with intent of use under NTEP.
on the learnings from Phase 1, the program is Government Engagements
being expanded to Jhabua, in addition to Dhar,
USAID – Mukti Pay For Performance as Phase 2 (July 2021 to June 2022) The project is being implemented in close
collaboration with the state and district TB
Mukti is the World’s First Pay-for-Performance and demonstrates body weight gain as per
society. The NTEP staff supports program
program designed to improve the nutritional clinically accepted standards (‘treatment Technical Advisory
implementation and verification of the program
status and treatment outcomes of TB patients. success’ under the program). Child Fund,
Mukti Program is guided by a Technical outcomes. State and district leadership is also
USAID drives this initiative as the outcome as the risk investors and implementer,
Advisory Group (TAG) composed of senior actively helping in incorporating the program
funder through its PAHAL project implemented invests resources and efforts to achieve the
leaders and experts from World Health in the state’s Program Implementation Plan
by IPE Global. This is done in technical mentioned outcomes, using a combination of
Organization (WHO), Population Council, New (PIP) under NHM, to ensure resources for
collaboration with the Central TB Division and four strategies.
Delhi, Yenepoya Medical College, Mangalore, scaling-up across the state.
Government of Madhya Pradesh. Child Fund
India is the risk investor and implementation National Institute of Nutrition, Hyderabad. The
◄ Counsel TB Patients on the
partner of this initiative.
importance of treatment compliance and Program for Appropriate Technologies in Health
nutrition intake
Objective and Geographic Focus
◄ Ensure supplementary nutrition of TB
(PATH)
To use pay-for-performance mechanism to patients by providing locally procured
drive improvements in nutritional status and protein-rich food baskets monthly Complementary Grant ▼ Uttar Pradesh

◄ Conduct positive deviance sessions – a PATH has provided technical assistance

treatment outcomes of 10,000 TB patients Under the BMGF funded Complementary
community-based model to promote and support to the State TB Cell,
across 16 districts in the state of Madhya Grant, PATH has been spearheading the work
peer to peer learning to strengthen the private sector
Pradesh, starting with 1000 patients in in building partnerships under NTEP and
Dhar district. ◄ Connect enrolled TB patients to engagement efforts of NTEP. Technical
transitioning donor supported partnerships
nutrition support schemes offered by assistance includes- deploying
to government funded as per the partnership
the government including Direct Benefit dedicated HR at regional level,
Approach and Framework guidance document. In 2021, PATH engaged
Transfer improving the NPY-DBT deployment,
closely with CTD to support setting up of NTSU,
Mukti is a pay-for-performance mechanism to orientation of NTSU and STSUs and closely monitoring and supportive supervision;
drive TB-nutrition outcomes. It was designed working with various partners to achieve the liaising & coordination support, capacity
in consultation with the MP State Government Learnings from Mukti Phase 1 (March program goals. PATH extended technical and building of NTEP staff on partnerships;
to address the issue of undernutrition which is 2020-June 2021) administrative support for development of and organizing and facilitating
attributable to 55% of the annual TB incidence. multiple guidelines like Technical Guidance CMEs etc. PATH is implementing “99
Phase 1 of the Mukti project 1,000 TB patients
USAID as the outcome funder through the for Comprehensive Package for Differentiated DOTS lite” pilot project in selected
enrolled from all 31 Designated Microscopic
PAHAL project, pays Rs.12,500 per patient, Care of TB patients, AYUSH and NTEP districts to improve the treatment
Centers (DMC) of the district.
only if a TB patient completes treatment Collaboration and TB PPM learning India adherence among DSTB and DRTB
chapter on PPM related topics etc. patients in both public & private.

85 INDIA TB REPORT 2022 INDIA TB REPORT 2022 86

 PATH is supporting popularization and AYUSH Providers and linkages to Tuberculosis Implementation private sector by deploying Truenaat machines
of TB Arogya Saathi App to improve nearest public health testing facility. Framework Agreement (TIFA) at 5 sub-district laboratories and thereby
presumptive TB cases from informal reducing TAT for diagnosis and improving
PATH under USAID funded, JSI managed testing. At the end of the project in March 2021,
TIFA mechanism, carried out a needs these truenaat machines were successfully
Launch of 99 DOTS lite pilot project- Shahjahanpur, by DTO in the presence of DyDTO, consultants of RTPMU Lucknow and assessment exercise to establish State TSUs handed over to the state.
PATH PO. Dated: 7th December 2021
for strengthening the NTEP in 5 States. The
exercise was completed in a short span of 2
months and the report handed over to CTD
Joint Efforts for TB Elimination (JEET)
and USAID for establishing the TSUs.
The Global Fund (TGF) funded project JEET
remained operational in existing PPSA
Next Generation Sequencing (NGS) geography till December 2021 while support
of PPSA lite was ended in March 2021.
With funding from Rockefeller foundation, During this period, JEET project managed to
PATH is partnering with NIRT- Chennai to carry achieve – 67% notification against the target
out gene sequencing using Oxford Nanopore set up by TGF (JEET 1.0, 2018 to Mar 21).
for genotyping of tuberculosis. The objective Due to pandemic, a drop in notification was
is to utilize Next Generation Sequencing using observed but gradually the team achieved
Minion for drug resistance prediction of 1st 92% of notification against TGF target set
line, 2nd line and newer drugs. This support will for April 2021 to September 2021. Across the
enable the first Indian report on genotyping country, approx. 14,000 private providers were
of M. tuberculosis drug resistance using direct reached. Public health actions in private sector
sputum samples for targeted NGS. were scaled up with UDST uptake from close
▼ Maharashtra ▼ MCGM
to 4% in 2018 to more than 30% by Mar 21. HIV
PATH provided technical know-how
PATH provided technical assistance testing increased from 20% in 2018 to 94% by
to the State TB Cell, Maharashtra, TRACE-TB
to Mumbai District TB control society the end of the year.
and various districts to devise a
(MDTCS) in its efforts to engage with PATH has partnered with Wadhwani AI under Significant support to the district team was
procurement plan, procedural
the private sector. Innovative effort USAID’s TRACE-TB grant for the evaluation provided by sharing necessary analysis & data
documents for procurement and of public health impact & scalability of AI
by establishing an expert panel of files on sample transport structure, status of
contracting services as per partnership solutions and its integration with Nikshay
private clinicians and practitioners was FDC/HIV, compounder incentive structure and
guidance document 2019. With the T.A 2.0. PATH will support Wadhwani in piloting &
introduced to support the selection conducting CMEs with Private Providers (PPs)
and handholding support from PATH on testing various AI tools to plug the gaps in the
committee of MCGM in outsourcing for awareness generation in PPSA districts.
procurement and contracting, State has TB care cascade while improving quality.
diagnosis services at ceiling price for
onboarded PPSA agency in 11 districts
EPTB. This technical support by PATH was JEET 2.0 – Programmatic Management
and 395 LTs have been outsourced for
able to help streamline and standardize Creating An Ecosystem for Faster of TB preventive Treatment
the TrueNat and CBNAAT labs across
the selection process of private Diagnosis and Early Treatment
Maharashtra. M&E support to state CHRI will be implementing this project funded
providers and curtail administrative Initiation
included creating a monitoring tool kit by The Global Fund as Sub Recipient of CHAI
red tape which normally dissuades
for PPSA payment tracking, validation Funded by India Health Fund, the project and will be working in total of 4 states & 1 UT,
private providers from engaging with
checklist and monthly monitoring supported early diagnosis of TB and RIF covering a total of 33 districts.
the government. PATH has successfully
report for the newly onboarded PPSAs. resistance for patients seeking care from
transitioned its support to MDTCS
on private sector engagement to the
technical support units.

87 INDIA TB REPORT 2022 INDIA TB REPORT 2022 88

Piramal Swasthya Management Research Institute Achievements closely with the Central TB Division and the
Ministry of Tribal Affairs. A joint review of
◄ Joint launch of the Tribal TB Initiative by the NTSU was conducted by the Central TB
Tribal TB Initiative the Ministry of Health and Family Welfare Division and the Ministry of Tribal Affairs in
Ministry of Health and Family Welfare (MoHFW) and Ministry of Tribal Affairs (MoTA) have signed Services and the Ministry of Tribal Affairs on October 2021.
a Joint Action Plan for Elimination of TB, following which the Tribal TB Initiative was launched in 26th March 2021, reiterating commitment
March 2021 to achieve India’s vision for ‘Ending TB with priority focus on TB hotspots of tribal for addressing Tribal TB at the highest level.
Joint Campaign called “Aashwasan”
areas’. The Tribal TB Initiative brings together multiple stakeholders with diverse capabilities ◄ On 7th April, 2021, Union Minister of
targeting COVID 19 awareness and
required to tackle multi-dimensional issues prevalent in Tribal areas. Piramal Swasthya with Health and Family Welfare along with the
support of USAID India is the implementing partner for the initiative and working with 161 high Tuberculosis Active Case Finding
Union Minister of Tribal Affairs launched
priority tribal districts across 18 states in India. ‘Anamaya’, the Tribal Health Collaborative A joint campaign called “Aashwasan”
With the goal to reduce morbidity and mortality from TB among the tribal populations in India, through video conference. Anamaya is a targeting COVID 19 awareness and
project aims to: unique multi-stakeholder initiative wherein Tuberculosis Active Case Finding has been
non-governmental organisations working initiated in January 2022. The Campaign will
◄ Foster Community Engagement: Building that increase notification, diagnosis, in the tribal health space have allied reach over 600 hard to reach tribal blocks in
partnerships with various community- early initiation of treatment and ensure themselves with the mission of ending 100 Tribal Districts over 100 days. Aashwasan
based organisations and representative treatment adherence and completion. all preventable deaths among the tribal will work closely with all partners in the tribal
groups to design, curate, and plan the communities of India.
◄ Research and policy advocacy: Generating district and leverage COVID 19 activities
scale-up of behaviour change models to
evidence on TB burden among Tribal towards achieving TB Elimination goals in the
reduce the burden of TB.
population and creating platforms Tribal Districts. This campaign works closely
A National Technical Support Unit
◄ Health Systems Strengthening: By for disseminating best practices; and with front line health workers, community
(NTSU) for Tribal TB
facilitating interventions and deployment advocating for policy changes influencers including PRI members, Tribal
of technology driven tools/interventions NTSU for Tribal TB has been set up by Piramal Healers, will help identify best practices for TB
Swasthya Management Research Institute Active Case finding in hard-to-reach areas and
with support from USAID India and will work influence positive behavior change.

REACH (Resource Group for Education and Advocacy

for Community Health)

Strengthening a community-led response to TB in India

The Accountability Leadership by Local communities for Inclusive, Enabling
Services (ALLIES) Project

Through the ALLIES project supported by USAID and implemented in 15 districts of Chhattisgarh,
Jharkhand, Odisha and Tamil Nadu, trained TB Champions work in close coordination with the
NTEP to implement a Community Accountability Framework (CAF), to understand and improve
the Quality of Care (QoC) and Quality of Services (QoS) offered to people with TB.

89 INDIA TB REPORT 2022 INDIA TB REPORT 2022 90

Key achievements in 2021: Unite to ACT - Scaling up the TB Strengthening TB survivor-led a TB REACH Wave 7 grant. A strategic effort
Survivor - TB Champion Model networks to integrate the empowerment of women in
◄ CAF model refined through a national-level
the community with TB care and prevention
consultative meeting in March 2021; 225 TB
In 2021, building on results from previous In November 2021, REACH concluded an efforts, the project was implemented in four
Champions trained on CAF met with 7766
engagement of TB Champions, REACH began 18-month intervention to support and districts of Tamilnadu. The project had two key
people with TB from 120 TB Units to assess
implementing the Unite to ACT project with strengthen TB Mukt Vahini (TMV), Bihar’s arms - one led by a cadre of trained Women
aspects of QoC and QoS
support from the Global Fund through The survivor-led network, with support from the TB Leaders who fast-tracked screening at
◄ Over 240 Block Action Plans developed by Foundation for Innovative New Diagnostics Stop TB Partnership through the Challenge health facilities for enhanced case finding and
TB Champions to resolve gaps identified (FIND) India as the PR. The goal of the Unite Facility for Civil Society mechanism. To the second led by Community Health Mentors
through CAF to ACT (Amplifying Community action for TB) mitigate the impact on TB during the COVID-19 (CHMs) who were involved in organising
◄ 258 healthcare workers trained on the project is to accelerate efforts towards TB pandemic, REACH and TMV worked in community meetings to create awareness
Achieving Excellence in TB Care and Services elimination in India by unifying and scaling collaboration with the state NTEP to establish on TB and reduce stigma. REACH partnered
curriculum, designed to support NTEP staff up community action for TB. The project is a peer support mechanism for people with TB with GramVaani to offer a comprehensive
to adopt person-centred approaches being implemented in ten states by REACH, through structured telecounseling and real- audio-based training package on health for
with MAMTA and World Vision India as sub- time coordination to identify and resolve any women through an IVRS-based channel called
◄ Stigma assessment tool administered by
sub-recipients. In addition, REACH provides issues that emerged. ‘Saadhikka Vaa Penne’ (‘come on women,
trained TB Champions to measure stigma
technical support in 15 other states and let’s achieve’).
among people with TB, families, healthcare Key achievements in 2021:
union territories.
workers and the general community ◄ 10 district chapters of TB Mukt Key achievements in 2021:
Key achievements in 2021:
◄ Unique Art Skilling workshop held for TB Vahini formed ◄ Over 9.2 lakh people screened for TB; over
Champions, with a focus on using art to ◄ Revision and updating of the TB survivors to 65,000 identified with symptoms of TB and
◄ A first-of-its-kind Leadership training for TB
address TB-related stigma TB Champion training curriculum, through over 2300 diagnosed with TB
Champions developed
a consultative process with NTEP and
◄ Two new state-level survivor-led networks ◄ 75 TB Champions led anti-stigma campaigns ◄ Over 82% of those identified with symptoms
TB Champions
established in Tamil Nadu and Sikkim; for World TB Day, reaching 2800 people underwent any one test for TB
existing networks strengthened through ◄ ToT of 77 Master trainers - including NTEP
in the community. Campaign formally ◄ Health facilities without TB-specific staff
livelihood training and Learn to Lead staff and TB Champions - on community
launched by Bihar Deputy Chief Minister, benefited more from the facility-based
knowledge series engagement through
Smt Renu Devi and concluded with Bihar’s screening; WTLs supported bi-directional
◄ 16 journalists from across India selected for ◄ 464 new TB survivors trained as TB Health Minister Shri Mangal Pandey taking screening for TB-COVID-19
Fellowship programme to report on TB Champions through 16 state and the anti-stigma pledge with TMV members
◄ Over 1000 women completed at least 6 of
district-level workshops in Delhi,
◄ 281 elected representatives, including ◄ 44 TB Champions from 22 districts provided 14 audio modules
Bihar, Uttarakhand, Rajasthan and
MLAs, Ward Counsellors, Mayors and PRI peer support through telecounseling
Madhya Pradesh ◄ WTLs and CHMs empowered to use
members, sensitised on TB to over 9500 people with TB; over
knowledge for action for themselves, their
◄ Announcement of Uttarakhand TB Mukt 8500 people counselled on COVID-19
◄ Technical support provided to CTD in families and their communities
Network by newly trained TB Champions in appropriate behaviours and encouraged to
development of curriculum and modules
the state get vaccinated.
for roll out of rapid scale-up of TB Engaging the private sector through
Champions training and to operationalise ◄ Technical assistance to Himachal Pradesh
an integrated TB-NCD approach
the Framework for a gender-responsive for commencement of structured process Empowering women for enhanced TB
approach to TB of training and engaging TB Champions case-finding Building on the successful private sector
and sensitising NTEP staff engagement model in Chennai, REACH
In December 2021, REACH concluded the
provides integrated screening for Non-
Mentors for Community Health project,
Communicable Diseases (NCDs) for people
supported by the Stop TB Partnership through
seeking care for TB in the private sector.

91 INDIA TB REPORT 2022 INDIA TB REPORT 2022 92

Through linking to Care initiative supported with symptoms of TB and facilitated
by the Lilly Global Health Partnership, people screening of NCDs for eligible people
TBPPM-Learning Network India
with TB symptoms, people with TB and The Tuberculosis (TB) Public Private Mix Learning Network (TBPPM-LN) India is an offshoot of the
◄ Of 7897 people referred with symptoms of
their contacts are screened for TB, Diabetes Global TBPPM-LN that was initiated in 2019 by the PPM Working Group. The TBPPM-LN collaborates
TB, 3238 diagnosed with TB
and Hypertension followed by counseling with a wide range of stakeholders and is supported by partner-organizations, including high TB
on lifestyle modification and are linked to ◄ Free NAAT testing facilitated for over 4000 burden countries, PPM implementing agencies around the world and international organizations
appropriate services for management of NCDs, people such as WHO, Global Fund, USAID. The network’s goal is to create, nurture and maintain a dynamic
in addition to TB services. This holistic support ◄ Of 9051 eligible people, 73% screened for global exchange of expertise and best practices in the area of private provider engagement in TB.
package is provided through 40 Nakshatra Diabetes and 71% for Hypertension The TBPPM-LN is funded by the Bill and Melinda Gates Foundation and led by McGill University
Centres that are housed at community and International TB Center. The India chapter was spearheaded in early 2021 when the Advisory
◄ Of 6581 people screened, 2338 (25%) found
private hospitals in Chennai. Board for the India chapter was put together.
with Diabetes; of 6401 people screened,
Key achievements (January - November 2021): 755 (11.9%) found with Hypertension The TBPPM-LN India has partaken in the following initiatives in 2021:
◄ 731 private practitioners referred people
The Advisory Board for the TBPPM-LN India chapter

Everwell Health Solutions

Everwell Health Solutions (enterprise based out of Delhi and Bangalore) has been partnering with
the NTEP under the guidance of CTD to support India’s Digital TB strategy. Our work is supported
by the Bill & Melinda Gates Foundation along with catalytic support from USAID & Global Fund.

Our work areas across 2021 span across –

◄ Development and Maintenance of Nikshay ecosystem. This includes design, development,

maintenance of the following applications –
Crux of the India chapter roadmap- objectives, focus areas and activities
▼ Nikshay staff web application

▼ Nikshay staff mobile application

Understand and Learn Empower potential Bridge and build Support ongoing
▼ TB Aarogya Sathi mobile application for patients Objectives about the TBPPM PPSA organizations peer-to-peer public sector
space in India connections capacity building
▼ Nikshay reports & data collection forms

▼ Nikshay dashboards

▼ TBC India website PPM Action Facilitating Community

interaction A culture shift in PPM
peer-to-peer linkages Action
Create Targeted
◄ Strategic support (technology, deployment, rollout) for Digital Adherence Technologies Focus Areas
Learning opportunities
including 99DOTS, MERM, 99DOTS lite, and adherence marking via TB Aarogya Sathi application.
Knowledge Management
◄ Programmatic Support in implementation of Nikshay ecosystem and Digital Adherence
technologies. This includes training of trainers, documentation, and field support (including
an L2 helpdesk for Nikshay) Webinars Peer-to peer learning Collaborate
Activities Features Database for PPSA with the CTD
Resources One-on-ones and the TSUs
Details on the work done in these tracks are included in other sections of this report.

93 INDIA TB REPORT 2022 INDIA TB REPORT 2022 94

Landscaping and Community Building Mentor-mentee facilitation
John Snow India (JSIPL)
of practitioners
Potential PPSA organizations have been Tuberculosis Implementation Framework Agreement (TIFA)
A series of one-on-one interactions were held matched with experienced PPSA implementers
to facilitate learning and collaboration. TIFA in India kick started its activities in the third TIFA designed and launched a targeted
with stakeholders using snowball method
quarter of 2021. The first TB commitment grant request for application (RFA) in December
(n=39). This helped identify learning needs,
was awarded to PATH to undertake the needs 2021 to solicit bids for TCGs in pediatric TB,
design the network’s activities for peer-to-
Targeted Learning assessment of contracting under the National differentiated models of TB care, and the
peer learning and identify feature stories from
Tuberculosis Elimination Program (NTEP) underreporting of TB deaths. We adapted our
the field which were showcased on the TB- To understand the workings of the flagship
in five states (Andhra Pradesh, Telangana, existing guidance for targeted solicitations,
PPM website. PPSA scheme, closed peer-to-peer exchange
Odisha, Delhi, and Gujarat) for establishing finalized the RFA requirements, worked with
meetings were hosted. The first was with
STSUs to accelerate progress toward TB USAID and the central TB division (CTD) on the
Profiling of potential organizations to the PPSA implementing agencies in August
elimination in India. The assessment provided thematic areas, released the RFA to targeted
apply for PPSA 2021 and the second with State TB Officers
information on opportunities and constraints organizations, and hosted a virtual bidders’
in September 2021 respectively. Rich insights
to setting up State TSUs in the selected conference by the end of December 2021.
The PPSA scheme has had few applicants from these meetings have been collated
states. It also brought out information on TIFA India continued to engage with potential
in most states due to various reasons as reports and disseminated to the CTD
achievements in the TB domain; the need organizations to develop TB commitment
including low awareness among NGOs and NTSU.
for thorough assessments of capacity and grants in coordination and collaboration with
and organizations. To improve the uptake program domains at state level; technical areas CTD and USAID India.
of the scheme, the network developed a for capacity development; and additions/
Webinars
directory of organizations and updated their modifications in existing procurement/social
eligibility to apply for upcoming PPSA calls. The chapter organized its first webinar on contracting policies.
An eligibility checklist was developed based ‘Contracting Mechanisms in TB space in
on the Guidance document for Partnerships India’ in November 2021. Keeping in view that Supply Chain Management Strengthening (SCMS) Project for TB Drugs
and applied to relevant organizations. A total currently the majority of the applicants for
of 366 NGOs, 37 for profit organizations are PPSA are NGOs, it was imperative to explore JSI is a part of the “Supply Chain Management As part of technical assistance, JSI is engaging
mapped and a dynamic directory is created. the potential role of for-profit organizations Strengthening (SCMS) Project for TB and closely with the CTD to revise the Standard
This directory has been shared with the in TBPPM. With this understanding a webinar HIV/AIDS drugs”. The Project is led by Plan Operating Procedures on key supply chain
CTD and the National Technical Support was organized to explore the role of for-profit International (India Chapter), the Principal processes. JSI will develop a Learning
Unit (NTSU). organizations in December 2021. This has Recipient (PR) for the TB and HIV Supply Management System with digitized content
been viewed as a beginning to an important Chain grant under the Global Fund to Fight to promote self-learning, particularly in the
Peer-to-peer interactions dialogue in engaging for profit organization in AIDS, Tuberculosis and Malaria (GFATM) for current context of COVID-19 pandemic and
PPM space in TB in India. India to support Central TB Division (CTD) execute a series of face-to-face trainings.
Peer-to-peer interactions were facilitated towards TB elimination. The aim of the project The project intends to work towards
Looking forward in 2022, the plan is to
by various methods: (i) Webinars (ii) Friday is to strengthen the technical capacity of increasing the usage of Nikshay Aushadhi, the
consolidate the network further and
forums (iii) Chat group on WhatsApp the Central TB Division (CTD), State TB Cells electronic Logistics Management System
set an example for other high burden
application of PPSA implementers. The latter (STC) to design, manage and monitor supply cross last mile facilities.
countries on the utility of country-specific
grew to be a 30-member strong and active chains for improved access and availability of
Learning Networks.
group in 2021, where rapport was created to high-quality TB drugs, diagnostics and other
get peers engaged in discussions. commodities across India.

95 INDIA TB REPORT 2022 INDIA TB REPORT 2022 96

Centers for Disease Control and Prevention India SHARE India supported MCGM, kicking off
‘Moving towards TB-free Mumbai: prevalence
of surveillance data to inform programmatic
needs and strategies. The objective of the
The U.S. Centers for Disease Control and the IPC activities in support of the TB Mukt and treatment of latent TB infection (LTBI) Expand ELEVATE project (E2) is to improve
Prevention (CDC) India continued to support Bharat initiative to 10 states of India (Andhra among household contacts of persons with the capacity of selected state, district, and
the Government of India’s (GOI) tuberculosis Pradesh, Gujarat, Karnataka, Madhya Pradesh, TB’ initiative. The project successfully tested subdistrict level health staff to effectively
(TB) elimination efforts in 2021, supporting Maharashtra, Manipur, Himachal Pradesh, 500 HHCs, 273 were IGRA positive, 169 eligible conduct data analyses and data reviews
the broader effort during COVID-19 pandemic Tamil Nadu, Telangana, West Bengal). individuals were initiated on TPT and 5 TB to improve data quality and use TB data
challenges. CDC expanded its efforts to cases started on anti-TB treatment. for informing program improvement. The
support the National TB Elimination Program Expand ELEVATE project is implemented in 11
Latent TB Infection
(NTEP) in TB infection prevention and control states in India (Himachal Pradesh, Mizoram,
The End DR-TB Dharavi Project
(IPC), latent TB infection (LTBI) diagnosis CDC continued to support NTEP Nagpur Sikkim, West Bengal, Bihar, Odisha, Andhra
and treatment, drug-resistant TB (DR TB), (Maharashtra) and Indira Gandhi Government The End DR-TB project in Dharavi slum of Pradesh, Karnataka, Maharashtra, Rajasthan,
laboratory system strengthening, and TB data Medical college (IGGMC) to implement Mumbai aimed to improve treatment outcomes and Chhattisgarh).
quality improvement across India. Household contact Active and Latent among DR TB patients by monitoring for ADR CDC through implementing partner SHARE
Tuberculosis Intervention in Nagpur (HAaLT using point-of-care technology, reducing lost- India provided 7 data analysts (DA) to support
TB infection prevention control TB in Nagpur) project. Even with the challenges to-follow-ups (LTFU) by tracking migration, the state NTEP to implement the project in
of the COVID-19 pandemic, the CDC team and and diagnosing tuberculosis earlier through select districts. CDC conducted E2 training
The COVID-19 pandemic underscored the partners initiated latent TB infection diagnosis active case finding among household contacts of trainers for DAs and pilot state (Haryana)
need for IPC at healthcare facilities. In and treatment among household contacts of DR TB patients. In 2021, 352/355 DR TB NTEP staff in Dec 2021.
collaboration with the Municipal Corporation (HHC) and enhanced pediatric diagnosis patients were screened for ADR monthly
of Greater Mumbai (MCGM), CDC and partners using stool, saliva, and nasopharyngeal using POC audiometry and ECG. Eighty-four
supported the airborne infection control (AIC) samples. Additionally, in collaboration with (24 %) patients reporting ADR were referred CDC Country Director, Dr. Megnha Desai (middle), TB
unit in Mumbai to build institutional capacity IGGMC, CDC with implementing partner branch chief, Dr. Christine Ho (right)and CDC public health
for ADR management at public health facilities
specialist, Dr. Toufique Ahmed, at World TB Day 2021 event.
and strengthen AIC measures in primary and SHARE India, conducted training in HAaLT in Mumbai. Trained project field coordinators
secondary health care facilities in ten wards. project LTBI diagnosis, treatment, adverse (FC) successfully tracked migrant patients and
Through this effort, the HCF staff were trained drug reaction (ADR) management, enhanced re-engaged them in care during COVID-19
on AIC, and five follow-up assessments in pediatric diagnosis for medical officers, pandemic. The FCs along with NTEP team
313 HCFs were conducted during 2021. In Nagpur NTEP staff, and ASHA workers. To successfully managed to improve treatment
the follow up period, between 2020 and 2021, assess the feasibility of interferon gamma adherence to more than 98% on treatment
there was significant improvement in AIC release assays (IGRA), the CDC India and CDC during COVID-19 pandemic. Moreover, FCs
compliance in indicators of N95 respirators use Atlanta team trained lab technician (LT) from were able to diagnose 19 new TB cases during
by healthcare workers crowd management IGGMC Nagpur in IGRA testing. For enhanced HHC screening of DR TB cases in this slum.
and use of outside space for social distancing pediatric diagnosis, CDC teams trained LTs MCGM has planned to use the tools and
by 22, 15, and 17% respectively. in CBNAAT based TB diagnosis using stool Dharavi slum best practices in Malwani slum
sample and nasopharyngeal swab. Total 456 in Mumbai.
AIC efforts ongoing, and with support from
HHCs received IGRA testing, of them 198 were
CDC-SHARE, and in collaboration with Mumbai
found positive and 118 individuals meeting
NTEP, next steps include sustaining and Expand ELEVATE
the criteria were initiated on TB preventive
mainstreaming the IPC activities within MCGM (Engaging Local Experts to Validate
therapy (TPT) and 9 TB cases started on anti-
through a national health mission supported and Analyze TB data to End TB) Project
TB treatment in 2021.
IPC unit at city level. Beyond Mumbai, CDC
and partners are also working with the Central CDC expanded the LTBI programming to CDC is supporting NTEP towards responding
TB Division and State TB programs to expand Mumbai where CDC and implementing partner to the 2019 Joint Monitoring Mission (JMM)
NTEP recommendation to improve the use

97 INDIA TB REPORT 2022 INDIA TB REPORT 2022 98

The International Union Against Tuberculosis and Support Unit (NTSU) that will implement
the key functions of advocacy and social
TB related stigma and migration. Research
publications are underway.
Lung Disease, South-East Asia mobilization, creative design and campaign
A systematic review was published under
development, knowledge management and
The International Union Against Tuberculosis institutions that focuses on the programmatic the Research, Evidence, And Development
measurement and evaluation.
and Lung Disease (The Union) is the world’s first and clinical management of people with TB Initiative (READ IT) project, on Active Case
scientific global health organization, founded and DR-TB. Finding programmatic (ACF) data (Sharath et
Research al, 2021). The review used the program ACF
in 1920. The Union, a leader in ending TB, HIV.
The project works towards the establishment
The Union provides project implementation, An operational research study on the data obtained from states and from various
of Centres of Excellence in DRTB Care; has
operations research, technical support, and implementation status of TB preventive projects that conducted ACF activities. Many
completed two batches of DTOs Program
capacity building services. treatment (TPT) among child contacts <6years implementation challenges, related to health
Management Training and baseline
of pulmonary TB patients and people living systems, healthcare provision and difficulties
The Union and the Central TB Division have assessment of 7 STDCs, deployed the Health
with HIV was conducted across 12 districts experienced by patients, were elicited.
been closely working to raise the public Volunteers training on NTEP using the
in India under The Global Fund supported
discourse and build awareness about Modernised Training Strategy, and 23 ECHO A series of strategic interventions were
Project Axshya. It was a mixed-methods
TB in India. Hubs at STDCs and strategic NTEP institutions recommended addressing the implementation
study utilizing the quantitative programmatic
and is engaging 138 corporate sector challenges, the six gaps identified in ACF
data, a field survey and telephonic interviews
engagement through Corporate TB Pledge. outcomes and the expected indicators that
Notable interventions in India with patients and providers. The study was
It is also supporting the mBPaL regimen trial, could potentially improve the efficacy and
completed in March 2021. The study found
Axshya Plus and building capacity of WGS labs across effectiveness of community-based ACF in
about 40% of eligible child contacts and about
the country and the DRTB surveillance India (Burugina Nagaraja, S.; Thekkur, P.;
Axshya Plus is an initiative to strengthen 29% of the PLHIVs were initiated on TPT
system framework. Satyanarayana, S.; Tharyan, P.; Sagili, K.D.;
preventive care for contacts of TB Patients and among whom the completion rates were 60%
and 72% respectively. Several challenges in Tonsing, J.; Rao, R.; Sachdeva, K.S. Active Case
create a suitable environment by collaborating
National Technical Support Unit: initiating and completing TPT were identified Finding for Tuberculosis in India: A Syntheses
with various stakeholders. The project focuses
Advocacy, Communication, and Social by the participants, key challenges included of Activities and Outcomes Reported by the
on four essential interventions- TB prevention
Mobilization limited and overburdened staff for service National Tuberculosis Elimination Programme.
therapy, multi-sectoral engagement, public
delivery, lack of counselling, lack of awareness Trop. Med. Infect. Dis. 2021, 6, 206. https://doi.
financial management system and operational
The Union hosts a Secretariat in steering about TPT, adverse events, lack of TPT drugs, org/10.3390/tropicalmed6040206)
research. Programmatic Management of TB
the Advocacy, Communication and Social
preventive treatment- PMTPT component is
Mobilisation (ACSM) activities towards
being implemented in 107 districts across
the mass movement (Jan Andolan) goals
seven states- Assam, Himachal Pradesh,
of eliminating TB by 2025. The structure
William J. Clinton Foundation (WJCF)
Maharashtra, West Bengal, Chhattisgarh,
envisaged consists of a National Technical Service Delivery
Jharkhand, Madhya Pradesh.

PFMS technical assistance is being provided Capacity building workshop in Lucknow to develop state
▼ Joint Effort for Elimination of the NTEP. JEET facilitated over 500,000
ACSM plans
in 24 States and 2 Union territories. The Tuberculosis (JEET) patient notifications over three years,
multi-sectoral engagement component would
Implemented from 2018-2021, the while nationally the share of private
be implemented in pan India.
GFATM supported project JEET was sector notification improved from 24%
implemented across 182 districts with in 2018 to 33% in 2021.
iDEFEAT TB the objectives of notifying patients ▼ Scaling up TB Preventive Therapy (TPT)
receiving care in the private sector (JEET 2.0)
The iDEFEAT TB project is an initiative that
strives to strengthen India’s TB-related and improving access to quality care,
To support NTEP’s priority to address
free drugs and diagnostics through
the burden of latent TB, the JEET 2.0

99 INDIA TB REPORT 2022 INDIA TB REPORT 2022 100

 project initiated in 2021, expanded the effectiveness of IGRA testing for refill monitoring, WJCF partnered with has deployed a one-of-its-kind patient
access to Tuberculosis Preventive LTBI followed by X-ray to rule out active 1MG to home deliver FDCs to private- management system to enable chemists
Therapy (TPT) for children and adult TB whilst the “Treat only” model via sector patients in three districts. This and informal providers to offer free
contacts of Index Pulmonary TB patients an X-ray screening to out active intervention has improved access of X-ray to any symptomatic patient. The
in 66 districts across 11 states as per pulmonary TB before starting preventive free government FDC drugs to private project has contributed to notifications
the approved national guidelines. In treatment, is being implemented in sector patients. increasing by 32%, notifying providers
six of these districts, the “Test & Treat” remaining districts. ▼ Deploying Medicine Event Reminder increasing by 83% and microbiological
model is being piloted to demonstrate Monitor (MERM) and 99 DOTS Sticker confirmations increasing by 6x
for TB patients in the private sector compared to 2019.

Innovations in Private Sector Achievements of the Faridabad Pilot Given limited experience of MERM and
Engagement 99DOTS in the private sector, WJCF is Technical Assistance at the Central and
Sample Collection TAT
conducting a pilot across seven districts State level
▼ Partnership with TATA-1mg for 7%7%
of Gujarat and Bihar to demonstrate the
improving access to FDCs in the Private ▼ Building capacity of states in
operational feasibility of deploying these
Sector engagement with private sector
technologies, identifying appropriate
86% and strengthening uptake of Direct
WJCF partnered with TATA-1MG, a patient and provider segments for
Collection within 24 hrs
Benefits Transfer
digital healthcare platform, with the aim adoption and measuring the impact
to improve quality of service delivery Collection within 24 hrs-48 hrs WJCF, with under the grant from
on adherence for each technology.
and increase access to government Collection after 48 hrs BMGF, undertook pilots and research
Approximately 700 patients have
Fixed-Dose Combinations (FDC) in the studies to inform states’ plans to
been enrolled in the pilot till Dec 2021,
private sector. Medicine Delivery TAT contract, implement and monitor
which is expected to be completed by
3% Patient Provider Support Agencies
▼ Faridabad Pilot 22% August 2022.
(PPSAs) through state funding, and
To understand the feasibility of for- ▼ Project ADITYA – A technology
ensure efficient disbursement of Direct
profit organizations to implement 75% augmented, low HR PPSA model
Benefit Transfer (DBT) schemes in focus
PPSAs as well as establish a model for Project ADITYA, supported by TB geographies. WJCF supported states in
Delivery within 24 hrs
such partnerships with NTEP, 1MG was Reach and launched in February 2021 strategic procurement of PPSA services,
Delivery within 24 hrs-48 hrs
brought on-board to implement a PPSA at Durg, aims to demonstrate a model working closely with STOs and NHM
Delivery after 48 hrs
in Faridabad via a BMGF grant. 1MG of comprehensive engagement of all teams to provide technical assistance
leverages their existing capability of formal and informal providers through for effective contract management.
doorstep sample collection, medicine a resource light model with the aim Some of these initiatives include:
Achievements of Drug Delivery Pilot
delivery and patient counselling. While to reduce diagnostic delays. ADITYA
▪ Support Bank Account seeding
notifications and follow-ups were Medicine Delivery TAT Status
ADITYA project Launch by STO in Bihar
facilitated by tele-counsellors with the 5%
14%
compounder’s support. Under this pilot, To increase bank account seeding
3080 patients have been provided with of notified TB patients under NPY,
services as of Dec. 2021. 81% a pilot communications campaign

▼ Drug-Delivery Pilot Delivery within 24 Hours was conducted through automated

Delivery within 48 Hours voice blasts, on-demand content and
To demonstrate alternative models for
Delivery within 72 Hours
IVRS. Over a four-month pilot, the
improving access to FDCs and ensure
bank seeding amongst patients in

101 INDIA TB REPORT 2022 INDIA TB REPORT 2022 102

 mHealth campaign launch by GCC Commissioner
the intervention districts (9.5%) was real-time monitoring of the TB was conducted in Chennai between
statistically significant and higher programme, establish a system for 2018-20 to identify subgroups with the
than that in the non-intervention evidence-based decision-making and highest risk for TB and determine drivers
districts (7.7%). estimate implications of programme of care-seeking. A pilot was undertaken to
performance and interventions explore the feasibility andeffectiveness
▪ Capacity Building Initiatives
on the status of the TB epidemic. of mHealth entry points for
WJCF has supported the State and Dashboard to track programmatic improving TB care-seeking
District NTEP team to increase the indicators and integration of the among men using social media.
awareness and adoption of the ‘All-India TB Model’, developed by
Nikshay application. In 2021, 41 the Imperial College London, is
Nikshay Paramarsh virtual sessions currently underway. Sample social media ad
were conducted across 314 districts.
In 2022, self-paced Nikshay e-learning
Research
module courseware will be launched
in 10 regional languages. ▼ UNITAID-backed demonstration
study for a new short drug regimen
Overall Status (3HP) for TB preventive therapy for
Total
(From start of pilot)
vulnerable groups
Patients receiving services As a coordinating partner for
3452
on-boarded Ahmedabad
IMPAACT4TB, WJCF is facilitating a
Patients receiving service Surat 2355 demonstration study to roll out a
Patients receiving services Delhi 535 new short drug regimen (3HP) for
TB preventive therapy. The key
Nikshay Paramarsha Trainings in Madhya Pradesh objective of the study is to gather
evidence on the effectiveness of
the new regimen, the feasibility
of rollout under programmatic
conditions, and to document
and analyze any drug-drug reactions
that may occur.

▼ Exploring feasibility and effectiveness

of mHealth to improve TB care-seeking
▪ Establishing a War Room at Central among key population segments
TB Division
WJCF, with the support of Surgo Ventures,
WJCF, is working closely with WHO, supported the Greater Chennai
BMGF, Imperial College London, Corporation (GCC) to improve case
Gramener and Everwell to set up a detection through innovations in active
War Room at the Central TB Division. case finding and better care-seeking by
The War Room is envisaged to enable vulnerable groups. A care-seeking study

103 INDIA TB REPORT 2022 INDIA TB REPORT 2022 104

Multi-sectoral Convergence for TB Elimination Program Implementation (07 July), M/o of ‘Workplace policy on TB and related
Electronics & Information Technology (22 Comorbidities including Occupational
The multisectoral collaboration aims to associations and other key stakeholders for July), M/o Road Transport & Highways (10 Lung Diseases’ developed by Govt. of
strengthen the national response against collaborative action on vulnerability reduction, Aug), M/o Panchyati Raj (11 Aug), M/o of Jharkhand has been shared with all State
Tuberculosis elimination through a “Whole of integration of TB related services in existing Heavy Industries (12 Aug), M/o Small, Micro TB Cells to develop similar workplace
Government” approach and engagement of health infrastructure and social protection for & Medium Enterprises, M/o Youth Affairs &
policy for their respective States/UTs.
key corporate sectors to achieve the targets of TB patients and affected families. Sports etc.
It will influence and engage industries
ending TB by 2025. It has become an integral
▼ Meetings with North-Eastern Council and workplaces to ensure access to
part of NTEP to take convergent action and
Formation of National Inter-Ministerial (NEC) information and services related to
reach out to the key population served by
Task Force on Tuberculosis (NIMTE-TB) TB at workplaces. In this regard, the
various Ministries/ Public Sector Undertakings, A meeting under the Chairmanship
civil society and other key stakeholders. of Shri C.H. Kharshiing, Planning necessary communications were sent
The MoH&FW has proposed ‘National Inter-
Adviser & I/C Adviser (Health), North to industries/ corporates and Principal
Mission ‘End TB by 2025’ needs concerted and Ministerial Task Force on Tuberculosis (NIMTF-
Eastern Council (NEC), was held to Secretary (Health) of all States/UTs in
collaborative action to address TB challenges TB) for the engagement of all key Ministries
of Govt. of India for meaningful partnership discuss and develop an action plan for November 2021.
as the disease is driven by the number of socio-
economic factors, and ending TB requires a and convergence at policy programme and implementation of activities as laid out ▼ Ministry of Railways
multi-sectoral approach that includes active scheme for accelerated action towards TB in the Memorandum of Understanding
Coordination and follow-up meetings
participation of Ministries, PSUs, Corporates elimination in the mission mode. For inter- (MOU) signed between North Eastern
were held with the Ministry of Railways
and other several organisations with ministerial collaboration, 23 key ministries Council and Central TB Division on
to implement activities as laid out in the
shared responsibilities. have been targeted, and communications 8th October 2020. The meeting was
have been sent to ensure commitment and signed MoU with CTD. Further state-
The convergent and integrated response attended, among others, by the
action at the highest level. level coordination meetings were held
for strengthening national response against representatives of Central TB Division
to enrol health facilities under M/o
TB through; (CTD), State Tuberculosis Officer (STO)
Railways in NIKSHAY. State and district
Partnership with Key Ministries of GoI Meghalaya and Consultant WHO-NTEP.
level coordination has been expedited
▼ Integrating TB service in the health for Multi-sectoral collaboration, efforts
The Action Plan has been developed for mapping Peripheral Health
facilities under various Ministries/ PSEs. have been made to
and shared with the North Eastern Institutions (PHIs) and registration
▼ Reaching out to the masses with
◄ strengthen partnership and formulation Council. Action points with tentative in NIKSHAY.
awareness & prevention activities
of Joint Working Group where MoUs are timelines have been prioritised in sync
and information on TB care and
already in place; with activities laid out in the signed MoU
related services. Corporate Sector Engagement
between NEC and CTD.
▼ Adoption of TB free workplace policy ◄ follow up with Ministries where partnership/
Ministry of Health and Family Welfare,
MoUs are already proposed, and ▼ Ministry of Labour & Employment
and workplace intervention Government of India, launched the Corporate
◄ explore collaboration and engagement The Policy Framework to address TB, TB Pledge (CTP) initiative to galvanise
▼ Addressing socio-economic determinants
of TB and reducing stigma & with new Ministries/PSUs. related co-morbidities and HIV in the corporates to jointly work towards a shared
discrimination against people infected Several meetings were organised in the World of Work developed by the Ministry vision of eliminating TB in India. The initiative
and affected by tuberculosis. virtual platforms and physical follow-up of Labour & Employment and CTD has was launched in April 2019 and offered a
meetings. These meetings were attended been shared with major Corporates, tiered based approach for corporates to use
▼ Promoting local action for Active Case
by senior officials, consultants and nodal industries of public and private sector their resources (human and financial) to
Finding (ACF).
officers identified by Ministries. E.g., and business associations. State combat TB, raise awareness on TB as a curable
Several activities have been undertaken Meetings were conducted with M/o Rural disease, and ultimately improve TB health
Governments have been encouraged
to engage various Ministries, Public Development (28 June), M/o Consumer outcomes. CTP, an initiative under NTEP, aims
to adopt TB Workplace Policy in sync
Sector Enterprises, corporates & business Affairs (01 July), M/o of Statistics and to engage corporate, industries and business
with the national policy framework. The
associations to work jointly as a shared

105 INDIA TB REPORT 2022 INDIA TB REPORT 2022 106

responsibility of TB elimination in the country. TB patients. in the private sector was also approved by Other Achievements
Currently, there are 138 members under NTEP; the project is expected to start soon.
◄ Jubilant Bhartia Foundation started
the corporate TB Pledge, including ◄ Online platform- To service the increasing
screening and nutrition support project ◄ Integration of DR-TB in corporate-led
10 Business Associations. number of corporate TB pledge
among the elderly population in one block testing initiatives including Apollo Tyres,
members more effectively, the CTP
In the last one year, through various of Gajraula (UP) APPL, Goodricke, BEST Mumbai etc.
secretariat developed and launched a
corporate supported initiatives, more than
◄ Ambuja Cement – Extended its TB services ◄ DR-TB Consortium under Corporate comprehensive CTP online platform (www.
five lac TB screening and facilitating TB
under the community engagement project TB Pledge corporatetbpledge.org) in March 2021. The
testing for over 18,000 people have been
to three more locations in the country. platform aims to serve as an informative
carried out. About 1500 TB patients were DR-TB Consortium is providing a platform
Workplace intervention for the corporate sector to deliberate and interactive channel for existing and new
identified through CTP efforts in the last
the programme need and support to members and provide access to TB resources
one year. Ten workplace interventions were initiated
be extended under corporate social like a menu of CSR investment opportunities,
Key CSR projects/activities initiated/ ◄ Adani – TB and Workplace intervention best practices and campaigns materials etc.,
responsibility. Three meetings of DR-TB
implemented by CTP members during the last initiated at its Mundra port location to the Corporate TB Pledge members.
consortium members were organized
one year are: targeting over 10,000 workforces. by the Union in 2021. Through DR-TB ◄ Recognition of CTP members- Four CTP
◄ Fujifilm launched the Mobile X-ray van Adani formed a TB and workplace consortium, following partnerships have members were felicitated by the MoHFW
initiative; the van with portable digital committee and signed a statement been facilitated in DR-TB: on the occasion of World TB Day in March
X-ray will cover around nine lac people on a stigma-free workplace. 2021 for their exceptional work in TB.
• Initiation of DR-TB clinic facilitated
in selected north and east India pockets, ◄ Welspun Foundation. Started TB and in Medanta Hospital, Gurugram and ◄ Cluster-based screening – Pilot
focusing on truckers, migrants, and workplace intervention by organising a formal MoU was established with intervention on cluster-based screening in
slum dwellers. training of trainer’s program support of WHO Kutch district with Adani and Welspun is
◄ RITES Limited – One mobile X-Ray Van in Gandhidham. being implemented.
• Pilot project in three districts of
donated by RITES was flagged off by the ◄ FOKIA- formed a TB and workplace Maharashtra to improve access to newer ◄ First Regional Workshop on TB and Workplace
honourable Chief Minister of Haryana committee and adopted a statement drugs for patients in the private sector organised in Assam focusing on the tea sector.
◄ Dow Chemical ACF project- Dow Chemical of commitment
• Initiation of certification process of culture ◄ Business Associations Engagement-
launched a pilot project associated with ◄ Parry Agro, McLeod Russel, Goodricke and DST of Pathkind lab, Gurugram
NTEP in Malad Mumbai to screen 50,000 ▼ The Union signed MoU with ASSOCHAM to
and APPL – Tea sector-focused TB free
people from slum areas. • Active case finding through mobile mobilise member companies to work on TB.
Workplace interventions initiated in Assam.
X-Ray along with NAAT services in Rewari
◄ Nayara Energy extended its nutrition ▼ NTEP and The Union organised TB and
◄ BATA – Initiated Workplace intervention at
support initiative for TB patients to workplace training programs with 15
its Patna plant. State Level engagement
Jamnagar district Gujarat. The project was companies associated with Ranjan Gaon
◄ Effectual services organised TB and Industries association in Pune.
first launched in Devbhumi Dwarka district The Corporate TB Pledge secretariat engages
workplace awareness activities
of Gujarat. with State TB Cells for providing technical ▼ Federation of Kutch Industries
◄ Apollo Tyres Foundation - Initiated support for corporate engagement at the state Association (FOKIA) signed LoI with
◄ Seven new DMCs were launched by Apollo
Workplace intervention at its Kerala plants. level. Support extended for TB workplace policy, The Union to promote corporate
Tyres Foundation to improve access for
truckers and migrants. Apollo Tyres ◄ BEST, Mumbai – was recognised for their organising state consultations for corporate engagement in TB.
Foundation, in association with NTEP, also TB and workplace intervention. engagement, workplace intervention, training
▼ NTEP and The Union organised
implemented two rounds of campaigns for DTOs and PPM coordinators etc. Focus
corporate consultation in Ahmedabad
(ATF TB Free Transshipment campaign – states are Haryana, Uttarakhand, Telangana,
DR-TB in association with PHD Chamber.
Mar 2021 and Sep 2021). More than 1,30,000 Assam, Gujarat, Mumbai and Maharashtra.
people were screened, 3556 TB testing ◄ Vitaris/Mylan supported project on
were facilitated to identify around 150 improving access to new drugs for patients

107 INDIA TB REPORT 2022 INDIA TB REPORT 2022 108

 People’s
movement
towards a
TB-free India ADVOCACY,
by 2025 COMMUNICATION
AND COMMUNITY
ENGAGEMENT

109 INDIA TB REPORT 2022

09 INDIA TB REPORT 2022 110
 Thus, community engagement as a strategy is to spread TB awareness through media and
critical for the country’s aim of Ending TB by other channels including political advocacy for
2025. In addition, there was concerted effort garnering support to end TB in the country.

Some notable interventions include:

Highest Political Commitment towards TB Mukt

Bharat Abhiyaan by Hon’ble Governors
In a first of its kind, highest level advocacy TB elimination was on the agenda during the 51st Annual
Governor’s Conference
commitment, TB was a key agenda point at
the 51st Conference of Governors, held on11
November 2021. The conference was chaired
by the President of India. A comprehensive
kit on tuberculosis has been prepared and
shared with Governors and Lieutenant

Advocacy, Governors (including: factsheets, state-wise

information on the TB burden, success stories

Communication of patients, and the government’s roadmap

for eliminating TB by 2025). In his address,

and Community the President of India also urged the delegates

to support TB elimination efforts at the

Engagement state level.

Second Parliamentary Meeting on TB

After the successful and widely acclaimed Vice President addressing Members of Parliament at the
second Parliamentary meeting on TB in July 2021
sensitization of Members of Parliament (MP)
Advocacy, communication and community Under the National Strategic Plan (2017-25),
on TB in 2019, the CTD got the opportunity
engagement provides the necessary thrust a community-led response is one of the key
to organise a second round of sensitization
to accelerate universal TB Care coverage catalysts to reach the last mile and support
for the MPs on 9th July 2021. The meeting
and preventive services. In recognition of TB patients through their treatment and
was chaired by the Vice President of India,
the clarion call for Ending TB in India by the recovery phase.
M. Venkaiah Naidu and attended by the
Hon’ble Prime Minister, the Ministry of Health
Efforts are being made under the National Speaker of the Lok Sabha (Lower House of
and Family Welfare (MoHFW) launched the
TB Elimination Programme to actively Parliament), India’s Union Health Minister,
TB-Mukt Bharat Abhiyaan - A Jan Andolan to
engage various stakeholders including and over 55 MPs from across party lines. The
eliminate TB from India by 2025.
civil society and community in programme provision of a dashboard for MPs, to review
Well-designed Advocacy and IEC is crucial as planning and design, service delivery, and track the progress of the TB program was
it plays a complementary and catalytic role monitoring and in advocacy. These include announced and the MPs were urged to utilise
across all thematic areas of the programme Elected Representatives and local self- that to provide supportive supervision to the
while aligning efforts with other public health governments, Civil Society Organizations, TB program in their respective constituencies.
programmes for synergised communication. industries, etc. and TB affected communities. The meeting ended with the TB pledge taken
by all Members of Parliament (MP).

111 INDIA TB REPORT 2022 INDIA TB REPORT 2022 112

National Conference on Women Winning Against TB Launch of Phase II of Azadi Ka Amrit Mahotsav
The MoHFW and the Ministry of Women National Conference on Women Winning against TB with
Members of Parliament.
The National AIDS Control Organization campaigns, activities designed to generate
and Child Development (MoWCD) jointly
(NACO), MoHFW, launched the Phase II (HIV awareness on HIV and TB among members
organized a national conference on gender-
& TB campaign) of the New India@75 Azadi of RRCs and school students (class 9th & 11th)
based approach to TB elimination on 16th
ka Amrit Mahotsav on 12th October 2021 in a were conducted.
December 2021. The conference was chaired
hybrid mode. Students of 25 schools and 25
by the Vice President of India and attended
colleges from each State participated in this
by the Union Ministers for Women and
event. Approximately, 75,000 students joined
Child Development and Health and Family
the event virtually and the programme was
Welfare, State Ministers and Secretaries
live-streamed on social media handles of
from both these ministries, Members of
NACO and MoHFW. The event was graced by
Parliament, senior ministry functionaries,
Hon’ble Minsiter of State, Dr. Bharati Pravin
partner organizations and TB champions and
Pawar. To continue the celebration, activities
survivors. The delegates were sensitised about
were carried out in schools and colleges
the challenges faced by TB afflicted women,
across the country in both the physical as
and the parliamentarians were requested to
well as the online modes as per the COVID
promote implementation of gender-sensitive
situation prevailing in the State. During these
policies for TB elimination.

New India@75 Other Significant Events

The New India@75 initiative, to commemorate To align with the 75th year of Independence,
India’s 75th Independence Day, was rolled out it was envisioned to fruitfully engage 75
◄ ACSM Planning Workshop (Pilot intervention in 5 States)
as a mega mass mobilization and engagement schools and 75 Red Ribbon Clubs (RRCs) in a
Five priority states - Uttar Pradesh, Madhya
movement. For this, NACO has been phased manner throughout the year to spread
Pradesh, Meghalaya, Himachal Pradesh
entrusted with the task of organising three awareness about HIV, TB and Voluntary Blood
and Telangana - have been chosen to pilot
major awareness campaigns on HIV/AIDS, Donation Day.
innovative ACSM interventions. The CTD
Tuberculosis and Voluntary Blood Donation.
organized a capacity building workshop for
the State TB Officers and State IEC Officers to
Launch of Phase I facilitate the States in designing their State
specific plans with budgeting considerations
In this context, the 1st phase of the campaign and expected outcomes.
was launched on 12th August 2021 on
International Youth Day by Hon’ble Union ◄ Implementation of ACSM in Uttar Pradesh
Minister of Health & Family Welfare. More
than 1,23,000 students, from different schools The CTD supported Uttar Pradesh in participated in this resulting in over 270 media
and colleges across the country, attended implementing various ACSM interventions articles published on tuberculosis. CTD’s
this event virtually. After the launch, students including a media briefing workshop, chaired support to the State TB Office towards PRI
from 25 schools and 25 colleges from each by the Hon’ble State Health Minister. More engagement helped in securing the inclusion
state participated in awareness activities on than 140 journalists from across the state of a chapter on TB in the induction training
HIV/AIDS, Tuberculosis and Voluntary Blood
Donation for two months.

113 INDIA TB REPORT 2022 INDIA TB REPORT 2022 114

of newly elected Gram Pradhans. The social
media training, conceptualized and organized
for state and district TB program officials,
helped to build their capacity to engage
digital platforms for TB messaging. In just four
months post the training, there was a 417%
increase in the number of Twitter posts from
NTEP district handles, and a 484% increase in
the reach of these posts

◄ TB module included in the Gram Pradhan induction material in Uttar Pradesh

In addition to the State IEC/ACSM Officers and 210 participants attended the workshop on
State TB Officers, this workshop was attended day 1 and around 114 participants attended
by WHO consultants, PPM coordinators, ACSM the workshop on day 2.
NTSU Team including all the partners, CTD
team & representatives from BMGF. Around

◄ A Pilot to Build Radio Consortium

The All India Radio (AIR) network is the world’s and held initial consultative meetings with the
largest terrestrial broadcaster and can play a Station Directors of four major AIR stations in
proactive and meaningful role in contributing UP (Lucknow, Kanpur, Prayagraj, Varanasi).
to Ending TB by 2025 in the country. In that The proposal received an enthusiastic
context and to explore engaging with AIR, a response and is being taken up for a
team from CTD visited Uttar Pradesh in July planned engagement.

Nikshay Patrika Newsletter

Nikshay Patrika is the quarterly newsletter heartening that the teams at the state and
of National Tuberculosis Elimination district levels are voluntarily coming forward
Programme. In the past few months, it has with their submissions/contributions to share
not only widened the coverage but also carries and amplify their learnings and good practices
◄ National Workshop on Advocacy, Communication & Social Mobilization informative articles on diverse themes and to a national audience.
topics. This reaches out to a steadily growing
The National Workshop on Advocacy, were supported in (1) preparing State-specific Besides the extensive advocacy and
community involving NTEP staff, partner
Communication & Social Mobilization was held ACSM annual activity plans, along with communication intervention, combined
organisations working in the field and sharing
virtually on 17th & 18th January. The workshop timelines and budgets, for the upcoming PIP community engagement efforts were also
educative and informative updates, learnings
aimed at building the capacity of the IEC teams cycle (April 2022- Mar 2023) and (2) building fostered through activities at various levels:
and reflections on a quarterly basis. It is also
across all States to help them execute the capacity on specific ACSM activities, including
ACSM function at the State as well as District engagement with elected representatives,
levels in a structured and systematic manner. media, TB survivors, religious leaders, faith-
based organizations, and social media
In this workshop the State IEC/ACSM officials
interventions.

115 INDIA TB REPORT 2022 INDIA TB REPORT 2022 116

◄ A facilitator’s manual for TB Champion Training
Institutional Mechanisms for a Community-led
A facilitator’s manual on Training curriculum for empowering TB Survivor to TB response to TB
Champions has been developed incorporating newer initiatives in the programme.
TB Forums at National, State and District levels stigma & discrimination and of patient
provide an institutional platform to: support requirements, and advocate for
◄ Three Zonal levels National Training of Trainers on Community Engagement
◄ Include community as an important their solutions.
Three Zonal levels National Training of Trainers on Community Engagement were conducted stakeholder under the programme
covering all States/UTs across the country. The trainers were identified through the nominations ▪ To identify and recognise (1) best practices
◄ Improve the quality of TB services and
from the States/UTs. across the country on community
◄ Facilitate setting up of patient centric services. engagement and (2) the contribution made

These forums have representation from by community members, survivor networks

◄ 3500 TB Survivors Trained
people affected by TB, elected representatives, and civil society organizations to the fight
More than 3500 TB survivors were trained as TB Champions across the country. policy makers, civil society organisations/ against TB.
NGOs, and programme managers. Creation of
◄ Guidance Document on Community Engagement The National TB Forum was reconstituted
community-led TB forums of people affected
with civil society and ICMR representatives
by TB at the sub-district and village level, is
A “Guidance Document on Community Document” has been developed by the CTD in as co-chairs. Equal representation was
also being facilitated.
collaboration with WHO and partners implementing community engagement activities. The ensured from line ministries, namely,
document aims to guide the States/ UTs in planning, designing and monitoring the activities Ministry of Rural Development, Ministry of
under community engagement. TB Forums have the mandate: Panchayati Raj, Ministry of Social Justice &
Empowerment, Ministry of Health & Family
◄ Self learning courses for TB Champions ▪ To advise on ensuring patient centric Welfare, departments, civil societies, affected
delivery of services. community, academician, media, subject
A certificate course titled “Self learning courses for TB Champions” has been developed and experts, etc. By the end of 2021, all States had
hosted on e-platforms. These are now available through Arogya Sathi on iGOT, Gramvani and ▪ To advise on formulation of policies
formed TB Forums, while 711 districts had
Swasthy e-Gurukul. The certificate is auto-generated upon successfully completing the courses. and strategies for engaging communities,
District TB Forums in place. Most of the States
The aim is to provide different platforms for any interested citizen to undergo the courses at increasing community participation and Districts also reported convening their
his or her convenience. and providing feedback on their meetings and discussing relevant issues.
    implementation.  
Engaging with TB affected Communities
▪ To discuss concerns of TB affected
While there are multiple strategies under communities, including that on TB related
NTEP to increase awareness and mitigate National TB Forum
stigma, it is well established that affected
communities play a vital role in enhancing
effectiveness of these strategies and bridge State TB Forum
the gaps. Communities, especially those who
had been affected with TB in the past, have the
unique advantage of being able to motivate District TB Forum
their peers, understanding the issues on
the ground and the ability to articulate their
requirements. Thus, community engagement
as a strategy is critical for the country’s aim of Patient Support
TB Champion
Group
Ending TB by 2025.

117 INDIA TB REPORT 2022 INDIA TB REPORT 2022 118

Promoting
holistic
well-being
through best BEST PRACTICES
practices and AND SUCCESS
success stories
STORIES

10
 Health Auto for Timely Transport

Intervention Problem Statement

Health Autos were introduced in Warangal ◄ Early and timely detection of TB.
(Urban) District of Telangana.
◄ absence of local transport in the
The following free services are rural context,
being provided:
◄ Further, even if transport is available
◄ On-demand pick-up and drop-off service it leads to loss employment/ daily
to the healthcare facility for presumptive wages to reach health institution
and current TB patients

◄ For Pre-booking

Best Practices ◄ For sputum collection,

◄ Going to testing centers, medicine Progress

and Success Stories collection, follow-up visits and any other
TB hospital visits, 12 autos were in operation, 59
This ensures timely visits to the hospital individuals with TB symptoms were
free of cost thus supports to reduce Out-of- transported wherein all the 59 were
Pocket Expenditure (OOPE) tested and 8 were diagnosed for TB.
Introduction
India is now better prepared to address TB dimensions of health systems challenges,
better than ever before. It possesses advanced both unfinished and emerging.
and effective interventions and technologies
This chapter captures best practices and
for diagnosis, treatment and care of TB.
success stories designed and implemented
This includes mandatory notification of all
at various levels of health care delivery
TB cases, integration of the programme
as a response to a specific problem to
with the general health services (National
improve a health outcome or addressing
Health Mission), expansion of diagnostics
a programmatic dimension required for
services, programmatic management of drug
improved performance. This may include
resistant TB (PMDT) service expansion, single
(but are not limited to) innovations that
window service for TB-HIV cases, national
apply systems thinking to health problems
drug resistance surveillance and revision of
such as the use of information technology
partnership guidelines.
to strengthen continuum of TB cascade
NTEP further supports and encourages care and to addressing human resource
future endeavours on enabling and fostering shortages and challenges in capacity building,
innovations at all levels, through public and innovations that address the needs of
and private sector and addressing various the program.

121 INDIA TB REPORT 2022 INDIA TB REPORT 2022 122

Kerala TAMILNADU

SWEET (System for Workplace Post-COVID catch-up campaign for augmenting

Engagement to Eliminate TB) case-finding activities under NTEP- a programmatic
experience from Tamilnadu
Objective

◄ To promote awareness on TB prevention, screening and treatment across selected workplace Objective
◄ To advocate for and facilitate an environment that minimizes and prevents TB transmission
across selected workplace The TB disease notifications in the months of In this context, under the collaboration
◄ To support and facilitate early and free TB diagnosis across workplaces April and May (months of major lockdowns of Mission director - National Health Mission,
due to COVID waves) had declined by 63% in State and district TB Cell, WHO Consultants-
◄ To facilitate and ensure access to free TB drugs and adherence to all workers
2020 and by 52% in 2021, compared to the base Tamilnadu and Directorate of Medical Education
◄ To ensure care and support to all workforce post the completion of treatment
year of 2019. Certain mathematical modelling (DME) institutions, a short study among
◄ To advocate and facilitate a stigma free environment for accessing TB associated services
studies have predicted an increase in TB post-COVID individuals under programmatic
notifications as well as mortalities due to TB settings was planned and conducted in
Activities
during the post-pandemic (Global TB report 4 districts – Chennai, Kanniyakumari,
◄ Collected the list of prominent workplaces, industries with numbers of employees working 2020). Also, evidence is gaining globally on the Thoothukudi and Tiruvannamalai of Tamil
there from the District Labour Office. interactions between COVID and TB as well Nadu between last week of June-2021 to
◄ Identified 5916 work places, industries and 42358 workers throughout the state as other comorbidities which might increase August-2021 to understand the risk for TB
◄ Screened in 219 industries with 8956 workers. the risk for TB disease among the post-COVID among them and subsequently guide the
◄ Identified 465 presumptive TB cases and tested 256 from them and One individual diagnosed individuals. programme managers in developing policies.
to have TB and initiated the treatment
◄ State took initiative for Airborne Infection Control (AIC) measures in 60 workplaces
◄ 18 TB Survivors and 26 LSG heads participated in the workplace intervention.
Brief Methodology

In the above four districts, teams were formed from respective District TB Offices, WHO-
Conclusion
Consultants, and the respective medical colleges (Department of Thoracic Medicine
◄ SWEET program provides TB awareness, screening and treatment across selected workplaces. and Community Medicine, where available). The following activities were conducted:
◄ Education and support for AIC activities, modifications in the workplace and prevent TB ◄ Individuals affected with COVID between the months of March-May 2021 were
transmission across selected workplace.
contacted for consent through telephonic interview.
◄ Ensured care and support to the TB patient and provide free TB drugs.
◄ Those consented for the interview were requested to come to a nearby health
◄ Providing Periodic Sensitization of all workers and displayed IEC materials at workplaces.
facility for screening.
◄ Facilitate stigma free environment for accessing TB associated services
◄ SWEET program activities documented quarterly. ◄ In one group, everyone who visited was subjected to Chest X-Ray and Random
◄ A TB champion/socially committed volunteer is coordinating the activities. Blood Glucose. If eligible were requested to deposit a sputum sample for TRUNAT
testing for TB.

◄ In another group, symptoms were elicited and those found eligible were requested
to deposit a sputum sample for TRUNAT testing for TB.

◄ Information on comorbidities, treatment with steroids during their COVID illness in

the past as well as hospitalization for the same was elicited.

123 INDIA TB REPORT 2022 INDIA TB REPORT 2022 124

Results of the study
ASSAM
Response Rate:
Reaching out to the Tea Garden population and
A total of 5378 individuals who had been affected with COVID during the months of
March-June were contacted through telephonic interview for their consent to visit the
unreached (The Trans Gender Community) in Assam
nearby health facility for screening for TB through Chest X-Ray or symptom assessment. during Covid pandemic
Of which 25% (1210) of the individuals accepted to come to the facility. However, only
6.7% (358) of the individuals visited the facility for TB screening.
Problem Statement

◄ Identifying the TB cases of tea gardens

TB and related comorbidities
◄ Reaching the unreached community (The Trans
Gender Community)
◄ Total number of individuals diagnosed with TB: 11 (3.1%). 13% (11/ of the
Intervention
overall NAAT tests performed were positive.
◄ Total reported to have any symptoms (fever/cough/hemoptysis/loss weight/ ◄ Intersectoral Engagement with ABITA (Assam Branch
appetite): 124 (34%). of Indian Tea Association)
◄ Total number of individuals who underwent a sputum testing by TruNAAT: Progress
126(35%)
◄ 17 TB Detection Centers (TDC) have been established
◄ Total number of individuals having any Chest X-ray abnormality: 123 (34%).
at Tea Gardens. Resources like HR & Equipment were
◄ Total number of individuals having an abnormal Random Blood Sugar
provided by tea garden authorities. Lab consumables
(>140 mg/dl): 135 (38%).
supply chain management has been managed by
◄ Total self-reported to have past H/o Diabetes: 107 (29%).
NTEP.

◄ In addition to this, 3 TB detection centers were

Concluding remarks and potential for scale up made functional during the social isolation period
due to the COVID-19 pandemic.

◄ As a result that all tea gardens of Assam are now

◄ The yield for TB was higher among post-COVID-19 individuals as compared to
having TB treatment centers and 20 TDCs where tea
general active case finding campaigns conducted in the state.
garden workers along with nearby villagers of the
◄ Post-COVID-19 recovered individuals were found to be at a higher risk of developing
gardens are getting TB services.
TB disease and experiences from Tamilnadu shows that integrated testing for TB
among post-COVID-19 recovered population is feasible under the routine program ◄ Capacity building for tea garden workers and drivers
setting. on sputum collection drives were organized by
◄ TB case finding could be improved by including the same under vulnerable groups gardens in collaboration with NTEP.
for active case finding (ACF) campaigns. ◄ A training program on ill-effects of Tobacco and
◄ Also, it was found that many of the individuals had a residual lung abnormality awareness on TB and HIV was organized in Kamrup
through Chest X-Ray and symptoms which warrants guidance on rehabilitative (Metro) among the members of the transgender
support and regular screening either with radiological imaging, symptoms community.
screening or through microbiological (NAAT) testing for TB as the above findings
clearly shows that they are higher risk to TB per se because of COVID-19 illness or
due to other added co-morbidities and their drug-intake history.

125 INDIA TB REPORT 2022 INDIA TB REPORT 2022 126

Examples of Best Practices in Uttar Pradesh Examples of Best Practices in Uttar Pradesh

Involvement of Panchayati Raj Institution for TB Inclusion of ACF in Dastak Abhiyan

Elimination A massive door-to-door campaign was launched by the Government of Uttar Pradesh to ensure
While encouraging larger inter-departmental participation to promote multi-sectoral approach active case finding and eradication of communicable diseases.
towards TB elimination in Uttar Pradesh, the State TB Cell involved Panchayati Raj Institution (PRI) Frontline health workers team visited every house from door to door and screened the community
representatives especially newly elected Gram Pradhans in TB programmes. for symptoms of communicable diseases – Acute Diarrhoeal diseases, Influenza - H1N1, Dengue,
Initially, the State TB Cell (STC) approached Panchayati Raj Department to include TB programme Chikungunya, Acute Encephalitis syndrome, Japanese Encephalitis, Malaria, Kala Azar and
related activities in the Gram Pradhan induction training module. A five-pager TB module was Tuberculosis.
successfully developed to meet the purpose. The initiative witnessed the convergence of various departments such Panchayati Raj/ Municipal
The newly elected Gram Pradhans was sensitized at the block-level towards TB during their Corporation, Education, Agriculture and Animal Husbandry with Health and Family Welfare being
induction training conducted from September 16th, 2021 through October 31st, 2021. District TB nodal departments.
Officers/ NTEP District Coordinators in close collaboration with Panchayati Raj Department actively In this Marathon exercise, 1809 TB cases were diagnosed while 1791 patients were initiated with
discussed TB during induction training. Convincing role for stakeholders, frontline workers and treatment and introduced to Nikshay.
community at large to combat TB at the grass-root level were expected from Gram Pradhans out
It is worth to mentioning that Dastak Abhiyan commenced across seven districts of Gorakhpur
of these TB sensitisation sessions.
and Basti division focusing on Encephalitis in 2018. Later on, it was gradually extended to 18
Eventually, it encouraged Gram Pradhans to participate in Active Case Findings (ACFs) campaigns. districts in 2019. While 2020 witnessed its implementation across the entire 75 districts of Uttar
It is noteworthy to mention that Uttar Pradesh elects over 59,000 Gram Pradhans and probably Pradesh focusing on all communicable diseases including Tuberculosis.
the first state to conduct TB sensitisation sessions for all elected village representatives.

127 INDIA TB REPORT 2022 INDIA TB REPORT 2022 128

 Success story of Mr. Tuvitho Ngouri Success story of Mr. Chekhro Tsuha,
took the initiative to go for a check-up. Later When he started his medication, he vomited
on, it came to his notice that he was diagnosed every time he swallows a pill because he was
with active TB. The Doctor advised him to take taking them with only little amount of food
treatment and medication for six months. With as had no appetite. So, the doctor gave him
that, he started his treatment on 23 July 2019. some vitamins for his appetite which helped
For six months, he sincerely took TB antibiotics him to take the medicine. After few months of
which were given to him by the TB Active case his medication, he decided to go back home
finding group. He was not left alone with the with his parents and take proper rest but after
medication. However, the TB supervisors and getting home he was still having fever and
team which was send to his locality had done vomiting was not stopping, so, he was advised
a tremendous job by attending him when to to go and get another check up from the
take the dose, enquiring whether he was out Government TB centre so he went for another
of medication and needed more, and not checkup and did sputum test again. After the
forgetting the counselling, assuring that the results came in the Doctor told me that he had
disease was curable. With the help of the TB MDR-TB also known as multidrug resistant
Supervisor, he completed his treatment course TB, which is resistant to many different drugs
on 7 January 2020. And his final report came due to which he developed side effects from
out negative. Today, he is proud to say that the medication. After few months of the
he was completely healed from his TB disease medication the report for his culture test came
Mr. Tuvitho Ngouri age 46/ male from Meluri
because of the aid and service provided. He Mr. Chekhro Tsuha, 24 years old and a TB out to be negative but he had to continue his
Village, under Phek district of Nagaland. He
was grateful to the TB monitoring team and survivor from Dimapur, Nagaland. A few years medication and complete the course as to
is delighted to share his battle with TB and
supervisors who assiduously worked and ago, he moved to Chennai for his higher studies. prevent from getting infected again in the
success of healing. Well, to begin with his short
offered constant provisions to him to be After some few years of moving in to Chennai, future. After 18 months long of treatment, his
struggle with the disease. He was struggling
cured. Today, people’s fear has increased in he realized that he was not feeling well. He final culture test which came out as negative
for several months with fluctuation of weight
due course of time because of many kinds was coughing a lot and he had no appetite and he was declared cured. After having TB, he
and often my body feels sluggish. Sometimes
of sickness. Likewise, people are aware of and also his chest was hurting. So, he decided now appreciates being healthy much more, TB
his body used to sweat a lot and he was off with
TB being contagious, most TB patients face to go for a check up to the hospital where he changed his life. It has humbled him as well as
fever for several months. Later on, he started
discrimination and criticism. Due to this issue, did his Chest X-ray, CT scan and Sputum test. enriched him as a person, teaching how much
to cough but he thought it was a normal flu,
some don’t go for a check-up, some because of He was given medicines for some few days we have to be thankful for. He felt like, he can
like any other day. However, it prolonged for
ignorance and some with many other reasons. until the result of his test came in. So, after now relate to the suffering of so many people
a long period of time. He took some coughing
However, he would encourage people not to a week he returned to the hospital to collect in around the world who have TB and hope
syrup, pain-killer like every person would do
live in fear of TB patients because it is curable his result and it came out to be TB positive. more will be done to not just treat the disease,
but it only reduced the pain for a few days and
disease. And to those who are fighting with The doctor then told him that the medication but treat the person - providing nutritional
the same sickness used to occur again like a
TB do not lose hope but sincerely receive for TB treatment is usually six months so he and emotional support. He believes that could
cycle of sickness. One day, a group of TB Active
treatment and medication. got scared at first because it felt like forever. give people with TB the hope they need.
case founders came to his locality and he also

129 INDIA TB REPORT 2022 INDIA TB REPORT 2022 130

 Technological
breakthroughs
to reduce
TB incidence RESEARCH AND
rates INNOVATIONS

131 INDIA TB REPORT 2022

11 INDIA TB REPORT 2022 132
 ◄ A TB vaccine that is effective before ◄ Innovative strategies to address broader
and after exposure, as well as across a determinants of TB infection and disease.
wide-range of age groups and geographical
settings and

Keeping in view the recommendations of the Joint Monitoring Mission (JMM) 2019 with respect
to the third pillar of NSP 2017-25 on research & innovations, the programme is collaborating with
the different stakeholders like ICMR, DBT, DST & SERB-DST towards augmenting development of
additional new tools required to end TB as well as reinforcing the rapid uptake of available tools
and products. These can be varied – such as simple triage/screening, use of non-sputum clinical
specimens for accurate bacteriologic diagnosis of extrapulmonary and pediatric TB, simpler/
safer/shorter universal curative TB treatment regimens and rapid scale up of available tools,
such as novel specific skin tests (e.g., C-TB) for diagnosing latent TB, automated digital chest
x-ray interpretation and newer drugs/regimens, all of which in line with and based on the latest
global guidance.

Implementation Arrangements
Research and The National TB Elimination Programme supports Operational Research (OR) under the guidance

Innovations
of a task force mechanism at State and National levels. The Global scientific evidence as well
as evidence from the in country OR studies help bring in periodical changes in policies and
programme management practices.

National Operational Research Committee (NORC)

Introduction A National OR Committee meeting was held
Tuberculosis research and development are critical for meeting the under the Chairmanship of Dr D.C.S. Reddy
global TB targets set out in the United Nations’ Sustainable Development (Chairman National OR Committee) from 7th
Goals (SDGs) and the World Health Organization’s End TB Strategy. to 9th December 2021 consequent to the OR
A substantial technological breakthrough will be necessary to dramatically accelerate call given out in November 2020. 65 proposals
the rate at which tuberculosis incidence reduces relative to previous levels. “Intensified were received of, which 36 were considered
research and innovation” are the third pillar of the End TB Strategy. SDG 3b calls for funding based on NTEP priorities, scoring and selection
research on new vaccines and medicines for communicable and non-communicable criteria.
diseases that disproportionately affectdeveloping nations.
Collaboration with other stakeholders (ICMR, DBT,
To end the TB epidemic in India, we need:

◄ Affordable and accessible diagnostics, which ◄ Shorter, safer, and more effective regimens
DST, SERB-DST)
are rapid point-of-care tests for detecting for treating TB infection, drug-susceptible Various National entities such as Indian Council Engineering Research Board (SERB-DST) are
TB infection and disease, including presence of TB, and drug-resistant TB of Medical Research (ICMR) through India TB actively engaged in research based on the
drug resistance if any. Research Consortium (ITRC), Department priorities articulated by NTEP.
of Biotechnology (DBT), Department of Key research activities undertaken in the year
Science & Technology (DST) and Science and 2020-21 are as follows:

133 INDIA TB REPORT 2022 INDIA TB REPORT 2022 134

◄ Diagnostics negative impacts of COVID-19 on TB healthcare services, and to use mathematical modelling
to estimate the impact of COVID-19 and COVID-19 response measures, on TB incidence and TB
▼ Validation studies for a few diagnostic ▼ Modified BPaL regimen (BDQ, associated mortality, and model the impact of “recovery” measures. This study is done by AIIMS,
equipment viz., TB detection kit, TB Pretomanid and Linezolid), a three-year New Delhi in collaboration with the Central TB Division and is supported by the Department of
sample concentration and transport study was initiated in October 2021 as a Science & Technology.
kit, TB DNA extraction kit etc., which pilot in 10 sites across the country.
are aimed at conducting point of care
▼ End TB trial – is a multi-country trial on
tests to address challenges in sample
shorter (6-9 month) regimen for MDR-TB.
Innovations
transport.
Artificial Intelligence (AI) holds great promise for improving the delivery of healthcare and
▼ A multi-state validation study of C-TB
◄ Vaccines medicine worldwide. AI, especially in the case of TB, can assist in increasing the accuracy of
skin test to detect TB infection.
A study on the utility of r-BCG for diagnosis, screening for disease and support diverse public health interventions, such as disease
▼ Blood based triage test (POC)- Supported surveillance, outbreak response, and health systems management.
prevention of disease among house-
by Department of Biotechnology.
hold contacts was initiated by ICMR.
12,722 participants were enrolled in Key initiatives undertaken are:
◄ Therapeutics three arms, (1) Immuvac (2) VPM1002
▼ HICON-R study- High dose of Rifampicin (recombinant BCG) and (3) Placebo. At the ◄ Automated reading of Chest X ray: The ◄ An AI solution to detect TB from Cough
(25mg/kg) in comparison to the end of one year of follow up, the safety CTD in collaboration with NIC and ICMR sounds and Voices.
conventional regimen of 10 mg/kg. of both vaccines has been established. is developing this AI solution to detect TB
◄ An AI solution is being developed to screen
related changes from X-Ray images
for TB from cough sounds and voices with
▪ BEAT (Building Evidence for Advance
◄ Implementation Research ◄ Automated reading of LPA strips: LPA the support of WIAI.
treatment against Tuberculosis)
The Science & Engineering Board, is one of the critical tools for DST of TB
study – using Bedaquiline, Delamanid, ◄ Chatbot: A chatbot has been developed
DST (SERB-DST) is supporting NTEP in patients. The solution is in the final stages
Linezolid and Clofazimine, to reduce in collaboration with NIC for providing
mathematical modelling for TB and for the of development and work is in progress
XDR TB treatment to 6 – 9 months from information on TB, Treatment of TB and
various studies being undertaken on the towards integration into Nikshay with the
available TB services under NTEP.
the current duration of 18 months. support of Wadhwani Institute of Artificial
basic biology and other research studies.
Intelligence (WIAI).

BRICS Multi-country study, as part of BRICS-STI ◄ Prediction of Lost to follow up: An AI

framework program algorithm to identify patients who are

potentially at risk for not being able to
complete the full course of treatment is
BRICS multi-country project titled
being developed with the support of WIAI.
‘Epidemiological impact and intersection of
This can allow the health system/ treatment
the COVID-19 and tuberculosis pandemics
supporters to focus more on such patients
in Brazil, Russia, India and South Africa’
right from treatment initiation, thus
(IMPAC19TB) a multi-country study is being
assisting implementation of Differentiated
undertaken with the objective to estimate
TB care.
differential losses along the TB care cascade
attributable to COVID-19, the impact of
COVID-19 on trends in mycobacterium
tuberculosis population structure, determine
the effect of TB on patient-level COVID-19
outcomes, to determine programme and other
in-country response measures to mitigate the

135 INDIA TB REPORT 2022 INDIA TB REPORT 2022 136

Putting proper
financial
management
at the HEALTH
forefront of FINANCING
health policies

12
 Institutional Arrangements
The Central TB Division, being a part of the State and district levels, the State TB
the National Health Mission (NHM) holds Cell and the District TB Centre are
the overall responsibility of the financial responsible respectively.
management of the program. Similarly, at

Budget
Program expenditures are budgeted under the Demand for Grants of the MoHFW Flexible Pool
for Communicable Diseases funding arrangement. These are reflected in two separate budget
lines- General Component (GC) and Externally Aided Component (EAC).

◄ Fund Flow and Releases: The fund flow ◄ Accounting: The accounting records for
remains within the existing financial all payments are made against approved
management system of the MoHFW, which budget. Budget lines are maintained by the
operates through the centralized Pay Principal Accounts Officer and compiled
and Accounts office. Release of funds to by the Controller General of Accounts
States is done in installments through (CGA). The compiled monthly accounts
State Treasury. are reconciled with the CTD record
of transactions.
◄ Sanctions & Approvals: All procurements
of commodities are processed by the ◄ Financial Reporting: A financial report is
Central Medical Services Society (CMSS), submitted by the CTD to MoHFW and the
an autonomous society under MoHFW, donors like The Global Fund and World
the Government of India approved by the Bank on periodic intervals based on the
Cabinet. All fund releases for commodity compiled monthly accounts and the CTD’s
advances for approved contracts are own record of expenditures.

Health
routed through the Integrated Finance
◄ External Audit: The audits are being
Division (IFD) and processed by the
conducted as per the standard terms of

Financing
Drawing and Disbursing Office (DDO) and
reference. The audit reports are being
Pay and Accounts Office (PAO). All the
made available to all donors as per the
program expenditures follow the standard
agreement. At State-level audits are
government systems of the PAO and
being done as per State NHM manual and
are subject to control as per the General
guidance for audit by empaneled chartered
Financial Rules (GFR) of the Government
Introduction of India. Payments are made through
accountancy firms. All the States are
required to submit the annual audit report
National TB Elimination Programme is a guidelines available on the programme electronic funds transfer through treasury
to CTD by 30th September.
centrally sponsored scheme under NHM website (Financial Manual for NTEP). The since the financial year 2014-2015.
to implement the programme activities financial management arrangements to
as envisaged under NSP 2017-25 as per account for and report on program funds,
NTEP guidelines. includes both Domestic Budgetary Support
(DBS) and External Aided Component (EAC).
The procedures for the financial management
The arrangements are as follows:
are being followed as per the manuals and

139 INDIA TB REPORT 2022 INDIA TB REPORT 2022 140

Financial Performance of NTEP Budget alloted in PIP 2021-22(%)

(Rs. in crores)

2.04%
6.17%
Description 2016-17 2017-18 2018-19 2019-20 2020-21 2021-22 Total

Budget Requested 1000.00 2200.00 4115.00 3525.00 3554.00 3628.85 18022.85

14.71%
33.48%
Budget Estimates/
640.00 1840.00 3140.00 3333.21 3109.93 3409.94 15473.08 0.56%
Approved Budget
0.56%
Total Releases to 2.10%
533.17 871.36 907.65 870.81 629.71 480.35 4293.05 1.28%
States
0.34%
2.05% 0.36%
Total Expenditure 677.78 2759.44 2237.79 3130.11 3097.98 1811.91 13715.01
8.50%
*Till 11th March 2022 25.22% 2.00%

Program Implementation Planning

◄ Introduction ◄ Achievements in 2021

▼ Programme Implementation Plan (PIP) ▼ NTEP PIP guidance document to support

of NTEP is an integral part of the NHM States/UTs on Planning NTEP activities
and it is the most crucial instrument by in alignment with NHM PIP template
which States submit their costed plans has been developed and disseminated. External Aided Component (EAC)
and propose strategies, activities & Rs. 2516.82 crores have been recommended
World Bank - Program Towards Elimination of Tuberculosis (PTETB)
receive resources under the NHM. with approval of competent authority.
◄ Introduction ◄ Implementation Arrangements
▼ State-specific TB elimination plans are ▼ Additional Rs. 25.48 crores have been
aligned with the National strategic recommended in Supplementary PIP
GoI, has engaged with World Bank project The PTETB was carved out of the NSP by
plan 2017-2025. All Key Activities as per for four States.
PTETB (PI 67523) (Loan No. 8926) and availed result area, geographical area with the
the NSP are distributed with 37 FMR
an International Bank for Reconstruction selection of priority States and timeframe.
codes under 18 budget heads of the
and Development (IBRD) loan of USD 400 The program focuses on four result areas
Planning tool.
million to advance progress toward priority (PfR) and these results areas are inter-
◄ Way Forward outcomes of the NSP 2017-25. IBRD linked and mutually reinforcing:
financing is US$400 million or 30 percent of ▪ scaling up private sector engagement
▼ NTEP PIP guidance note has been 15th Finance Commission, PM ABHIM the total program cost estimate of US$1.334
Rolling out TB patient management
updated as per simplified two-year PIP and ECRP. billion. The GOI will finance the remaining
and support interventions;
matrix (2022-23 and 2023-24) of NHM 70 percent. The full GOI request for IBRD
▼ Mid-Term Reviews are planned at ▪ Strengthening diagnostics and
and circulated with all States and UTs financing for the period 2019 to 2025 is
the end of every quarter to provide management of DR-TB; and
US$500 million and the remaining US$100
▼ The programme division has prepared course corrections in case of shifting
million requested by GOI will be considered ▪ Strengthening the NTEP (then,
District Health Action Plan along with of priorities.
by the World Bank by March 2022. RNTCP) institutional capacity and
the key interventions in alignment with
information systems.

141 INDIA TB REPORT 2022 INDIA TB REPORT 2022 142

 Result Area 3: Strengthening The Program will help the GOI build the
Detection, Treatment, and Monitoring institutional capacities required to succeed.
Considering the estimated TB burden and the gap between private notifications and
of Drug-Resistant TB (US$70 Million) Three DLIs will be used to incentivize this
estimated TB burden, the GOI selected nine States for the participation in the program:
results area. The prior result #4.0 will be
Uttar Pradesh, Maharashtra, Bihar, Rajasthan, Madhya Pradesh, Karnataka, West Bengal, Assam, The aim is to scale-up DR-TB interventions in
about a Nikshay mechanism for deduplication
and Tamil Nadu. India to aggressively respond to the complex
(of patients and providers) and reconciliation
and costly DR-TB challenge.
of different provider types. DLI#4.1 will be
Under this Results Area, DLI#3.1 will about human resources for health in TB.
Program Financing
incentivize rifampicin susceptibility testing for DLI#4.2 will be about the development and
1600 TB patients. roll-out of a performance-based management
1400 1334
scheme between the central government
1200 and States. The amounts included under
Result Area 4: Strengthening RNTCP
1000 934 the DLI#4.2 only serve as incentives under
Institutional Capacity and Information
the Program. These amounts will not match
800 Systems (US$93 Million)
the exact amount of performance-based
600 management incentives paid by CTD to States.
400 The transformative nature of India’s NSP and
400 World Health Organization (WHO) has been
the scale of its ambition are unprecedented
200 among countries with high burdens of TB. appointed as Independent Verification Agency
0 (IVA) for verifying programmatic DLIs.
Amount (US$ million)

Total Program Cost GoI IBRD

Achievements in 2021
◄ 10 Technical Support Units (TSUs) have Indicators (DLIs) achievements has been
Result Area 1: Scaling-up Private Result Area 2: Rolling out TB been established under this project. One completed in December 2021. Subsequent
Provider Engagement (US$176 Million) Patient Management and Support National TSU and 9 State TSUs were made to this Central TB Division has submitted
Interventions (US$60 Million) functional by December 2021. the revised claim of (USD 103.96 million) to
The aim is to scale up private sector World Bank.
◄ In line with Result Area 4 of PTETB, Human
engagement to ensure timely diagnosis and TB control outcomes depend on whether
Resource Plan and Capacity Building ◄ 66% (USD 267.16 million) of total project
notification and effective management of TB TB patients seek care early and adhere
Plan for NTEP has been developed with cost has been submitted for disbursement
among patients in line with Standards of TB to treatment. Thus, the GOI is rolling out
the support of National Health Systems in year 2 itself.
Care in India. TB patient support as one of its strategic
Resource Centre and same has been
Four Disbursement Linked Indicators (DLIs) interventions to eliminate TB. ◄ Program Division is performing well in most
approved for further implementation.
will be used to incentivize this results area. Prior of the DLIs, 6 DLIs out of total 10 DLIs have
Three DLIs will be used to incentivize this Dissemination of HRH operational Plan
result #1.0 will be about revision of national achieved the final year targets in 2nd year
results area. Prior result #2.0 will be about the findings to the all States/UTs during
guidelines for engagement with private itself. Hence full claim has been submitted
development of information systems modules the National Consultative Workshop in
providers. DLI# 1.1 and DLI# 1.2 are related to for disbursement.
in Nikshay 2.0 to enable implementation of October 2021.
results in TB notifications, management, and ◄ Implementation Mission by the World Bank
the DBT schemes. DLI#2.1 will be about rolling
treatment outcomes by private providers. DLI# ◄ Program Division prepared the claim
out digital payment and certification systems is undertaken biannually to understand
1.3 will be about institutional strengthening to for year 2 results by analyzing the
at district level for processing DBT payments the technical and financial implementation
support private sector engagement. The GOI achievements of DLIs to WHO which is the
to patients and private providers. DLI#2.2 will progress of PTETB. Last Biannual
will provide incentives to private providers Independent Verification Agency (IVA) and
be about the proportion of patients receiving Implementation Mission was held on
who notify TB patients. IVA has completed the verification process
DBT through Nikshay. July 2021.
for year 2 claim on Disbursement Linked

143 INDIA TB REPORT 2022 INDIA TB REPORT 2022 144

 Actual Claim The Global Fund to Fight AIDS, Tuberculosis and
450 Malaria (GFATM)
400 400
The Global Fund has been a long-standing partner, supporting the National Tuberculosis
350
Elimination Programme (NTEP) in reducing TB burden of the country. As a part of the Global
300 267.16
Fund grant of USD 201 million, received by Central TB Division for grant period January 2018 to
250 163.2 March 2021, division successfully implemented high impact program activities across the country
200 including procurement of Second Line Drugs, newer drugs (Bedaquiline), rapid molecular
190
150 41 diagnostics (CBNAAT & TrueNat), CBNAAT cartridges and TrueNat chips, digital X-ray machines,
100 110 AMC services for the diagnostic equipment, technical support to strengthen Public Financial
50 41 Management Services, Operational Research, ACF in vulnerable groups and counselling support
0 to DR-TB patients.
Q1 Year 1 Year 1 Year 2 Year 3 Year 4 Year 5
(2019) (2019) (2020) (2021) (2022) (2023) Fostering the partnership, the Global Fund has allocated USD 200 million grant to Central TB
Division for next three years i.e. from April, 2021-March, 2024, under Payment for Result modality
(PfR), allowing high degree of flexibility for the National Program to focus on impact and

PTETB Technical Assistance (TA) Facility achievement of results, and autonomy to focus on health outcomes. The entire grant is tied with
three Disbursement Linked Indicators related to achievement of MDR/RR TB-notification and
The World Bank executed TA trust fund facility with BMGF funding was established in December treatment outcome; and increase in presumptive TB testing through rapid molecular diagnostics
2020. The TA will leverage the World Bank comparative advantage and global expertise against the set targets.
to strengthen the NTEP and State capacity to carry forward bold policy, managerial and
As part of current Global Fund Grant 2021-2024, Central TB Division has engaged following Sub-
implementation reforms through capacity building and knowledge sharing. The objectives for TA
Recipients to supplement NTEP efforts:
facilities are as follows:
◄ National Institute for Research (NIRT): ◄ Tata Institute of Social Sciences (TISS):
(i) Deploy targeted, just-in-time TA in critical areas to strengthen the GOI’s execution of PTETB
NIRT has been roped in to strengthen TB TISS will continue supporting NTEP through
interventions at central and, State levels;
surveillance under National Tuberculosis Saksham Pravaah project as the Sub
(ii) generate evidence to inform policy decisions and mid-course adjustments; and Elimination Programme by undertaking Recipient to strengthen DRTB treatment
District Level Annual Survey and District and adherence support through psycho-
(iii) facilitate learning and knowledge exchanges between India and other peer countries.
Level Sentinel Survey (DLSS). The project social counseling services and other
aims to provide sub national level social protection and nutrition linkages

Way Forward measure of TB burden of newly diagnosed

bacteriological pulmonary cases, level of
in four States i.e. Maharashtra, Gujarat,
Karnataka and Rajasthan. Another crucial
The World Bank and Central TB Division have identified the following areas for TA support: underreporting and annual trend of TB component of project is to transition
prevalence and incidence. NIRT through counselling services to NTEP staff (STS and
◄ NTEP HRH operational staff plan and TA ◄ Review and documentation of technical and
DLAS will also support the CTD in verification TBHV) through their capacity building by
to CTD and select States in HRH planning, implementation lessons and experiences
of State/district claims for awarding a creating a pool of Master trainers across
recruitment, and deployment; Four States of the CTD’s roll-out of performance
National Certification of progress towards the Country.
viz., West Bengal, Bihar, Maharashtra and incentives to States in line with the
TB free status.
Madhya Pradesh have been identified for TB index; private sector scale-up; and
TA support for operationalizing HRH Plan. DBT experiences.

145 INDIA TB REPORT 2022 INDIA TB REPORT 2022 146

Annexures

Table of Contents

Annexure Title Page Annexure Title Page

1.1 Presumptive TB cases examination 151 3.1 Treatment outcome of TB patients notified in 2020 (Public Sector) 175

1.2 TB case notification 153 3.2 Treatment outcome of TB patients notified in 2020 (Private Sector) 177

1.3 Notified TB patients characterstics 155 3.3 Treatment outcome of TB patients notified in 2020 (Total) 179

1.4 Patient transfer status 157 3.4 Treatment outcome of new TB patients notified in 2020 (Public Sector) 181

Treatment outcome of previously treated TB patients notified in 2020

1.5 Paediatric TB cases notification and treatment initiation Status 158 3.5 183
(Public Sector)
Treatment outcome of TB - HIV patients notified in 2020 (Public
1.6 Tribal TB cases notification and treatment initiation Status 159 3.6 185
Sector)
Gender disaggregated data on total TB notification, Pediatric TB Treatment outcome of TB - HIV patients notified in 2020 (Private
1.7 161 3.7 187
notification and treatment inititaion Sector)

1.8 Gender disaggregated data on treatment outcomes 162 3.8 Treatment outcome of TB - HIV patients notified in 2020 (Total) 189

Treatment outcome of paediatric TB patients notified in 2020 (Public

2.1 TB - HIV 163 3.9 191
Sector)
Provider initiated testing and counselling among presumptive TB Treatment outcome of paediatric TB patients notified in 2020 (Private
2.2 164 3.10 193
patients and paediatric TB patients Sector)

2.3 Intensified TB case finding activities in ICTC centres 165 3.11 Treatment outcome of paediatric TB patients notified in 2020 (Total) 195

2.4 Intensified TB case finding activities in ART centres 166 3.12 Treatment outcome of male TB patients notified in 2020 197

2.5 TB - Diabetes 167 3.13 Treatment outcome of female TB patients notified in 2020 199

2.6 TB - Tobacco 169 3.14 Treatment outcome of transgenders TB patients notified in 2020 201

2.7 TB - Alcohol 171 3.15 Treatment outcome of tribal TB patients notified in 2020 203

2.8 TB - COVID 173 4.1 PMDT infrastructure 205

2.9 TB - Pregnancy 174 4.2 Testing in TRUNAAT 207

4.3 Testing in CBNAAT 209

147 INDIA TB REPORT 2022 INDIA TB REPORT 2022 148

Annexures

Table of Contents

Annexure Title Page Annexure Title Page

TB Preventive Treatment (TPT) among eligible HHC children <5year

4.4 Testing in line probe assay (LPA) 211 7.4 245
[2021] plus eligible HHC>/=5year [Jul to Dec 2021]

4.5 Testing in culture and DST (CDST) 213 8.1 State level - Program staffing status in 2021 247

4.6 Laboratory Infrastructure 215 8.2 STDC - Program staffing status in 2021 249

4.7 MDR/RR TB diagnosed in 2021 219 8.3 IRL - Program staffing status in 2021 251

4.8 MDR/RR TB diagnosed with additional resistance in 2021 221 8.4 CDST - Program staffing status in 2021 253

4.9 Pre XDR, XDR & H-mono/poly resistance TB diagnosed in 2021 223 8.5 DRTB Centre - Program staffing status in 2021 255

Treatment outcome of MDR/RR TB patients initiated on shorter MDR-

4.10 225 8.6 District Level - Program staffing status in 2021 257
TB regimen (inj containing) during 2020
Treatment outcome of H- mono/poly resistance TB patients initiated
4.11 227 8.7 Medical college - Program staffing status in 2021 259
on treatment during 2020
Treatment outcome of MDR/RR TB patients initiated on longer oral M/
4.12 229 9 Nikhay Poshan Yojana 261
XDR-TB regimen during 2019
Treatment outcome MDR/RR TB patients with / without additional
4.13 231 10 Key Program Reviews done from the National level in the year 2021 263
resistance initiated on treatment in 2019

4.14 Treatment outcome of XDR TB patients initiated on treatment in 2019 233

5.1 Private health facilities registration status 235

Private health facilities that have notified atleast one TB Patient

5.2 236
during the year 202

6 Active case finding 237

7.1 Contact tracing for pulmonary bacteriologically confirmed TB in 2021 239

TB preventive treatment among eligible Household contacts of

7.2 241
Pulmonary Bacteriologically Confirmed TB <5 years of age [2021]
TB preventive treatment among eligible Household contacts of
7.3 Pulmonary Bacteriologically Confirmed TB ≥5 years of age [Jul to Dec 243
2021]

149 INDIA TB REPORT 2022 INDIA TB REPORT 2022 150

1.1 Presumptive TB cases examination

Presumptive TB Cases examination Presumptive TB Cases examination

Population Number Needed to Test by
Number examined by Number examined by
State 2021 Rate* (per lakh
(in lakhs) NAAT Total (% of population)
Microscopy CBNAAT Truenat Total Microscopy NAAT
total tested)
Andaman & Nicobar Islands 4 4588 323 1113 1436 (23.8%) 6024 1,542 33 6
Andhra Pradesh 529 270481 66940 413065 480005 (64.0%) 750486 1,419 71 40
Arunachal Pradesh 17 8154 3023 6124 9147 (52.9%) 17301 1,038 7 16
Assam 355 110846 13317 1915 15232 (12.1%) 126078 355 9 4
Bihar 1,271 318041 22291 40501 62792 (16.5%) 380833 300 14 6
Chandigarh 12 11203 3007 184 3191 (22.2%) 14394 1,213 7 6
Chhattisgarh 305 146736 27731 40198 67929 (31.6%) 214665 703 15 8
Dadra and Nagar Haveli and
8 11502 3168 1198 4366 (27.5%) 15868 1,915 27 9
Daman and Diu
Delhi 193 102802 11944 18824 30768 (23.0%) 133570 692 7 4
Goa 16 58 7116 6280 13396 (99.6%) 13454 868 12 11
Gujarat 708 803728 24170 61476 85646 (9.6%) 889374 1,256 20 10
Haryana 299 175602 20540 24152 44692 (20.3%) 220294 737 10 5
Himachal Pradesh 76 99539 31620 25230 56850 (36.4%) 156389 2,066 19 11
Jammu & Kashmir 148 163371 11907 19950 31857 (16.3%) 195228 1,323 44 9
Jharkhand 402 162810 15403 24343 39746 (19.6%) 202556 504 9 5
Karnataka 724 336786 43696 158000 201696 (37.5%) 538482 743 24 11
Kerala 346 89664 43674 94758 138432 (60.7%) 228096 660 20 14
Ladakh 3 1546 2277 151 2428 (61.1%) 3974 1,137 22 35
Lakshadweep 1 0 64 981 1045 (100.0%) 1045 1,572 NA 21
Madhya Pradesh 857 560826 16270 57623 73893 (11.6%) 634719 741 11 8
Maharashtra 1,272 863458 152089 43309 195398 (18.5%) 1058856 832 22 2
Manipur 32 7710 5764 174 5938 (43.5%) 13648 431 17 7
Meghalaya 37 15747 6595 1479 8074 (33.9%) 23821 637 12 6
Mizoram 13 4843 2836 0 2836 (36.9%) 7679 600 18 6
Nagaland 21 8003 7041 794 7835 (49.5%) 15838 761 8 6
Odisha 468 795396 38278 40380 78658 (9.0%) 874054 1,867 31 8
Puducherry 15 11070 3826 515 4341 (28.2%) 15411 1,011 9 5
Punjab 310 106845 19888 12575 32463 (23.3%) 139308 449 7 4
Rajasthan 812 438494 21004 33231 54235 (11.0%) 492729 607 9 6
Sikkim 7 7104 4653 1161 5814 (45.0%) 12918 1,952 17 8
Tamil Nadu 824 650499 36156 98991 135147 (17.2%) 785646 953 19 9
Telangana 382 191017 21751 40953 62704 (24.7%) 253721 664 13 9
Tripura 40 15274 3270 4992 8262 (35.1%) 23536 590 13 11
Uttar Pradesh 2,361 907245 73989 187842 261831 (22.4%) 1169076 495 8 5
Uttarakhand 118 65282 5027 8533 13560 (17.2%) 78842 668 7 8
West Bengal 1,009 812795 50552 91939 142491 (14.9%) 955286 947 21 8
INDIA 13,993 8279065 821200 1562934 2384134 (22.4%) 10663199 762

151 INDIA TB REPORT 2022 INDIA TB REPORT 2022 152

1.2 TB Case Notification

Target TB patients expected to be notified TB patients notified (Achievement against target %) TB case notification rate
State/UT
Public Private Total Public Private Total Public Private Total
Andaman & Nicobar Islands 590 10 600 502 (85%) 5 (50%) 507 (85%) 128 1 130
Andhra Pradesh 90000 25000 115000 62100 (69%) 24732 (99%) 86832 (76%) 117 47 164
Arunachal Pradesh 3450 50 3500 2710 (79%) 14 (28%) 2724 (78%) 163 1 163
Assam 51100 11000 62100 29389 (58%) 8252 (75%) 37641 (61%) 83 23 106
Bihar 90000 100000 190000 61467 (68%) 70236 (70%) 131703 (69%) 48 55 104
Chandigarh 6900 600 7500 4220 (61%) 500 (83%) 4720 (63%) 356 42 398
Chhattisgarh 35000 20000 55000 23644 (68%) 8772 (44%) 32416 (59%) 77 29 106
Dadra and Nagar Haveli and Daman and Diu 1450 150 1600 948 (65%) 65 (43%) 1013 (63%) 114 8 122
Delhi 80000 30000 110000 67726 (85%) 35312 (118%) 103038 (94%) 351 183 534
Goa 2400 800 3200 1648 (69%) 370 (46%) 2018 (63%) 106 24 130
Gujarat 128000 67000 195000 92888 (73%) 51843 (77%) 144731 (74%) 131 73 204
Haryana 60000 34000 94000 45741 (76%) 23342 (69%) 69083 (73%) 153 78 231
Himachal Pradesh 13500 1500 15000 12997 (96%) 1495 (100%) 14492 (97%) 172 20 191
Jammu & Kashmir 10900 3100 14000 9458 (87%) 1368 (44%) 10826 (77%) 64 9 73
Jharkhand 43000 22000 65000 35146 (82%) 17033 (77%) 52179 (80%) 87 42 130
Karnataka 80000 55000 135000 52922 (66%) 19513 (35%) 72435 (54%) 76 28 104
Kerala 22000 6000 28000 15364 (70%) 6508 (108%) 21872 (78%) 44 19 63
Ladakh 460 100 560 280 (61%) 11 (11%) 291 (52%) 80 3 83
Lakshadweep 20 0 20 12 (60%) NA 12 (60%) 18 0 18
Madhya Pradesh 150100 90000 240100 110814 (74%) 55532 (62%) 166346 (69%) 129 65 194
Maharashtra 160000 110000 270000 110136 (69%) 89840 (82%) 199976 (74%) 87 71 157
Manipur 2500 1000 3500 1251 (50%) 542 (54%) 1793 (51%) 39 17 57
Meghalaya 5250 750 6000 3281 (62%) 871 (116%) 4152 (69%) 88 23 111
Mizoram 3850 150 4000 1480 (38%) 269 (179%) 1749 (44%) 116 21 137
Nagaland 4250 750 5000 2924 (69%) 724 (97%) 3648 (73%) 141 35 175
Odisha 55000 10000 65000 45047 (82%) 7334 (73%) 52381 (81%) 96 16 112
Puducherry 4400 100 4500 3396 (77%) 48 (48%) 3444 (77%) 223 3 226
Punjab 52000 20000 72000 35870 (69%) 14272 (71%) 50142 (70%) 116 46 162
Rajasthan 152200 72800 225000 103011 (68%) 46214 (63%) 149225 (66%) 127 57 184
Sikkim 1480 170 1650 1272 (86%) 101 (59%) 1373 (83%) 190 15 206
Tamil Nadu 90000 55000 145000 64456 (72%) 18367 (33%) 82823 (57%) 78 22 100
Telangana 49200 32800 82000 41484 (84%) 19230 (59%) 60714 (74%) 109 50 159
Tripura 3450 50 3500 2433 (71%) 110 (220%) 2543 (73%) 61 3 64
Uttar Pradesh 375000 225000 600000 314042 (84%) 139670 (62%) 453712 (76%) 133 59 192
Uttarakhand 20300 11700 32000 17290 (85%) 5499 (47%) 22789 (71%) 147 47 193
West Bengal 105000 35000 140000 69352 (66%) 21135 (60%) 90487 (65%) 69 21 90
INDIA 1952750 1041580 2994330 1446701 (74%) 689129 (66%) 2135830 (71%) 104 49 153
TB Patients Notification is based on notification by diagnosing PHI.

153 INDIA TB REPORT 2022 INDIA TB REPORT 2022 154

1.3 Notified TB Patients - Characteristics

Type of Case Site of disease Basis of Diagnosis Diagnostic Test

State/UT Previously Extra Bacteriologically Clinically Molecular
New DRTB Pulmonary Microscopy Chest X-ray Others
Treated Pulmonary Confirmed Diagnosed Tests
Andaman & Nicobar Islands 437 (86.2%) 35 (6.9%) 35 (6.9%) 294 (58%) 213 (42%) 283 (56%) 224 (44%) 146 (29%) 137 (27%) 86 (17%) 138 (27%)
Andhra Pradesh 74857 (86.2%) 9403 (10.8%) 2572 (3.0%) 64910 (75%) 21922 (25%) 43878 (51%) 42954 (49%) 3992 (5%) 39834 (46%) 25564 (29%) 17442 (20%)
Arunachal Pradesh 2235 (82.0%) 313 (11.5%) 176 (6.5%) 1708 (63%) 1016 (37%) 1677 (62%) 1047 (38%) 503 (18%) 1174 (43%) 483 (18%) 564 (21%)
Assam 33370 (88.7%) 3520 (9.4%) 751 (2.0%) 27699 (74%) 9942 (26%) 16080 (43%) 21561 (57%) 11462 (30%) 4604 (12%) 12768 (34%) 8807 (23%)
Bihar 119930 (91.1%) 8942 (6.8%) 2831 (2.1%) 106915 (81%) 24788 (19%) 38859 (30%) 92844 (70%) 18553 (14%) 20218 (15%) 76011 (58%) 16921 (13%)
Chandigarh 4013 (85.0%) 587 (12.4%) 120 (2.5%) 2394 (51%) 2326 (49%) 2243 (48%) 2477 (52%) 1515 (32%) 718 (15%) 381 (8%) 2106 (45%)
Chhattisgarh 29331 (90.5%) 2499 (7.7%) 586 (1.8%) 22877 (71%) 9539 (29%) 14586 (45%) 17830 (55%) 8511 (26%) 6015 (19%) 11407 (35%) 6483 (20%)
Dadra and Nagar Haveli and Daman and Diu 875 (86.4%) 108 (10.7%) 30 (3.0%) 586 (58%) 427 (42%) 413 (41%) 600 (59%) 196 (19%) 217 (21%) 205 (20%) 395 (39%)
Delhi 88334 (85.7%) 11374 (11.0%) 3330 (3.2%) 46741 (45%) 56297 (55%) 54067 (52%) 48971 (48%) 25682 (25%) 26988 (26%) 20864 (20%) 29504 (29%)
Goa 1830 (90.7%) 134 (6.6%) 54 (2.7%) 1155 (57%) 863 (43%) 1155 (57%) 863 (43%) 43 (2%) 1107 (55%) 144 (7%) 724 (36%)
Gujarat 115756 (80.0%) 25749 (17.8%) 3226 (2.2%) 109471 (76%) 35260 (24%) 51105 (35%) 93626 (65%) 38277 (26%) 12525 (9%) 65767 (45%) 28162 (19%)
Haryana 59461 (86.1%) 8223 (11.9%) 1399 (2.0%) 47042 (68%) 22041 (32%) 38979 (56%) 30104 (44%) 16119 (23%) 22639 (33%) 12778 (18%) 17547 (25%)
Himachal Pradesh 12279 (84.7%) 1845 (12.7%) 368 (2.5%) 9495 (66%) 4997 (34%) 9957 (69%) 4535 (31%) 5015 (35%) 4918 (34%) 978 (7%) 3581 (25%)
Jammu & Kashmir 9555 (88.3%) 1158 (10.7%) 113 (1.0%) 6359 (59%) 4467 (41%) 5459 (50%) 5367 (50%) 2966 (27%) 2485 (23%) 1873 (17%) 3502 (32%)
Jharkhand 47948 (91.9%) 3450 (6.6%) 781 (1.5%) 43885 (84%) 8294 (16%) 22897 (44%) 29282 (56%) 14043 (27%) 8814 (17%) 23369 (45%) 5953 (11%)
Karnataka 62621 (86.5%) 7471 (10.3%) 2343 (3.2%) 49199 (68%) 23236 (32%) 41591 (57%) 30844 (43%) 16455 (23%) 24888 (34%) 12250 (17%) 18842 (26%)
Kerala 20196 (92.3%) 1364 (6.2%) 312 (1.4%) 12784 (58%) 9088 (42%) 13355 (61%) 8517 (39%) 4391 (20%) 8862 (41%) 949 (4%) 7670 (35%)
Ladakh 246 (84.5%) 41 (14.1%) 4 (1.4%) 182 (63%) 109 (37%) 184 (63%) 107 (37%) 72 (25%) 112 (38%) 10 (3%) 97 (33%)
Lakshadweep 12 (100.0%) 0 (.0%) (.0%) 10 (83%) 2 (17%) 9 (75%) 3 (25%) 0 (0%) 9 (75%) 2 (17%) 1 (8%)
Madhya Pradesh 145696 (87.6%) 18054 (10.9%) 2596 (1.6%) 131339 (79%) 35007 (21%) 54931 (33%) 111415 (67%) 36085 (22%) 18711 (11%) 84109 (51%) 27441 (16%)
Maharashtra 170295 (85.2%) 17477 (8.7%) 12204 (6.1%) 122403 (61%) 77573 (39%) 87565 (44%) 112411 (56%) 27547 (14%) 56622 (28%) 61722 (31%) 54085 (27%)
Manipur 1577 (88.0%) 181 (10.1%) 35 (2.0%) 1189 (66%) 604 (34%) 1148 (64%) 645 (36%) 420 (23%) 727 (41%) 289 (16%) 357 (20%)
Meghalaya 3523 (84.9%) 374 (9.0%) 255 (6.1%) 2613 (63%) 1539 (37%) 2538 (61%) 1614 (39%) 1085 (26%) 1451 (35%) 631 (15%) 985 (24%)
Mizoram 1446 (82.7%) 191 (10.9%) 112 (6.4%) 1011 (58%) 738 (42%) 1057 (60%) 692 (40%) 151 (9%) 905 (52%) 140 (8%) 553 (32%)
Nagaland 3149 (86.3%) 407 (11.2%) 92 (2.5%) 2467 (68%) 1181 (32%) 1909 (52%) 1739 (48%) 776 (21%) 1132 (31%) 873 (24%) 867 (24%)
Odisha 47988 (91.6%) 3908 (7.5%) 485 (.9%) 37920 (72%) 14461 (28%) 27908 (53%) 24473 (47%) 20507 (39%) 7389 (14%) 12285 (23%) 12200 (23%)
Puducherry 2875 (83.5%) 217 (6.3%) 352 (10.2%) 2148 (62%) 1296 (38%) 2437 (71%) 1007 (29%) 1353 (39%) 1059 (31%) 143 (4%) 889 (26%)
Punjab 44311 (88.4%) 5005 (10.0%) 826 (1.6%) 33800 (67%) 16342 (33%) 26095 (52%) 24047 (48%) 13958 (28%) 12025 (24%) 11842 (24%) 12317 (25%)
Rajasthan 126803 (85.0%) 19356 (13.0%) 3066 (2.1%) 110028 (74%) 39197 (26%) 65866 (44%) 83359 (56%) 44954 (30%) 20780 (14%) 56343 (38%) 27148 (18%)
Sikkim 1028 (74.9%) 123 (9.0%) 222 (16.2%) 874 (64%) 499 (36%) 890 (65%) 483 (35%) 151 (11%) 731 (53%) 205 (15%) 286 (21%)
Tamil Nadu 72513 (87.6%) 8005 (9.7%) 2305 (2.8%) 59997 (72%) 22826 (28%) 51426 (62%) 31397 (38%) 29800 (36%) 21503 (26%) 11941 (14%) 19579 (24%)
Telangana 53332 (87.8%) 5959 (9.8%) 1423 (2.3%) 44842 (74%) 15872 (26%) 31254 (51%) 29460 (49%) 13494 (22%) 17718 (29%) 17713 (29%) 11789 (19%)
Tripura 2288 (90.0%) 237 (9.3%) 18 (.7%) 1941 (76%) 602 (24%) 1614 (63%) 929 (37%) 895 (35%) 719 (28%) 368 (14%) 561 (22%)
Uttar Pradesh 397821 (87.7%) 42904 (9.5%) 12987 (2.9%) 341444 (75%) 112268 (25%) 175391 (39%) 278321 (61%) 90138 (20%) 84916 (19%) 203981 (45%) 74677 (16%)
Uttarakhand 19924 (87.4%) 2360 (10.4%) 505 (2.2%) 16508 (72%) 6281 (28%) 10260 (45%) 12529 (55%) 6311 (28%) 3872 (17%) 8054 (35%) 4552 (20%)
West Bengal 78530 (86.8%) 9130 (10.1%) 2827 (3.1%) 63770 (70%) 26717 (30%) 60264 (67%) 30223 (33%) 41413 (46%) 18761 (21%) 10385 (11%) 19928 (22%)
INDIA 1856385 (86.9%) 220104 (10.3%) 59341 (2.8%) 1528000 (72%) 607830 (28%) 959330 (45%) 1176500 (55%) 496979 (23%) 455285 (21%) 746913 (35%) 436653 (20%)

155 INDIA TB REPORT 2022 INDIA TB REPORT 2022 156

1.4 Patient Transfer Status & Treatment Initiation Status 1.5 P
 aediatric TB cases notification & Treatment initiation
status
State Patients Transfer Transfer Net TB Net TB Patients Paediatric TB patients Net paediatric TB Paediatric Patients initiated on
Notified Out In Patients Notified Initiated on Treatment notified (Based On patients* notified treatment
State Diagnosing PHI) (Based On Current PHI)
Andaman & Nicobar
507 8 17 516 497 (96%)
Islands
Public Private Total Public Private Total Public Private Total
Andhra Pradesh 86832 510 1440 87762 86146 (98%)
Andaman &
Arunachal Pradesh 2724 42 190 2872 2707 (94%) 22 0 22 22 0 22 21 (95%) 0 (NA) 21 (95%)
Nicobar Islands
Assam 37641 569 658 37730 35807 (95%) Andhra Pradesh 1405 977 2382 1646 791 2437 1607 (98%) 785 (99%) 2392 (98%)
Bihar 131703 842 4627 135488 128535 (95%) Arunachal Pradesh 258 1 259 274 0 274 260 (95%) 0 (NA) 260 (95%)
Chandigarh 4720 1847 369 3242 3052 (94%) Assam 878 304 1182 1045 121 1166 975 (93%) 114 (94%) 1089 (93%)
Chhattisgarh 32416 248 447 32615 31871 (98%) Bihar 3070 8873 11943 3127 8977 12104 2863 (92%) 8949 (100%) 11812 (98%)
Dadra and Nagar Haveli Chandigarh 404 31 435 257 9 266 244 (95%) 7 (78%) 251 (94%)
1013 314 65 764 750 (98%)
and Daman and Diu
Chhattisgarh 772 629 1401 885 527 1412 871 (98%) 522 (99%) 1393 (99%)
Delhi 103038 20017 1281 84302 73226 (87%)
Dadra and Nagar
Goa 2018 113 133 2038 1942 (95%) Haveli and Daman 62 7 69 39 4 43 39 (100%) 4 (100%) 43 (100%)
and Diu
Gujarat 144731 4169 722 141284 138983 (98%)
Delhi 8119 2365 10484 8139 1398 9537 7295 (90%) 1183 (85%) 8478 (89%)
Haryana 69083 3053 5223 71253 65704 (92%)
Goa 56 8 64 54 7 61 49 (91%) 7 (100%) 56 (92%)
Himachal Pradesh 14492 339 644 14797 14430 (98%)
Gujarat 2865 3555 6420 3584 2683 6267 3507 (98%) 2674 (100%) 6181 (99%)
Jammu & Kashmir 10826 129 308 11005 10237 (93%) Haryana 2171 1476 3647 2682 1142 3824 2474 (92%) 1097 (96%) 3571 (93%)
Jharkhand 52179 370 1367 53176 51466 (97%) Himachal Pradesh 394 53 447 448 22 470 435 (97%) 19 (86%) 454 (97%)
Karnataka 72435 1926 933 71442 68641 (96%) Jammu & Kashmir 480 99 579 521 62 583 494 (95%) 59 (95%) 553 (95%)
Kerala 21872 361 513 22024 20950 (95%) Jharkhand 1072 1617 2689 1159 1557 2716 1101 (95%) 1554 (100%) 2655 (98%)
Ladakh 291 17 45 319 308 (97%) Karnataka 1845 1127 2972 2215 696 2911 2158 (97%) 665 (96%) 2823 (97%)

Lakshadweep 12 1 9 20 20 (100%) Kerala 376 276 652 573 92 665 558 (97%) 86 (93%) 644 (97%)
Ladakh 4 0 4 4 0 4 4 (100%) 0 (NA) 4 (100%)
Madhya Pradesh 166346 1817 3719 168248 163022 (97%)
Lakshadweep 1 0 1 1 0 1 1 (100%) 0 (NA) 1 (100%)
Maharashtra 199976 4931 1550 196595 186264 (95%)
Madhya Pradesh 7724 4517 12241 8700 3647 12347 8518 (98%) 3601 (99%) 12119 (98%)
Manipur 1793 14 95 1874 1734 (93%)
Maharashtra 5827 6872 12699 7430 5189 12619 6987 (94%) 4996 (96%) 11983 (95%)
Meghalaya 4152 112 153 4193 3957 (94%)
Manipur 42 12 54 49 7 56 43 (88%) 6 (86%) 49 (88%)
Mizoram 1749 8 40 1781 1757 (99%)
Meghalaya 173 108 281 222 61 283 209 (94%) 59 (97%) 268 (95%)
Nagaland 3648 41 80 3687 3611 (98%) Mizoram 64 13 77 70 7 77 69 (99%) 7 (100%) 76 (99%)
Odisha 52381 620 386 52147 50657 (97%) Nagaland 164 33 197 169 28 197 163 (96%) 28 (100%) 191 (97%)
Puducherry 3444 2099 64 1409 1303 (93%) Odisha 1528 370 1898 1690 194 1884 1626 (96%) 182 (94%) 1808 (96%)
Punjab 50142 863 2797 52076 48160 (92%) Puducherry 98 3 101 47 0 47 45 (96%) 0 (NA) 45 (96%)
Rajasthan 149225 2151 3960 151034 140997 (93%) Punjab 1835 918 2753 2078 809 2887 1945 (94%) 787 (97%) 2732 (95%)

Sikkim 1373 31 97 1439 1387 (96%) Rajasthan 3801 3490 7291 4123 3198 7321 3847 (93%) 3144 (98%) 6991 (95%)
Sikkim 52 7 59 57 6 63 56 (98%) 6 (100%) 62 (98%)
Tamil Nadu 82823 749 2936 85010 81562 (96%)
Tamil Nadu 1541 1170 2711 1733 1022 2755 1664 (96%) 998 (98%) 2662 (97%)
Telangana 60714 825 1035 60924 59141 (97%)
Telangana 1183 724 1907 1353 562 1915 1309 (97%) 543 (97%) 1852 (97%)
Tripura 2543 13 247 2777 2670 (96%)
Tripura 35 2 37 42 0 42 41 (98%) 0 (NA) 41 (98%)
Uttar Pradesh 453712 4023 15210 464899 439242 (94%)
Uttar Pradesh 14265 12063 26328 17001 9987 26988 16021 (94%) 9813 (98%) 25834 (96%)
Uttarakhand 22789 974 1761 23576 22180 (94%)
Uttarakhand 760 240 1000 845 174 1019 816 (97%) 167 (96%) 983 (96%)
West Bengal 90487 1078 2103 91512 87593 (96%) West Bengal 1973 973 2946 2592 377 2969 2489 (96%) 356 (94%) 2845 (96%)
INDIA 2135830 55224 55224 2135830 2030509 (95%) India 65319 52913 118232 72284 42979 115263 70804 (98%) 42418 (99%) 113222 (98%)
Net TB Patients – TB Notified patients that are currently in the facility/ District/ State whom are accounted after transferred out and transferred in patients. * - Net TB Patients – TB Notified patients that are currently in the facility/ District/ State whom are accounted after transferred out and transferred in patients.

157 INDIA TB REPORT 2022 INDIA TB REPORT 2022 158

1.6 T
 ribal TB cases notification & Treatment
initiation status
Number of Districts Tribal TB patients notified Net Tribal TB patients* notified
Tribal TB Patients initiated on treatment
(Based On Diagnosing PHI) (Based On Current PHI)
State mapped as Tribal district
(partly or wholly) Public Private Total Public Private Total Public Private Total

Andaman & Nicobar Islands NA 59 0 59 63 0 63 62 (98.4%) NA 62 (98.4%)

Andhra Pradesh 8 9257 2596 11853 9460 2351 11811 9253 (97.8%) 2347 (99.8%) 11600 (98.2%)
Arunachal Pradesh 14 2549 14 2563 2714 0 2714 2574 (94.8%) NA 2574 (94.8%)
Assam 7 6132 818 6950 6394 674 7068 6226 (97.4%) 653 (96.9%) 6879 (97.3%)
Bihar NA NA NA 0 0 0 0 NA NA NA
Chandigarh NA NA NA 0 0 0 0 NA NA NA
Chhattisgarh 19 9785 1025 10810 10664 980 11644 10481 (98.3%) 938 (95.7%) 11419 (98.1%)
Dadra and Nagar Haveli and Daman and Diu 1 643 45 688 432 38 470 426 (98.6%) 38 (100.0%) 464 (98.7%)
Delhi NA NA NA 0 0 0 0 NA NA NA
Goa NA NA NA 0 0 0 0 NA NA NA
Gujarat 14 16631 5369 22000 18624 3828 22452 18245 (98.0%) 3815 (99.7%) 22060 (98.3%)
Haryana NA NA NA 0 0 0 0 NA NA NA
Himachal Pradesh 3 162 1 163 380 4 384 373 (98.2%) 4 (100.0%) 377 (98.2%)
Jammu & Kashmir 1 19 0 19 57 0 57 56 (98.2%) NA 56 (98.2%)
Jharkhand 15 18847 9253 28100 19102 9000 28102 18192 (95.2%) 8965 (99.6%) 27157 (96.6%)
Karnataka 4 1836 287 2123 2684 110 2794 2274 (84.7%) 64 (58.2%) 2338 (83.7%)
Kerala 4 367 86 453 796 17 813 786 (98.7%) 13 (76.5%) 799 (98.3%)
Ladakh 2 280 11 291 286 24 310 275 (96.2%) 24 (100.0%) 299 (96.5%)
Lakshadweep 1 12 0 12 20 0 20 20 (100.0%) NA 20 (100.0%)
Madhya Pradesh 20 18210 6470 24680 21239 5007 26246 20788 (97.9%) 4903 (97.9%) 25691 (97.9%)
Maharashtra 15 10479 2562 13041 12940 1759 14699 12503 (96.6%) 1731 (98.4%) 14234 (96.8%)
Manipur 6 683 118 801 866 94 960 821 (94.8%) 93 (98.9%) 914 (95.2%)
Meghalaya 7 3281 871 4152 3836 357 4193 3643 (95.0%) 358 (100.3%) 4001 (95.4%)
Mizoram 8 1478 269 1747 1589 192 1781 1574 (99.1%) 192 (100.0%) 1766 (99.2%)
Nagaland 11 2924 724 3648 3156 531 3687 3119 (98.8%) 527 (99.2%) 3646 (98.9%)
Odisha 13 18056 2253 20309 20276 1020 21296 20194 (99.6%) 1004 (98.4%) 21198 (99.5%)
Puducherry NA NA NA 0 0 0 0 NA NA NA
Punjab 1 0 4 4 0 1 1 NA NA NA
Rajasthan 8 12385 2492 14877 15003 2350 17353 14210 (94.7%) 2291 (97.5%) 16501 (95.1%)
Sikkim 1 49 0 49 86 0 86 81 (94.2%) NA 81 (94.2%)
Tamil Nadu NA 171 6 177 442 1 443 440 (99.5%) 1 (100.0%) 441 (99.5%)
Telangana 8 5096 2053 7149 5235 2060 7295 5112 (97.7%) 2046 (99.3%) 7158 (98.1%)
Tripura NA 238 0 238 266 1 267 261 (98.1%) 1 (100.0%) 262 (98.1%)
Uttar Pradesh NA 3347 242 3589 3692 302 3994 3619 (98.0%) 294 (97.4%) 3913 (98.0%)
Uttarakhand 1 12 0 12 46 0 46 46 (100.0%) NA 46 (100.0%)
West Bengal NA NA NA 0 0 0 0 NA NA NA
INDIA 205 142988 37569 180557 160348 30701 191049 155654 (97.1%) 30302 (98.7%) 185956 (97.3%)
Net TB Patients – TB Notified patients that are currently in the facility/ District/ State whom are accounted after transferred out and transferred in patients.

159 INDIA TB REPORT 2022 INDIA TB REPORT 2022 160

 1.7 G
 ender-disaggregated data on Total TB notification, 1.8 G
 ender-disaggregated data on TB notification,
Paediatric TB notification & Treatment initiation Treatment outcomes
Paediatric TB Cases TB Cases Notified-2020 Success Rate Death Rate
TB Cases Notified Total TB Cases initiated on treatment
Notified
State State Trans Trans Trans
Trans Trans Trans Male Female Male Female Male Female
Male Female Male Female Male Female Gender Gender Gender
Gender Gender Gender
Andaman & Andaman &
288 228 0 9 13 0 279 (97%) 218 (96%) 0 (NA) 263 171 0 216 (82%) 154 (90%) 0 (NA) 12 (5%) 4 (2%) 0 (NA)
Nicobar Islands Nicobar Islands

Andhra Pradesh 57380 30345 36 1190 1246 1 56324 (98%) 29787 (98%) 35 (97%) Andhra Pradesh 41020 21862 32 36519 (89%) 20127 (92%) 29 (91%) 1838 (4%) 650 (3%) 2 (6%)
Arunachal Arunachal
1554 1312 6 136 137 1 1465 (94%) 1237 (94%) 5 (83%) 1288 1132 4 1061 (82%) 949 (84%) 4 (100%) 53 (4%) 25 (2%) 0 (0%)
Pradesh Pradesh

Assam 25178 12543 11 534 631 1 23916 (95%) 11882 (95%) 9 (82%) Assam 23167 11352 21 19208 (83%) 9667 (85%) 21 (100%) 1022 (4%) 400 (4%) 0 (0%)

Bihar 83314 52105 66 7097 5000 7 78711 (94%) 49761 (96%) 63 (95%) Bihar 63111 36546 74 48458 (77%) 28995 (79%) 50 (68%) 2189 (3%) 1149 (3%) 3 (4%)

Chandigarh 1727 1509 7 100 162 4 1627 (94%) 1418 (94%) 7 (100%) Chandigarh 1515 1309 5 1151 (76%) 1123 (86%) 4 (80%) 87 (6%) 42 (3%) 0 (0%)

Chhattisgarh 20529 12070 17 727 682 3 20036 (98%) 11818 (98%) 17 (100%) Chhattisgarh 18493 10593 18 15818 (86%) 9248 (87%) 14 (78%) 1002 (5%) 376 (4%) 2 (11%)

Dadra and Nagar Dadra and

Nagar Haveli
Haveli and 454 309 0 13 30 0 444 (98%) 306 (99%) 0 (NA) 460 275 0 431 (94%) 255 (93%) 0 (NA) 10 (2%) 7 (3%) 0 (NA)
and Daman and
Daman and Diu Diu
Delhi 42360 41952 55 3539 5990 8 36197 (85%) 36982 (88%) 47 (85%) Delhi 38153 35181 56 26398 (69%) 26460 (75%) 35 (63%) 1290 (3%) 716 (2%) 2 (4%)
Goa 1227 810 1 30 31 0 1166 (95%) 775 (96%) 1 (100%) Goa 887 695 2 729 (82%) 607 (87%) 2 (100%) 57 (6%) 32 (5%) 0 (0%)
Gujarat 90173 51076 41 3060 3205 2 88533 (98%) 50409 (99%) 41 (100%) Gujarat 73866 41423 56 63970 (87%) 37464 (90%) 50 (89%) 4027 (5%) 1444 (3%) 1 (2%)
Haryana 42386 28833 32 1641 2181 2 38791 (92%) 26883 (93%) 30 (94%) Haryana 37986 25019 31 29102 (77%) 20380 (81%) 23 (74%) 1907 (5%) 730 (3%) 1 (3%)
Himachal Pradesh 9154 5641 2 206 264 0 8924 (97%) 5504 (98%) 2 (100%) Himachal
8210 5082 7 7070 (86%) 4567 (90%) 6 (86%) 538 (7%) 185 (4%) 0 (0%)
Pradesh
Jammu & Kashmir 6410 4591 4 259 324 0 5918 (92%) 4315 (94%) 4 (100%)
Jammu &
5162 3634 4 4251 (82%) 3036 (84%) 3 (75%) 196 (4%) 113 (3%) 0 (0%)
Jharkhand 35967 17191 19 1437 1278 1 34803 (97%) 16646 (97%) 17 (89%) Kashmir
Karnataka 44975 26433 35 1456 1453 2 43181 (96%) 25425 (96%) 35 (100%) Jharkhand 31191 14460 9 25783 (83%) 12250 (85%) 8 (89%) 1144 (4%) 424 (3%) 0 (0%)

Kerala 14203 7816 4 305 360 0 13482 (95%) 7464 (95%) 4 (100%) Karnataka 39537 22949 48 31243 (79%) 19481 (85%) 32 (67%) 3267 (8%) 1219 (5%) 4 (8%)

Ladakh 169 150 0 1 3 0 165 (98%) 143 (95%) 0 (NA) Kerala 13414 7219 8 10720 (80%) 6045 (84%) 5 (63%) 1217 (9%) 450 (6%) 1 (13%)

Lakshadweep 9 11 0 0 1 0 9 (100%) 11 (100%) 0 (NA) Ladakh 127 116 0 99 (78%) 89 (77%) 0 (NA) 8 (6%) 11 (9%) 0 (NA)
Lakshadweep 8 9 0 7 (88%) 8 (89%) 0 (NA) 0 (0%) 0 (0%) 0 (NA)
Madhya Pradesh 104097 64085 65 6528 5811 8 100545 (97%) 62415 (97%) 62 (95%)
Madhya Pradesh 85532 50151 76 66420 (78%) 41525 (83%) 61 (80%) 3471 (4%) 1323 (3%) 1 (1%)
Maharashtra 104495 92037 88 4857 7760 2 98722 (94%) 87465 (95%) 77 (88%)
Maharashtra 81008 66324 88 67268 (83%) 56972 (86%) 77 (88%) 4614 (6%) 2370 (4%) 4 (5%)
Manipur 1205 667 1 34 22 0 1119 (93%) 614 (92%) 1 (100%)
Manipur 1008 555 1 808 (80%) 436 (79%) 1 (100%) 35 (3%) 20 (4%) 0 (0%)
Meghalaya 2540 1650 3 131 152 0 2390 (94%) 1564 (95%) 3 (100%)
Meghalaya 2254 1606 4 1787 (79%) 1318 (82%) 4 (100%) 122 (5%) 63 (4%) 0 (0%)
Mizoram 1030 751 0 47 30 0 1013 (98%) 744 (99%) 0 (NA)
Mizoram 1088 900 0 962 (88%) 811 (90%) 0 (NA) 26 (2%) 24 (3%) 0 (NA)
Nagaland 2270 1414 3 95 102 0 2223 (98%) 1385 (98%) 3 (100%)
Nagaland 2134 1380 4 1718 (81%) 1121 (81%) 2 (50%) 57 (3%) 39 (3%) 1 (25%)
Odisha 34763 17367 18 930 954 0 33768 (97%) 16872 (97%) 17 (94%)
Odisha 30204 14766 25 26649 (88%) 13324 (90%) 22 (88%) 1803 (6%) 703 (5%) 0 (0%)
Puducherry 911 496 1 25 22 0 837 (92%) 465 (94%) 1 (100%)
Puducherry 783 436 1 627 (80%) 367 (84%) 0 (0%) 58 (7%) 22 (5%) 0 (0%)
Punjab 29536 22507 34 1080 1802 5 27202 (92%) 20925 (93%) 33 (97%)
Punjab 26639 19811 41 20749 (78%) 16224 (82%) 33 (80%) 1769 (7%) 892 (5%) 6 (15%)
Rajasthan 99101 51876 57 3862 3456 3 91979 (93%) 48967 (94%) 51 (89%)
Rajasthan 87795 45619 46 71039 (81%) 38893 (85%) 40 (87%) 3495 (4%) 1120 (2%) 1 (2%)
Sikkim 737 701 0 25 38 0 712 (97%) 675 (96%) 0 (NA)
Sikkim 642 497 0 575 (90%) 447 (90%) 0 (NA) 29 (5%) 16 (3%) 0 (NA)
Tamil Nadu 57201 27702 30 1372 1382 1 54824 (96%) 26709 (96%) 29 (97%)
Tamil Nadu 47157 21757 29 38192 (81%) 18666 (86%) 27 (93%) 3109 (7%) 940 (4%) 1 (3%)
Telangana 36515 24387 27 773 1141 1 35353 (97%) 23761 (97%) 27 (100%) Telangana 37280 23549 28 32791 (88%) 21362 (91%) 23 (82%) 1356 (4%) 519 (2%) 1 (4%)
Tripura 2080 696 0 26 16 0 1999 (96%) 671 (96%) 0 (NA) Tripura 1593 542 2 1279 (80%) 458 (85%) 2 (100%) 123 (8%) 36 (7%) 0 (0%)
Uttar Pradesh 269072 195598 224 12475 14501 12 253280 (94%) 185755 (95%) 207 (92%) Uttar Pradesh 212835 150653 176 174676 (82%) 128972 (86%) 137 (78%) 10414 (5%) 4494 (3%) 5 (3%)
Uttarakhand 13647 9912 15 409 610 0 12780 (94%) 9386 (95%) 14 (93%) Uttarakhand 11595 8074 12 9485 (82%) 6917 (86%) 10 (83%) 539 (5%) 204 (3%) 0 (0%)
West Bengal 61412 30065 23 1299 1670 0 58856 (96%) 28718 (96%) 19 (83%) West Bengal 52038 25416 23 43509 (84%) 21637 (85%) 19 (83%) 3167 (6%) 1151 (5%) 2 (9%)
India 1298069 836836 925 55708 62460 64 1231573 (95%) 798075 (95%) 861 (93%) India 1079443 671063 931 880768 (82%) 570355 (85%) 744 (80%) 54051 (5%) 21913 (3%) 38 (4%)

161 INDIA TB REPORT 2022 INDIA TB REPORT 2022 162

2.1 TB – HIV 2.2 P
 rovider initiated testing and counselling among
presumptive TB cases and Paediatric TB patients
TB patients with known HIV status (%) TB-HIV co-infected patients Presumptive TB Cases Paediatric TB Patients
State
Public Private Total Diagnosed Put on ART* Put on CPT* State HIV positive HIV positive
With known With known
Examined cases among Notified patients among
Andaman & Nicobar HIV status* HIV status
488 (95%) 1 (100%) 489 (95%) 3 2 (100%) 0 (%) tested* tested
Islands
Andaman & Nicobar
Andhra Pradesh 63099 (100%) 24320 (100%) 87419 (100%) 4286 4142 (97%) 4196 (98%) 6024 423 (7%) 187 (3%) 22 21 (95%) 0 (0.0%)
Islands
Arunachal Pradesh 2707 (94%) 0 (NA) 2707 (94%) 2 5 (250%) 5 (250%) Andhra Pradesh 750486 159610 (21%) 65473 (9%) 2389 2368 (99%) 9 (0.4%)

Assam 29733 (88%) 3485 (84%) 33218 (88%) 289 241 (83%) 269 (93%) Arunachal Pradesh 17301 1671 (10%) 830 (5%) 274 259 (95%) 0 (0.0%)

Bihar 53840 (84%) 66080 (92%) 119920 (89%) 1429 1240 (87%) 1044 (73%) Assam 126078 22065 (18%) 7294 (6%) 1161 944 (81%) 1 (0.1%)

Chandigarh 3034 (97%) 84 (69%) 3118 (96%) 209 194 (93%) 208 (100%) Bihar 380833 31558 (8%) 8834 (2%) 12069 10039 (83%) 42 (0.4%)

Chhattisgarh 24763 (97%) 6483 (90%) 31246 (96%) 390 345 (88%) 379 (97%) Chandigarh 14394 6278 (44%) 2414 (17%) 259 252 (97%) 4 (1.6%)
Dadra and Nagar Haveli Chhattisgarh 214665 12130 (6%) 5459 (3%) 1404 1252 (89%) 8 (0.6%)
710 (100%) 50 (100%) 760 (100%) NA NA NA
and Daman and Diu
Dadra and Nagar Haveli
15868 3392 (21%) 970 (6%) 42 42 (100%) 0 (0.0%)
Delhi 58661 (87%) 10707 (64%) 69368 (82%) 1080 975 (90%) 1055 (98%) and Daman and Diu
Goa 1618 (98%) 255 (67%) 1873 (92%) 62 60 (97%) 62 (100%) Delhi 133570 22155 (17%) 8220 (6%) 9521 7790 (82%) 9 (0.1%)
Gujarat 100124 (99%) 38146 (94%) 138270 (98%) 2834 2788 (98%) 2897 (102%) Goa 13454 24 (%) 24 (%) 61 56 (92%) 0 (0.0%)
Haryana 50431 (96%) 17811 (95%) 68242 (96%) 447 421 (94%) 383 (86%) Gujarat 889374 219076 (25%) 73387 (8%) 6208 5810 (94%) 11 (0.2%)

Himachal Pradesh 14099 (99%) 560 (97%) 14659 (99%) 87 85 (98%) 94 (108%) Haryana 220294 63487 (29%) 21597 (10%) 3805 3663 (96%) 1 (0.0%)

Jammu & Kashmir 9546 (92%) 586 (90%) 10132 (92%) 42 36 (86%) 41 (98%) Himachal Pradesh 156389 8757 (6%) 3315 (2%) 469 463 (99%) 0 (0.0%)

Jharkhand 33922 (93%) 13165 (79%) 47087 (89%) 347 294 (85%) 266 (77%) Jammu & Kashmir 195228 5834 (3%) 1241 (1%) 581 542 (93%) 0 (0.0%)

Karnataka 58094 (98%) 11349 (95%) 69443 (97%) 3848 3718 (97%) 3840 (100%) Jharkhand 202556 19160 (9%) 5778 (3%) 2706 2019 (75%) 3 (0.1%)

Kerala 17868 (94%) 2651 (85%) 20519 (93%) 215 193 (90%) 210 (98%) Karnataka 538482 65656 (12%) 41028 (8%) 2845 2706 (95%) 5 (0.2%)
Kerala 228096 6608 (3%) 2769 (1%) 665 612 (92%) 0 (0.0%)
Ladakh 280 (95%) 22 (92%) 302 (95%) NA NA NA
Ladakh 3974 97 (2%) 26 (1%) 4 4 (100%) 0 (0.0%)
Lakshadweep 20 (100%) 0 (NA) 20 (100%) NA NA NA
Lakshadweep 1045 9 (1%) 9 (1%) 1 1 (100%) 0 (0.0%)
Madhya Pradesh 116120 (96%) 43580 (91%) 159700 (95%) 1397 1190 (85%) 1301 (93%)
Madhya Pradesh 634719 136721 (22%) 38173 (6%) 12301 11223 (91%) 8 (0.1%)
Maharashtra 123404 (98%) 66692 (95%) 190096 (97%) 5808 5570 (96%) 5754 (99%)
Maharashtra 1058856 544082 (51%) 83589 (8%) 12555 12038 (96%) 32 (0.3%)
Manipur 1479 (88%) 117 (62%) 1596 (85%) 117 112 (96%) 116 (99%)
Manipur 13648 1071 (8%) 390 (3%) 55 46 (84%) 1 (2.2%)
Meghalaya 3331 (87%) 231 (65%) 3562 (85%) 110 99 (90%) 103 (94%)
Meghalaya 23821 2764 (12%) 1244 (5%) 280 192 (69%) 0 (0.0%)
Mizoram 1579 (99%) 192 (100%) 1771 (99%) 259 250 (97%) 256 (99%)
Mizoram 7679 1239 (16%) 522 (7%) 75 74 (99%) 1 (1.4%)
Nagaland 2968 (94%) 413 (78%) 3381 (92%) 279 255 (91%) 280 (100%)
Nagaland 15838 1644 (10%) 743 (5%) 192 178 (93%) 2 (1.1%)
Odisha 47891 (99%) 3903 (99%) 51794 (99%) 545 512 (94%) 540 (99%)
Odisha 874054 114541 (13%) 38294 (4%) 1878 1853 (99%) 0 (0.0%)
Puducherry 1389 (99%) 0 (NA) 1389 (99%) 31 31 (100%) 31 (100%)
Puducherry 15411 4327 (28%) 1076 (7%) 47 41 (87%) 0 (0.0%)
Punjab 36421 (95%) 12388 (90%) 48809 (94%) 1034 969 (94%) 975 (94%)
Punjab 139308 32250 (23%) 12834 (9%) 2872 2701 (94%) 4 (0.1%)
Rajasthan 102792 (96%) 40507 (93%) 143299 (95%) 1404 1315 (94%) 1367 (97%)
Rajasthan 492729 153499 (31%) 54445 (11%) 7294 6845 (94%) 11 (0.2%)
Sikkim 1287 (96%) 98 (99%) 1385 (96%) 8 6 (75%) 8 (100%)
Sikkim 12918 290 (2%) 177 (1%) 63 61 (97%) 0 (0.0%)
Tamil Nadu 68272 (99%) 12256 (78%) 80528 (95%) 2984 2788 (93%) 2941 (99%) Tamil Nadu 785646 293348 (37%) 98198 (12%) 2734 2441 (89%) 2 (0.1%)
Telangana 43689 (99%) 16489 (98%) 60178 (99%) 1720 1354 (79%) 1010 (59%) Telangana 253721 69771 (27%) 24489 (10%) 1882 1842 (98%) 8 (0.4%)
Tripura 2680 (97%) 11 (85%) 2691 (97%) 40 40 (100%) 39 (98%) Tripura 23536 666 (3%) 332 (1%) 42 42 (100%) 0 (0.0%)
Uttar Pradesh 334691 (96%) 107212 (93%) 441903 (95%) 2454 2330 (95%) 2341 (95%) Uttar Pradesh 1169076 234041 (20%) 56644 (5%) 26952 24966 (93%) 16 (0.1%)
Uttarakhand 18163 (94%) 3750 (86%) 21913 (93%) 121 84 (69%) 95 (79%) Uttarakhand 78842 6355 (8%) 2200 (3%) 1012 946 (93%) 2 (0.2%)
West Bengal 80239 (98%) 8268 (90%) 88507 (97%) 997 913 (92%) 979 (98%) West Bengal 955286 277894 (29%) 127336 (13%) 2959 2810 (95%) 0 (0.0%)
INDIA 1509432 (96%) 511862 (92%) 2021294 (95%) 34877 32577 (93%) 33085 (95%) INDIA 10663199 2522493 (24%) 789541 (7%) 118232 107142 (91%) 180 (0.2%)

*- Source of data – NACP Monthly Progress Reports * Data source for HIV status among presumptive TB cases: Annexure M reports

163 INDIA TB REPORT 2022 INDIA TB REPORT 2022 164

2.3 I ntensified TB case finding activities in 2.4 I ntensified TB case finding activities in ART centre -
ICTC Centres – Year 2021 (January to November 2021) Year 2021 (January to December 2021)
Clients attending ICTC Centres PLHIV PLHIV
Cumulative No. of
PLHIV PLHIV with referred PLHIV PLHIV bacterio-
ICTC attendees (excl. pregnant no. of PLHIV on times PLHIV
screened for presumptive for TB tested for diagnosed logically
State Referred for Diagnosed Put on State ART at ARTCs attended ART
women) TB TB diagnosis TB with TB con-
TB testing with TB treatment as on Dec' 2021 centre in 2021
test firmed
Andaman & Nicobar Andaman &
14,294 206 28 6 136 686 686 8 8 8 - -
Islands Nicobar Islands
Andhra Pradesh 1,94,189 14,13,132 13,53,571 54,119 53,736 52,747 2,921 2,105
Andhra Pradesh 4,52,847 47,207 2,696 2,484
Arunachal
Arunachal Pradesh 8,404 369 132 1 205 726 720 49 49 49 2 2
Pradesh
Assam 89,119 5,665 595 245 Assam 8,841 49,829 49,604 708 541 322 177 36

Bihar 2,77,381 20,504 3,502 337 Bihar 65,221 4,39,614 4,10,336 8,710 7,021 5,076 1,371 643
Chandigarh 45,906 29 3 - Chandigarh 5,732 31,061 31,061 217 217 178 80 30
Chhattisgarh 1,66,919 12,146 586 388 Chhattisgarh 16,318 1,28,109 1,24,068 3,378 2,788 2,626 331 241
Dadra and Nagar Haveli Delhi 33,809 2,55,588 2,50,060 2,955 2,218 1,896 842 317
14,307 420 304 49
and Daman and Diu
Delhi 1,98,533 7,717 232 127 Goa 3,103 27,293 24,408 267 250 248 12 10

Goa 20,511 1,052 21 10 Gujarat 73,229 5,34,323 5,30,097 41,462 33,624 33,346 2,487 1,145

Gujarat 6,45,401 61,114 2,873 2,522 Haryana 21,121 94,026 92,838 1,558 1,554 1,234 404 303
Haryana 3,25,106 13,918 1,511 241 Himachal 4,780 34,992 34,464 384 377 377 47 32
Pradesh
Himachal Pradesh 84,270 4,359 133 84
J&K 3,045 30,521 30,503 89 89 81 41 11
Jammu & Kashmir 42,250 2,853 74 1
Jharkhand 12,877 1,00,378 97,394 2,057 1,921 1,875 296 205
Jharkhand 1,16,207 9,239 1,076 344
Karnataka 1,69,311 12,19,943 11,82,558 61,848 55,116 53,633 3,187 1,439
Karnataka 11,48,449 80,870 3,367 2,967
Kerala 14,846 1,20,094 1,20,029 2,117 2,068 2,005 193 92
Kerala 2,78,818 12,868 105 36
Madhya
Ladakh 589 11 - - 31,861 1,63,582 1,57,281 10,790 10,337 9,502 998 356
Pradesh
Lakshadweep - - - - Maharashtra 2,54,886 20,34,908 19,59,494 1,07,646 1,03,553 1,01,020 4,788 1,983
Madhya Pradesh 2,97,730 20,858 2,101 1,054 Manipur 13,604 1,05,142 1,05,136 529 529 522 84 42
Maharashtra 18,86,193 1,68,692 8,184 7,307
Meghalaya 3,427 24,687 22,934 147 144 68 22 12
Manipur 26,543 564 13 2
Mizoram 12,253 62,152 61,772 371 370 342 105 73
Meghalaya 14,817 599 101 42
Nagaland 10,600 62,064 59,522 560 524 510 231 112
Mizoram 27,234 1,961 63 16
Odisha 22,209 1,14,088 1,05,371 7,565 4,270 4,199 282 178
Nagaland 34,297 1,854 137 75
Odisha 5,45,503 63,465 1,576 1,212 Pondicherry 1,245 11,544 9,805 315 315 315 32 21

Puducherry 41,693 102 57 11 Punjab 44,928 2,87,293 2,84,583 4,263 3,707 3,466 641 427
Punjab 3,24,462 16,054 608 239 Rajasthan 48,704 3,54,619 3,41,786 15,127 15,099 14,932 1,274 590
Rajasthan 5,06,495 26,494 1,133 792 Sikkim 238 2,036 2,036 15 15 15 1 1
Sikkim 6,202 75 22 3
Tamil Nadu 1,21,550 10,24,651 9,94,193 46,299 45,941 45,266 2,701 1,586
Tamil Nadu 17,08,569 1,14,383 2,650 2,593
Telangana 84,851 7,18,771 6,51,068 73,888 23,964 22,215 1,493 985
Telangana 3,28,045 22,204 1,092 924
Tripura 2,560 12,252 12,209 213 213 204 17 8
Tripura 31,201 3,612 66 11
Uttar Pradesh 6,91,953 52,723 4,877 2,519 Uttar Pradesh 94,126 7,49,896 7,47,761 13,103 12,402 12,063 1,672 861

Uttarakhand 70,360 2,937 607 122 Uttarakhand 4,495 35,422 31,139 4,247 682 447 160 92
West Bengal 5,44,526 22,822 973 590 West Bengal 45,236 2,94,154 2,90,132 4,589 3,106 3,038 397 235
INDIA 1,10,15,134 7,99,946 41,498 27,354 India 14,23,744 1,05,37,576 1,01,68,619 4,69,593 3,86,748 3,73,825 27,289 14,173
*- Source of data – NACP Monthly Progress Reports

165 INDIA TB REPORT 2022 INDIA TB REPORT 2022 166

2.5 TB-Diabetes

TB- DM patients initiated on

TB patients with known DM status (%) TB - DM Patients diagnosed among tested (%)
Anti-diabetic treatment (%)
State
Public Private Total Public Private Total Public Private Total

Andaman & Nicobar Islands 475 (92%) 1 (100%) 476 (92%) 97 (20%) 1 (100%) 98 (21%) 73 (75%) 1 (100%) 74 (76%)
Andhra Pradesh 61941 (98%) 24186 (99%) 86127 (98%) 8510 (14%) 2730 (11%) 11240 (13%) 5624 (66%) 1513 (55%) 7137 (63%)
Arunachal Pradesh 2425 (84%) NA 2425 (84%) 48 (2%) NA 48 (2%) 38 (79%) NA 38 (79%)
Assam 25194 (75%) 3082 (75%) 28276 (75%) 2003 (8%) 379 (12%) 2382 (8%) 926 (46%) 171 (45%) 1097 (46%)
Bihar 40308 (63%) 63915 (89%) 104223 (77%) 2236 (6%) 3668 (6%) 5904 (6%) 1327 (59%) 691 (19%) 2018 (34%)
Chandigarh 2913 (93%) 77 (64%) 2990 (92%) 272 (9%) 3 (4%) 275 (9%) 173 (64%) 3 (100%) 176 (64%)
Chhattisgarh 22815 (90%) 5976 (83%) 28791 (88%) 2062 (9%) 358 (6%) 2420 (8%) 1093 (53%) 137 (38%) 1230 (51%)
Dadra and Nagar Haveli and Daman and Diu 698 (98%) 50 (100%) 748 (98%) 36 (5%) 2 (4%) 38 (5%) 31 (86%) 2 (100%) 33 (87%)
Delhi 54940 (81%) 10714 (64%) 65654 (78%) 4438 (8%) 1205 (11%) 5643 (9%) 2249 (51%) 303 (25%) 2552 (45%)
Goa 1596 (96%) 231 (60%) 1827 (90%) 308 (19%) 36 (16%) 344 (19%) 237 (77%) 17 (47%) 254 (74%)
Gujarat 98844 (98%) 37285 (92%) 136129 (96%) 5561 (6%) 1939 (5%) 7500 (6%) 4856 (87%) 1641 (85%) 6497 (87%)
Haryana 48108 (92%) 17044 (91%) 65152 (91%) 3592 (7%) 1071 (6%) 4663 (7%) 2638 (73%) 826 (77%) 3464 (74%)
Himachal Pradesh 14048 (99%) 559 (97%) 14607 (99%) 1272 (9%) 38 (7%) 1310 (9%) 1096 (86%) 34 (89%) 1130 (86%)
Jammu & Kashmir 9078 (88%) 581 (89%) 9659 (88%) 592 (7%) 35 (6%) 627 (6%) 296 (50%) 23 (66%) 319 (51%)
Jharkhand 26703 (73%) 13216 (80%) 39919 (75%) 1405 (5%) 1342 (10%) 2747 (7%) 751 (53%) 305 (23%) 1056 (38%)
Karnataka 56623 (95%) 10801 (90%) 67424 (94%) 8683 (15%) 1472 (14%) 10155 (15%) 6271 (72%) 882 (60%) 7153 (70%)
Kerala 17523 (93%) 2582 (83%) 20105 (91%) 5834 (33%) 816 (32%) 6650 (33%) 3546 (61%) 455 (56%) 4001 (60%)
Ladakh 238 (81%) 18 (75%) 256 (80%) 12 (5%) 1 (6%) 13 (5%) 12 (100%) 1 (100%) 13 (100%)
Lakshadweep 20 (100%) NA 20 (100%) 8 (40%) NA 8 (40%) 7 (88%) NA 7 (88%)
Madhya Pradesh 108962 (90%) 42289 (89%) 151251 (90%) 6194 (6%) 2659 (6%) 8853 (6%) 2994 (48%) 790 (30%) 3784 (43%)
Maharashtra 118769 (94%) 64409 (92%) 183178 (93%) 8136 (7%) 4140 (6%) 12276 (7%) 5771 (71%) 2473 (60%) 8244 (67%)
Manipur 1073 (64%) 91 (48%) 1164 (62%) 192 (18%) 11 (12%) 203 (17%) 139 (72%) 5 (45%) 144 (71%)
Meghalaya 3128 (82%) 226 (63%) 3354 (80%) 172 (5%) 1 (0%) 173 (5%) 119 (69%) 1 (100%) 120 (69%)
Mizoram 1549 (97%) 192 (100%) 1741 (98%) 89 (6%) 21 (11%) 110 (6%) 77 (87%) 21 (100%) 98 (89%)
Nagaland 2560 (81%) 391 (74%) 2951 (80%) 110 (4%) 29 (7%) 139 (5%) 65 (59%) 2 (7%) 67 (48%)
Odisha 46261 (96%) 3658 (93%) 49919 (96%) 3668 (8%) 230 (6%) 3898 (8%) 2773 (76%) 180 (78%) 2953 (76%)
Puducherry 1383 (98%) NA 1383 (98%) 410 (30%) NA 410 (30%) 326 (80%) NA 326 (80%)
Punjab 34630 (90%) 11711 (86%) 46341 (89%) 3932 (11%) 1007 (9%) 4939 (11%) 1846 (47%) 317 (31%) 2163 (44%)
Rajasthan 96297 (90%) 38658 (89%) 134955 (89%) 3177 (3%) 1461 (4%) 4638 (3%) 2209 (70%) 852 (58%) 3061 (66%)
Sikkim 1260 (94%) 96 (97%) 1356 (94%) 117 (9%) 9 (9%) 126 (9%) 105 (90%) 8 (89%) 113 (90%)
Tamil Nadu 67118 (97%) 13423 (85%) 80541 (95%) 18321 (27%) 3515 (26%) 21836 (27%) 14874 (81%) 2720 (77%) 17594 (81%)
Telangana 42072 (95%) 15384 (91%) 57456 (94%) 2752 (7%) 980 (6%) 3732 (6%) 2321 (84%) 689 (70%) 3010 (81%)
Tripura 2577 (93%) 11 (85%) 2588 (93%) 405 (16%) 2 (18%) 407 (16%) 178 (44%) 1 (50%) 179 (44%)
Uttar Pradesh 303754 (87%) 97621 (84%) 401375 (86%) 16296 (5%) 4126 (4%) 20422 (5%) 6705 (41%) 1234 (30%) 7939 (39%)
Uttarakhand 17008 (88%) 3378 (78%) 20386 (86%) 1261 (7%) 146 (4%) 1407 (7%) 588 (47%) 77 (53%) 665 (47%)
West Bengal 77291 (94%) 8005 (87%) 85296 (93%) 10820 (14%) 1033 (13%) 11853 (14%) 7636 (71%) 801 (78%) 8437 (71%)
India 1410182 (89%) 489861 (88%) 1900043 (89%) 123021 (9%) 34466 (7%) 157487 (8%) 79970 (65%) 17176 (50%) 97146 (62%)

167 INDIA TB REPORT 2022 INDIA TB REPORT 2022 168

2.6 TB-Tobacco

Tobacco users linked with Tobacco cessation

TB patients with known Tobacco usage status (%) Tobacco users identified amongst screened (%)
centres (%)
State
Public Private Total Public Private Total Public Private Total

Andaman & Nicobar Islands 439 (85%) 1 (100%) 440 (85%) 73 (17%) 0 (0%) 73 (17%) 26 (36%) NA 26 (36%)
Andhra Pradesh 60037 (95%) 23811 (98%) 83848 (96%) 9480 (16%) 1576 (7%) 11056 (13%) 1713 (18%) 308 (20%) 2021 (18%)
Arunachal Pradesh 2375 (83%) NA 2375 (83%) 235 (10%) NA 235 (10%) 90 (38%) NA 90 (38%)
Assam 22567 (67%) 2607 (63%) 25174 (67%) 6304 (28%) 285 (11%) 6589 (26%) 1240 (20%) 105 (37%) 1345 (20%)
Bihar 34313 (54%) 39063 (55%) 73376 (54%) 4203 (12%) 3198 (8%) 7401 (10%) 857 (20%) 62 (2%) 919 (12%)
Chandigarh 2850 (91%) 77 (64%) 2927 (90%) 169 (6%) 0 (0%) 169 (6%) 102 (60%) NA 102 (60%)
Chhattisgarh 21280 (84%) 4208 (58%) 25488 (78%) 6572 (31%) 344 (8%) 6916 (27%) 3118 (47%) 186 (54%) 3304 (48%)
Dadra and Nagar Haveli and Daman and Diu 433 (61%) 40 (80%) 473 (62%) 53 (12%) 1 (3%) 54 (11%) 40 (75%) 1 (100%) 41 (76%)
Delhi 43358 (64%) 5474 (33%) 48832 (58%) 2833 (7%) 137 (3%) 2970 (6%) 711 (25%) 27 (20%) 738 (25%)
Goa 1504 (91%) 32 (8%) 1536 (75%) 116 (8%) 1 (3%) 117 (8%) 8 (7%) 0 (0%) 8 (7%)
Gujarat 97439 (97%) 37255 (92%) 134694 (95%) 16835 (17%) 3451 (9%) 20286 (15%) 7133 (42%) 1386 (40%) 8519 (42%)
Haryana 45995 (88%) 15922 (85%) 61917 (87%) 1984 (4%) 674 (4%) 2658 (4%) 890 (45%) 178 (26%) 1068 (40%)
Himachal Pradesh 13951 (98%) 547 (95%) 14498 (98%) 1956 (14%) 42 (8%) 1998 (14%) 1831 (94%) 34 (81%) 1865 (93%)
Jammu & Kashmir 7525 (73%) 488 (75%) 8013 (73%) 582 (8%) 18 (4%) 600 (7%) 205 (35%) 6 (33%) 211 (35%)
Jharkhand 23696 (65%) 4109 (25%) 27805 (52%) 3202 (14%) 190 (5%) 3392 (12%) 1085 (34%) 39 (21%) 1124 (33%)
Karnataka 52227 (88%) 9392 (78%) 61619 (86%) 9211 (18%) 472 (5%) 9683 (16%) 2952 (32%) 152 (32%) 3104 (32%)
Kerala 16539 (87%) 2149 (69%) 18688 (85%) 2289 (14%) 140 (7%) 2429 (13%) 1572 (69%) 82 (59%) 1654 (68%)
Ladakh 214 (73%) 17 (71%) 231 (72%) 6 (3%) 0 (0%) 6 (3%) 0 (0%) NA 0 (0%)
Lakshadweep 20 (100%) NA 20 (100%) 0 (0%) NA 0 (0%) NA NA NA
Madhya Pradesh 75801 (63%) 26134 (55%) 101935 (61%) 12259 (16%) 837 (3%) 13096 (13%) 2061 (17%) 187 (22%) 2248 (17%)
Maharashtra 105457 (83%) 47223 (67%) 152680 (78%) 10270 (10%) 1339 (3%) 11609 (8%) 3415 (33%) 335 (25%) 3750 (32%)
Manipur 1112 (66%) 77 (41%) 1189 (63%) 238 (21%) 14 (18%) 252 (21%) 41 (17%) 2 (14%) 43 (17%)
Meghalaya 3117 (81%) 235 (66%) 3352 (80%) 1179 (38%) 156 (66%) 1335 (40%) 217 (18%) 12 (8%) 229 (17%)
Mizoram 1517 (95%) 192 (100%) 1709 (96%) 539 (36%) 80 (42%) 619 (36%) 332 (62%) 57 (71%) 389 (63%)
Nagaland 2610 (83%) 394 (74%) 3004 (81%) 396 (15%) 69 (18%) 465 (15%) 244 (62%) 34 (49%) 278 (60%)
Odisha 44875 (93%) 3526 (89%) 48401 (93%) 8567 (19%) 206 (6%) 8773 (18%) 3637 (42%) 121 (59%) 3758 (43%)
Puducherry 1375 (98%) NA 1375 (98%) 213 (15%) NA 213 (15%) 208 (98%) NA 208 (98%)
Punjab 32706 (85%) 8748 (64%) 41454 (80%) 1385 (4%) 150 (2%) 1535 (4%) 251 (18%) 2 (1%) 253 (16%)
Rajasthan 84291 (78%) 31990 (74%) 116281 (77%) 7215 (9%) 2401 (8%) 9616 (8%) 2090 (29%) 641 (27%) 2731 (28%)
Sikkim 794 (59%) 72 (73%) 866 (60%) 69 (9%) 3 (4%) 72 (8%) 2 (3%) 3 (100%) 5 (7%)
Tamil Nadu 61338 (89%) 11624 (74%) 72962 (86%) 11602 (19%) 807 (7%) 12409 (17%) 2558 (22%) 117 (14%) 2675 (22%)
Telangana 41637 (94%) 15167 (90%) 56804 (93%) 5618 (13%) 943 (6%) 6561 (12%) 2549 (45%) 522 (55%) 3071 (47%)
Tripura 1991 (72%) 9 (69%) 2000 (72%) 266 (13%) 1 (11%) 267 (13%) 17 (6%) 0 (0%) 17 (6%)
Uttar Pradesh 233920 (67%) 48157 (42%) 282077 (61%) 23646 (10%) 4351 (9%) 27997 (10%) 4803 (20%) 309 (7%) 5112 (18%)
Uttarakhand 14286 (74%) 2525 (58%) 16811 (71%) 1407 (10%) 143 (6%) 1550 (9%) 415 (29%) 41 (29%) 456 (29%)
West Bengal 70889 (86%) 7706 (84%) 78595 (86%) 15654 (22%) 1060 (14%) 16714 (21%) 4839 (31%) 435 (41%) 5274 (32%)
India 1224478 (78%) 348971 (62%) 1573449 (74%) 166626 (14%) 23089 (7%) 189715 (12%) 51252 (31%) 5384 (23%) 56636 (30%)

169 INDIA TB REPORT 2022 INDIA TB REPORT 2022 170

2.7 TB-Alcohol

TB patients with known Alcohol usage status (%) Alcohol users identified amongst screened (%) Alcohol users linked with Deaddiction centres (%)
State
Public Private Total Public Private Total Public Private Total

Andaman & Nicobar Islands 456 (89%) 1 (100%) 457 (89%) 71 (16%) 0 (0%) 71 (16%) 32 (45%) NA 32 (45%)
Andhra Pradesh 59221 (93%) 23646 (97%) 82867 (94%) 7896 (13%) 1254 (5%) 9150 (11%) 1329 (17%) 267 (21%) 1596 (17%)
Arunachal Pradesh 2353 (82%) NA 2353 (82%) 164 (7%) NA 164 (7%) 60 (37%) NA 60 (37%)
Assam 21694 (65%) 2683 (65%) 24377 (65%) 3813 (18%) 166 (6%) 3979 (16%) 999 (26%) 75 (45%) 1074 (27%)
Bihar 33850 (53%) 38258 (54%) 72108 (53%) 774 (2%) 393 (1%) 1167 (2%) 193 (25%) 31 (8%) 224 (19%)
Chandigarh 2762 (88%) 77 (64%) 2839 (88%) 133 (5%) 3 (4%) 136 (5%) 63 (47%) 2 (67%) 65 (48%)
Chhattisgarh 20627 (81%) 4110 (57%) 24737 (76%) 4264 (21%) 184 (4%) 4448 (18%) 2239 (53%) 125 (68%) 2364 (53%)
Dadra and Nagar Haveli and Daman and Diu 402 (56%) 41 (82%) 443 (58%) 49 (12%) 1 (2%) 50 (11%) 34 (69%) 0 (0%) 34 (68%)
Delhi 42111 (62%) 5291 (32%) 47402 (56%) 2505 (6%) 60 (1%) 2565 (5%) 506 (20%) 12 (20%) 518 (20%)
Goa 1497 (90%) 32 (8%) 1529 (75%) 128 (9%) 2 (6%) 130 (9%) 17 (13%) 0 (0%) 17 (13%)
Gujarat 96594 (96%) 36838 (91%) 133432 (94%) 5638 (6%) 571 (2%) 6209 (5%) 2559 (45%) 245 (43%) 2804 (45%)
Haryana 45134 (86%) 15583 (83%) 60717 (85%) 1303 (3%) 309 (2%) 1612 (3%) 557 (43%) 93 (30%) 650 (40%)
Himachal Pradesh 13851 (97%) 545 (94%) 14396 (97%) 1530 (11%) 38 (7%) 1568 (11%) 1325 (87%) 25 (66%) 1350 (86%)
Jammu & Kashmir 7274 (70%) 460 (71%) 7734 (70%) 354 (5%) 7 (2%) 361 (5%) 104 (29%) 4 (57%) 108 (30%)
Jharkhand 22404 (61%) 4042 (24%) 26446 (50%) 2277 (10%) 58 (1%) 2335 (9%) 910 (40%) 7 (12%) 917 (39%)
Karnataka 51578 (87%) 9084 (76%) 60662 (85%) 7151 (14%) 278 (3%) 7429 (12%) 2222 (31%) 87 (31%) 2309 (31%)
Kerala 16341 (86%) 2052 (66%) 18393 (84%) 2333 (14%) 117 (6%) 2450 (13%) 1350 (58%) 59 (50%) 1409 (58%)
Ladakh 223 (76%) 17 (71%) 240 (75%) 11 (5%) 1 (6%) 12 (5%) 2 (18%) 0 (0%) 2 (17%)
Lakshadweep 20 (100%) NA 20 (100%) 0 (0%) NA 0 (0%) NA NA NA
Madhya Pradesh 72595 (60%) 25995 (55%) 98590 (59%) 4322 (6%) 266 (1%) 4588 (5%) 1010 (23%) 60 (23%) 1070 (23%)
Maharashtra 103398 (82%) 45965 (66%) 149363 (76%) 6104 (6%) 629 (1%) 6733 (5%) 2200 (36%) 154 (24%) 2354 (35%)
Manipur 1152 (68%) 76 (40%) 1228 (66%) 183 (16%) 13 (17%) 196 (16%) 47 (26%) 3 (23%) 50 (26%)
Meghalaya 3048 (79%) 218 (61%) 3266 (78%) 641 (21%) 31 (14%) 672 (21%) 155 (24%) 3 (10%) 158 (24%)
Mizoram 1508 (95%) 190 (99%) 1698 (95%) 238 (16%) 50 (26%) 288 (17%) 57 (24%) 2 (4%) 59 (20%)
Nagaland 2592 (82%) 389 (73%) 2981 (81%) 209 (8%) 17 (4%) 226 (8%) 113 (54%) 3 (18%) 116 (51%)
Odisha 44705 (93%) 3522 (89%) 48227 (92%) 7349 (16%) 162 (5%) 7511 (16%) 3125 (43%) 94 (58%) 3219 (43%)
Puducherry 1374 (98%) NA 1374 (98%) 273 (20%) NA 273 (20%) 267 (98%) NA 267 (98%)
Punjab 32273 (84%) 8535 (62%) 40808 (78%) 1291 (4%) 188 (2%) 1479 (4%) 227 (18%) 4 (2%) 231 (16%)
Rajasthan 81995 (76%) 30924 (71%) 112919 (75%) 2901 (4%) 644 (2%) 3545 (3%) 1021 (35%) 181 (28%) 1202 (34%)
Sikkim 750 (56%) 67 (68%) 817 (57%) 46 (6%) 2 (3%) 48 (6%) 4 (9%) 2 (100%) 6 (13%)
Tamil Nadu 61044 (88%) 11554 (73%) 72598 (85%) 13691 (22%) 804 (7%) 14495 (20%) 3060 (22%) 145 (18%) 3205 (22%)
Telangana 41309 (94%) 14994 (89%) 56303 (92%) 6422 (16%) 929 (6%) 7351 (13%) 3249 (51%) 458 (49%) 3707 (50%)
Tripura 1852 (67%) 10 (77%) 1862 (67%) 290 (16%) 1 (10%) 291 (16%) 19 (7%) 0 (0%) 19 (7%)
Uttar Pradesh 223052 (64%) 42624 (37%) 265676 (57%) 7423 (3%) 773 (2%) 8196 (3%) 1867 (25%) 195 (25%) 2062 (25%)
Uttarakhand 13804 (72%) 2417 (56%) 16221 (69%) 992 (7%) 89 (4%) 1081 (7%) 312 (31%) 33 (37%) 345 (32%)
West Bengal 69567 (85%) 7478 (81%) 77045 (84%) 8984 (13%) 524 (7%) 9508 (12%) 2947 (33%) 211 (40%) 3158 (33%)
India 1194410 (76%) 337718 (60%) 1532128 (72%) 101753 (9%) 8564 (3%) 110317 (7%) 34181 (34%) 2580 (30%) 36761 (33%)

171 INDIA TB REPORT 2022 INDIA TB REPORT 2022 172

2.8 TB COVID 2.9 TB-Pregnancy

TB notified patients screened for COVID-19

TB-COVID 19 patients detected Female TB patients screened for Pregnancy Pregnant TB patients identified
disease
State State
Public Private Total Public Private Total Public Private Total Public Private Total
Andaman & Nicobar Andaman & Nicobar
220 1 221 1 0 1 183 0 183 0 0 0
Islands Islands
Andhra Pradesh 59087 23212 82299 188 35 223 Andhra Pradesh 13351 4234 17585 93 34 127

Arunachal Pradesh 1756 0 1756 2 0 2 Arunachal Pradesh 736 0 736 0 0 0

Assam 19561 2300 21861 42 15 57 Assam 6758 895 7653 37 6 43

Bihar 33886 20059 53945 34 60 94 Bihar 11973 9085 21058 173 117 290

Chandigarh 2827 75 2902 15 0 15 Chandigarh 635 33 668 7 0 7

Chhattisgarh 18430 3586 22016 69 3 72 Chhattisgarh 6105 1475 7580 45 9 54

Dadra and Nagar Haveli Dadra and Nagar Haveli
324 35 359 2 0 2 233 22 255 1 0 1
and Daman and Diu and Daman and Diu
Delhi 39309 4159 43468 70 56 126 Delhi 14811 3731 18542 134 25 159
Goa 1315 37 1352 53 1 54 Goa 451 101 552 1 0 1
Gujarat 63507 22105 85612 227 112 339 Gujarat 23319 7726 31045 279 78 357
Haryana 37764 10943 48707 83 23 106 Haryana 11939 4026 15965 135 33 168
Himachal Pradesh 8060 261 8321 54 3 57 Himachal Pradesh 3892 218 4110 37 1 38
Jammu & Kashmir 7880 543 8423 14 0 14 Jammu & Kashmir 2923 230 3153 17 2 19
Jharkhand 22607 3848 26455 29 11 40 Jharkhand 5881 2382 8263 51 12 63
Karnataka 46512 8035 54547 338 71 409 Karnataka 15833 3217 19050 155 20 175
Kerala 11291 1909 13200 450 37 487 Kerala 5051 936 5987 35 6 41
Ladakh 136 16 152 6 0 6 Ladakh 101 12 113 4 0 4
Lakshadweep 16 0 16 0 0 0 Lakshadweep 10 0 10 0 0 0
Madhya Pradesh 44622 9442 54064 167 32 199 Madhya Pradesh 26720 7683 34403 192 53 245
Maharashtra 92453 39895 132348 623 218 841 Maharashtra 37929 19381 57310 292 103 395
Manipur 500 50 550 3 1 4 Manipur 413 36 449 5 0 5
Meghalaya 1350 180 1530 15 1 16 Meghalaya 1076 92 1168 13 1 14
Mizoram 928 130 1058 9 0 9 Mizoram 528 66 594 0 0 0
Nagaland 1029 12 1041 3 0 3 Nagaland 841 105 946 2 2 4
Odisha 39425 2805 42230 110 8 118 Odisha 10760 947 11707 61 4 65
Puducherry 1128 0 1128 13 0 13 Puducherry 384 0 384 3 0 3
Punjab 25279 3796 29075 83 10 93 Punjab 9456 3033 12489 84 9 93
Rajasthan 46506 16799 63305 77 42 119 Rajasthan 22552 7207 29759 192 65 257
Sikkim 568 23 591 25 0 25 Sikkim 501 51 552 0 1 1
Tamil Nadu 54809 8047 62856 468 50 518 Tamil Nadu 17026 4181 21207 268 19 287
Telangana 40545 14640 55185 73 67 140 Telangana 9028 3712 12740 115 61 176
Tripura 1576 6 1582 9 0 9 Tripura 563 2 565 7 0 7
Uttar Pradesh 228305 29543 257848 233 69 302 Uttar Pradesh 76896 22155 99051 572 135 707
Uttarakhand 12743 2216 14959 40 5 45 Uttarakhand 4548 844 5392 41 3 44
West Bengal 70664 7102 77766 376 62 438 West Bengal 18023 2612 20635 186 12 198
INDIA 1036918 235810 1272728 4004 992 4996 INDIA 361429 110430 471859 3237 811 4048

173 INDIA TB REPORT 2022 INDIA TB REPORT 2022 174

3.1 T
 reatment outcome of TB patients notified in 2020
(Public Sector)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 434 242 141 (58%) 370 (85%) 16 (3.7%) 6 (1.4%) 3 (0.7%) 8 (1.8%) 1 (0.2%)
Andhra Pradesh 45783 27954 22134 (79%) 40487 (88%) 2210 (4.8%) 349 (0.8%) 103 (0.2%) 867 (1.9%) 591 (1.3%)
Arunachal Pradesh 2420 1247 816 (65%) 2013 (83%) 78 (3.2%) 123 (5.1%) 23 (1.0%) 76 (3.1%) 23 (1.0%)
Assam 30860 15466 9216 (60%) 25853 (84%) 1256 (4.1%) 587 (1.9%) 113 (0.4%) 433 (1.4%) 1116 (3.6%)
Bihar 52661 30111 13951 (46%) 38953 (74%) 1310 (2.5%) 2109 (4.0%) 285 (0.5%) 633 (1.2%) 3482 (6.6%)
Chandigarh 2624 1291 916 (71%) 2146 (82%) 119 (4.5%) 99 (3.8%) 14 (0.5%) 51 (1.9%) 41 (1.6%)
Chhattisgarh 22127 10552 7910 (75%) 19267 (87%) 1142 (5.2%) 369 (1.7%) 113 (0.5%) 240 (1.1%) 581 (2.6%)
Dadra and Nagar Haveli and Daman and Diu 661 306 279 (91%) 616 (93%) 16 (2.4%) 5 (0.8%) 2 (0.3%) 1 (0.2%) 7 (1.1%)
Delhi 55183 27205 13193 (48%) 41432 (75%) 1330 (2.4%) 2601 (4.7%) 344 (0.6%) 1545 (2.8%) 1290 (2.3%)
Goa 1277 776 338 (44%) 1056 (83%) 84 (6.6%) 33 (2.6%) 8 (0.6%) 26 (2.0%) 4 (0.3%)
Gujarat 77114 36707 31039 (85%) 67086 (87%) 4250 (5.5%) 1111 (1.4%) 786 (1.0%) 1726 (2.2%) 155 (0.2%)
Haryana 44995 28947 17351 (60%) 35885 (80%) 1916 (4.3%) 1002 (2.2%) 297 (0.7%) 480 (1.1%) 1131 (2.5%)
Himachal Pradesh 12713 8501 5580 (66%) 11174 (88%) 695 (5.5%) 122 (1.0%) 42 (0.3%) 233 (1.8%) 127 (1.0%)
Jammu & Kashmir 8194 4091 2962 (72%) 6793 (83%) 294 (3.6%) 110 (1.3%) 46 (0.6%) 73 (0.9%) 459 (5.6%)
Jharkhand 30707 17520 10053 (57%) 25836 (84%) 902 (2.9%) 682 (2.2%) 150 (0.5%) 242 (0.8%) 1295 (4.2%)
Karnataka 49669 30794 22399 (73%) 40108 (81%) 3939 (7.9%) 1299 (2.6%) 333 (0.7%) 1411 (2.8%) 437 (0.9%)
Kerala 17696 10674 7538 (71%) 14459 (82%) 1379 (7.8%) 310 (1.8%) 121 (0.7%) 216 (1.2%) 573 (3.2%)
Ladakh 226 122 51 (42%) 171 (76%) 19 (8.4%) 4 (1.8%) 2 (0.9%) 1 (0.4%) 18 (8.0%)
Lakshadweep 17 8 9 (113%) 15 (88%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (11.8%)
Madhya Pradesh 106113 48914 30165 (62%) 88971 (84%) 3847 (3.6%) 3547 (3.3%) 642 (0.6%) 1233 (1.2%) 3524 (3.3%)
Maharashtra 94885 44916 30921 (69%) 79205 (83%) 4574 (4.8%) 1986 (2.1%) 532 (0.6%) 2704 (2.8%) 578 (0.6%)
Manipur 1387 763 521 (68%) 1132 (82%) 48 (3.5%) 38 (2.7%) 6 (0.4%) 17 (1.2%) 75 (5.4%)
Meghalaya 3451 1989 1206 (61%) 2770 (80%) 178 (5.2%) 109 (3.2%) 27 (0.8%) 86 (2.5%) 72 (2.1%)
Mizoram 1831 917 630 (69%) 1636 (89%) 50 (2.7%) 27 (1.5%) 5 (0.3%) 25 (1.4%) 49 (2.7%)
Nagaland 2844 1598 1214 (76%) 2294 (81%) 80 (2.8%) 65 (2.3%) 26 (0.9%) 24 (0.8%) 284 (10.0%)
Odisha 41418 24560 19934 (81%) 36741 (89%) 2421 (5.8%) 542 (1.3%) 105 (0.3%) 239 (0.6%) 431 (1.0%)
Puducherry 1219 826 542 (66%) 993 (81%) 80 (6.6%) 28 (2.3%) 14 (1.1%) 37 (3.0%) 3 (0.2%)
Punjab 35765 22516 13320 (59%) 28681 (80%) 1910 (5.3%) 1053 (2.9%) 176 (0.5%) 443 (1.2%) 1385 (3.9%)
Rajasthan 93363 54974 36008 (66%) 76759 (82%) 3327 (3.6%) 2720 (2.9%) 515 (0.6%) 1324 (1.4%) 1266 (1.4%)
Sikkim 1065 641 440 (69%) 956 (90%) 43 (4.0%) 9 (0.8%) 1 (0.1%) 17 (1.6%) 15 (1.4%)
Tamil Nadu 53983 36131 26817 (74%) 44529 (82%) 3437 (6.4%) 1177 (2.2%) 303 (0.6%) 1915 (3.5%) 612 (1.1%)
Telangana 39396 21593 19321 (89%) 34431 (87%) 1358 (3.4%) 246 (0.6%) 165 (0.4%) 1033 (2.6%) 1015 (2.6%)
Tripura 2134 1412 1043 (74%) 1737 (81%) 159 (7.5%) 50 (2.3%) 9 (0.4%) 60 (2.8%) 42 (2.0%)
Uttar Pradesh 257186 122589 71829 (59%) 213703 (83%) 9735 (3.8%) 8011 (3.1%) 1501 (0.6%) 3912 (1.5%) 2326 (0.9%)
Uttarakhand 14992 7052 4151 (59%) 12737 (85%) 589 (3.9%) 399 (2.7%) 74 (0.5%) 315 (2.1%) 199 (1.3%)
West Bengal 69430 47208 34523 (73%) 58574 (84%) 3914 (5.6%) 1396 (2.0%) 436 (0.6%) 1165 (1.7%) 1146 (1.7%)
INDIA 1275823 691113 644070 (93%) 1059569 (83%) 56705 (4.4%) 32324 (2.5%) 7322 (0.6%) 22811 (1.8%) 24355 (1.9%)

175 INDIA TB REPORT 2022 INDIA TB REPORT 2022 176

3.2 T
 reatment outcome of TB patients notified in 2020
(Private Sector)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 0 NA NA NA NA NA NA NA NA

Andhra Pradesh 17131 3395 2245 (66%) 16188 (94%) 280 (1.6%) 150 (0.9%) 19 (0.1%) 145 (0.8%) 264 (1.5%)
Arunachal Pradesh 4 0 NA 1 (25%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (25.0%)
Assam 3680 759 170 (22%) 3043 (83%) 166 (4.5%) 47 (1.3%) 12 (0.3%) 17 (0.5%) 256 (7.0%)
Bihar 47070 4678 478 (10%) 38550 (82%) 2031 (4.3%) 1642 (3.5%) 231 (0.5%) 435 (0.9%) 3261 (6.9%)
Chandigarh 205 89 34 (38%) 132 (64%) 10 (4.9%) 5 (2.4%) 0 (0.0%) 2 (1.0%) 23 (11.2%)
Chhattisgarh 6977 806 524 (65%) 5813 (83%) 238 (3.4%) 316 (4.5%) 24 (0.3%) 21 (0.3%) 491 (7.0%)
Dadra and Nagar Haveli and Daman and Diu 74 8 6 (75%) 70 (95%) 1 (1.4%) 0 (0.0%) 0 (0.0%) 1 (1.4%) 1 (1.4%)
Delhi 18207 7638 68 (1%) 11461 (63%) 678 (3.7%) 847 (4.7%) 44 (0.2%) 100 (0.5%) 572 (3.1%)
Goa 307 68 10 (15%) 282 (92%) 5 (1.6%) 15 (4.9%) 0 (0.0%) 0 (0.0%) 4 (1.3%)
Gujarat 38231 4160 587 (14%) 34398 (90%) 1222 (3.2%) 1299 (3.4%) 90 (0.2%) 348 (0.9%) 589 (1.5%)
Haryana 18041 5519 1768 (32%) 13620 (75%) 722 (4.0%) 1003 (5.6%) 98 (0.5%) 95 (0.5%) 1589 (8.8%)
Himachal Pradesh 586 214 124 (58%) 469 (80%) 28 (4.8%) 22 (3.8%) 6 (1.0%) 11 (1.9%) 34 (5.8%)
Jammu & Kashmir 606 200 210 (105%) 497 (82%) 15 (2.5%) 10 (1.7%) 3 (0.5%) 0 (0.0%) 44 (7.3%)
Jharkhand 14953 1081 44 (4%) 12205 (82%) 666 (4.5%) 1696 (11.3%) 19 (0.1%) 67 (0.4%) 110 (0.7%)
Karnataka 12865 4615 1109 (24%) 10648 (83%) 551 (4.3%) 256 (2.0%) 35 (0.3%) 107 (0.8%) 436 (3.4%)
Kerala 2945 1463 576 (39%) 2311 (78%) 289 (9.8%) 61 (2.1%) 10 (0.3%) 18 (0.6%) 34 (1.2%)
Ladakh 17 5 5 (100%) 17 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Lakshadweep 0 0 NA NA NA NA NA NA NA
Madhya Pradesh 29646 4320 1747 (40%) 19035 (64%) 948 (3.2%) 2545 (8.6%) 125 (0.4%) 198 (0.7%) 5433 (18.3%)
Maharashtra 52535 18551 2151 (12%) 45112 (86%) 2414 (4.6%) 1102 (2.1%) 184 (0.4%) 620 (1.2%) 280 (0.5%)
Manipur 177 88 12 (14%) 113 (64%) 7 (4.0%) 5 (2.8%) 0 (0.0%) 0 (0.0%) 14 (7.9%)
Meghalaya 413 101 0 (0%) 339 (82%) 7 (1.7%) 39 (9.4%) 0 (0.0%) 3 (0.7%) 11 (2.7%)
Mizoram 157 64 46 (72%) 137 (87%) 0 (0.0%) 4 (2.5%) 0 (0.0%) 2 (1.3%) 3 (1.9%)
Nagaland 674 60 18 (30%) 547 (81%) 17 (2.5%) 25 (3.7%) 0 (0.0%) 0 (0.0%) 84 (12.5%)
Odisha 3577 416 373 (90%) 3254 (91%) 85 (2.4%) 42 (1.2%) 2 (0.1%) 9 (0.3%) 95 (2.7%)
Puducherry 1 1 1 (100%) 1 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Punjab 10726 3416 374 (11%) 8325 (78%) 757 (7.1%) 119 (1.1%) 28 (0.3%) 51 (0.5%) 989 (9.2%)
Rajasthan 40097 6714 1493 (22%) 33213 (83%) 1289 (3.2%) 2655 (6.6%) 241 (0.6%) 215 (0.5%) 1082 (2.7%)
Sikkim 74 29 9 (31%) 66 (89%) 2 (2.7%) 0 (0.0%) 0 (0.0%) 2 (2.7%) 0 (0.0%)
Tamil Nadu 14960 5817 1869 (32%) 12356 (83%) 613 (4.1%) 535 (3.6%) 39 (0.3%) 121 (0.8%) 696 (4.7%)
Telangana 21461 6340 4360 (69%) 19745 (92%) 518 (2.4%) 130 (0.6%) 61 (0.3%) 123 (0.6%) 522 (2.4%)
Tripura 3 0 NA 2 (67%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Uttar Pradesh 106478 9210 4051 (44%) 90082 (85%) 5178 (4.9%) 3869 (3.6%) 548 (0.5%) 1055 (1.0%) 1897 (1.8%)
Uttarakhand 4689 1090 116 (11%) 3675 (78%) 154 (3.3%) 215 (4.6%) 30 (0.6%) 35 (0.7%) 396 (8.4%)
West Bengal 8047 2753 1040 (38%) 6591 (82%) 406 (5.0%) 160 (2.0%) 31 (0.4%) 57 (0.7%) 275 (3.4%)
INDIA 475614 93668 25618 (27%) 392298 (82%) 19297 (4.1%) 18814 (4.0%) 1880 (0.4%) 3858 (0.8%) 19486 (4.1%)

177 INDIA TB REPORT 2022 INDIA TB REPORT 2022 178

3.3 T
 reatment outcome of TB patients notified in
2020 (Total)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 434 242 141 (58%) 370 (85%) 16 (3.7%) 6 (1.4%) 3 (0.7%) 8 (1.8%) 1 (0.2%)
Andhra Pradesh 62914 31349 24379 (78%) 56675 (90%) 2490 (4.0%) 499 (0.8%) 122 (0.2%) 1012 (1.6%) 855 (1.4%)
Arunachal Pradesh 2424 1247 816 (65%) 2014 (83%) 78 (3.2%) 123 (5.1%) 23 (0.9%) 76 (3.1%) 24 (1.0%)
Assam 34540 16225 9386 (58%) 28896 (84%) 1422 (4.1%) 634 (1.8%) 125 (0.4%) 450 (1.3%) 1372 (4.0%)
Bihar 99731 34789 14429 (41%) 77503 (78%) 3341 (3.4%) 3751 (3.8%) 516 (0.5%) 1068 (1.1%) 6743 (6.8%)
Chandigarh 2829 1380 950 (69%) 2278 (81%) 129 (4.6%) 104 (3.7%) 14 (0.5%) 53 (1.9%) 64 (2.3%)
Chhattisgarh 29104 11358 8434 (74%) 25080 (86%) 1380 (4.7%) 685 (2.4%) 137 (0.5%) 261 (0.9%) 1072 (3.7%)
Dadra and Nagar Haveli and Daman and Diu 735 314 285 (91%) 686 (93%) 17 (2.3%) 5 (0.7%) 2 (0.3%) 2 (0.3%) 8 (1.1%)
Delhi 73390 34843 13261 (38%) 52893 (72%) 2008 (2.7%) 3448 (4.7%) 388 (0.5%) 1645 (2.2%) 1862 (2.5%)
Goa 1584 844 348 (41%) 1338 (84%) 89 (5.6%) 48 (3.0%) 8 (0.5%) 26 (1.6%) 8 (0.5%)
Gujarat 115345 40867 31626 (77%) 101484 (88%) 5472 (4.7%) 2410 (2.1%) 876 (0.8%) 2074 (1.8%) 744 (0.6%)
Haryana 63036 34466 19119 (55%) 49505 (79%) 2638 (4.2%) 2005 (3.2%) 395 (0.6%) 575 (0.9%) 2720 (4.3%)
Himachal Pradesh 13299 8715 5704 (65%) 11643 (88%) 723 (5.4%) 144 (1.1%) 48 (0.4%) 244 (1.8%) 161 (1.2%)
Jammu & Kashmir 8800 4291 3172 (74%) 7290 (83%) 309 (3.5%) 120 (1.4%) 49 (0.6%) 73 (0.8%) 503 (5.7%)
Jharkhand 45660 18601 10097 (54%) 38041 (83%) 1568 (3.4%) 2378 (5.2%) 169 (0.4%) 309 (0.7%) 1405 (3.1%)
Karnataka 62534 35409 23508 (66%) 50756 (81%) 4490 (7.2%) 1555 (2.5%) 368 (0.6%) 1518 (2.4%) 873 (1.4%)
Kerala 20641 12137 8114 (67%) 16770 (81%) 1668 (8.1%) 371 (1.8%) 131 (0.6%) 234 (1.1%) 607 (2.9%)
Ladakh 243 127 56 (44%) 188 (77%) 19 (7.8%) 4 (1.6%) 2 (0.8%) 1 (0.4%) 18 (7.4%)
Lakshadweep 17 8 9 (113%) 15 (88%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (11.8%)
Madhya Pradesh 135759 53234 31912 (60%) 108006 (80%) 4795 (3.5%) 6092 (4.5%) 767 (0.6%) 1431 (1.1%) 8957 (6.6%)
Maharashtra 147420 63467 33072 (52%) 124317 (84%) 6988 (4.7%) 3088 (2.1%) 716 (0.5%) 3324 (2.3%) 858 (0.6%)
Manipur 1564 851 533 (63%) 1245 (80%) 55 (3.5%) 43 (2.7%) 6 (0.4%) 17 (1.1%) 89 (5.7%)
Meghalaya 3864 2090 1206 (58%) 3109 (80%) 185 (4.8%) 148 (3.8%) 27 (0.7%) 89 (2.3%) 83 (2.1%)
Mizoram 1988 981 676 (69%) 1773 (89%) 50 (2.5%) 31 (1.6%) 5 (0.3%) 27 (1.4%) 52 (2.6%)
Nagaland 3518 1658 1232 (74%) 2841 (81%) 97 (2.8%) 90 (2.6%) 26 (0.7%) 24 (0.7%) 368 (10.5%)
Odisha 44995 24976 20307 (81%) 39995 (89%) 2506 (5.6%) 584 (1.3%) 107 (0.2%) 248 (0.6%) 526 (1.2%)
Puducherry 1220 827 543 (66%) 994 (81%) 80 (6.6%) 28 (2.3%) 14 (1.1%) 37 (3.0%) 3 (0.2%)
Punjab 46491 25932 13694 (53%) 37006 (80%) 2667 (5.7%) 1172 (2.5%) 204 (0.4%) 494 (1.1%) 2374 (5.1%)
Rajasthan 133460 61688 37501 (61%) 109972 (82%) 4616 (3.5%) 5375 (4.0%) 756 (0.6%) 1539 (1.2%) 2348 (1.8%)
Sikkim 1139 670 449 (67%) 1022 (90%) 45 (4.0%) 9 (0.8%) 1 (0.1%) 19 (1.7%) 15 (1.3%)
Tamil Nadu 68943 41948 28686 (68%) 56885 (83%) 4050 (5.9%) 1712 (2.5%) 342 (0.5%) 2036 (3.0%) 1308 (1.9%)
Telangana 60857 27933 23681 (85%) 54176 (89%) 1876 (3.1%) 376 (0.6%) 226 (0.4%) 1156 (1.9%) 1537 (2.5%)
Tripura 2137 1412 1043 (74%) 1739 (81%) 159 (7.4%) 50 (2.3%) 9 (0.4%) 60 (2.8%) 42 (2.0%)
Uttar Pradesh 363664 131799 75880 (58%) 303785 (84%) 14913 (4.1%) 11880 (3.3%) 2049 (0.6%) 4967 (1.4%) 4223 (1.2%)
Uttarakhand 19681 8142 4267 (52%) 16412 (83%) 743 (3.8%) 614 (3.1%) 104 (0.5%) 350 (1.8%) 595 (3.0%)
West Bengal 77477 49961 35563 (71%) 65165 (84%) 4320 (5.6%) 1556 (2.0%) 467 (0.6%) 1222 (1.6%) 1421 (1.8%)
INDIA 1751437 784781 484079 (62%) 1451867 (83%) 76002 (4.3%) 51138 (2.9%) 9202 (0.5%) 26669 (1.5%) 43841 (2.5%)

179 INDIA TB REPORT 2022 INDIA TB REPORT 2022 180

3.4 T
 reatment outcome of New TB patients notified in
2020 (Public Sector)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 392 214 124 (58%) 335 (85%) 15 (3.8%) 4 (1.0%) 3 (0.8%) 6 (1.5%) 1 (0.3%)
Andhra Pradesh 38948 23336 18710 (80%) 34599 (89%) 1868 (4.8%) 279 (0.7%) 72 (0.2%) 669 (1.7%) 508 (1.3%)
Arunachal Pradesh 2109 1059 708 (67%) 1775 (84%) 65 (3.1%) 104 (4.9%) 20 (0.9%) 60 (2.8%) 19 (0.9%)
Assam 27270 13568 8136 (60%) 22908 (84%) 1094 (4.0%) 506 (1.9%) 86 (0.3%) 365 (1.3%) 982 (3.6%)
Bihar 45824 25850 12260 (47%) 34221 (75%) 1127 (2.5%) 1804 (3.9%) 247 (0.5%) 519 (1.1%) 3019 (6.6%)
Chandigarh 2299 1065 759 (71%) 1886 (82%) 104 (4.5%) 87 (3.8%) 13 (0.6%) 44 (1.9%) 36 (1.6%)
Chhattisgarh 19998 9289 7057 (76%) 17467 (87%) 1018 (5.1%) 312 (1.6%) 95 (0.5%) 198 (1.0%) 532 (2.7%)
Dadra and Nagar Haveli and Daman and Diu 562 262 236 (90%) 526 (94%) 13 (2.3%) 3 (0.5%) 1 (0.2%) 1 (0.2%) 7 (1.2%)
Delhi 46905 21782 10398 (48%) 35304 (75%) 1015 (2.2%) 2121 (4.5%) 251 (0.5%) 1164 (2.5%) 1133 (2.4%)
Goa 1167 688 306 (44%) 972 (83%) 75 (6.4%) 30 (2.6%) 5 (0.4%) 24 (2.1%) 4 (0.3%)
Gujarat 57012 24951 22211 (89%) 50590 (89%) 2917 (5.1%) 793 (1.4%) 377 (0.7%) 814 (1.4%) 114 (0.2%)
Haryana 38386 23455 14301 (61%) 30810 (80%) 1532 (4.0%) 840 (2.2%) 211 (0.5%) 361 (0.9%) 974 (2.5%)
Himachal Pradesh 10966 6956 4558 (66%) 9658 (88%) 595 (5.4%) 104 (0.9%) 31 (0.3%) 196 (1.8%) 109 (1.0%)
Jammu & Kashmir 7258 3420 2477 (72%) 6035 (83%) 249 (3.4%) 94 (1.3%) 37 (0.5%) 58 (0.8%) 392 (5.4%)
Jharkhand 27996 15931 9268 (58%) 23639 (84%) 819 (2.9%) 621 (2.2%) 130 (0.5%) 204 (0.7%) 1206 (4.3%)
Karnataka 42540 25365 18742 (74%) 34695 (82%) 3336 (7.8%) 1009 (2.4%) 219 (0.5%) 1125 (2.6%) 370 (0.9%)
Kerala 16379 9686 6911 (71%) 13458 (82%) 1282 (7.8%) 269 (1.6%) 99 (0.6%) 161 (1.0%) 537 (3.3%)
Ladakh 186 93 38 (41%) 145 (78%) 11 (5.9%) 3 (1.6%) 2 (1.1%) 0 (0.0%) 14 (7.5%)
Lakshadweep 16 8 9 (113%) 15 (94%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (6.3%)
Madhya Pradesh 92331 40858 25775 (63%) 77857 (84%) 3244 (3.5%) 3064 (3.3%) 509 (0.6%) 929 (1.0%) 3083 (3.3%)
Maharashtra 81822 37501 26234 (70%) 68847 (84%) 3803 (4.6%) 1518 (1.9%) 354 (0.4%) 2245 (2.7%) 468 (0.6%)
Manipur 1245 669 447 (67%) 1011 (81%) 42 (3.4%) 37 (3.0%) 5 (0.4%) 14 (1.1%) 68 (5.5%)
Meghalaya 3083 1737 1073 (62%) 2487 (81%) 159 (5.2%) 95 (3.1%) 17 (0.6%) 76 (2.5%) 64 (2.1%)
Mizoram 1632 770 550 (71%) 1465 (90%) 46 (2.8%) 25 (1.5%) 4 (0.2%) 17 (1.0%) 42 (2.6%)
Nagaland 2478 1338 1033 (77%) 2006 (81%) 66 (2.7%) 56 (2.3%) 22 (0.9%) 21 (0.8%) 242 (9.8%)
Odisha 37857 22114 18183 (82%) 33703 (89%) 2167 (5.7%) 462 (1.2%) 82 (0.2%) 193 (0.5%) 388 (1.0%)
Puducherry 1087 708 475 (67%) 903 (83%) 66 (6.1%) 18 (1.7%) 9 (0.8%) 29 (2.7%) 3 (0.3%)
Punjab 30938 18562 11041 (59%) 24883 (80%) 1592 (5.1%) 878 (2.8%) 134 (0.4%) 358 (1.2%) 1217 (3.9%)
Rajasthan 77611 42959 29005 (68%) 64712 (83%) 2586 (3.3%) 2204 (2.8%) 353 (0.5%) 1017 (1.3%) 1069 (1.4%)
Sikkim 944 541 363 (67%) 852 (90%) 39 (4.1%) 7 (0.7%) 1 (0.1%) 16 (1.7%) 14 (1.5%)
Tamil Nadu 46848 30295 22844 (75%) 39059 (83%) 2916 (6.2%) 905 (1.9%) 188 (0.4%) 1510 (3.2%) 535 (1.1%)
Telangana 34089 18061 16654 (92%) 30033 (88%) 1124 (3.3%) 172 (0.5%) 104 (0.3%) 834 (2.4%) 860 (2.5%)
Tripura 1891 1241 933 (75%) 1546 (82%) 142 (7.5%) 41 (2.2%) 9 (0.5%) 53 (2.8%) 38 (2.0%)
Uttar Pradesh 224050 102861 61417 (60%) 187420 (84%) 8300 (3.7%) 6999 (3.1%) 1214 (0.5%) 2915 (1.3%) 2019 (0.9%)
Uttarakhand 13122 5769 3413 (59%) 11187 (85%) 494 (3.8%) 349 (2.7%) 55 (0.4%) 253 (1.9%) 177 (1.3%)
West Bengal 61117 40724 30316 (74%) 52040 (85%) 3355 (5.5%) 1114 (1.8%) 303 (0.5%) 894 (1.5%) 1026 (1.7%)
INDIA 1098358 573686 386965 (67%) 919049 (84%) 47276 (4.3%) 26927 (2.5%) 5262 (0.5%) 17343 (1.6%) 21271 (1.9%)

181 INDIA TB REPORT 2022 INDIA TB REPORT 2022 182

3.5 T
 reatment outcome of Previously Treated TB patients
notified in 2020 (Public Sector)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 42 28 17 (61%) 35 (83%) 1 (2.4%) 2 (4.8%) 0 (0.0%) 2 (4.8%) 0 (0.0%)
Andhra Pradesh 6835 4618 3424 (74%) 5888 (86%) 342 (5.0%) 70 (1.0%) 31 (0.5%) 198 (2.9%) 83 (1.2%)
Arunachal Pradesh 311 188 108 (57%) 238 (77%) 13 (4.2%) 19 (6.1%) 3 (1.0%) 16 (5.1%) 4 (1.3%)
Assam 3590 1898 1080 (57%) 2945 (82%) 162 (4.5%) 81 (2.3%) 27 (0.8%) 68 (1.9%) 134 (3.7%)
Bihar 6837 4261 1691 (40%) 4732 (69%) 183 (2.7%) 305 (4.5%) 38 (0.6%) 114 (1.7%) 463 (6.8%)
Chandigarh 325 226 157 (69%) 260 (80%) 15 (4.6%) 12 (3.7%) 1 (0.3%) 7 (2.2%) 5 (1.5%)
Chhattisgarh 2129 1263 853 (68%) 1800 (85%) 124 (5.8%) 57 (2.7%) 18 (0.8%) 42 (2.0%) 49 (2.3%)
Dadra and Nagar Haveli and Daman and Diu 99 44 43 (98%) 90 (91%) 3 (3.0%) 2 (2.0%) 1 (1.0%) 0 (0.0%) 0 (0.0%)
Delhi 8278 5423 2795 (52%) 6128 (74%) 315 (3.8%) 480 (5.8%) 93 (1.1%) 381 (4.6%) 157 (1.9%)
Goa 110 88 32 (36%) 84 (76%) 9 (8.2%) 3 (2.7%) 3 (2.7%) 2 (1.8%) 0 (0.0%)
Gujarat 20102 11756 8828 (75%) 16496 (82%) 1333 (6.6%) 318 (1.6%) 409 (2.0%) 912 (4.5%) 41 (0.2%)
Haryana 6609 5492 3050 (56%) 5075 (77%) 384 (5.8%) 162 (2.5%) 86 (1.3%) 119 (1.8%) 157 (2.4%)
Himachal Pradesh 1747 1545 1022 (66%) 1516 (87%) 100 (5.7%) 18 (1.0%) 11 (0.6%) 37 (2.1%) 18 (1.0%)
Jammu & Kashmir 936 671 485 (72%) 758 (81%) 45 (4.8%) 16 (1.7%) 9 (1.0%) 15 (1.6%) 67 (7.2%)
Jharkhand 2711 1589 785 (49%) 2197 (81%) 83 (3.1%) 61 (2.3%) 20 (0.7%) 38 (1.4%) 89 (3.3%)
Karnataka 7129 5429 3657 (67%) 5413 (76%) 603 (8.5%) 290 (4.1%) 114 (1.6%) 286 (4.0%) 67 (0.9%)
Kerala 1317 988 627 (63%) 1001 (76%) 97 (7.4%) 41 (3.1%) 22 (1.7%) 55 (4.2%) 36 (2.7%)
Ladakh 40 29 13 (45%) 26 (65%) 8 (20.0%) 1 (2.5%) 0 (0.0%) 1 (2.5%) 4 (10.0%)
Lakshadweep 1 0 0 (NA) 0 (0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (100.0%)
Madhya Pradesh 13782 8056 4390 (54%) 11114 (81%) 603 (4.4%) 483 (3.5%) 133 (1.0%) 304 (2.2%) 441 (3.2%)
Maharashtra 13063 7415 4687 (63%) 10358 (79%) 771 (5.9%) 468 (3.6%) 178 (1.4%) 459 (3.5%) 110 (0.8%)
Manipur 142 94 74 (79%) 121 (85%) 6 (4.2%) 1 (0.7%) 1 (0.7%) 3 (2.1%) 7 (4.9%)
Meghalaya 368 252 133 (53%) 283 (77%) 19 (5.2%) 14 (3.8%) 10 (2.7%) 10 (2.7%) 8 (2.2%)
Mizoram 199 147 80 (54%) 171 (86%) 4 (2.0%) 2 (1.0%) 1 (0.5%) 8 (4.0%) 7 (3.5%)
Nagaland 366 260 181 (70%) 288 (79%) 14 (3.8%) 9 (2.5%) 4 (1.1%) 3 (0.8%) 42 (11.5%)
Odisha 3561 2446 1751 (72%) 3038 (85%) 254 (7.1%) 80 (2.2%) 23 (0.6%) 46 (1.3%) 43 (1.2%)
Puducherry 132 118 67 (57%) 90 (68%) 14 (10.6%) 10 (7.6%) 5 (3.8%) 8 (6.1%) 0 (0.0%)
Punjab 4827 3954 2279 (58%) 3798 (79%) 318 (6.6%) 175 (3.6%) 42 (0.9%) 85 (1.8%) 168 (3.5%)
Rajasthan 15752 12015 7003 (58%) 12047 (76%) 741 (4.7%) 516 (3.3%) 162 (1.0%) 307 (1.9%) 197 (1.3%)
Sikkim 121 100 77 (77%) 104 (86%) 4 (3.3%) 2 (1.7%) 0 (0.0%) 1 (0.8%) 1 (0.8%)
Tamil Nadu 7135 5836 3973 (68%) 5470 (77%) 521 (7.3%) 272 (3.8%) 115 (1.6%) 405 (5.7%) 77 (1.1%)
Telangana 5307 3532 2667 (76%) 4398 (83%) 234 (4.4%) 74 (1.4%) 61 (1.1%) 199 (3.7%) 155 (2.9%)
Tripura 243 171 110 (64%) 191 (79%) 17 (7.0%) 9 (3.7%) 0 (0.0%) 7 (2.9%) 4 (1.6%)
Uttar Pradesh 33136 19728 10412 (53%) 26283 (79%) 1435 (4.3%) 1012 (3.1%) 287 (0.9%) 997 (3.0%) 307 (0.9%)
Uttarakhand 1870 1283 738 (58%) 1550 (83%) 95 (5.1%) 50 (2.7%) 19 (1.0%) 62 (3.3%) 22 (1.2%)
West Bengal 8313 6484 4207 (65%) 6534 (79%) 559 (6.7%) 282 (3.4%) 133 (1.6%) 271 (3.3%) 120 (1.4%)
INDIA 177465 117427 71496 (61%) 140520 (79%) 9429 (5.3%) 5397 (3.0%) 2060 (1.2%) 5468 (3.1%) 3084 (1.7%)

183 INDIA TB REPORT 2022 INDIA TB REPORT 2022 184

3.6 T
 reatment outcome of TB-HIV patients notified in
2020 (Public)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 4 2 2 (100%) 3 (75%) 1 (25.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Andhra Pradesh 3287 2130 1353 (64%) 2582 (79%) 453 (13.8%) 31 (0.9%) 9 (0.3%) 52 (1.6%) 56 (1.7%)
Arunachal Pradesh 5 3 3 (100%) 4 (80%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Assam 201 69 30 (43%) 131 (65%) 27 (13.4%) 5 (2.5%) 2 (1.0%) 2 (1.0%) 20 (10.0%)
Bihar 1287 625 201 (32%) 777 (60%) 77 (6.0%) 59 (4.6%) 8 (0.6%) 9 (0.7%) 193 (15.0%)
Chandigarh 154 21 6 (29%) 59 (38%) 26 (16.9%) 28 (18.2%) 0 (0.0%) 3 (1.9%) 15 (9.7%)
Chhattisgarh 465 262 141 (54%) 343 (74%) 62 (13.3%) 14 (3.0%) 4 (0.9%) 3 (0.6%) 32 (6.9%)
Dadra and Nagar Haveli and Daman and Diu 13 3 3 (100%) 10 (77%) 3 (23.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Delhi 854 328 128 (39%) 538 (63%) 49 (5.7%) 70 (8.2%) 9 (1.1%) 7 (0.8%) 125 (14.6%)
Goa 47 28 6 (21%) 37 (79%) 6 (12.8%) 0 (0.0%) 0 (0.0%) 1 (2.1%) 0 (0.0%)
Gujarat 2463 1037 588 (57%) 1759 (71%) 394 (16.0%) 112 (4.5%) 30 (1.2%) 23 (0.9%) 15 (0.6%)
Haryana 512 302 152 (50%) 382 (75%) 54 (10.5%) 11 (2.1%) 5 (1.0%) 3 (0.6%) 19 (3.7%)
Himachal Pradesh 108 69 33 (48%) 79 (73%) 20 (18.5%) 1 (0.9%) 1 (0.9%) 2 (1.9%) 3 (2.8%)
Jammu & Kashmir 59 19 6 (32%) 46 (78%) 3 (5.1%) 1 (1.7%) 0 (0.0%) 0 (0.0%) 7 (11.9%)
Jharkhand 256 141 43 (30%) 169 (66%) 18 (7.0%) 9 (3.5%) 3 (1.2%) 4 (1.6%) 11 (4.3%)
Karnataka 4027 2332 1212 (52%) 2717 (67%) 794 (19.7%) 192 (4.8%) 17 (0.4%) 82 (2.0%) 43 (1.1%)
Kerala 231 78 33 (42%) 132 (57%) 65 (28.1%) 7 (3.0%) 2 (0.9%) 1 (0.4%) 8 (3.5%)
Ladakh 1 0 NA 0 (0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (100.0%)
Lakshadweep #N/A #N/A NA NA NA NA NA NA NA
Madhya Pradesh 1190 511 225 (44%) 858 (72%) 148 (12.4%) 56 (4.7%) 6 (0.5%) 12 (1.0%) 55 (4.6%)
Maharashtra 4980 1782 888 (50%) 3681 (74%) 679 (13.6%) 188 (3.8%) 19 (0.4%) 77 (1.5%) 83 (1.7%)
Manipur 89 44 32 (73%) 69 (78%) 10 (11.2%) 5 (5.6%) 0 (0.0%) 2 (2.2%) 2 (2.2%)
Meghalaya 119 51 29 (57%) 82 (69%) 20 (16.8%) 9 (7.6%) 0 (0.0%) 1 (0.8%) 3 (2.5%)
Mizoram 238 92 48 (52%) 202 (85%) 12 (5.0%) 3 (1.3%) 1 (0.4%) 2 (0.8%) 12 (5.0%)
Nagaland 254 93 58 (62%) 160 (63%) 17 (6.7%) 2 (0.8%) 3 (1.2%) 3 (1.2%) 55 (21.7%)
Odisha 563 302 153 (51%) 429 (76%) 88 (15.6%) 10 (1.8%) 0 (0.0%) 7 (1.2%) 10 (1.8%)
Puducherry 20 12 7 (58%) 13 (65%) 2 (10.0%) 1 (5.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Punjab 886 535 200 (37%) 575 (65%) 133 (15.0%) 52 (5.9%) 11 (1.2%) 9 (1.0%) 50 (5.6%)
Rajasthan 1136 628 288 (46%) 846 (74%) 113 (9.9%) 47 (4.1%) 9 (0.8%) 9 (0.8%) 24 (2.1%)
Sikkim 6 1 0 (0%) 3 (50%) 3 (50.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Tamil Nadu 2217 1335 648 (49%) 1541 (70%) 383 (17.3%) 54 (2.4%) 9 (0.4%) 63 (2.8%) 34 (1.5%)
Telangana 1706 1171 743 (63%) 1300 (76%) 179 (10.5%) 15 (0.9%) 8 (0.5%) 42 (2.5%) 70 (4.1%)
Tripura 23 9 4 (44%) 15 (65%) 6 (26.1%) 1 (4.3%) 0 (0.0%) 1 (4.3%) 0 (0.0%)
Uttar Pradesh 2057 893 242 (27%) 1367 (66%) 237 (11.5%) 103 (5.0%) 18 (0.9%) 22 (1.1%) 56 (2.7%)
Uttarakhand 198 74 30 (41%) 145 (73%) 27 (13.6%) 11 (5.6%) 0 (0.0%) 3 (1.5%) 7 (3.5%)
West Bengal 716 469 179 (38%) 442 (62%) 110 (15.4%) 21 (2.9%) 4 (0.6%) 6 (0.8%) 53 (7.4%)
INDIA 30372 15451 7714 (50%) 21496 (71%) 4220 (13.9%) 1118 (3.7%) 178 (0.6%) 451 (1.5%) 1062 (3.5%)

185 INDIA TB REPORT 2022 INDIA TB REPORT 2022 186

3.7 T
 reatment outcome of TB-HIV patients notified in
2020 (Private)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 0 0 NA NA NA NA NA NA NA

Andhra Pradesh 126 38 25 (66%) 109 (87%) 9 (7.1%) 1 (0.8%) 0 (0.0%) 3 (2.4%) 4 (3.2%)
Arunachal Pradesh 0 0 NA NA NA NA NA NA NA
Assam 11 2 1 (50%) 9 (82%) 1 (9.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (9.1%)
Bihar 205 36 1 (3%) 156 (76%) 26 (12.7%) 6 (2.9%) 1 (0.5%) 2 (1.0%) 9 (4.4%)
Chandigarh 0 0 NA NA NA NA NA NA NA
Chhattisgarh 25 7 3 (43%) 16 (64%) 3 (12.0%) 1 (4.0%) 0 (0.0%) 1 (4.0%) 4 (16.0%)
Dadra and Nagar Haveli and Daman and Diu 0 0 NA NA NA NA NA NA NA
Delhi 74 24 2 (8%) 59 (80%) 8 (10.8%) 2 (2.7%) 0 (0.0%) 1 (1.4%) 2 (2.7%)
Goa 2 0 0 (NA) 2 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Gujarat 234 35 3 (9%) 181 (77%) 32 (13.7%) 9 (3.8%) 1 (0.4%) 3 (1.3%) 7 (3.0%)
Haryana 84 29 8 (28%) 53 (63%) 10 (11.9%) 11 (13.1%) 0 (0.0%) 0 (0.0%) 9 (10.7%)
Himachal Pradesh 0 0 NA NA NA NA NA NA NA
Jammu & Kashmir 1 0 NA 0 (0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Jharkhand 45 5 0 (0%) 26 (58%) 6 (13.3%) 10 (22.2%) 0 (0.0%) 1 (2.2%) 1 (2.2%)
Karnataka 160 54 10 (19%) 109 (68%) 33 (20.6%) 3 (1.9%) 1 (0.6%) 2 (1.3%) 4 (2.5%)
Kerala 14 3 0 (0%) 5 (36%) 6 (42.9%) 2 (14.3%) 0 (0.0%) 0 (0.0%) 1 (7.1%)
Ladakh 0 0 NA NA NA NA NA NA NA
Lakshadweep 0 0 NA NA NA NA NA NA NA
Madhya Pradesh 74 16 4 (25%) 52 (70%) 7 (9.5%) 7 (9.5%) 0 (0.0%) 0 (0.0%) 7 (9.5%)
Maharashtra 537 166 12 (7%) 400 (74%) 86 (16.0%) 21 (3.9%) 0 (0.0%) 4 (0.7%) 5 (0.9%)
Manipur 16 10 0 (0%) 11 (69%) 3 (18.8%) 2 (12.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Meghalaya 8 2 0 (0%) 7 (88%) 0 (0.0%) 1 (12.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Mizoram 6 2 3 (150%) 6 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Nagaland 14 2 0 (0%) 13 (93%) 0 (0.0%) 1 (7.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Odisha 10 2 3 (150%) 6 (60%) 1 (10.0%) 1 (10.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Puducherry 0 0 NA NA NA NA NA NA NA
Punjab 60 16 3 (19%) 44 (73%) 8 (13.3%) 0 (0.0%) 0 (0.0%) 2 (3.3%) 4 (6.7%)
Rajasthan 97 19 0 (0%) 71 (73%) 10 (10.3%) 8 (8.2%) 0 (0.0%) 0 (0.0%) 4 (4.1%)
Sikkim 0 0 NA NA NA NA NA NA NA
Tamil Nadu 83 53 5 (9%) 51 (61%) 9 (10.8%) 7 (8.4%) 0 (0.0%) 1 (1.2%) 5 (6.0%)
Telangana 125 31 27 (87%) 105 (84%) 14 (11.2%) 0 (0.0%) 0 (0.0%) 2 (1.6%) 3 (2.4%)
Tripura 0 0 NA NA NA NA NA NA NA
Uttar Pradesh 186 26 6 (23%) 138 (74%) 24 (12.9%) 4 (2.2%) 1 (0.5%) 4 (2.2%) 3 (1.6%)
Uttarakhand 18 2 0 (0%) 15 (83%) 2 (11.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
West Bengal 30 7 4 (57%) 19 (63%) 7 (23.3%) 2 (6.7%) 1 (3.3%) 0 (0.0%) 1 (3.3%)
INDIA 2245 587 120 (20%) 1663 (74%) 305 (13.6%) 99 (4.4%) 5 (0.2%) 26 (1.2%) 74 (3.3%)

187 INDIA TB REPORT 2022 INDIA TB REPORT 2022 188

3.8 T
 reatment outcome of TB-HIV patients notified in
2020 (Total)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 4 2 2 (100%) 3 (75%) 1 (25.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Andhra Pradesh 3413 2168 1378 (64%) 2691 (79%) 462 (13.5%) 32 (0.9%) 9 (0.3%) 55 (1.6%) 60 (1.8%)
Arunachal Pradesh 5 3 3 (100%) 4 (80%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Assam 212 71 31 (44%) 140 (66%) 28 (13.2%) 5 (2.4%) 2 (0.9%) 2 (0.9%) 21 (9.9%)
Bihar 1492 661 202 (31%) 933 (63%) 103 (6.9%) 65 (4.4%) 9 (0.6%) 11 (0.7%) 202 (13.5%)
Chandigarh 154 21 6 (29%) 59 (38%) 26 (16.9%) 28 (18.2%) 0 (0.0%) 3 (1.9%) 15 (9.7%)
Chhattisgarh 490 269 144 (54%) 359 (73%) 65 (13.3%) 15 (3.1%) 4 (0.8%) 4 (0.8%) 36 (7.3%)
Dadra and Nagar Haveli and Daman and Diu 13 3 3 (100%) 10 (77%) 3 (23.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Delhi 928 352 130 (37%) 597 (64%) 57 (6.1%) 72 (7.8%) 9 (1.0%) 8 (0.9%) 127 (13.7%)
Goa 49 28 6 (21%) 39 (80%) 6 (12.2%) 0 (0.0%) 0 (0.0%) 1 (2.0%) 0 (0.0%)
Gujarat 2697 1072 591 (55%) 1940 (72%) 426 (15.8%) 121 (4.5%) 31 (1.1%) 26 (1.0%) 22 (0.8%)
Haryana 596 331 160 (48%) 435 (73%) 64 (10.7%) 22 (3.7%) 5 (0.8%) 3 (0.5%) 28 (4.7%)
Himachal Pradesh 108 69 33 (48%) 79 (73%) 20 (18.5%) 1 (0.9%) 1 (0.9%) 2 (1.9%) 3 (2.8%)
Jammu & Kashmir 60 19 6 (32%) 46 (77%) 3 (5.0%) 1 (1.7%) 0 (0.0%) 0 (0.0%) 7 (11.7%)
Jharkhand 301 146 43 (29%) 195 (65%) 24 (8.0%) 19 (6.3%) 3 (1.0%) 5 (1.7%) 12 (4.0%)
Karnataka 4187 2386 1222 (51%) 2826 (67%) 827 (19.8%) 195 (4.7%) 18 (0.4%) 84 (2.0%) 47 (1.1%)
Kerala 245 81 33 (41%) 137 (56%) 71 (29.0%) 9 (3.7%) 2 (0.8%) 1 (0.4%) 9 (3.7%)
Ladakh 1 0 NA 0 (0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (100.0%)
Lakshadweep 0 0 NA NA NA NA NA NA NA
Madhya Pradesh 1264 527 229 (43%) 910 (72%) 155 (12.3%) 63 (5.0%) 6 (0.5%) 12 (0.9%) 62 (4.9%)
Maharashtra 5517 1948 900 (46%) 4081 (74%) 765 (13.9%) 209 (3.8%) 19 (0.3%) 81 (1.5%) 88 (1.6%)
Manipur 105 54 32 (59%) 80 (76%) 13 (12.4%) 7 (6.7%) 0 (0.0%) 2 (1.9%) 2 (1.9%)
Meghalaya 127 53 29 (55%) 89 (70%) 20 (15.7%) 10 (7.9%) 0 (0.0%) 1 (0.8%) 3 (2.4%)
Mizoram 244 94 51 (54%) 208 (85%) 12 (4.9%) 3 (1.2%) 1 (0.4%) 2 (0.8%) 12 (4.9%)
Nagaland 268 95 58 (61%) 173 (65%) 17 (6.3%) 3 (1.1%) 3 (1.1%) 3 (1.1%) 55 (20.5%)
Odisha 573 304 156 (51%) 435 (76%) 89 (15.5%) 11 (1.9%) 0 (0.0%) 7 (1.2%) 10 (1.7%)
Puducherry 20 12 7 (58%) 13 (65%) 2 (10.0%) 1 (5.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Punjab 946 551 203 (37%) 619 (65%) 141 (14.9%) 52 (5.5%) 11 (1.2%) 11 (1.2%) 54 (5.7%)
Rajasthan 1233 647 288 (45%) 917 (74%) 123 (10.0%) 55 (4.5%) 9 (0.7%) 9 (0.7%) 28 (2.3%)
Sikkim 6 1 0 (0%) 3 (50%) 3 (50.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Tamil Nadu 2300 1388 653 (47%) 1592 (69%) 392 (17.0%) 61 (2.7%) 9 (0.4%) 64 (2.8%) 39 (1.7%)
Telangana 1831 1202 770 (64%) 1405 (77%) 193 (10.5%) 15 (0.8%) 8 (0.4%) 44 (2.4%) 73 (4.0%)
Tripura 23 9 4 (44%) 15 (65%) 6 (26.1%) 1 (4.3%) 0 (0.0%) 1 (4.3%) 0 (0.0%)
Uttar Pradesh 2243 919 248 (27%) 1505 (67%) 261 (11.6%) 107 (4.8%) 19 (0.8%) 26 (1.2%) 59 (2.6%)
Uttarakhand 216 76 30 (39%) 160 (74%) 29 (13.4%) 11 (5.1%) 0 (0.0%) 3 (1.4%) 7 (3.2%)
West Bengal 746 476 183 (38%) 461 (62%) 117 (15.7%) 23 (3.1%) 5 (0.7%) 6 (0.8%) 54 (7.2%)
INDIA 32617 16038 7834 (49%) 23159 (71%) 4525 (13.9%) 1217 (3.7%) 183 (0.6%) 477 (1.5%) 1136 (3.5%)

189 INDIA TB REPORT 2022 INDIA TB REPORT 2022 190

3.9 T
 reatment outcome of Paediatric TB patients notified
in 2020 (Public)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 17 2 0 (0%) 17 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Andhra Pradesh 1441 281 226 (80%) 1344 (93%) 28 (1.9%) 7 (0.5%) 2 (0.1%) 5 (0.3%) 21 (1.5%)
Arunachal Pradesh 273 87 49 (56%) 237 (87%) 6 (2.2%) 10 (3.7%) 3 (1.1%) 7 (2.6%) 3 (1.1%)
Assam 993 357 211 (59%) 841 (85%) 25 (2.5%) 11 (1.1%) 4 (0.4%) 6 (0.6%) 38 (3.8%)
Bihar 2756 901 423 (47%) 2097 (76%) 60 (2.2%) 103 (3.7%) 10 (0.4%) 20 (0.7%) 222 (8.1%)
Chandigarh 221 78 51 (65%) 192 (87%) 7 (3.2%) 6 (2.7%) 0 (0.0%) 6 (2.7%) 2 (0.9%)
Chhattisgarh 861 162 121 (75%) 794 (92%) 21 (2.4%) 11 (1.3%) 2 (0.2%) 1 (0.1%) 19 (2.2%)
Dadra and Nagar Haveli and Daman and Diu 42 14 10 (71%) 41 (98%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Delhi 6986 2450 860 (35%) 5545 (79%) 69 (1.0%) 159 (2.3%) 36 (0.5%) 132 (1.9%) 150 (2.1%)
Goa 51 19 6 (32%) 46 (90%) 3 (5.9%) 0 (0.0%) 0 (0.0%) 1 (2.0%) 1 (2.0%)
Gujarat 3061 570 472 (83%) 2837 (93%) 93 (3.0%) 18 (0.6%) 14 (0.5%) 19 (0.6%) 7 (0.2%)
Haryana 2409 886 521 (59%) 2066 (86%) 28 (1.2%) 30 (1.2%) 6 (0.2%) 20 (0.8%) 70 (2.9%)
Himachal Pradesh 510 212 126 (59%) 457 (90%) 14 (2.7%) 6 (1.2%) 0 (0.0%) 4 (0.8%) 6 (1.2%)
Jammu & Kashmir 472 140 97 (69%) 402 (85%) 11 (2.3%) 2 (0.4%) 1 (0.2%) 0 (0.0%) 29 (6.1%)
Jharkhand 999 343 185 (54%) 861 (86%) 19 (1.9%) 17 (1.7%) 4 (0.4%) 6 (0.6%) 43 (4.3%)
Karnataka 2122 449 304 (68%) 1916 (90%) 62 (2.9%) 30 (1.4%) 2 (0.1%) 21 (1.0%) 18 (0.8%)
Kerala 624 108 70 (65%) 568 (91%) 4 (0.6%) 10 (1.6%) 2 (0.3%) 3 (0.5%) 23 (3.7%)
Ladakh 4 0 NA 4 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Lakshadweep 0 0 NA NA NA NA NA NA NA
Madhya Pradesh 7576 1090 693 (64%) 6838 (90%) 123 (1.6%) 182 (2.4%) 19 (0.3%) 24 (0.3%) 210 (2.8%)
Maharashtra 5108 1456 758 (52%) 4423 (87%) 106 (2.1%) 54 (1.1%) 12 (0.2%) 149 (2.9%) 37 (0.7%)
Manipur 61 14 9 (64%) 50 (82%) 1 (1.6%) 1 (1.6%) 0 (0.0%) 0 (0.0%) 5 (8.2%)
Meghalaya 191 83 49 (59%) 163 (85%) 4 (2.1%) 3 (1.6%) 3 (1.6%) 3 (1.6%) 6 (3.1%)
Mizoram 111 29 17 (59%) 100 (90%) 0 (0.0%) 2 (1.8%) 0 (0.0%) 3 (2.7%) 1 (0.9%)
Nagaland 163 53 41 (77%) 129 (79%) 4 (2.5%) 6 (3.7%) 1 (0.6%) 2 (1.2%) 20 (12.3%)
Odisha 1524 464 383 (83%) 1377 (90%) 58 (3.8%) 20 (1.3%) 7 (0.5%) 3 (0.2%) 15 (1.0%)
Puducherry 44 11 6 (55%) 42 (95%) 1 (2.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Punjab 2180 872 543 (62%) 1928 (88%) 64 (2.9%) 39 (1.8%) 12 (0.6%) 10 (0.5%) 65 (3.0%)
Rajasthan 4004 1117 756 (68%) 3447 (86%) 76 (1.9%) 88 (2.2%) 15 (0.4%) 34 (0.8%) 58 (1.4%)
Sikkim 52 19 12 (63%) 49 (94%) 0 (0.0%) 1 (1.9%) 0 (0.0%) 0 (0.0%) 2 (3.8%)
Tamil Nadu 1627 304 172 (57%) 1514 (93%) 20 (1.2%) 19 (1.2%) 2 (0.1%) 11 (0.7%) 27 (1.7%)
Telangana 1244 389 379 (97%) 1114 (90%) 31 (2.5%) 3 (0.2%) 4 (0.3%) 17 (1.4%) 35 (2.8%)
Tripura 44 22 12 (55%) 33 (75%) 4 (9.1%) 0 (0.0%) 0 (0.0%) 3 (6.8%) 1 (2.3%)
Uttar Pradesh 12438 3448 1947 (56%) 10672 (86%) 290 (2.3%) 271 (2.2%) 46 (0.4%) 129 (1.0%) 107 (0.9%)
Uttarakhand 708 152 82 (54%) 621 (88%) 14 (2.0%) 15 (2.1%) 3 (0.4%) 12 (1.7%) 14 (2.0%)
West Bengal 2152 717 453 (63%) 1817 (84%) 84 (3.9%) 41 (1.9%) 11 (0.5%) 24 (1.1%) 58 (2.7%)
INDIA 63069 17299 10044 (58%) 54582 (87%) 1330 (2.1%) 1165 (1.8%) 221 (0.4%) 675 (1.1%) 1313 (2.1%)

191 INDIA TB REPORT 2022 INDIA TB REPORT 2022 192

3.10 T
 reatment outcome of Paediatric TB patients
notified in 2020 (Private)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 0 0 NA NA NA NA NA NA NA

Andhra Pradesh 834 53 32 (60%) 804 (96%) 6 (0.7%) 5 (0.6%) 1 (0.1%) 2 (0.2%) 6 (0.7%)
Arunachal Pradesh 3 0 NA 0 (0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (33.3%)
Assam 120 21 4 (19%) 101 (84%) 2 (1.7%) 1 (0.8%) 0 (0.0%) 0 (0.0%) 9 (7.5%)
Bihar 5938 268 23 (9%) 4743 (80%) 100 (1.7%) 176 (3.0%) 20 (0.3%) 21 (0.4%) 764 (12.9%)
Chandigarh 11 2 0 (0%) 7 (64%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (18.2%)
Chhattisgarh 442 31 48 (155%) 382 (86%) 1 (0.2%) 12 (2.7%) 0 (0.0%) 0 (0.0%) 44 (10.0%)
Dadra and Nagar Haveli and Daman and Diu 7 0 NA 7 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Delhi 1426 425 8 (2%) 1046 (73%) 15 (1.1%) 57 (4.0%) 4 (0.3%) 12 (0.8%) 51 (3.6%)
Goa 5 3 0 (0%) 5 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Gujarat 2843 157 10 (6%) 2711 (95%) 39 (1.4%) 42 (1.5%) 3 (0.1%) 9 (0.3%) 31 (1.1%)
Haryana 1024 242 81 (33%) 831 (81%) 4 (0.4%) 49 (4.8%) 3 (0.3%) 4 (0.4%) 80 (7.8%)
Himachal Pradesh 25 8 5 (63%) 20 (80%) 0 (0.0%) 2 (8.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Jammu & Kashmir 38 4 5 (125%) 35 (92%) 1 (2.6%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (5.3%)
Jharkhand 1266 55 2 (4%) 1095 (86%) 28 (2.2%) 116 (9.2%) 3 (0.2%) 3 (0.2%) 6 (0.5%)
Karnataka 868 106 37 (35%) 798 (92%) 10 (1.2%) 8 (0.9%) 0 (0.0%) 1 (0.1%) 28 (3.2%)
Kerala 164 24 7 (29%) 151 (92%) 2 (1.2%) 3 (1.8%) 0 (0.0%) 1 (0.6%) 2 (1.2%)
Ladakh 1 0 NA 1 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Lakshadweep 0 0 NA NA NA NA NA NA NA
Madhya Pradesh 2784 159 72 (45%) 2239 (80%) 29 (1.0%) 234 (8.4%) 7 (0.3%) 9 (0.3%) 219 (7.9%)
Maharashtra 3948 1119 95 (8%) 3520 (89%) 52 (1.3%) 58 (1.5%) 10 (0.3%) 44 (1.1%) 20 (0.5%)
Manipur 12 2 2 (100%) 6 (50%) 0 (0.0%) 1 (8.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Meghalaya 65 11 0 (0%) 48 (74%) 0 (0.0%) 7 (10.8%) 0 (0.0%) 1 (1.5%) 5 (7.7%)
Mizoram 6 0 NA 5 (83%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Nagaland 28 3 2 (67%) 23 (82%) 0 (0.0%) 1 (3.6%) 0 (0.0%) 0 (0.0%) 3 (10.7%)
Odisha 238 12 9 (75%) 216 (91%) 4 (1.7%) 5 (2.1%) 0 (0.0%) 0 (0.0%) 8 (3.4%)
Puducherry 0 0 NA NA NA NA NA NA NA
Punjab 672 130 23 (18%) 554 (82%) 21 (3.1%) 8 (1.2%) 1 (0.1%) 1 (0.1%) 54 (8.0%)
Rajasthan 2908 181 109 (60%) 2441 (84%) 25 (0.9%) 212 (7.3%) 48 (1.7%) 9 (0.3%) 92 (3.2%)
Sikkim 4 2 1 (50%) 4 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Tamil Nadu 1351 181 220 (122%) 1262 (93%) 4 (0.3%) 24 (1.8%) 0 (0.0%) 1 (0.1%) 24 (1.8%)
Telangana 688 196 130 (66%) 632 (92%) 11 (1.6%) 4 (0.6%) 2 (0.3%) 4 (0.6%) 15 (2.2%)
Tripura 0 0 NA NA NA NA NA NA NA
Uttar Pradesh 8885 372 249 (67%) 7953 (90%) 167 (1.9%) 270 (3.0%) 28 (0.3%) 46 (0.5%) 131 (1.5%)
Uttarakhand 239 48 7 (15%) 201 (84%) 3 (1.3%) 6 (2.5%) 2 (0.8%) 2 (0.8%) 17 (7.1%)
West Bengal 320 56 16 (29%) 268 (84%) 8 (2.5%) 4 (1.3%) 1 (0.3%) 0 (0.0%) 13 (4.1%)
INDIA 37163 3871 1198 (31%) 32109 (86%) 532 (1.4%) 1305 (3.5%) 133 (0.4%) 170 (0.5%) 1627 (4.4%)

193 INDIA TB REPORT 2022 INDIA TB REPORT 2022 194

3.11 T
 reatment outcome of Paediatric TB patients
notified in 2020 (Total)
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 17 2 0 (0%) 17 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Andhra Pradesh 2275 334 258 (77%) 2148 (94%) 34 (1.5%) 12 (0.5%) 3 (0.1%) 7 (0.3%) 27 (1.2%)
Arunachal Pradesh 276 87 49 (56%) 237 (86%) 6 (2.2%) 10 (3.6%) 3 (1.1%) 7 (2.5%) 4 (1.4%)
Assam 1113 378 215 (57%) 942 (85%) 27 (2.4%) 12 (1.1%) 4 (0.4%) 6 (0.5%) 47 (4.2%)
Bihar 8694 1169 446 (38%) 6840 (79%) 160 (1.8%) 279 (3.2%) 30 (0.3%) 41 (0.5%) 986 (11.3%)
Chandigarh 232 80 51 (64%) 199 (86%) 7 (3.0%) 6 (2.6%) 0 (0.0%) 6 (2.6%) 4 (1.7%)
Chhattisgarh 1303 193 169 (88%) 1176 (90%) 22 (1.7%) 23 (1.8%) 2 (0.2%) 1 (0.1%) 63 (4.8%)
Dadra and Nagar Haveli and Daman and Diu 49 14 11 (79%) 48 (98%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Delhi 8412 2875 868 (30%) 6591 (78%) 84 (1.0%) 216 (2.6%) 40 (0.5%) 144 (1.7%) 201 (2.4%)
Goa 56 22 6 (27%) 51 (91%) 3 (5.4%) 0 (0.0%) 0 (0.0%) 1 (1.8%) 1 (1.8%)
Gujarat 5904 727 482 (66%) 5548 (94%) 132 (2.2%) 60 (1.0%) 17 (0.3%) 28 (0.5%) 38 (0.6%)
Haryana 3433 1128 602 (53%) 2897 (84%) 32 (0.9%) 79 (2.3%) 9 (0.3%) 24 (0.7%) 150 (4.4%)
Himachal Pradesh 535 220 131 (60%) 477 (89%) 14 (2.6%) 8 (1.5%) 0 (0.0%) 4 (0.7%) 6 (1.1%)
Jammu & Kashmir 510 144 102 (71%) 437 (86%) 12 (2.4%) 2 (0.4%) 1 (0.2%) 0 (0.0%) 31 (6.1%)
Jharkhand 2265 398 187 (47%) 1956 (86%) 47 (2.1%) 133 (5.9%) 7 (0.3%) 9 (0.4%) 49 (2.2%)
Karnataka 2990 555 341 (61%) 2714 (91%) 72 (2.4%) 38 (1.3%) 2 (0.1%) 22 (0.7%) 46 (1.5%)
Kerala 788 132 77 (58%) 719 (91%) 6 (0.8%) 13 (1.6%) 2 (0.3%) 4 (0.5%) 25 (3.2%)
Ladakh 5 0 NA 5 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Lakshadweep 0 0 NA NA NA NA NA NA NA
Madhya Pradesh 10360 1249 765 (61%) 9077 (88%) 152 (1.5%) 416 (4.0%) 26 (0.3%) 33 (0.3%) 429 (4.1%)
Maharashtra 9056 2575 853 (33%) 7943 (88%) 158 (1.7%) 112 (1.2%) 22 (0.2%) 193 (2.1%) 57 (0.6%)
Manipur 73 16 11 (69%) 56 (77%) 1 (1.4%) 2 (2.7%) 0 (0.0%) 0 (0.0%) 5 (6.8%)
Meghalaya 256 94 49 (52%) 211 (82%) 4 (1.6%) 10 (3.9%) 3 (1.2%) 4 (1.6%) 11 (4.3%)
Mizoram 117 29 17 (59%) 105 (90%) 0 (0.0%) 2 (1.7%) 0 (0.0%) 3 (2.6%) 1 (0.9%)
Nagaland 191 56 43 (77%) 152 (80%) 4 (2.1%) 7 (3.7%) 1 (0.5%) 2 (1.0%) 23 (12.0%)
Odisha 1762 476 392 (82%) 1593 (90%) 62 (3.5%) 25 (1.4%) 7 (0.4%) 3 (0.2%) 23 (1.3%)
Puducherry 44 11 6 (55%) 42 (95%) 1 (2.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Punjab 2852 1002 566 (56%) 2482 (87%) 85 (3.0%) 47 (1.6%) 13 (0.5%) 11 (0.4%) 119 (4.2%)
Rajasthan 6912 1298 865 (67%) 5888 (85%) 101 (1.5%) 300 (4.3%) 63 (0.9%) 43 (0.6%) 150 (2.2%)
Sikkim 56 21 13 (62%) 53 (95%) 0 (0.0%) 1 (1.8%) 0 (0.0%) 0 (0.0%) 2 (3.6%)
Tamil Nadu 2978 485 392 (81%) 2776 (93%) 24 (0.8%) 43 (1.4%) 2 (0.1%) 12 (0.4%) 51 (1.7%)
Telangana 1932 585 509 (87%) 1746 (90%) 42 (2.2%) 7 (0.4%) 6 (0.3%) 21 (1.1%) 50 (2.6%)
Tripura 44 22 12 (55%) 33 (75%) 4 (9.1%) 0 (0.0%) 0 (0.0%) 3 (6.8%) 1 (2.3%)
Uttar Pradesh 21323 3820 2196 (57%) 18625 (87%) 457 (2.1%) 541 (2.5%) 74 (0.3%) 175 (0.8%) 238 (1.1%)
Uttarakhand 947 200 89 (45%) 822 (87%) 17 (1.8%) 21 (2.2%) 5 (0.5%) 14 (1.5%) 31 (3.3%)
West Bengal 2472 773 469 (61%) 2085 (84%) 92 (3.7%) 45 (1.8%) 12 (0.5%) 24 (1.0%) 71 (2.9%)
INDIA 100232 21170 11242 (53%) 86691 (86%) 1862 (1.9%) 2470 (2.5%) 354 (0.4%) 845 (0.8%) 2940 (2.9%)

195 INDIA TB REPORT 2022 INDIA TB REPORT 2022 196

3.12 T
 reatment outcome of Male TB patients notified
in 2020
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 263 167 89 (53%) 216 (82%) 12 (4.6%) 6 (2.3%) 1 (0.4%) 5 (1.9%) 1 (0.4%)
Andhra Pradesh 41020 22496 17318 (77%) 36519 (89%) 1838 (4.5%) 366 (0.9%) 89 (0.2%) 753 (1.8%) 589 (1.4%)
Arunachal Pradesh 1288 720 475 (66%) 1061 (82%) 53 (4.1%) 63 (4.9%) 16 (1.2%) 29 (2.3%) 14 (1.1%)
Assam 23167 11289 6431 (57%) 19208 (83%) 1022 (4.4%) 470 (2.0%) 87 (0.4%) 314 (1.4%) 913 (3.9%)
Bihar 63111 22994 9332 (41%) 48458 (77%) 2189 (3.5%) 2468 (3.9%) 329 (0.5%) 678 (1.1%) 4441 (7.0%)
Chandigarh 1515 777 523 (67%) 1151 (76%) 87 (5.7%) 81 (5.3%) 11 (0.7%) 26 (1.7%) 45 (3.0%)
Chhattisgarh 18493 7860 5750 (73%) 15818 (86%) 1002 (5.4%) 452 (2.4%) 92 (0.5%) 186 (1.0%) 638 (3.4%)
Dadra and Nagar Haveli and Daman and Diu 460 202 187 (93%) 431 (94%) 10 (2.2%) 4 (0.9%) 2 (0.4%) 1 (0.2%) 5 (1.1%)
Delhi 38153 19569 7344 (38%) 26398 (69%) 1290 (3.4%) 2107 (5.5%) 220 (0.6%) 881 (2.3%) 953 (2.5%)
Goa 887 522 216 (41%) 729 (82%) 57 (6.4%) 35 (3.9%) 5 (0.6%) 17 (1.9%) 2 (0.2%)
Gujarat 73866 28177 21461 (76%) 63970 (87%) 4027 (5.5%) 1737 (2.4%) 638 (0.9%) 1378 (1.9%) 481 (0.7%)
Haryana 37986 22530 12194 (54%) 29102 (77%) 1907 (5.0%) 1364 (3.6%) 275 (0.7%) 376 (1.0%) 1634 (4.3%)
Himachal Pradesh 8210 5576 3671 (66%) 7070 (86%) 538 (6.6%) 95 (1.2%) 31 (0.4%) 161 (2.0%) 86 (1.0%)
Jammu & Kashmir 5162 2572 1855 (72%) 4251 (82%) 196 (3.8%) 72 (1.4%) 34 (0.7%) 52 (1.0%) 299 (5.8%)
Jharkhand 31191 13709 7348 (54%) 25783 (83%) 1144 (3.7%) 1648 (5.3%) 113 (0.4%) 224 (0.7%) 996 (3.2%)
Karnataka 39537 24167 15859 (66%) 31243 (79%) 3267 (8.3%) 1137 (2.9%) 271 (0.7%) 1058 (2.7%) 555 (1.4%)
Kerala 13414 8860 6013 (68%) 10720 (80%) 1217 (9.1%) 252 (1.9%) 92 (0.7%) 158 (1.2%) 385 (2.9%)
Ladakh 127 59 22 (37%) 99 (78%) 8 (6.3%) 4 (3.1%) 1 (0.8%) 1 (0.8%) 8 (6.3%)
Lakshadweep 8 4 4 (100%) 7 (88%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (12.5%)
Madhya Pradesh 85532 36444 21232 (58%) 66420 (78%) 3471 (4.1%) 4236 (5.0%) 517 (0.6%) 961 (1.1%) 5965 (7.0%)
Maharashtra 81008 36567 19989 (55%) 67268 (83%) 4614 (5.7%) 2008 (2.5%) 458 (0.6%) 1707 (2.1%) 469 (0.6%)
Manipur 1008 582 364 (63%) 808 (80%) 35 (3.5%) 24 (2.4%) 5 (0.5%) 14 (1.4%) 56 (5.6%)
Meghalaya 2254 1292 739 (57%) 1787 (79%) 122 (5.4%) 93 (4.1%) 17 (0.8%) 51 (2.3%) 51 (2.3%)
Mizoram 1088 576 389 (68%) 962 (88%) 26 (2.4%) 20 (1.8%) 2 (0.2%) 14 (1.3%) 27 (2.5%)
Nagaland 2134 1081 792 (73%) 1718 (81%) 57 (2.7%) 64 (3.0%) 17 (0.8%) 16 (0.7%) 217 (10.2%)
Odisha 30204 17817 14167 (80%) 26649 (88%) 1803 (6.0%) 421 (1.4%) 79 (0.3%) 187 (0.6%) 339 (1.1%)
Puducherry 783 596 411 (69%) 627 (80%) 58 (7.4%) 25 (3.2%) 11 (1.4%) 21 (2.7%) 2 (0.3%)
Punjab 26639 15463 7870 (51%) 20749 (78%) 1769 (6.6%) 745 (2.8%) 122 (0.5%) 293 (1.1%) 1393 (5.2%)
Rajasthan 87795 43763 25859 (59%) 71039 (81%) 3495 (4.0%) 3755 (4.3%) 541 (0.6%) 1060 (1.2%) 1538 (1.8%)
Sikkim 642 397 280 (71%) 575 (90%) 29 (4.5%) 6 (0.9%) 1 (0.2%) 8 (1.2%) 5 (0.8%)
Tamil Nadu 47157 31303 21441 (68%) 38192 (81%) 3109 (6.6%) 1329 (2.8%) 278 (0.6%) 1514 (3.2%) 853 (1.8%)
Telangana 37280 18290 15212 (83%) 32791 (88%) 1356 (3.6%) 267 (0.7%) 153 (0.4%) 745 (2.0%) 993 (2.7%)
Tripura 1593 1104 796 (72%) 1279 (80%) 123 (7.7%) 40 (2.5%) 8 (0.5%) 48 (3.0%) 29 (1.8%)
Uttar Pradesh 212835 84101 46826 (56%) 174676 (82%) 10414 (4.9%) 7394 (3.5%) 1277 (0.6%) 2974 (1.4%) 2514 (1.2%)
Uttarakhand 11595 5241 2727 (52%) 9485 (82%) 539 (4.6%) 377 (3.3%) 64 (0.6%) 231 (2.0%) 346 (3.0%)
West Bengal 52038 35967 25723 (72%) 43509 (84%) 3167 (6.1%) 1135 (2.2%) 335 (0.6%) 798 (1.5%) 914 (1.8%)
INDIA 1079443 522834 320909 (61%) 880768 (82%) 54051 (5.0%) 34300 (3.2%) 6192 (0.6%) 16940 (1.6%) 27757 (2.6%)

197 INDIA TB REPORT 2022 INDIA TB REPORT 2022 198

3.13 T
 reatment outcome of Female TB patients notified
in 2020
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 171 75 52 (69%) 154 (90%) 4 (2.3%) 0 (0.0%) 2 (1.2%) 3 (1.8%) 0 (0.0%)
Andhra Pradesh 21862 8840 7051 (80%) 20127 (92%) 650 (3.0%) 133 (0.6%) 33 (0.2%) 259 (1.2%) 265 (1.2%)
Arunachal Pradesh 1132 526 340 (65%) 949 (84%) 25 (2.2%) 60 (5.3%) 7 (0.6%) 47 (4.2%) 10 (0.9%)
Assam 11352 4931 2951 (60%) 9667 (85%) 400 (3.5%) 164 (1.4%) 38 (0.3%) 136 (1.2%) 459 (4.0%)
Bihar 36546 11769 5086 (43%) 28995 (79%) 1149 (3.1%) 1277 (3.5%) 187 (0.5%) 389 (1.1%) 2295 (6.3%)
Chandigarh 1309 599 424 (71%) 1123 (86%) 42 (3.2%) 23 (1.8%) 3 (0.2%) 26 (2.0%) 19 (1.5%)
Chhattisgarh 10593 3491 2677 (77%) 9248 (87%) 376 (3.5%) 233 (2.2%) 43 (0.4%) 75 (0.7%) 434 (4.1%)
Dadra and Nagar Haveli and Daman and Diu 275 112 98 (88%) 255 (93%) 7 (2.5%) 1 (0.4%) 0 (0.0%) 1 (0.4%) 3 (1.1%)
Delhi 35181 15249 5909 (39%) 26460 (75%) 716 (2.0%) 1337 (3.8%) 168 (0.5%) 763 (2.2%) 908 (2.6%)
Goa 695 321 132 (41%) 607 (87%) 32 (4.6%) 13 (1.9%) 3 (0.4%) 9 (1.3%) 6 (0.9%)
Gujarat 41423 12671 10150 (80%) 37464 (90%) 1444 (3.5%) 672 (1.6%) 238 (0.6%) 695 (1.7%) 261 (0.6%)
Haryana 25019 11924 6918 (58%) 20380 (81%) 730 (2.9%) 641 (2.6%) 120 (0.5%) 199 (0.8%) 1082 (4.3%)
Himachal Pradesh 5082 3135 2031 (65%) 4567 (90%) 185 (3.6%) 49 (1.0%) 17 (0.3%) 82 (1.6%) 75 (1.5%)
Jammu & Kashmir 3634 1717 1315 (77%) 3036 (84%) 113 (3.1%) 48 (1.3%) 15 (0.4%) 21 (0.6%) 203 (5.6%)
Jharkhand 14460 4889 2749 (56%) 12250 (85%) 424 (2.9%) 730 (5.0%) 56 (0.4%) 85 (0.6%) 409 (2.8%)
Karnataka 22949 11216 7634 (68%) 19481 (85%) 1219 (5.3%) 415 (1.8%) 97 (0.4%) 459 (2.0%) 318 (1.4%)
Kerala 7219 3273 2099 (64%) 6045 (84%) 450 (6.2%) 118 (1.6%) 39 (0.5%) 76 (1.1%) 222 (3.1%)
Ladakh 116 68 34 (50%) 89 (77%) 11 (9.5%) 0 (0.0%) 1 (0.9%) 0 (0.0%) 10 (8.6%)
Lakshadweep 9 4 5 (125%) 8 (89%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (11.1%)
Madhya Pradesh 50151 16765 10664 (64%) 41525 (83%) 1323 (2.6%) 1851 (3.7%) 250 (0.5%) 470 (0.9%) 2987 (6.0%)
Maharashtra 66324 26862 13064 (49%) 56972 (86%) 2370 (3.6%) 1077 (1.6%) 258 (0.4%) 1617 (2.4%) 389 (0.6%)
Manipur 555 269 169 (63%) 436 (79%) 20 (3.6%) 19 (3.4%) 1 (0.2%) 3 (0.5%) 33 (5.9%)
Meghalaya 1606 797 467 (59%) 1318 (82%) 63 (3.9%) 55 (3.4%) 10 (0.6%) 38 (2.4%) 32 (2.0%)
Mizoram 900 405 287 (71%) 811 (90%) 24 (2.7%) 11 (1.2%) 3 (0.3%) 13 (1.4%) 25 (2.8%)
Nagaland 1380 576 439 (76%) 1121 (81%) 39 (2.8%) 26 (1.9%) 9 (0.7%) 8 (0.6%) 150 (10.9%)
Odisha 14766 7147 6130 (86%) 13324 (90%) 703 (4.8%) 163 (1.1%) 28 (0.2%) 61 (0.4%) 184 (1.2%)
Puducherry 436 230 132 (57%) 367 (84%) 22 (5.0%) 3 (0.7%) 3 (0.7%) 16 (3.7%) 1 (0.2%)
Punjab 19811 10441 5812 (56%) 16224 (82%) 892 (4.5%) 427 (2.2%) 81 (0.4%) 201 (1.0%) 981 (5.0%)
Rajasthan 45619 17906 11627 (65%) 38893 (85%) 1120 (2.5%) 1618 (3.5%) 215 (0.5%) 479 (1.1%) 810 (1.8%)
Sikkim 497 273 169 (62%) 447 (90%) 16 (3.2%) 3 (0.6%) 0 (0.0%) 11 (2.2%) 10 (2.0%)
Tamil Nadu 21757 10627 7237 (68%) 18666 (86%) 940 (4.3%) 383 (1.8%) 64 (0.3%) 521 (2.4%) 455 (2.1%)
Telangana 23549 9632 8461 (88%) 21362 (91%) 519 (2.2%) 109 (0.5%) 73 (0.3%) 410 (1.7%) 542 (2.3%)
Tripura 542 307 245 (80%) 458 (85%) 36 (6.6%) 10 (1.8%) 1 (0.2%) 12 (2.2%) 13 (2.4%)
Uttar Pradesh 150653 47621 29007 (61%) 128972 (86%) 4494 (3.0%) 4482 (3.0%) 771 (0.5%) 1989 (1.3%) 1704 (1.1%)
Uttarakhand 8074 2898 1538 (53%) 6917 (86%) 204 (2.5%) 236 (2.9%) 40 (0.5%) 118 (1.5%) 249 (3.1%)
West Bengal 25416 13979 9828 (70%) 21637 (85%) 1151 (4.5%) 421 (1.7%) 131 (0.5%) 423 (1.7%) 507 (2.0%)
INDIA 671063 261545 162931 (62%) 570355 (85%) 21913 (3.3%) 16808 (2.5%) 3005 (0.4%) 9715 (1.4%) 16052 (2.4%)

199 INDIA TB REPORT 2022 INDIA TB REPORT 2022 200

3.14 T
 reatment outcome of Transgenders TB patients
notified in 2020
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 0 0 NA NA NA NA NA NA NA

Andhra Pradesh 32 13 10 (77%) 29 (91%) 2 (6.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (3.1%)
Arunachal Pradesh 4 1 1 (100%) 4 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Assam 21 5 4 (80%) 21 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Bihar 74 26 11 (42%) 50 (68%) 3 (4.1%) 6 (8.1%) 0 (0.0%) 1 (1.4%) 7 (9.5%)
Chandigarh 5 4 3 (75%) 4 (80%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (20.0%) 0 (0.0%)
Chhattisgarh 18 7 7 (100%) 14 (78%) 2 (11.1%) 0 (0.0%) 2 (11.1%) 0 (0.0%) 0 (0.0%)
Dadra and Nagar Haveli and Daman and Diu 0 0 NA NA NA NA NA NA NA
Delhi 56 25 8 (32%) 35 (63%) 2 (3.6%) 4 (7.1%) 0 (0.0%) 1 (1.8%) 1 (1.8%)
Goa 2 1 0 (0%) 2 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Gujarat 56 19 15 (79%) 50 (89%) 1 (1.8%) 1 (1.8%) 0 (0.0%) 1 (1.8%) 2 (3.6%)
Haryana 31 12 7 (58%) 23 (74%) 1 (3.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 4 (12.9%)
Himachal Pradesh 7 4 2 (50%) 6 (86%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (14.3%) 0 (0.0%)
Jammu & Kashmir 4 2 2 (100%) 3 (75%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (25.0%)
Jharkhand 9 3 0 (0%) 8 (89%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Karnataka 48 26 15 (58%) 32 (67%) 4 (8.3%) 3 (6.3%) 0 (0.0%) 1 (2.1%) 0 (0.0%)
Kerala 8 4 2 (50%) 5 (63%) 1 (12.5%) 1 (12.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Ladakh 0 0 NA NA NA NA NA NA NA
Lakshadweep 0 0 NA NA NA NA NA NA NA
Madhya Pradesh 76 25 16 (64%) 61 (80%) 1 (1.3%) 5 (6.6%) 0 (0.0%) 0 (0.0%) 5 (6.6%)
Maharashtra 88 38 19 (50%) 77 (88%) 4 (4.5%) 3 (3.4%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Manipur 1 0 NA 1 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Meghalaya 4 1 0 (0%) 4 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Mizoram 0 0 NA NA NA NA NA NA NA
Nagaland 4 1 1 (100%) 2 (50%) 1 (25.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (25.0%)
Odisha 25 12 10 (83%) 22 (88%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (12.0%)
Puducherry 1 1 0 (0%) 0 (0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Punjab 41 28 12 (43%) 33 (80%) 6 (14.6%) 0 (0.0%) 1 (2.4%) 0 (0.0%) 0 (0.0%)
Rajasthan 46 19 15 (79%) 40 (87%) 1 (2.2%) 2 (4.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Sikkim 0 0 NA NA NA NA NA NA NA
Tamil Nadu 29 18 8 (44%) 27 (93%) 1 (3.4%) 0 (0.0%) 0 (0.0%) 1 (3.4%) 0 (0.0%)
Telangana 28 11 8 (73%) 23 (82%) 1 (3.6%) 0 (0.0%) 0 (0.0%) 1 (3.6%) 2 (7.1%)
Tripura 2 1 2 (200%) 2 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Uttar Pradesh 176 77 47 (61%) 137 (78%) 5 (2.8%) 4 (2.3%) 1 (0.6%) 4 (2.3%) 5 (2.8%)
Uttarakhand 12 3 2 (67%) 10 (83%) 0 (0.0%) 1 (8.3%) 0 (0.0%) 1 (8.3%) 0 (0.0%)
West Bengal 23 15 12 (80%) 19 (83%) 2 (8.7%) 0 (0.0%) 1 (4.3%) 1 (4.3%) 0 (0.0%)
INDIA 931 402 239 (59%) 744 (80%) 38 (4.1%) 30 (3.2%) 5 (0.5%) 14 (1.5%) 32 (3.4%)

201 INDIA TB REPORT 2022 INDIA TB REPORT 2022 202

3.15 T
 reatment outcome of Tribal TB patients notified
in 2020
TB patients Bacteriologically Treatment Failure
State Cure Rate Success Rate Death Rate % Lost to follow up % Regimen Change % Not evaluated
Notified Confirmed Rate

Andaman & Nicobar Islands 82 63 16 (25%) 68 (83%) 6 (7.3%) (0.0%) 1 (1.2%) 4 (4.9%) (0.0%)
Andhra Pradesh 8410 5034 3627 (72%) 7601 (90%) 348 (4.1%) 72 (0.9%) 13 (0.2%) 129 (1.5%) 101 (1.2%)
Arunachal Pradesh 2589 1417 780 (55%) 2120 (82%) 86 (3.3%) 150 (5.8%) 25 (1.0%) 80 (3.1%) 43 (1.7%)
Assam 6155 3120 1594 (51%) 5242 (85%) 286 (4.6%) 167 (2.7%) 20 (0.3%) 88 (1.4%) 231 (3.8%)
Bihar NA NA NA NA NA NA NA NA NA
Chandigarh NA NA NA NA NA NA NA NA NA
Chhattisgarh 10681 4691 3150 (67%) 9284 (87%) 507 (4.7%) 206 (1.9%) 53 (0.5%) 60 (0.6%) 478 (4.5%)
Dadra and Nagar Haveli and Daman and Diu 492 211 139 (66%) 440 (89%) 22 (4.5%) 3 (0.6%) (0.0%) 11 (2.2%) 3 (0.6%)
Delhi NA NA NA NA NA NA NA NA NA
Goa NA NA NA NA NA NA NA NA NA
Gujarat 19661 8674 5875 (68%) 17376 (88%) 986 (5.0%) 455 (2.3%) 166 (0.8%) 328 (1.7%) 59 (0.3%)
Haryana NA NA NA NA NA NA NA NA NA
Himachal Pradesh 315 206 144 (70%) 283 (90%) 9 (2.9%) 3 (1.0%) (0.0%) 5 (1.6%) 6 (1.9%)
Jammu & Kashmir 42 29 13 (45%) 23 (55%) 4 (9.5%) (0.0%) (0.0%) (0.0%) 15 (35.7%)
Jharkhand 25650 10732 5258 (49%) 21139 (82%) 1044 (4.1%) 1037 (4.0%) 82 (0.3%) 184 (0.7%) 1309 (5.1%)
Karnataka 2577 1651 1048 (63%) 2029 (79%) 221 (8.6%) 76 (2.9%) 16 (0.6%) 74 (2.9%) 52 (2.0%)
Kerala 883 528 358 (68%) 749 (85%) 74 (8.4%) 9 (1.0%) 5 (0.6%) 13 (1.5%) 16 (1.8%)
Ladakh 247 131 53 (40%) 189 (77%) 20 (8.1%) 4 (1.6%) 2 (0.8%) 2 (0.8%) 20 (8.1%)
Lakshadweep 17 8 7 (88%) 15 (88%) (0.0%) (0.0%) (0.0%) (0.0%) 2 (11.8%)
Madhya Pradesh 21331 8367 4301 (51%) 17895 (84%) 909 (4.3%) 923 (4.3%) 115 (0.5%) 232 (1.1%) 923 (4.3%)
Maharashtra 12721 5952 4092 (69%) 11088 (87%) 592 (4.7%) 248 (1.9%) 57 (0.4%) 252 (2.0%) 63 (0.5%)
Manipur 976 551 346 (63%) 789 (81%) 38 (3.9%) 28 (2.9%) 6 (0.6%) 11 (1.1%) 78 (8.0%)
Meghalaya 4156 2377 1217 (51%) 3268 (79%) 238 (5.7%) 176 (4.2%) 35 (0.8%) 119 (2.9%) 164 (3.9%)
Mizoram 2149 1142 686 (60%) 1851 (86%) 79 (3.7%) 37 (1.7%) 9 (0.4%) 37 (1.7%) 61 (2.8%)
Nagaland 3621 1761 1183 (67%) 2888 (80%) 108 (3.0%) 108 (3.0%) 27 (0.7%) 32 (0.9%) 390 (10.8%)
Odisha 19558 12092 9032 (75%) 17437 (89%) 1238 (6.3%) 272 (1.4%) 45 (0.2%) 78 (0.4%) 270 (1.4%)
Puducherry NA NA NA NA NA NA NA NA NA
Punjab NA NA NA NA NA NA NA NA NA
Rajasthan 16150 10613 5676 (53%) 13652 (85%) 721 (4.5%) 445 (2.8%) 98 (0.6%) 316 (2.0%) 298 (1.8%)
Sikkim 75 55 37 (67%) 60 (80%) 5 (6.7%) (0.0%) (0.0%) 3 (4.0%) 4 (5.3%)
Tamil Nadu 474 292 252 (86%) 425 (90%) 27 (5.7%) 2 (0.4%) 2 (0.4%) 8 (1.7%) 7 (1.5%)
Telangana 8087 3720 1789 (48%) 7082 (88%) 259 (3.2%) 80 (1.0%) 49 (0.6%) 166 (2.1%) 355 (4.4%)
Tripura 198 109 96 (88%) 179 (90%) 13 (6.6%) (0.0%) 2 (1.0%) (0.0%) 2 (1.0%)
Uttar Pradesh 3456 1768 882 (50%) 3040 (88%) 146 (4.2%) 69 (2.0%) 40 (1.2%) 48 (1.4%) 35 (1.0%)
Uttarakhand 47 36 25 (69%) 35 (74%) 6 (12.8%) 2 (4.3%) 1 (2.1%) 1 (2.1%) 2 (4.3%)
West Bengal NA NA NA NA NA NA NA NA NA
INDIA 170800 85330 51676 (61%) 146247 (86%) 7992 (4.7%) 4572 (2.7%) 869 (0.5%) 2281 (1.3%) 4987 (2.9%)

203 INDIA TB REPORT 2022 INDIA TB REPORT 2022 204

4.1 PMDT- Infrastructure

Out of the total, no. of Nodal/ District Total number of Number of Medical
No. of Nodal DR-TB Number of
State No. of District DR-TB centres DR-TB centers are Airborne Infection beds in Nodal Colleges with DRTB centre
centres Medical Colleges
control compliant DRTB centre established

Andaman & Nicobar 1 3 0 0% 10 1 1

Andhra Pradesh 4 13 6 35% 140 26 10
Arunachal Pradesh 5 10 5 33% 62 1 1
Assam 6 24 10 33% 89 8 5
Bihar 7 31 17 45% 160 15 5
Chandigarh 1 0 0 0% 10 2 1
Chhattisgarh 7 22 7 24% 98 11 5
Dadra & Nagar Haveli Daman & Diu 0 1 1 100% 5 1 0
Delhi 4 25 17 59% 230 14 9
Goa 1 1 1 50% 14 1 1
Gujarat 5 37 37 88% 214 30 29
Haryana 3 22 14 56% 66 12 3
Himachal Pradesh 3 16 9 47% 92 7 5
Jammu & Kashmir 3 9 3 25% 30 10 7
Jharkhand 5 23 16 57% 117 7 2
Karnataka 6 27 16 48% 230 57 22
Kerala 2 14 12 75% 58 32 24
Ladakh 1 1 1 50% 6 0 0
Lakshadweep Zero DR-TB centre 0 0 0
Madhya Pradesh 10 41 28 55% 259 23 7
Maharashtra 20 47 40 60% 543 55 33
Manipur 1 3 0 0% 13 2 2
Meghalaya 3 6 3 33% 29 1 0
Mizoram 2 7 3 33% 21 1 1
Nagaland 2 5 2 29% 51 0 0
Odisha 3 28 27 87% 124 12 7
Puducherry 1 0 1 100% 14 9 9
Punjab 3 17 12 60% 82 9 4
Rajasthan 7 32 22 56% 218 24 16
Sikkim 1 5 4 67% 50 1 1
Tamil Nadu 7 24 25 81% 273 58 38
Telangana 3 25 13 46% 197 31 9
Tripura 1 1 1 50% 12 2 1
Uttar Pradesh 22 58 42 53% 522 55 25
Uttarakhand 3 3 2 33% 46 7 3
West Bengal 9 33 25 60% 249 29 20
INDIA 162 614 422 54% 4334 554 306

205 INDIA TB REPORT 2022 INDIA TB REPORT 2022 206

4.2 TESTING IN TRUNAAT

Paediatric Testing EP-TB Testing Private Samples Testing

Samples with Samples
Number Total MTB Total
Mycobacterium with RR/ Number of Number of Number of Number of
State of Truenat Tests RIF tests Number of Samples Number of Samples
TB (MTB) MDR-TB Total Tests Samples with Samples with Total Tests Samples with Samples with Total Tests
Machines performed performed with Mycobacterium with RR/MDR-TB
Detected Detected performed Mycobacterium TB RR/MDR-TB performed Mycobacterium TB RR/MDR-TB performed
TB (MTB) Detected Detected
(MTB) Detected Detected (MTB) Detected Detected
Andaman & Nicobar 5 1296 245 255 31 61 4 1 53 6 0 8 6 1
Andhra Pradesh 315 450394 29927 30205 768 5541 162 98 7168 6122 397 11335 2106 396
Arunachal Pradesh 22 6786 1049 1227 169 235 22 1 444 62 15 7 1 4
Assam 15 4182 1474 1250 66 269 58 5 167 32 5 152 38 0
Bihar 37 85083 20674 21520 1636 3666 792 84 1988 225 24 20460 5623 489
Chandigarh 5 4511 1178 1244 64 150 3 6 149 15 0 6 0 0
Chhattisgarh 158 49556 8483 8835 271 1775 221 199 2954 403 15 4422 919 27
Dadar & Nagar Haveli 1 1523 212 251 14 97 7 1 145 20 1 27 4 0
Daman & Diu 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Delhi 48 28977 8545 6960 399 5664 901 53 4309 892 34 516 164 9
Goa 7 6816 532 573 26 374 23 37 541 26 3 12 4 0
Gujarat 85 121545 34263 35575 1448 3235 408 37 2840 370 18 10298 3765 188
Haryana 45 40941 15597 16739 617 1660 451 65 1625 584 34 4064 1657 44
Himachal Pradesh 28 29219 3695 4031 87 1254 134 5 2602 308 16 1124 374 24
Jammu & Kashmir 25 24475 3742 3856 110 1832 129 23 1207 97 6 289 70 2
Jharkhand 266 44575 10293 9503 407 813 141 255 1046 96 9 3336 918 68
Karnataka 124 192503 24150 25621 1087 7277 392 1666 5924 495 128 12932 2873 142
Kerala 54 102592 6636 7620 141 1032 21 2 138 19 0 5115 640 64
Ladakh 2 151 9 6 0 1 0 0 0 0 0 7 0 0
Lakshadweep 10 981 6 3 0 0 0 0 0 0 0 0 0 0
Madhya Pradesh 70 116255 39442 32292 1732 4209 778 60 4166 790 35 17877 7090 323
Maharashtra 91 57721 12673 12595 1111 1965 231 410 1764 229 304 11912 3246 208
Manipur 5 188 15 15 1 5 0 0 2 0 0 0 0 0
Meghalaya 12 2232 277 355 37 143 0 84 36 6 0 78 3 0
Mizoram 4 0 0 0 0 0 0 0 0 0 0 0 0 0
Nagaland 7 850 83 122 8 4 1 0 1 1 0 2 0 0
Odhisa 56 54973 9671 9354 269 2230 163 55 3820 313 28 6220 5311 15
Pondicherry 5 583 92 27 1 22 0 0 0 0 0 0 0 0
Punjab 35 25752 9581 10546 351 1201 382 100 1547 364 14 1502 534 23
Rajasthan 61 50656 18807 15641 825 873 282 13 420 80 8 4532 792 15
Sikkim 6 1316 151 162 36 148 18 7 115 6 2 1 0 0
Tamil Nadu 147 156457 33306 35572 1174 3203 186 289 4037 555 55 10864 3426 163
Telangana 43 68269 14002 14117 729 1911 261 81 954 153 71 4473 1111 49
Tripura 10 6472 1141 1356 11 204 9 0 328 26 0 114 21 1
Uttar Pradesh 485 323718 107820 109489 6837 12206 3795 723 4890 819 194 19397 7719 840
Uttarakhand 52 16993 4850 5518 239 388 87 1 1123 182 4 358 148 10
West Bengal 186 119216 27683 29746 1225 3076 419 67 4296 524 48 3855 872 53
Grand Total 2527 2197757 450304 452181 21927 66724 10481 4428 60799 13820 1468 155295 49435 3158

207 INDIA TB REPORT 2022 INDIA TB REPORT 2022 208

4.3 TESTING IN CBNAAT

Paediatric Testing EP-TB Testing Private Samples Testing

Samples with Samples
Number of CBNAAT
Total Tests Mycobacterium with RR/ Number of Number of Number of Number of
State Machines (Including Number of Samples Number of Samples
performed TB (MTB) MDR-TB Total Tests Samples with Samples with Total Tests Samples with Samples with Total Tests
Mobile Vans) with Mycobacterium with RR/MDR-TB
Detected Detected performed Mycobacterium TB RR/MDR-TB performed Mycobacterium TB RR/MDR-TB performed
TB (MTB) Detected Detected
(MTB) Detected Detected (MTB) Detected Detected
Andaman & Nicobar 5 431 93 9 19 0 0 52 14 1 1 0 0
Andhra Pradesh 50 107520 13757 709 3044 113 7 7222 773 36 12764 3177 135
Arunachal Pradesh 12 3908 571 65 253 24 3 157 41 4 15 0 0
Assam 33 22916 6599 330 1141 215 11 1118 98 7 1568 346 23
Bihar 72 50190 14502 1547 1898 422 44 2390 452 62 13967 4238 414
Chandigarh 3 3435 626 60 785 99 6 1277 163 15 0 0 0
Chhattisgarh 32 34918 6962 186 1257 159 1 2822 359 14 2390 528 12
Dadar & Nagar Haveli 2 1448 184 10 101 8 0 228 53 1 21 5 0
Daman & Diu 3 2504 235 26 74 11 1 45 22 0 3 2 0
Delhi 41 21020 7689 761 2925 661 74 7204 1813 213 598 204 18
Goa 3 8212 851 67 669 41 1 2675 180 17 30 6 0
Gujarat 63 65044 19097 964 3041 582 40 8811 1738 136 8393 3333 202
Haryana 28 39249 15354 813 2026 573 24 2840 681 36 4021 1784 63
Himachal Pradesh 27 39252 6361 175 1882 198 5 5440 644 30 2033 610 19
Jammu & Kashmir 14 14396 2236 204 990 166 110 1201 106 7 575 168 0
Jharkhand 37 40655 12878 753 1059 195 8 1194 159 15 8777 2454 141
Karnataka 72 56706 9536 493 2557 190 13 6396 886 88 6084 1502 69
Kerala 38 49777 6061 231 2463 113 2 12815 1583 62 9826 1267 31
Ladakh 2 2435 246 14 33 3 0 246 64 5 45 17 3
Lakshadweep 1 70 5 0 0 0 0 0 0 0 0 0 0
Madhya Pradesh 75 42806 12913 696 2667 346 11 3270 546 21 5788 2404 247
Maharashtra 138 262395 103243 23307 66416 34911 17011 98443 43831 19523 100665 50478 20690
Manipur 10 6336 1003 64 215 9 1 254 51 1 66 17 3
Meghalaya 8 9610 2078 211 1179 109 11 694 149 24 686 116 9
Mizoram 9 4081 731 72 276 20 2 630 94 15 345 54 5
Nagaland 11 8528 1797 106 285 28 0 356 96 0 604 252 28
Odhisa 48 60415 17122 362 2475 340 12 6667 733 29 2888 566 9
Pondicherry 3 8048 1280 62 357 9 0 3931 395 13 16 0 0
Punjab 35 37336 14391 490 1746 715 149 3867 824 35 1799 697 26
Rajasthan 62 49849 21954 1324 2995 552 21 6740 1015 62 5935 2595 142
Sikkim 8 5570 949 276 593 105 26 761 124 32 32 8 4
Tamil Nadu 73 65219 13924 600 2978 102 1 8148 1091 25 5095 1479 31
Telangana 39 46713 8751 524 1516 146 14 2125 306 22 4764 1276 45
Tripura 7 4182 713 18 105 7 0 131 16 0 43 7 0
Uttar Pradesh 150 173292 68564 6368 9070 2248 215 14526 2558 342 24342 10013 1041
Uttarakhand 15 7926 3773 268 382 114 8 1151 226 17 451 213 19
West Bengal 79 77732 26392 1328 2634 393 31 8306 1387 105 4153 1007 66
Grand Total 1308 1434124 423421 43493 122106 43927 17863 224133 63271 21015 228783 90823 23495

209 INDIA TB REPORT 2022 INDIA TB REPORT 2022 210

4.4 Testing in line probe assay (LPA)

First Line Line Probe Assay Second Line Line Probe Assay

State Susceptible to Resistant to

Samples Resistant TO Resistant TO Susceptible to Resistant to Resistant TO Resistant TO Resistant to Mono low
both isoniazid & both isoniazid Samples Tested
Tested Rifampicin Isoniazid both FQ & SLI both FQ & SLI FQ SLI level Kanamycin
Rifampicin & Rifampicin
Andaman&Nicobar 248 130 (52%) 58 (23%) 25 (10%) 13 (5%) 157 100 (64%) 3 (2%) 36 (23%) 2 (1%) 0 (%)
Andhra Pradesh 12741 11009 (86%) 288 (2%) 146 (1%) 1052 (8%) 1481 1204 (81%) 4 (%) 143 (10%) 10 (1%) 0 (%)
Arunachal Pradesh 614 399 (65%) 97 (16%) 3 (%) 34 (6%) 164 92 (56%) 3 (2%) 33 (20%) 2 (1%) 0 (%)
Assam 6376 5128 (80%) 296 (5%) 78 (1%) 495 (8%) 910 601 (66%) 13 (1%) 174 (19%) 9 (1%) 1 (%)
Bihar 6324 4584 (72%) 944 (15%) 138 (2%) 376 (6%) 1798 841 (47%) 95 (5%) 635 (35%) 13 (1%) 0 (%)
Chandigarh 675 597 (88%) 37 (5%) 6 (1%) 35 (5%) 37 27 (73%) 0 (%) 10 (27%) 0 (%) 0 (%)
Chattisgarh 5785 5248 (91%) 126 (2%) 40 (1%) 311 (5%) 503 426 (85%) 10 (2%) 65 (13%) 2 (%) 0 (%)
Dadar and Nagar Haveli 22 16 (73%) 1 (5%) 1 (5%) 1 (5%) 5 1 (20%) 0 (%) 1 (20%) 2 (40%) 0 (%)
Daman & Diu 1325 678 (51%) 296 (22%) 74 (6%) 108 (8%) 711 319 (45%) 25 (4%) 194 (27%) 19 (3%) 6 (1%)
Delhi 23710 19362 (82%) 2054 (9%) 230 (1%) 1397 (6%) 3983 2330 (58%) 149 (4%) 1175 (30%) 15 (%) 33 (1%)
Goa 1241 1046 (84%) 65 (5%) 14 (1%) 44 (4%) 105 56 (53%) 8 (8%) 31 (30%) 1 (1%) 1 (1%)
Gujarat 10921 8319 (76%) 715 (7%) 273 (2%) 797 (7%) 3267 1683 (52%) 110 (3%) 845 (26%) 38 (1%) 19 (1%)
Haryana 13145 11236 (85%) 268 (2%) 92 (1%) 836 (6%) 1446 1036 (72%) 18 (1%) 158 (11%) 13 (1%) 1 (%)
Himachal Pradesh 4526 3956 (87%) 79 (2%) 20 (%) 156 (3%) 241 189 (78%) 4 (2%) 36 (15%) 0 (%) 0 (%)
Jammu & Kashmir 2503 1808 (72%) 120 (5%) 13 (1%) 88 (4%) 252 163 (65%) 6 (2%) 63 (25%) 1 (%) 2 (1%)
Jharkhand 1174 973 (83%) 70 (6%) 14 (1%) 29 (2%) 87 40 (46%) 5 (6%) 38 (44%) 0 (%) 4 (5%)
Karnataka 24196 19917 (82%) 682 (3%) 276 (1%) 1298 (5%) 3945 2727 (69%) 54 (1%) 522 (13%) 36 (1%) 2 (%)
Kerala 2378 1830 (77%) 121 (5%) 22 (1%) 111 (5%) 246 194 (79%) 3 (1%) 38 (15%) 3 (1%) 1 (%)
Ladakh 18 15 (83%) 3 (17%) 0 (%) 0 (%) 3 2 (67%) 0 (%) 0 (%) 0 (%) 0 (%)
Lakshdweep 741 522 (70%) 24 (3%) 6 (1%) 46 (6%) 69 55 (80%) 1 (1%) 12 (17%) 1 (1%) 0 (%)
Madhya Pradesh 17127 14201 (83%) 781 (5%) 301 (2%) 1094 (6%) 2748 1615 (59%) 65 (2%) 822 (30%) 18 (1%) 7 (%)
Maharashtra 55797 40884 (73%) 7740 (14%) 1168 (2%) 3178 (6%) 14373 7226 (50%) 1051 (7%) 4859 (34%) 201 (1%) 381 (3%)
Manipur 392 265 (68%) 11 (3%) 4 (1%) 58 (15%) 62 38 (61%) 0 (%) 8 (13%) 3 (5%) 0 (%)
Meghalaya 1278 1041 (81%) 102 (8%) 9 (1%) 68 (5%) 211 131 (62%) 7 (3%) 51 (24%) 4 (2%) 1 (%)
Mizoram 175 126 (72%) 4 (2%) 0 (%) 15 (9%) 26 14 (54%) 0 (%) 5 (19%) 0 (%) 0 (%)
Nagaland 331 268 (81%) 11 (3%) 13 (4%) 11 (3%) 38 22 (58%) 1 (3%) 7 (18%) 2 (5%) 0 (%)
Odhisa 9879 9225 (93%) 85 (1%) 28 (%) 179 (2%) 607 478 (79%) 3 (%) 60 (10%) 2 (%) 0 (%)
Puducherry 913 741 (81%) 12 (1%) 2 (%) 41 (4%) 47 40 (85%) 1 (2%) 4 (9%) 1 (2%) 0 (%)
Punjab 6819 5709 (84%) 349 (5%) 61 (1%) 397 (6%) 825 555 (67%) 22 (3%) 228 (28%) 10 (1%) 2 (%)
Rajasthan 30226 24755 (82%) 1171 (4%) 359 (1%) 1598 (5%) 4588 2914 (64%) 86 (2%) 946 (21%) 26 (1%) 7 (%)
Sikkim 139 101 (73%) 30 (22%) 2 (1%) 6 (4%) 53 32 (60%) 0 (%) 17 (32%) 0 (%) 3 (6%)
Tamil Naidu 25582 21861 (85%) 501 (2%) 299 (1%) 1708 (7%) 2803 2257 (81%) 27 (1%) 281 (10%) 23 (1%) 10 (%)
Telangana 9166 4679 (51%) 175 (2%) 107 (1%) 402 (4%) 889 278 (31%) 10 (1%) 49 (6%) 14 (2%) 1 (%)
Tripura 1059 922 (87%) 11 (1%) 7 (1%) 60 (6%) 83 63 (76%) 1 (1%) 5 (6%) 1 (1%) 0 (%)
Uttar Pradesh 34164 23956 (70%) 4119 (12%) 881 (3%) 2822 (8%) 9480 4082 (43%) 679 (7%) 3315 (35%) 149 (2%) 43 (%)
Uttrakhand 1184 1042 (88%) 56 (5%) 11 (1%) 75 (6%) 113 81 (72%) 5 (4%) 27 (24%) 0 (%) 0 (%)
West Bengal 15821 11447 (72%) 703 (4%) 95 (1%) 771 (5%) 1899 1076 (57%) 81 (4%) 392 (21%) 28 (1%) 13 (1%)
India 328715 257996 (78%) 22205 (7%) 4818 (1%) 19710 (6%) 58255 32988 (57%) 2550 (4%) 15285 (26%) 649 (1%) 538 (1%)

211 INDIA TB REPORT 2022 INDIA TB REPORT 2022 212

4.5 Testing in culture and DST (CDST)

SL-DST Culture

State MDR + FQ MDR + SLI

Samples Susceptible to FQ XDR MDR + Mox (2) Non-Tuberculous
resistance resistance Samples tested MTB +ve Culture -ve
tested & SLI detected* resistance detected Mycobacterium detected
detected detected
Andaman & Nicobar
9 0 (%) 3 (33%) 0 (%) 0 (%) 1 (11%) 423 34 (8%) 0 (%) 203 (48%)
Islands
Andhra Pradesh 43 14 (33%) 6 (14%) 0 (%) 1 (2%) 6 (14%) 9021 932 (10%) 0 (%) 2996 (33%)
Arunachal Pradesh 7 4 (57%) 1 (14%) 0 (%) 0 (%) 2 (29%) 18 0 (%) 0 (%) 3 (17%)
Assam 45 8 (18%) 16 (36%) 0 (%) 0 (%) 3 (7%) 4030 233 (6%) 0 (%) 2025 (50%)
Bihar 8 6 (75%) 0 (%) 0 (%) 0 (%) 0 (%) 9061 1640 (18%) 9 (%) 3202 (35%)
Chandigarh 0 NA NA NA NA NA 1554 226 (15%) 1 (%) 751 (48%)
Chhattisgarh 37 22 (59%) 4 (11%) 4 (11%) 0 (%) 5 (14%) 4462 586 (13%) 3 (%) 1491 (33%)
Dadra & Nagar Haveli 1 0 (%) 0 (%) 0 (%) 0 (%) 0 (%) 39 3 (8%) 0 (%) 26 (67%)
Daman & Diu 1 1 (100%) 1 (100%) 0 (%) 0 (%) 1 (100%) 16 2 (13%) 0 (%) 8 (50%)
Delhi 1851 1185 (64%) 88 (5%) 13 (1%) 32 (2%) 225 (12%) 36404 8914 (24%) 270 (1%) 16976 (47%)
Goa 33 17 (52%) 8 (24%) 0 (%) 3 (9%) 2 (6%) 1424 122 (9%) 13 (1%) 600 (42%)
Gujarat 787 244 (31%) 318 (40%) 0 (%) 59 (7%) 58 (7%) 13059 2283 (17%) 80 (1%) 5088 (39%)
Haryana 0 NA NA NA NA NA 2536 51 (2%) 0 (%) 1617 (64%)
Himachal Pradesh 8 4 (50%) 0 (%) 0 (%) 0 (%) 1 (13%) 10 4 (40%) 5 (50%) 1 (10%)
Jammu & Kashmir 4 1 (25%) 0 (%) 0 (%) 0 (%) 2 (50%) 112 17 (15%) 4 (4%) 25 (22%)
Jharkhand 3 1 (33%) 0 (%) 0 (%) 0 (%) 2 (67%) 2830 211 (7%) 0 (%) 479 (17%)
Karnataka 1014 511 (50%) 110 (11%) 18 (2%) 10 (1%) 36 (4%) 20689 3965 (19%) 27 (%) 7692 (37%)
Kerala 37 2 (5%) 1 (3%) 0 (%) 0 (%) 0 (%) 2674 135 (5%) 8 (%) 1476 (55%)
Ladakh 0 NA NA NA NA NA 2 0 (%) 0 (%) 1 (50%)
Lakshdweep 0 NA NA NA NA NA 0 NA NA NA
Madhya Pradesh 416 249 (60%) 39 (9%) 18 (4%) 10 (2%) 39 (9%) 14015 3005 (21%) 32 (%) 5677 (41%)
Maharashtra 8913 1867 (21%) 1376 (15%) 342 (4%) 417 (5%) 1269 (14%) 82455 14567 (18%) 153 (%) 38055 (46%)
Manipur 1 0 (%) 0 (%) 0 (%) 0 (%) 0 (%) 133 7 (5%) 1 (1%) 89 (67%)
Meghalaya 1 1 (100%) 0 (%) 0 (%) 0 (%) 0 (%) 639 49 (8%) 10 (2%) 264 (41%)
Mizoram 1 1 (100%) 0 (%) 0 (%) 0 (%) 0 (%) 0 NA NA NA
Nagaland 2 0 (%) 1 (50%) 0 (%) 0 (%) 1 (50%) 0 NA NA NA
Odisha 51 33 (65%) 8 (16%) 0 (%) 0 (%) 4 (8%) 3745 653 (17%) 8 (%) 1719 (46%)
Puducherry 11 5 (45%) 4 (36%) 1 (9%) 0 (%) 3 (27%) 289 73 (25%) 0 (%) 117 (40%)
Punjab 32 20 (63%) 4 (13%) 0 (%) 0 (%) 0 (%) 6868 1167 (17%) 10 (%) 3285 (48%)
Rajasthan 742 428 (58%) 57 (8%) 54 (7%) 14 (2%) 66 (9%) 22817 7053 (31%) 48 (%) 10730 (47%)
Sikkim 22 3 (14%) 0 (%) 0 (%) 0 (%) 3 (14%) 939 86 (9%) 0 (%) 515 (55%)
Tamil Nadu 459 222 (48%) 44 (10%) 24 (5%) 3 (1%) 33 (7%) 22792 3250 (14%) 96 (%) 12404 (54%)
Telangana 0 NA NA NA NA NA 3687 282 (8%) 0 (%) 1452 (39%)
Tripura 1 1 (100%) 0 (%) 0 (%) 0 (%) 0 (%) 462 29 (6%) 0 (%) 325 (70%)
Uttar Pradesh 235 15 (6%) 31 (13%) 16 (7%) 12 (5%) 8 (3%) 30411 2240 (7%) 3 (%) 12197 (40%)
Uttarakhand 0 NA NA NA NA NA 0 NA NA NA
West Bengal 111 11 (10%) 58 (52%) 0 (%) 6 (5%) 3 (3%) 10066 1485 (15%) 56 (1%) 3803 (38%)
India 14886 4876 (33%) 2178 (15%) 490 (3%) 567 (4%) 1773 (12%) 307682 53304 (17%) 837 (0.3%) 135292 (44%)
XDR Detected* - MDR/RR + FQ + SLI Resistance

213 INDIA TB REPORT 2022 INDIA TB REPORT 2022 214

4.6 Public Sector Laboratory

Name of the Culture Liquid Name of the Culture Liquid

S.No State FL LCDST SL LCDST FL LPA SL LPA S.No State FL LCDST SL LCDST FL LPA SL LPA
& DST Laboratory culture & DST Laboratory culture

1 Andhra Pradesh IRL, Visakhaptnam Available Certified Certified Certified Certified C&DST Laboratory,
28 Karnataka Available Certified Certified Certified Certified
RIMS, Raichur
C&DST Laboratory, Not Not Not Not
2 Andhra Pradesh Available 29 Karnataka NRL NTI, Bangalore Available Certified Certified Certified Certified
SMC, Vijayawada Certified Certified Certified Certified
C&DST Laboratory, Not Not Not 30 Kerala IRL Trivandrum Available Certified Certified Certified Certified
3 Andhra Pradesh Certified Certified
DTRC(DFIT),Nellore,A.P Available Certified Certified C&DST Laboratory, Not Not
31 Kerala Available Certified Certified
C&DST Laboratory, RDT Not GMC, Kozhikode Certified Certified
4 Andhra Pradesh Available Certified Certified Certified
Hospital, Bathalapalli Certified 32 Maharashtra IRL Nagpur Available Certified Certified Certified Certified
5 Assam IRL Guwahati Available Certified Certified Certified Certified 33 Maharashtra IRL Pune Available Certified Certified Certified Certified
C&DST Laboratory, C&DST Laboratory, JJ
6 Bihar Available Certified Certified Certified Certified 34 Maharashtra Available Certified Certified Certified Certified
JLNMCH Bhagalpur Hospital, Mumbai
7 Bihar IRL, Patna Available Certified Certified Certified Certified Not
B J Medical College, Not
35 Maharashtra Available Certified Certified
C&DST Not Pune Certified Certified
Not Not
8 Bihar Laboratory,IGIMS, Available Certified
Certified Certified Certified C&DST Laboratory,
Patna 36 Maharashtra Available Certified Certified Certified Certified
GMC, Aurangabad
Not Not
9 Bihar DFIT Darbhanga Available Certified Certified IRL, GTB Hospital,
Certified Certified 37 Maharashtra Available Certified Certified Certified Certified
Sewree, Mumbai
10 Chhattisgarh IRL, STDC Raipur Available Certified Certified Certified Certified
Not Not Not Not
38 Maharashtra Military Hospital, Pune Certified
C&DST Laboratory, Not Not Not Not Available Certified Certified Certified
11 Chhattisgarh Certified
AIIMS, Raipur Available Certified Certified Certified C&DST Laboratory, KEM
Not Not
IRL, PGIMER 39 Maharashtra Hospital and Medical Available Certified Certified
12 Chandigarh Available Certified Certified Certified Certified Certified Certified
Chandigarh College, Mumbai
IRL, New Delhi TB C&DST
13 Delhi Available Certified Certified Certified Certified 40 Madhya Pradesh Laboratory,NIRTH, Available Certified Certified Certified Certified
Centre (NDTB), Delhi
Jabalpur
IRL, AIIMS (Medicine),
14 Delhi Available Certified Certified Certified Certified 41 Madhya Pradesh IRL, STDC Indore Available Certified Certified Certified Certified
Delhi
15 Delhi NRL, NITRD, Delhi Available Certified Certified Certified Certified 42 Madhya Pradesh NRL, BMHRC ,Bhopal Available Certified Certified Certified Certified
C&DST C&DST Laboratory, Not Not Not
Not Not Not Not 43 Madhya Pradesh Certified Certified
16 Delhi Laboratory,RBIMPT, Available GRMC, Gwalior Available Certified Certified
Certified Certified Certified Certified
Delhi Not Not
44 Madhya Pradesh IRL STDC Bhopal Available Certified Certified
Not Not Not Certified Certified
17 Goa IRL Goa Available Certified
Certified Certified Certified C&DST Laboratory, Not Not
45 Madhya Pradesh Available Certified Certified
18 Gujarat IRL , STDC-Ahmedabad Available Certified Certified Certified Certified AIIMS, Bhopal Certified Certified

C&DST Laboratory, 46 Odisha IRL Cuttack, Available Certified Certified Certified Certified
19 Gujarat Available Certified Certified Certified Certified
MPSMS, Jamnagar NRL RMRC,
47 Odisha Available Certified Certified Certified Certified
Not Bhubaneswar
C&DST Laboratory,GMC Not
20 Gujarat Available Certified Certified
Surat Certified Certified 48 Punjab IRL, Patiala Available Certified Certified Certified Certified
Not Not Not C&DST
21 Himachal Pradesh IRL Dharampur Certified Certified
Available Certified Certified Laboratory,Guru Not Not Not
49 Punjab Available
Gobind Singh Medical Certified Certified Certified
C&DST Laboratory, Not Not Not Not College, Faridkot
22 Himachal Pradesh Available
IGIMS Shimla Certified Certified Certified Certified
50 Puducherry IRL Puducherry Available Certified Certified Certified Certified
Not Not
23 Haryana IRL Karnal Available Certified Certified 51 Rajasthan IRL Ajmer Available Certified Certified Certified Certified
Certified Certified
24 Jharkhand IRL, Ranchi Available Certified Certified Certified Certified C&DST Laboratory,
52 Rajasthan SMS Medical College, Available Certified Certified Certified Certified
Not Not Not Jaipur
25 Jammu & Kashmir IRL Srinagar Certified Certified
Available Certified Certified
C&DST Laboratory, Not
26 Karnataka IRL Bangalore Available Certified Certified Certified Certified 53 Rajasthan Available Certified Certified Certified
SNMC Jodhpur Certified
C&DST C&DST Laboratory, Not Not Not
27 Karnataka Available Certified Certified Certified Certified 54 Rajasthan Certified Certified
Laboratory,KIMS, Hubli AIIMS, Jodhpur Available Certified Certified

215 INDIA TB REPORT 2022 INDIA TB REPORT 2022 216

 Private Sector Laboratory

Name of the Culture Liquid Name of the Culture Liquid

S.No State FL LCDST SL LCDST FL LPA SL LPA S.No State FL LCDST SL LCDST FL LPA SL LPA
& DST Laboratory culture & DST Laboratory culture

Not Not Not Not Schamaka TeKnology, Not Not Not Not
55 Sikkim IRL, Gangtok Available 1 Gujarat Certified
Certified Certified Certified Certified Vadodara Available Certified Certified Certified
56 Tamil Nadu IRL STDC CHENNAI Available Certified Certified Certified Certified Microcare laboratory, Not Not Not Not
2 Gujarat Certified
57 Tamil Nadu IRL GMC MADURAI Available Certified Certified Certified Certified Surat Available Certified Certified Certified
C&DST Laboratory, Kasturba Medical Not Not Not Not
Not Not Not Not 3 Karnataka Certified
58 Tamil Nadu Coimbatore Medical Available College, Manipal Available Certified Certified Certified
Certified Certified Certified Certified
College Hospital,
Nazerath Hospital, Not Not Not
4 Meghalaya Certified Certified
C&DST Laboratory, Shilong Available Certified Certified
Not Not
59 Tamil Nadu GHTM Tambaram, Available Certified Certified
Certified Certified 5 Maharashtra Thyrocare, Mumbai Available Certified Certified Certified Certified
Chennai
C&DST Laboratory, P D Hinduja Hospital,
Not Not Not Not 6 Maharashtra Available Certified Certified Certified Certified
60 Tamil Nadu K.A.P.V. Government Available Mumbai
Certified Certified Certified Certified
Medical College, Trichy SRL Diagnostics, Not Not
7 Maharashtra Available Certified Certified
61 Tamil Nadu NRL NIRT, Chennai Available Certified Certified Certified Certified Mumbai Certified Certified
C&DST Laboratory, Not Not Not Not
62 Tripura Available Certified 8 Maharashtra Metropolis, Mumbai Available Certified Certified Certified
GMC, Agartala Certified Certified Certified Certified
63 Telangana IRL Hyderabad Available Certified Certified Certified Certified INFEXN Laboratory,
9 Maharashtra Available Certified Certified Certified Certified
Thane
Rajiv Gandhi Institute
Not Not Not Not
64 Telangana of Medical Sciences Available Aspira Path Lab, Navi Not Not
Certified Certified Certified Certified 10 Maharashtra Available Certified Certified
(RGIMS), Adilabad Mumbai Certified Certified
C&DST Laboratory, Not Babina Diagnostics, Not Not Not Not
65 Telangana Available Certified Certified Certified 11 Manipur Available
BPHRC Hyderabad Certified Imphal Certified Certified Certified Certified
Not Not Not Christian Medical Not
66 Uttarakhand IRL Dehradun Certified Certified 12 Tamil Nadu Available Certified Certified Certified
Available Certified Certified College,Vellore Certified
67 Uttar Pradesh IRL KGMU, Lucknow Available Certified Certified Certified Certified Vision Research
NRL, ICMR0NJIL&OMD, Fondation laboratory, Not Not Not
68 Uttar Pradesh Available Certified Certified Certified Certified 13 Tamil Nadu Available Certified
AGRA Shakar Nethralaya, Certified Certified Certified
Chennai
C&DST Laboratory, Not Not Not
69 Uttar Pradesh Certified Certified Subharti Medical Not Not Not Not
JNMC, AMU, Alligarh Available Certified Certified 14 Uttar Pradesh Certified
College, Meerut Available Certified Certified Certified
70 Uttar Pradesh IRL Agra Available Certified Certified Certified Certified
Shri Ram Murti Smarak Not Not Not Not
C&DST Laboratory, 15 Uttar Pradesh Available
71 Uttar Pradesh Available Certified Certified Certified Certified Institutions, Bareilly Certified Certified Certified Certified
BHU, Varanasi
C&DST Laboratory, LLRM Not Not SRL Diagnsotics, Not Not Not
72 Uttar Pradesh Available Certified Certified 16 West Bengal Available Certified
Meerut, Uttar Pradesh Certified Certified Kolkata Certified Certified Certified
C&DST Laboratory, Not Not Not Not AMRI Hospital, Not Not Not Not
73 Uttar Pradesh Available 17 West Bengal Available
Dr.RMLIMS, Lucknow Certified Certified Certified Certified Dhakuria, Kolkata Certified Certified Certified Certified
C&DST Laboratory, Not Not Not Not
74 Uttar Pradesh Certified
UPUMS, Safai, Etawah Available Certified Certified Certified
C&DST Laboratory,
Not Not Not
75 Uttar Pradesh BRD Medical College, Available Certified
Certified Certified Certified
Gorakhpur
76 West Bengal IRL, Kolkata West Bengal Available Certified Certified Certified Certified
C&DST Laboratory, Not
77 West Bengal Available Certified Certified Certified
NBMC, West Bengal Certified
C&DST Laboratory,
Not Not Not Not
78 West Bengal Burdwan Medical Available
Certified Certified Certified Certified
College, Burdwan
C&DST Laboratory,
Murshidabad Medical Not Not Not Not
79 West Bengal Available
College and Hospital, Certified Certified Certified Certified
Murshidabad

217 INDIA TB REPORT 2022 INDIA TB REPORT 2022 218

 4.7 MDR/RR TB DIAGNOSED IN 2021

Tested for Rifampicin Resistance^ MDR/RR patient diagnosed (2021)# MDR/ RR initiated on MDR/ RR initiated on Total No. of MDR/RR
MDR/ RR Initiated on
State Shorter MDR-TB (Inj Shorter MDR/RR-TB (oral) patients put on longer oral
Public Private treatment (%)#
Public Private Total Total containing) regimen regimen M/XDR-TB regimen
Sector Sector
Andaman & Nicobar
292 (56.7%) 0 (.0%) 292 (56.6%) 41 0 41 39 (95%) 18 (46%) 0 (%) 13 (33%)
Islands
Andhra Pradesh 56678 (89.4%) 19283 (79.1%) 75961 (86.6%) 1427 86 1513 1442 (95%) 1059 (73%) 92 (6%) 241 (17%)
Arunachal Pradesh 1641 (57.1%) NA 1641 (57.1%) 222 0 222 185 (83%) 146 (79%) 2 (1%) 33 (18%)
Assam 11020 (32.8%) 747 (18.1%) 11767 (31.2%) 405 43 448 400 (89%) 277 (69%) 3 (1%) 101 (25%)
Bihar 33357 (52.1%) 23902 (33.4%) 57259 (42.3%) 2515 725 3240 2862 (88%) 2302 (80%) 87 (3%) 285 (10%)
Chandigarh 1776 (56.9%) 31 (25.6%) 1807 (55.7%) 57 15 72 65 (90%) 4 (6%) 0 (%) 59 (91%)
Chhattisgarh 15598 (61.4%) 1792 (24.9%) 17390 (53.3%) 351 25 376 334 (89%) 286 (86%) 0 (%) 30 (9%)
Dadra & Nagar Haveli
587 (82.3%) 24 (48.0%) 611 (80.1%) 40 0 40 36 (90%) 7 (19%) 1 (3%) 27 (75%)
Daman & Diu
Delhi 27463 (40.6%) 6827 (40.7%) 34290 (40.6%) 1460 120 1580 1400 (89%) 579 (41%) 119 (9%) 679 (49%)
Goa 1384 (83.6%) 97 (25.3%) 1481 (72.7%) 52 2 54 47 (87%) 14 (30%) 0 (%) 33 (70%)
Gujarat 62989 (62.5%) 14372 (35.5%) 77361 (54.8%) 2408 259 2667 2465 (92%) 851 (35%) 519 (21%) 976 (40%)
Haryana 31078 (59.3%) 8554 (45.4%) 39632 (55.6%) 1193 90 1283 1219 (95%) 813 (67%) 13 (1%) 287 (24%)
Himachal Pradesh 11410 (80.2%) 426 (73.8%) 11836 (80.0%) 201 6 207 193 (93%) 70 (36%) 61 (32%) 60 (31%)
Jammu & Kashmir 6986 (67.5%) 379 (58.1%) 7365 (66.9%) 145 4 149 132 (89%) 41 (31%) 31 (23%) 47 (36%)
Jharkhand 18467 (50.5%) 7193 (43.3%) 25660 (48.3%) 805 91 896 797 (89%) 588 (74%) 16 (2%) 167 (21%)
Karnataka 40461 (68.1%) 4957 (41.3%) 45418 (63.6%) 1114 134 1248 1096 (88%) 464 (42%) 251 (23%) 330 (30%)
Kerala 12502 (66.1%) 1694 (54.4%) 14196 (64.5%) 168 18 186 179 (96%) 66 (37%) 0 (%) 113 (63%)
Ladakh 220 (74.6%) 10 (41.7%) 230 (72.1%) 4 0 4 4 (100%) 0 (%) 3 (75%) 1 (25%)
Lakshadweep 15 (75.0%) NA 15 (75.0%) No patients diagnosed
Madhya Pradesh 45181 (37.5%) 12174 (25.5%) 57355 (34.1%) 2047 312 2359 1956 (83%) 1526 (78%) 9 (%) 326 (17%)
Maharashtra 105473 (83.4%) 46964 (67.0%) 152437 (77.5%) 7291 2317 9608 9017 (94%) 1588 (18%) 535 (6%) 6187 (69%)
Manipur 1164 (69.2%) 84 (44.2%) 1248 (66.6%) 64 11 75 55 (73%) 24 (44%) 5 (9%) 15 (27%)
Meghalaya 2895 (75.5%) 106 (29.7%) 3001 (71.6%) 228 7 235 218 (93%) 127 (58%) 2 (1%) 71 (33%)
Mizoram 1095 (68.9%) 150 (78.1%) 1245 (69.9%) 122 0 122 120 (98%) 64 (53%) 0 (%) 51 (43%)
Nagaland 2200 (69.7%) 83 (15.6%) 2283 (61.9%) 104 0 104 101 (97%) 67 (66%) 0 (%) 26 (26%)
Odisha 38399 (79.7%) 2443 (61.9%) 40842 (78.3%) 432 7 439 421 (96%) 281 (67%) 6 (1%) 128 (30%)
Puducherry 1085 (77.1%) NA 1085 (77.1%) 18 1 19 18 (95%) 4 (22%) 0 (%) 10 (56%)
Punjab 21846 (56.9%) 3470 (25.3%) 25316 (48.6%) 617 21 638 574 (90%) 314 (55%) 22 (4%) 226 (39%)
Rajasthan 47661 (44.3%) 8718 (20.0%) 56379 (37.3%) 2380 94 2474 2045 (83%) 1249 (61%) 9 (%) 617 (30%)
Sikkim 1059 (79.1%) 80 (80.8%) 1139 (79.2%) 217 26 243 236 (97%) 153 (65%) 4 (2%) 65 (28%)
Tamil Nadu 53394 (77.2%) 8555 (54.1%) 61949 (72.9%) 1174 143 1317 1182 (90%) 809 (68%) 0 (%) 353 (30%)
Telangana 30206 (68.5%) 8926 (53.0%) 39132 (64.2%) 1071 81 1152 1082 (94%) 569 (53%) 110 (10%) 338 (31%)
Tripura 2581 (93.4%) 7 (53.8%) 2588 (93.2%) 20 0 20 16 (80%) 5 (31%) 0 (%) 11 (69%)
Uttar Pradesh 197439 (56.5%) 33013 (28.6%) 230452 (49.6%) 10873 1466 12339 10890 (88%) 9360 (86%) 27 (%) 1317 (12%)
Uttarakhand 9918 (51.6%) 1003 (23.1%) 10921 (46.3%) 463 27 490 453 (92%) 180 (40%) 4 (1%) 250 (55%)
West Bengal 57428 (69.8%) 4125 (44.7%) 61553 (67.3%) 2252 120 2372 2101 (89%) 1330 (63%) 8 (%) 683 (33%)
India 952948 (60.4%) 220189 (39.4%) 1173137 (54.9%) 41981 6251 48232 43380 (90%) 25235 (58%) 1939 (4%) 14156 (33%)

219 INDIA TB REPORT 2022 INDIA TB REPORT 2022 220

4.8 M
 DR/RR-TB DIAGNOSED WITH ADDITIONAL
RESISTANCE

MDR/RR + SLI resistance, Z resistant

MDR/RR + only SLI / Z resistant MDR/RR + SLI resistance, Z resistant
MDR/RR-TB + only SLI MDR/RR-TB + InhA & No. of MDR/RR + Z and/or InhA & KatG mutation detected
STATE and/or InhA & KatG mutation and/or InhA & KatG mutation detected
resistant diagnosed KatG mutation detected resistance detected put on treatment irrespective of the
detected put on longer oral M/XDR-TB regimen
type of regimen

Andaman & Nicobar 0 13 0 13 10 (77%) 9 (90%)

Andhra Pradesh 19 94 0 94 42 (45%) 40 (95%)
Arunachal Pradesh 1 9 0 5 1 (20%) 1 (100%)
Assam 3 60 0 47 35 (74%) 28 (80%)
Bihar 9 99 1 60 41 (68%) 32 (78%)
Chandigarh No patients diagnosed
Chhattisgarh 1 21 0 13 9 (69%) 4 (44%)
Dadra & Nagar Haveli Daman & Diu 2 4 2 8 8 (100%) 7 (88%)
Delhi 7 68 12 84 73 (87%) 68 (93%)
Goa 1 9 3 13 13 (100%) 13 (100%)
Gujarat 34 49 52 125 117 (94%) 92 (79%)
Haryana 9 50 2 28 28 (100%) 28 (100%)
Himachal Pradesh 0 19 3 15 15 (100%) 12 (80%)
Jammu & Kashmir 0 3 0 3 2 (67%) 2 (100%)
Jharkhand 3 2 0 3 2 (67%) 2 (100%)
Karnataka 8 63 5 62 47 (76%) 35 (74%)
Kerala 3 16 0 13 6 (46%) 4 (67%)
Ladakh No patients diagnosed
Lakshadweep No patients diagnosed
Madhya Pradesh 10 53 0 61 33 (54%) 21 (64%)
Maharashtra 103 1405 881 1951 1751 (90%) 1571 (90%)
Manipur 3 21 1 5 4 (80%) 2 (50%)
Meghalaya 1 3 1 4 3 (75%) 2 (67%)
Mizoram No patients diagnosed
Nagaland 1 6 0 7 6 (86%) 3 (50%)
Odisha 6 2 0 8 1 (13%) 1 (100%)
Puducherry 0 1 1 2 2 (100%) 2 (100%)
Punjab 1 17 10 27 23 (85%) 21 (91%)
Rajasthan 15 225 0 235 111 (47%) 36 (32%)
Sikkim 3 5 0 2 2 (100%) 0 (%)
Tamil Nadu 14 47 0 61 41 (67%) 37 (90%)
Telangana 13 14 0 23 16 (70%) 15 (94%)
Tripura 1 2 0 2 0 (%) 0 (%)
Uttar Pradesh 56 376 11 424 275 (65%) 254 (92%)
Uttarakhand 1 32 0 32 23 (72%) 12 (52%)
West Bengal 3 50 1 54 39 (72%) 29 (74%)
India 331 2840 986 3484 2779 (80%) 2383 (86%)

221 INDIA TB REPORT 2022 INDIA TB REPORT 2022 222

4.9 P
 RE-XDR TB, XDR TB & H-MONO/POLY RESISTANCE
TB DIAGNOSED IN 2021

Pre-XDR put XDR TB patients initiated XDR TB patients initiated H mono/poly DR-
Pre-XDR put on H mono/poly DR-TB
Pre-XDR-TB* on treatment on treatment irrespective on TB diagnosed
State longer oral M/XDR- XDR TB* diagnosed all oral longer regimen initiated on treatment
diagnosed irrespective of the of type of regimen
TB regimen (Public+Private)
type of regimen

Andaman & Nicobar 4 4 (100%) 4 (100%) No patients diagnosed 3 2 (67%)

Andhra Pradesh 76 58 (76%) 55 (95%) 4 4 (100%) 2 (50%) 1259 1182 (94%)
Arunachal Pradesh 4 1 (25%) 1 (100%) 1 1 (100%) 0 (%) 10 9 (90%)
Assam 50 44 (88%) 43 (98%) 3 3 (100%) 3 (100%) 193 175 (91%)
Bihar 363 318 (88%) 314 (99%) 6 6 (100%) 6 (100%) 127 90 (71%)
Chandigarh 8 8 (100%) 8 (100%) No patients diagnosed 45 44 (98%)
Chhattisgarh 45 36 (80%) 36 (100%) 1 1 (100%) 1 (100%) 260 248 (95%)
Dadra & Nagar Haveli 8 8 (100%) 7 (88%) No patients diagnosed 4 (100%)
Daman & Diu
Delhi 351 319 (91%) 317 (99%) No patients diagnosed 771 (92%)
Goa 14 13 (93%) 12 (92%) No patients diagnosed 27 (90%)
Gujarat 641 601 (94%) 538 (90%) 19 17 (89%) 17 (100%) 563 513 (91%)
Haryana 78 75 (96%) 73 (97%) 1 1 (100%) 1 (100%) 300 291 (97%)
Himachal Pradesh 25 23 (92%) 22 (96%) 1 1 (100%) 1 (100%) 156 149 (96%)
Jammu & Kashmir 8 8 (100%) 6 (75%) No patients diagnosed 35 (97%)
Jharkhand 55 45 (82%) 45 (100%) No patients diagnosed 16 (73%)
Karnataka 273 230 (84%) 227 (99%) 2 2 (100%) 2 (100%) 1174 1103 (94%)
Kerala 28 28 (100%) 28 (100%) No patients diagnosed 144 140 (97%)
Ladakh 1 1 (100%) 1 (100%) No patients diagnosed 2 2 (100%)
Lakshadweep No patients diagnosed
Madhya Pradesh 255 217 (85%) 217 (100%) 15 15 (100%) 12 (80%) 578 494 (85%)
Maharashtra 3163 3037 (96%) 2758 (91%) 254 221 (87%) 176 (80%) 2226 1908 (86%)
Manipur 3 3 (100%) 3 (100%) No patients diagnosed 33 (87%)
Meghalaya 57 56 (98%) 56 (100%) 1 1 (100%) 0 (%) 76 66 (87%)
Mizoram 1 1 (100%) 1 (100%) No patients diagnosed 5 5 (100%)
Nagaland 8 8 (100%) 8 (100%) No patients diagnosed 7 7 (100%)
Odisha 44 43 (98%) 43 (100%) 8 8 (100%) 7 (88%) 77 73 (95%)
Puducherry 4 4 (100%) 4 (100%) No patients diagnosed 24 24 (100%)
Punjab 48 42 (88%) 37 (88%) 2 2 (100%) 2 (100%) 358 328 (92%)
Rajasthan 462 371 (80%) 338 (91%) 6 5 (83%) 2 (40%) 1162 890 (77%)
Sikkim 30 29 (97%) 28 (97%) No patients diagnosed 10 10 (100%)
Tamil Nadu 71 57 (80%) 54 (95%) 1 0 (%) 0 (%) 1346 1253 (93%)
Telangana 39 35 (90%) 32 (91%) 8 7 (88%) 4 (57%) 365 333 (91%)
Tripura 2 0 (%) 0 (%) No patients diagnosed 53 48 (91%)
Uttar Pradesh 2067 1704 (82%) 1634 (96%) 38 35 (92%) 32 (91%) 1566 1162 (74%)
Uttarakhand 47 41 (87%) 39 (95%) 3 2 (67%) 2 (100%) 108 86 (80%)
WEST BENGAL 122 94 (77%) 90 (96%) 2 1 (50%) 1 (100%) 563 487 (87%)
INDIA 8455 7562 (89%) 7079 (94%) 376 333 (89%) 271 (81%) 13724 12008 (87%)

223 INDIA TB REPORT 2022 INDIA TB REPORT 2022 224

4.10 T
 reatment Outcome of MDR/ RR TB Patients initiated on
Shorter MDR-TB regimen (Inj containing) during 2020
State Registered Cure Rate Success Rate Death Rate Failure (%) Loss to follow up (%) Regimen Change (%) Not Evaluated (%)

Andaman & Nicobar 35 0 (0%) 16 (46%) 10 (29%) 4 (11%) 1 (3%) 4 (11%) 0 (0%)
Andhra Pradesh 1026 470 (46%) 725 (71%) 137 (13%) 9 (1%) 66 (6%) 63 (6%) 25 (2%)
Arunachal Pradesh 117 11 (9%) 87 (74%) 5 (4%) 2 (2%) 16 (14%) 4 (3%) 1 (1%)
Assam 501 77 (15%) 224 (45%) 48 (10%) 17 (3%) 50 (10%) 137 (27%) 18 (4%)
Bihar 2032 314 (15%) 828 (41%) 214 (11%) 39 (2%) 240 (12%) 456 (22%) 163 (8%)
Chandigarh 18 12 (67%) 12 (67%) 0 (0%) 0 (0%) 0 (0%) 6 (33%) 0 (0%)
Chhattisgarh 232 54 (23%) 134 (58%) 22 (9%) 2 (1%) 27 (12%) 23 (10%) 16 (7%)
Dadra & Nagar Haveli Daman & Diu 16 4 (25%) 5 (31%) 2 (13%) 0 (0%) 2 (13%) 7 (44%) 0 (0%)
Delhi 1269 365 (29%) 612 (48%) 72 (6%) 36 (3%) 184 (14%) 352 (28%) 4 (0%)
Goa 21 6 (29%) 8 (38%) 3 (14%) 1 (5%) 3 (14%) 6 (29%) 0 (0%)
Gujarat 1618 547 (34%) 749 (46%) 156 (10%) 100 (6%) 102 (6%) 497 (31%) 7 (0%)
Haryana 1038 291 (28%) 690 (66%) 125 (12%) 15 (1%) 96 (9%) 89 (9%) 19 (2%)
Himachal Pradesh 149 51 (34%) 93 (62%) 10 (7%) 0 (0%) 6 (4%) 39 (26%) 1 (1%)
Jammu & Kashmir 89 33 (37%) 46 (52%) 10 (11%) 3 (3%) 6 (7%) 14 (16%) 5 (6%)
Jharkhand 609 167 (27%) 380 (62%) 58 (10%) 10 (2%) 92 (15%) 30 (5%) 25 (4%)
Karnataka 930 310 (33%) 499 (54%) 133 (14%) 17 (2%) 92 (10%) 177 (19%) 10 (1%)
Kerala 94 31 (33%) 54 (57%) 7 (7%) 3 (3%) 6 (6%) 23 (24%) 0 (0%)
Madhya Pradesh 2400 471 (20%) 1363 (57%) 287 (12%) 48 (2%) 332 (14%) 246 (10%) 104 (4%)
Maharashtra 2822 672 (24%) 1223 (43%) 302 (11%) 45 (2%) 218 (8%) 939 (33%) 32 (1%)
Manipur 34 14 (41%) 22 (65%) 4 (12%) 0 (0%) 5 (15%) 0 (0%) 3 (9%)
Meghalaya 148 26 (18%) 90 (61%) 9 (6%) 7 (5%) 15 (10%) 27 (18%) 0 (0%)
Mizoram 74 28 (38%) 49 (66%) 7 (9%) 4 (5%) 3 (4%) 9 (12%) 2 (3%)
Nagaland 81 18 (22%) 43 (53%) 7 (9%) 1 (1%) 17 (21%) 8 (10%) 4 (5%)
Odisha 364 111 (30%) 240 (66%) 27 (7%) 8 (2%) 44 (12%) 37 (10%) 1 (0%)
Puducherry 6 3 (50%) 3 (50%) 0 (0%) 2 (33%) 1 (17%) 0 (0%) 0 (0%)
Punjab 395 118 (30%) 240 (61%) 40 (10%) 3 (1%) 42 (11%) 55 (14%) 8 (2%)
Rajasthan 2296 768 (33%) 1264 (55%) 255 (11%) 38 (2%) 269 (12%) 390 (17%) 67 (3%)
Sikkim 135 22 (16%) 78 (58%) 9 (7%) 0 (0%) 5 (4%) 38 (28%) 2 (1%)
Tamil Nadu 1025 370 (36%) 545 (53%) 129 (13%) 37 (4%) 151 (15%) 150 (15%) 10 (1%)
Telangana 963 430 (45%) 572 (59%) 109 (11%) 7 (1%) 61 (6%) 137 (14%) 64 (7%)
Tripura 21 10 (48%) 14 (67%) 1 (5%) 0 (0%) 1 (5%) 5 (24%) 0 (0%)
Uttar Pradesh 8742 1580 (18%) 4992 (57%) 1164 (13%) 132 (2%) 922 (11%) 1362 (16%) 94 (1%)
Uttarakhand 219 51 (23%) 124 (57%) 14 (6%) 2 (1%) 20 (9%) 47 (21%) 8 (4%)
West Bengal 1466 394 (27%) 997 (68%) 182 (12%) 41 (3%) 108 (7%) 108 (7%) 25 (2%)
India 30985 7829 (25%) 17021 (55%) 3558 (11%) 633 (2%) 3203 (10%) 5485 (18%) 718 (2%)

225 INDIA TB REPORT 2022 INDIA TB REPORT 2022 226

4.11 T
 reatment Outcome of H-Mono/Poly Resistance TB
Patients initiated on treatment during 2020
State Registered Cure Rate Success Rate Death Rate Failure (%) Loss to follow up (%) Regimen Change (%) Not Evaluated (%)
Andhra Pradesh 792 447 (56%) 697 (88%) 45 (6%) 5 (1%) 25 (3%) 8 (1%) 12 (2%)
Arunachal Pradesh 4 2 (50%) 4 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Assam 202 98 (49%) 173 (86%) 9 (4%) 4 (2%) 10 (5%) 1 (0%) 5 (2%)
Bihar 149 66 (44%) 106 (71%) 4 (3%) 3 (2%) 15 (10%) 8 (5%) 9 (6%)
Chandigarh 25 16 (64%) 18 (72%) 2 (8%) 0 (0%) 3 (12%) 1 (4%) 1 (4%)
Chhattisgarh 157 80 (51%) 133 (85%) 3 (2%) 2 (1%) 4 (3%) 2 (1%) 11 (7%)
Delhi 821 489 (60%) 665 (81%) 25 (3%) 18 (2%) 82 (10%) 29 (4%) 2 (0%)
Goa 13 7 (54%) 11 (85%) 1 (8%) 0 (0%) 1 (8%) 0 (0%) 0 (0%)
Gujarat 601 361 (60%) 422 (70%) 59 (10%) 57 (9%) 32 (5%) 27 (4%) 4 (1%)
Haryana 171 96 (56%) 151 (88%) 6 (4%) 2 (1%) 3 (2%) 2 (1%) 5 (3%)
Himachal Pradesh 172 105 (61%) 160 (93%) 7 (4%) 0 (0%) 2 (1%) 1 (1%) 0 (0%)
Jammu & Kashmir 31 15 (48%) 24 (77%) 1 (3%) 2 (6%) 0 (0%) 2 (6%) 1 (3%)
Jharkhand 16 8 (50%) 12 (75%) 1 (6%) 0 (0%) 2 (13%) 0 (0%) 0 (0%)
Karnataka 1160 764 (66%) 992 (86%) 75 (6%) 15 (1%) 52 (4%) 20 (2%) 5 (0%)
Kerala 119 71 (60%) 101 (85%) 5 (4%) 3 (3%) 6 (5%) 2 (2%) 1 (1%)
Madhya Pradesh 602 235 (39%) 487 (81%) 27 (4%) 16 (3%) 46 (8%) 16 (3%) 4 (1%)
Maharashtra 1353 672 (50%) 1101 (81%) 74 (5%) 21 (2%) 78 (6%) 47 (3%) 21 (2%)
Manipur 9 6 (67%) 7 (78%) 1 (11%) 0 (0%) 0 (0%) 1 (11%) 0 (0%)
Meghalaya 61 20 (33%) 47 (77%) 3 (5%) 1 (2%) 6 (10%) 2 (3%) 2 (3%)
Mizoram 2 1 (50%) 2 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Nagaland 4 0 (0%) 3 (75%) 0 (0%) 0 (0%) 1 (25%) 0 (0%) 0 (0%)
Odisha 128 62 (48%) 109 (85%) 8 (6%) 3 (2%) 4 (3%) 3 (2%) 1 (1%)
Puducherry 36 30 (83%) 31 (86%) 1 (3%) 0 (0%) 3 (8%) 1 (3%) 0 (0%)
Punjab 264 104 (39%) 215 (81%) 7 (3%) 6 (2%) 21 (8%) 7 (3%) 7 (3%)
Rajasthan 877 406 (46%) 717 (82%) 43 (5%) 16 (2%) 39 (4%) 24 (3%) 31 (4%)
Sikkim 5 2 (40%) 4 (80%) 1 (20%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Tamil Nadu 1757 1133 (64%) 1467 (83%) 101 (6%) 30 (2%) 122 (7%) 31 (2%) 5 (0%)
Telangana 991 638 (64%) 824 (83%) 54 (5%) 7 (1%) 23 (2%) 30 (3%) 51 (5%)
Tripura 51 31 (61%) 43 (84%) 3 (6%) 3 (6%) 2 (4%) 0 (0%) 0 (0%)
Uttar Pradesh 588 202 (34%) 496 (84%) 23 (4%) 7 (1%) 30 (5%) 16 (3%) 9 (2%)
Uttarakhand 109 55 (50%) 97 (89%) 2 (2%) 0 (0%) 5 (5%) 2 (2%) 2 (2%)
West Bengal 255 126 (49%) 225 (88%) 10 (4%) 2 (1%) 10 (4%) 3 (1%) 3 (1%)
India 11525 6348 (55%) 9544 (83%) 601 (5%) 223 (2%) 627 (5%) 286 (2%) 192 (2%)

227 INDIA TB REPORT 2022 INDIA TB REPORT 2022 228

4.12 T
 reatment Outcome of MDR/ RR TB Patients initiated
on Longer oral M/XDR-TB regimen during 2019
State Registered Cure Rate Success Rate Death Rate Failure (%) Loss to follow up (%) Regimen Change (%) Not Evaluated (%)

Andaman & Nicobar 2 0 (0%) 1 (50%) 1 (50%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)

Andhra Pradesh 63 21 (33%) 32 (51%) 21 (33%) 0 (0%) 5 (8%) 2 (3%) 1 (2%)

Arunachal Pradesh 1 0 (0%) 1 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)

Bihar 44 10 (23%) 29 (66%) 4 (9%) 1 (2%) 4 (9%) 2 (5%) 0 (0%)

Dadra & Nagar Haveli Daman & Diu 3 1 (33%) 1 (33%) 1 (33%) 0 (0%) 1 (33%) 0 (0%) 0 (0%)

Delhi 182 82 (45%) 136 (75%) 22 (12%) 1 (1%) 20 (11%) 2 (1%) 0 (0%)

Gujarat 482 254 (53%) 341 (71%) 73 (15%) 29 (6%) 35 (7%) 3 (1%) 0 (0%)

Haryana 16 2 (13%) 10 (63%) 1 (6%) 0 (0%) 4 (25%) 0 (0%) 0 (0%)

Himachal Pradesh 2 1 (50%) 1 (50%) 0 (0%) 0 (0%) 1 (50%) 0 (0%) 0 (0%)

Jharkhand 1 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (100%) 0 (0%)

Karnataka 147 70 (48%) 101 (69%) 27 (18%) 4 (3%) 12 (8%) 2 (1%) 1 (1%)

Kerala 25 16 (64%) 21 (84%) 4 (16%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)

Ladakh 1 0 0 0 0 0 0 0

Madhya Pradesh 27 3 (11%) 16 (59%) 3 (11%) 0 (0%) 3 (11%) 2 (7%) 1 (4%)

Maharashtra 175 45 (26%) 117 (67%) 17 (10%) 6 (3%) 16 (9%) 12 (7%) 1 (1%)

Manipur 9 0 (0%) 9 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)

Mizoram 1 0 (0%) 1 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)

Puducherry 3 2 (67%) 3 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)

Punjab 48 14 (29%) 35 (73%) 3 (6%) 0 (0%) 6 (13%) 1 (2%) 0 (0%)

Rajasthan 42 15 (36%) 28 (67%) 5 (12%) 1 (2%) 1 (2%) 1 (2%) 3 (7%)

Sikkim 9 6 (67%) 8 (89%) 1 (11%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)

Tamil Nadu 94 34 (36%) 68 (72%) 10 (11%) 4 (4%) 10 (11%) 2 (2%) 0 (0%)

Telangana 19 8 (42%) 12 (63%) 1 (5%) 0 (0%) 0 (0%) 1 (5%) 3 (16%)

Uttar Pradesh 52 10 (19%) 37 (71%) 2 (4%) 0 (0%) 6 (12%) 5 (10%) 0 (0%)

Uttarakhand 2 0 (0%) 0 (0%) 1 (50%) 0 (0%) 1 (50%) 0 (0%) 0 (0%)

West Bengal 25 2 (8%) 19 (76%) 3 (12%) 0 (0%) 2 (8%) 1 (4%) 0 (0%)

India 1475 596 (40%) 1028 (70%) 200 (14%) 46 (3%) 127 (9%) 37 (3%) 10 (1%)

229 INDIA TB REPORT 2022 INDIA TB REPORT 2022 230

4.13 T
 reatment Outcome of MDR/ RR TB patients with/ cohort (excluding XDR-TB and H-mono/poly DR-TB)
without additional resistance - 2019
No. of MDR/RR-TB patients
Loss to Regimen Not Still on
State initiated on treatment during Cure Rate Success Rate Death Rate Failure (%)
follow up (%) hanged (%) evaluated (%) treatment (%)
2019 (includes all regimen) (c)

Andaman & Nicobar 45 2 (4%) 29 (64%) 4 (9%) 7 (16%) 2 (4%) 3 (7%) 0 (0%) 0 (0%)
Andhra Pradesh 2081 860 (41%) 1298 (62%) 305 (15%) 12 (1%) 215 (10%) 227 (11%) 13 (1%) 11 (1%)
Arunachal Pradesh 180 27 (15%) 100 (56%) 18 (10%) 4 (2%) 39 (22%) 16 (9%) 2 (1%) 1 (1%)
Assam 860 215 (25%) 518 (60%) 91 (11%) 20 (2%) 133 (15%) 84 (10%) 3 (0%) 11 (1%)
Bihar 3327 850 (26%) 1724 (52%) 361 (11%) 55 (2%) 495 (15%) 456 (14%) 43 (1%) 193 (6%)
Chandigarh 59 22 (37%) 37 (63%) 9 (15%) 2 (3%) 6 (10%) 5 (8%) 0 (0%) 0 (0%)
Chhattisgarh 365 98 (27%) 207 (57%) 56 (15%) 6 (2%) 51 (14%) 43 (12%) 1 (0%) 1 (0%)
Dadra and Nagar Haveli and Daman
32 98 (27%) 207 (57%) 56 (15%) 6 (2%) 51 (14%) 43 (12%) 1 (0%) 1 (0%)
and Diu
Delhi 2592 846 (33%) 1409 (54%) 206 (8%) 74 (3%) 393 (15%) 493 (19%) 2 (0%) 15 (1%)
Goa 40 13 (33%) 18 (45%) 4 (10%) 0 (0%) 6 (15%) 11 (28%) 0 (0%) 1 (3%)
Gujarat 3780 1492 (39%) 2116 (56%) 487 (13%) 244 (6%) 374 (10%) 541 (14%) 12 (0%) 6 (0%)
Haryana 1541 375 (24%) 998 (65%) 203 (13%) 17 (1%) 237 (15%) 70 (5%) 12 (1%) 4 (0%)
Himachal Pradesh 336 176 (52%) 241 (72%) 32 (10%) 3 (1%) 24 (7%) 33 (10%) 2 (1%) 1 (0%)
Jammu & Kashmir 148 78 (53%) 98 (66%) 15 (10%) 10 (7%) 8 (5%) 12 (8%) 0 (0%) 5 (3%)
Jharkhand 967 220 (23%) 550 (57%) 109 (11%) 15 (2%) 182 (19%) 72 (7%) 10 (1%) 29 (3%)
Karnataka 1884 736 (39%) 1068 (57%) 303 (16%) 59 (3%) 248 (13%) 190 (10%) 14 (1%) 2 (0%)
Kerala 236 103 (44%) 159 (67%) 29 (12%) 5 (2%) 14 (6%) 27 (11%) 1 (0%) 1 (0%)
Madhya Pradesh 3521 722 (21%) 2092 (59%) 443 (13%) 62 (2%) 587 (17%) 301 (9%) 26 (1%) 10 (0%)
Maharashtra 10501 2312 (22%) 5440 (52%) 1306 (12%) 177 (2%) 1406 (13%) 1957 (19%) 38 (0%) 177 (2%)
Manipur 55 26 (47%) 46 (84%) 3 (5%) 1 (2%) 3 (5%) 0 (0%) 2 (4%) 0 (0%)
Meghalaya 275 52 (19%) 154 (56%) 40 (15%) 14 (5%) 42 (15%) 22 (8%) 1 (0%) 2 (1%)
Mizoram 117 37 (32%) 77 (66%) 10 (9%) 1 (1%) 17 (15%) 10 (9%) 0 (0%) 2 (2%)
Nagaland 110 42 (38%) 73 (66%) 10 (9%) 1 (1%) 18 (16%) 6 (5%) 0 (0%) 2 (2%)
Orissa 610 189 (31%) 400 (66%) 72 (12%) 3 (0%) 67 (11%) 55 (9%) 2 (0%) 11 (2%)
Puducherry 16 8 (50%) 9 (56%) 3 (19%) 2 (13%) 1 (6%) 1 (6%) 0 (0%) 0 (0%)
Punjab 851 233 (27%) 472 (55%) 123 (14%) 14 (2%) 119 (14%) 106 (12%) 1 (0%) 16 (2%)
Rajasthan 4050 1308 (32%) 2248 (56%) 610 (15%) 50 (1%) 560 (14%) 483 (12%) 18 (0%) 81 (2%)
Sikkim 255 77 (30%) 166 (65%) 32 (13%) 6 (2%) 17 (7%) 26 (10%) 2 (1%) 6 (2%)
Tamil Nadu 1755 612 (35%) 972 (55%) 238 (14%) 45 (3%) 323 (18%) 163 (9%) 14 (1%) 0 (0%)
Telangana 1842 919 (50%) 1254 (68%) 227 (12%) 19 (1%) 140 (8%) 174 (9%) 6 (0%) 22 (1%)
Tripura 32 10 (31%) 18 (56%) 2 (6%) 1 (3%) 7 (22%) 4 (13%) 0 (0%) 0 (0%)
Uttar Pradesh 14935 2631 (18%) 8405 (56%) 2173 (15%) 194 (1%) 1888 (13%) 2096 (14%) 49 (0%) 130 (1%)
Uttarakhand 533 111 (21%) 271 (51%) 71 (13%) 4 (1%) 79 (15%) 87 (16%) 6 (1%) 15 (3%)
West Bengal 2942 799 (27%) 1852 (63%) 385 (13%) 81 (3%) 326 (11%) 260 (9%) 9 (0%) 29 (1%)
India 60873 16212 (27%) 34535 (57%) 7988 (13%) 1208 (2%) 8028 (13%) 8041 (13%) 289 (0%) 784 (1%)

231 INDIA TB REPORT 2022 INDIA TB REPORT 2022 232

4.14 Treatment Outcome of XDR-TB patients (2019 cohort)

No. of XDR-TB patients

Failure Loss to Regimen Not Still on
State initiated on treatment during Cure Rate Success Rate Death Rate
(%) follow up (%) Changed (%) evaluated (%) treatment (%)
2019 (d)

Andaman & Nicobar Islands 1 1 (100%) 1 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Andhra Pradesh 45 12 (27%) 24 (53%) 11 (24%) 0 (0%) 7 (16%) 2 (4%) 1 (2%) 0 (0%)
Arunachal Pradesh 1 0 (0%) 1 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Assam 7 0 (0%) 3 (43%) 2 (29%) 0 (0%) 1 (14%) 0 (0%) 0 (0%) 1 (14%)
Bihar 148 25 (17%) 68 (46%) 34 (23%) 4 (3%) 15 (10%) 9 (6%) 4 (3%) 14 (9%)
Chandigarh 2 0 (0%) 1 (50%) 1 (50%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Chhattisgarh 15 3 (20%) 7 (47%) 3 (20%) 1 (7%) 2 (13%) 2 (13%) 0 (0%) 0 (0%)
Dadra and Nagar Haveli and Daman
2 3 (20%) 7 (47%) 3 (20%) 1 (7%) 2 (13%) 0 (0%) 0 (0%) 0 (0%)
and Diu
Delhi 151 39 (26%) 88 (58%) 27 (18%) 2 (1%) 23 (15%) 10 (7%) 0 (0%) 1 (1%)
Goa 1 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (100%) 0 (0%) 0 (0%) 0 (0%)
Gujarat 198 80 (40%) 113 (57%) 44 (22%) 9 (5%) 18 (9%) 13 (7%) 1 (1%) 0 (0%)
Haryana 54 10 (19%) 31 (57%) 10 (19%) 0 (0%) 6 (11%) 6 (11%) 1 (2%) 0 (0%)
Himachal Pradesh 10 2 (20%) 5 (50%) 3 (30%) 1 (10%) 0 (0%) 1 (10%) 0 (0%) 0 (0%)
Jammu & Kashmir 5 3 (60%) 3 (60%) 1 (20%) 0 (0%) 0 (0%) 1 (20%) 0 (0%) 0 (0%)
Jharkhand 31 4 (13%) 18 (58%) 5 (16%) 0 (0%) 4 (13%) 2 (6%) 1 (3%) 1 (3%)
Karnataka 40 10 (25%) 19 (48%) 9 (23%) 1 (3%) 7 (18%) 2 (5%) 1 (3%) 1 (3%)
Kerala 12 4 (33%) 8 (67%) 1 (8%) 0 (0%) 2 (17%) 1 (8%) 0 (0%) 0 (0%)
Madhya Pradesh 109 21 (19%) 60 (55%) 25 (23%) 1 (1%) 14 (13%) 5 (5%) 0 (0%) 4 (4%)
Maharashtra 1066 264 (25%) 554 (52%) 202 (19%) 35 (3%) 119 (11%) 121 (11%) 2 (0%) 33 (3%)
Meghalaya 37 10 (27%) 22 (59%) 8 (22%) 1 (3%) 5 (14%) 0 (0%) 1 (3%) 0 (0%)
Nagaland 3 0 (0%) 0 (0%) 0 (0%) 0 (0%) 3 (100%) 0 (0%) 0 (0%) 0 (0%)
Odisha 12 3 (25%) 6 (50%) 4 (33%) 1 (8%) 1 (8%) 0 (0%) 0 (0%) 0 (0%)
Puducherry 2 2 (100%) 2 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Punjab 20 6 (30%) 15 (75%) 2 (10%) 0 (0%) 1 (5%) 1 (5%) 0 (0%) 1 (5%)
Rajasthan 118 30 (25%) 60 (51%) 30 (25%) 4 (3%) 15 (13%) 4 (3%) 0 (0%) 5 (4%)
Sikkim 8 3 (38%) 6 (75%) 1 (13%) 0 (0%) 0 (0%) 0 (0%) 1 (13%) 0 (0%)
Tamil Nadu 63 20 (32%) 28 (44%) 15 (24%) 2 (3%) 13 (21%) 4 (6%) 1 (2%) 0 (0%)
Telangana 68 29 (43%) 40 (59%) 12 (18%) 1 (1%) 7 (10%) 3 (4%) 4 (6%) 1 (1%)
Tripura 1 1 (100%) 1 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Uttar Pradesh 636 137 (22%) 344 (54%) 158 (25%) 4 (1%) 78 (12%) 33 (5%) 1 (0%) 18 (3%)
Uttarakhand 36 9 (25%) 14 (39%) 14 (39%) 1 (3%) 6 (17%) 0 (0%) 0 (0%) 1 (3%)
West Bengal 123 23 (19%) 73 (59%) 23 (19%) 2 (2%) 14 (11%) 3 (2%) 0 (0%) 8 (7%)
India 3025 751 (25%) 1615 (53%) 647 (21%) 70 (2%) 362 (12%) 223 (7%) 19 (1%) 89 (3%)
West Bengal 2942 799 (27%) 1852 (63%) 385 (13%) 81 (3%) 326 (11%) 260 (9%) 9 (0%) 29 (1%)
India 60873 16212 (27%) 34535 (57%) 7988 (13%) 1208 (2%) 8028 (13%) 8041 (13%) 289 (0%) 784 (1%)

233 INDIA TB REPORT 2022 INDIA TB REPORT 2022 234

5.1 Private Health Facilities Registration Status 5.2 P
 rivate Health Facilities that have notified at least
ONE TB patient during the year 2021
Health Facilities Total Health
State Hospitals Laboratories Chemists
Registered State Hospitals Laboratories Chemists Facilities notifying
TB case
Andaman & Nicobar Islands 11 0 0 11
Andaman & Nicobar Islands 2 0 0 2
Andhra Pradesh 7623 2013 18349 27985
Arunachal Pradesh 44 8 33 85 Andhra Pradesh 1572 441 47 2060

Assam 1403 416 1366 3185 Arunachal Pradesh 1 1 0 2

Bihar 7589 459 289 8337 Assam 442 269 41 752

CHANDIGARH 118 53 16 187 Bihar 2736 71 23 2830

Chhattisgarh 2212 426 3881 6519 CHANDIGARH 24 33 3 60

Dadra and Nagar Haveli and Daman Chhattisgarh 645 144 34 823
113 21 67 201
and Diu Dadra and Nagar Haveli and Daman
11 3 0 14
Delhi 4355 410 53 4818 and Diu

Goa 573 43 327 943 Delhi 781 66 3 850

Goa 37 6 0 43
Gujarat 10673 626 6518 17817
Gujarat 3757 293 9 4059
Haryana 2653 669 3233 6555
Haryana 1047 307 23 1377
Himachal Pradesh 511 244 14 769
Himachal Pradesh 86 43 1 130
Jammu & Kashmir 777 444 111 1332
Jammu & Kashmir 128 105 18 251
Jharkhand 2442 215 977 3634
Jharkhand 671 47 9 727
Karnataka 18244 2422 11979 32645
Karnataka 2191 802 124 3117
Kerala 6581 1540 10 8131
Kerala 261 262 0 523
Ladakh 40 7 3 50
Ladakh 5 0 0 5
Lakshadweep 0 0 0 0
Madhya Pradesh 2385 286 29 2700
Madhya Pradesh 7208 598 897 8703
Maharashtra 6319 1698 146 8163
Maharashtra 40343 3596 5995 49934
MANIPUR 15 21 0 36
Manipur 77 48 190 315
Meghalaya 24 14 0 38
Meghalaya 89 24 27 140
Mizoram 15 10 0 25
Mizoram 34 17 411 462
Nagaland 23 20 5 48
Nagaland 53 21 74 148
Odisha 522 177 68 767
Odisha 2284 380 892 3556
Puducherry 4 2 0 6
Puducherry 33 4 10 47
Punjab 861 170 57 1088
Punjab 2444 444 170 3058
Rajasthan 1427 204 15 1646
Rajasthan 2801 379 772 3952
Sikkim 5 3 0 8
Sikkim 69 22 168 259
Tamil Nadu 2159 657 43 2859
Tamil Nadu 17553 3022 4197 24772
Telangana 1341 329 231 1901
Telangana 5189 818 1690 7697
Tripura 5 22 0 27
TRIPURA 64 163 30 257 Uttar Pradesh 5677 595 92 6364
Uttar Pradesh 18849 1799 1620 22268 Uttarakhand 184 70 3 257
Uttarakhand 548 130 219 897 West Bengal 983 1556 25 2564
West Bengal 8468 2967 4977 16412 Grand Total 36346 8727 1049 46122
INDIA 172068 24448 69565 266081 INDIA 172068 24448 69565 266081

235 INDIA TB REPORT 2022 INDIA TB REPORT 2022 236

6 Active Case Finding

State
Estimated Population
Vulnerable Population Mapped (%)
Population screened amongst Presumptive TB cases tested out TB cases diagnosed among
(Lakhs) mapped vulnerable population (%) of those screened (%) tested (%)

Andaman & Nicobar Islands 3.9 314615 (80.5%) 284916 (90.6%) 2370 (0.8%) 65 (2.7%)
Andhra Pradesh 528.9 6063664 (11.5%) 3487832 (57.5%) 94610 (2.7%) 3147 (3.3%)
Arunachal Pradesh 16.7 132362 (7.9%) 99903 (75.5%) 2302 (2.3%) 83 (3.6%)
Assam 354.8 384744 (1.1%) 138770 (36.1%) 10400 (7.5%) 259 (2.5%)
Bihar 1270.9 15322461 (12.1%) 1771794 (11.6%) 31485 (1.8%) 2912 (9.2%)
Chandigarh 11.9 145297 (12.2%) 6962 (4.8%) 703 (10.1%) 36 (5.1%)
Chhattisgarh 305.3 30298657 (99.2%) 26373567 (87.0%) 33338 (0.1%) 2300 (6.9%)
Dadra and Nagar Haveli and Daman and Diu 8.3 977909 (118.0%) 921614 (94.2%) 3092 (0.3%) 32 (1.0%)
Delhi 193.0 3312162 (17.2%) 286859 (8.7%) 5857 (2.0%) 1256 (21.4%)
Goa 15.5 898290 (57.9%) 127771 (14.2%) 576 (0.5%) 9 (1.6%)
Gujarat 708.1 99989514 (141.2%) 30289260 (30.3%) 288571 (1.0%) 2716 (0.9%)
Haryana 299.1 39803861 (133.1%) 10179622 (25.6%) 37449 (0.4%) 945 (2.5%)
Himachal Pradesh 75.7 7421723 (98.1%) 5721350 (77.1%) 22270 (0.4%) 1273 (5.7%)
Jammu & Kashmir 147.5 4503638 (30.5%) 2945140 (65.4%) 99447 (3.4%) 691 (0.7%)
Jharkhand 402.1 12768377 (31.8%) 11044041 (86.5%) 13329 (0.1%) 2005 (15.0%)
Karnataka 693.3 15522352 (22.4%) 11092777 (71.5%) 40358 (0.4%) 689 (1.7%)
Kerala 345.6 1097851 (3.2%) 525907 (47.9%) 18512 (3.5%) 435 (2.3%)
Ladakh 3.5 12170 (3.5%) 7721 (63.4%) 232 (3.0%) 0 (0.0%)
Lakshadweep 0.7 70000 (105.3%) 971 (1.4%) 495 (51.0%) 0 (0.0%)
Madhya Pradesh 856.7 17819555 (20.8%) 6084648 (34.1%) 91797 (1.5%) 9732 (10.6%)
Maharashtra 1272.3 17284535 (13.6%) 16246964 (94.0%) 210575 (1.3%) 5443 (2.6%)
Manipur 31.7 1121811 (35.4%) 142693 (12.7%) 4365 (3.1%) 134 (3.1%)
Meghalaya 37.4 1283328 (34.3%) 977234 (76.1%) 3662 (0.4%) 142 (3.9%)
Mizoram 12.8 405869 (31.7%) 245261 (60.4%) 3504 (1.4%) 36 (1.0%)
Nagaland 20.8 179241 (8.6%) 34381 (19.2%) 2145 (6.2%) 75 (3.5%)
Odisha 468.1 6249087 (13.4%) 4617869 (73.9%) 122314 (2.6%) 5259 (4.3%)
Puducherry 15.2 202 (0.0%) 202 (100.0%) 30 (14.9%) 0 (0.0%)
Punjab 309.9 4010451 (12.9%) 2533329 (63.2%) 10981 (0.4%) 513 (4.7%)
Rajasthan 811.7 9795177 (12.1%) 6573206 (67.1%) 50601 (0.8%) 1771 (3.5%)
Sikkim 6.7 49913 (7.5%) 33412 (66.9%) 802 (2.4%) 10 (1.2%)
Tamil Nadu 824.3 2588207 (3.1%) 1397431 (54.0%) 55852 (4.0%) 1887 (3.4%)
Telangana 381.9 3049293 (8.0%) 698133 (22.9%) 63700 (9.1%) 2665 (4.2%)
Tripura 39.9 374457 (9.4%) 254856 (68.1%) 3041 (1.2%) 39 (1.3%)
Uttar Pradesh 2360.9 75678835 (32.1%) 67589474 (89.3%) 232920 (0.3%) 25080 (10.8%)
Uttarakhand 118.0 2592292 (22.0%) 301447 (11.6%) 3612 (1.2%) 278 (7.7%)
West Bengal 1008.6 27756627 (27.5%) 10842545 (39.1%) 187606 (1.7%) 1855 (1.0%)
India 13961.6 409278527 (29.3%) 223879862 (54.7%) 1752903 (0.8%) 73772 (4.2%)

237 INDIA TB REPORT 2022 INDIA TB REPORT 2022 238

7.1 C
 ontact Tracing for Pulmonary Bacteriologically
Confirmed TB (PBCT) 2021
No. of HHC <5years No. of
No. of HHC No. of HHC
Average Average Notified No. of Notified No. of Notified
No. of Notified enumerated ≥5years (any age)
no. of no. of PBCT with PBCT with "0" PBCT with "0"
PBCT visited for during contact Average no. of enumerated enumerated
HHC per HHC per "0" HHC
States Notified PBCT HHC per notified during contact during contact HHC ≥5years HHC (any age)
contact tracing tracing visit notified notified <5years
PBCT visited tracing visit tracing reported during reported during
(%) among notified PBCT PBCT reported
among notified visit among
visited visited during visits visits (%) visits (%)
PBCT PBCT notified PBCT
(%)
ANDAMAN & NICOBAR ISLANDS 222.0 208 (94%) 49 0.2 673.0 3.2 722.0 3.5 135 (65%) 25 (12%) 24 (12%)
ANDHRA PRADESH 39362.0 34432 (87%) 2087 0.1 55927.0 1.6 58014.0 1.7 24113 (70%) 6846 (20%) 6806 (20%)
ARUNACHAL PRADESH 1125.0 845 (75%) 360 0.4 1956.0 2.3 2316.0 2.7 447 (53%) 241 (29%) 235 (28%)
ASSAM 14501.0 10224 (71%) 1556 0.2 20159.0 2.0 21715.0 2.1 6060 (59%) 3182 (31%) 3158 (31%)
BIHAR 32087.0 18295 (57%) 7546 0.4 49542.0 2.7 57088.0 3.1 9276 (51%) 6093 (33%) 5992 (33%)
CHANDIGARH 1408.0 1329 (94%) 245 0.2 3675.0 2.8 3920.0 2.9 203 (15%) 32 (2%) 32 (2%)
CHHATTISGARH 13198.0 10238 (78%) 2651 0.3 24017.0 2.3 26668.0 2.6 5179 (51%) 2620 (26%) 2577 (25%)
DADRA AND NAGAR HAVELI AND
258.0 258 (100%) 77 0.3 845.0 3.3 922.0 3.6 44 (17%) 2 (1%) 2 (1%)
DAMAN AND DIU
DELHI 23924.0 17679 (74%) 2662 0.2 32175.0 1.8 34837.0 2.0 6663 (38%) 2359 (13%) 2335 (13%)
GOA 903.0 791 (88%) 47 0.1 1462.0 1.8 1509.0 1.9 528 (67%) 143 (18%) 143 (18%)
GUJARAT 44421.0 43153 (97%) 10553 0.2 144575.0 3.4 155128.0 3.6 14877 (34%) 1993 (5%) 1954 (5%)
HARYANA 32640.0 28052 (86%) 7029 0.3 70881.0 2.5 77910.0 2.8 10006 (36%) 2961 (11%) 2826 (10%)
HIMACHAL PRADESH 8564.0 8426 (98%) 1608 0.2 28611.0 3.4 30219.0 3.6 3175 (38%) 281 (3%) 281 (3%)
JAMMU & KASHMIR 4695.0 4154 (88%) 1030 0.2 11450.0 2.8 12480.0 3.0 2106 (51%) 917 (22%) 903 (22%)
JHARKHAND 21153.0 12745 (60%) 4283 0.3 27389.0 2.1 31672.0 2.5 6271 (49%) 4072 (32%) 3973 (31%)
KARNATAKA 34394.0 33186 (96%) 6207 0.2 89385.0 2.7 95592.0 2.9 13522 (41%) 1962 (6%) 1953 (6%)
KERALA 10985.0 10172 (93%) 1400 0.1 17432.0 1.7 18832.0 1.9 4763 (47%) 1786 (18%) 1752 (17%)
LADAKH 175.0 135 (77%) 67 0.5 385.0 2.9 452.0 3.3 38 (28%) 10 (7%) 10 (7%)
LAKSHADWEEP 8.0 7 (88%) 1 0.1 22.0 3.1 23.0 3.3 5 (71%) 3 (43%) 3 (43%)
MADHYA PRADESH 48158.0 40564 (84%) 13821 0.3 107348.0 2.6 121169.0 3.0 14624 (36%) 6628 (16%) 6537 (16%)
MAHARASHTRA 54821.0 49878 (91%) 7145 0.1 113216.0 2.3 120361.0 2.4 25056 (50%) 6631 (13%) 6585 (13%)
MANIPUR 986.0 741 (75%) 221 0.3 2309.0 3.1 2530.0 3.4 329 (44%) 83 (11%) 78 (11%)
MEGHALAYA 1954.0 1708 (87%) 813 0.5 5391.0 3.2 6204.0 3.6 540 (32%) 257 (15%) 257 (15%)
MIZORAM 817.0 754 (92%) 260 0.3 1438.0 1.9 1698.0 2.3 362 (48%) 210 (28%) 200 (27%)
NAGALAND 1739.0 1315 (76%) 211 0.2 2384.0 1.8 2595.0 2.0 693 (53%) 296 (23%) 284 (22%)
ODISHA 26212.0 24673 (94%) 4167 0.2 52336.0 2.1 56503.0 2.3 14132 (57%) 6890 (28%) 6826 (28%)
PUDUCHERRY 749.0 746 (100%) 83 0.1 1888.0 2.5 1971.0 2.6 356 (48%) 24 (3%) 24 (3%)
PUNJAB 22652.0 20535 (91%) 3393 0.2 42766.0 2.1 46159.0 2.2 10084 (49%) 4773 (23%) 4670 (23%)
RAJASTHAN 55161.0 43625 (79%) 8202 0.2 107038.0 2.5 115240.0 2.6 22650 (52%) 7631 (17%) 7521 (17%)
SIKKIM 573.0 493 (86%) 64 0.1 1180.0 2.4 1244.0 2.5 239 (48%) 27 (5%) 27 (5%)
TAMIL NADU 45161.0 43097 (95%) 3721 0.1 78857.0 1.8 82578.0 1.9 27508 (64%) 5906 (14%) 5858 (14%)
TELANGANA 26488.0 24506 (93%) 2369 0.1 48534.0 2.0 50903.0 2.1 15213 (62%) 3392 (14%) 3358 (14%)
TRIPURA 1543.0 1509 (98%) 182 0.1 5097.0 3.4 5279.0 3.5 658 (44%) 16 (1%) 16 (1%)
UTTAR PRADESH 148916.0 116511 (78%) 32669 0.3 299983.0 2.6 332652.0 2.9 54772 (47%) 31389 (27%) 30798 (26%)
UTTARAKHAND 9110.0 6342 (70%) 1716 0.3 14497.0 2.3 16213.0 2.6 2988 (47%) 1602 (25%) 1580 (25%)
WEST BENGAL 53172.0 50081 (94%) 9920 0.2 109694.0 2.2 119614.0 2.4 23891 (48%) 10890 (22%) 10714 (21%)
INDIA 782235.0 661407 (85%) 138415 0.2 1574517.0 2.4 1712932.0 2.6 321506 (49%) 122173 (18%) 120292 (18%)

239 INDIA TB REPORT 2022 INDIA TB REPORT 2022 240

7.2 T
 B Preventive Treatment (TPT) among eligible Pulmonary Bacteriologically Confirmed TB
children <5years household contact (HHC) of (PBCT) [2021]
Screening, diagnosis and treatment of TB Screening, diagnosis and treatment of TB Ruling out active TB and TPT initiation
No. of HHC No. of HHC No. of HHC
State <5years of No. of HHC <5years No. of HHC <5years of No. of HHC <5years No. of HHC <5years of
<5years of PBCT <5years of PBCT No. of HHC <5years of
PBCT of PBCT screened PBCT diagnosed with of PBCT put on TB PBCT not diagnosed TB
symptomatic for evaluated for TB PBCT initiated TPT (%)
for TB (%) TB (%) treatment (%) and eligible for TPT
TB (%) (%)
ANDAMAN & NICOBAR
49.0 49 (100%) 1 (2%) 1 (100%) 1 (100%) 1 (100%) 48.0 41 (85%)
ISLANDS
ANDHRA PRADESH 2087.0 1971 (94%) 22 (1%) 13 (59%) 10 (77%) 9 (90%) 2077.0 1258 (61%)
ARUNACHAL PRADESH 360.0 311 (86%) 27 (9%) 27 (100%) 27 (100%) 27 (100%) 333.0 80 (24%)
ASSAM 1556.0 1211 (78%) 21 (2%) 13 (62%) 8 (62%) 7 (88%) 1548.0 497 (32%)
BIHAR 7546.0 6134 (81%) 64 (1%) 37 (58%) 23 (62%) 17 (74%) 7523.0 1882 (25%)
CHANDIGARH 245.0 243 (99%) 1 (0%) 1 (100%) 0 (0%) #DIV/0! 245.0 210 (86%)
CHHATTISGARH 2651.0 2151 (81%) 54 (3%) 42 (78%) 33 (79%) 26 (79%) 2618.0 903 (34%)
DADRA AND NAGAR HAVELI
77.0 77 (100%) 0 (0%) #DIV/0! #DIV/0! #DIV/0! 77.0 76 (99%)
AND DAMAN AND DIU
DELHI 2662.0 1720 (65%) 46 (3%) 38 (83%) 30 (79%) 21 (70%) 2632.0 1083 (41%)
GOA 47.0 47 (100%) 1 (2%) 0 (0%) #DIV/0! #DIV/0! 47.0 38 (81%)
GUJARAT 10553.0 10464 (99%) 404 (4%) 375 (93%) 24 (6%) 23 (96%) 10529.0 8506 (81%)
HARYANA 7029.0 6352 (90%) 63 (1%) 49 (78%) 35 (71%) 36 (103%) 6994.0 3305 (47%)
HIMACHAL PRADESH 1608.0 1596 (99%) 98 (6%) 91 (93%) 30 (33%) 30 (100%) 1578.0 1347 (85%)
JAMMU & KASHMIR 1030.0 916 (89%) 24 (3%) 21 (88%) 13 (62%) 11 (85%) 1017.0 666 (65%)
JHARKHAND 4283.0 3223 (75%) 112 (3%) 103 (92%) 98 (95%) 95 (97%) 4185.0 1213 (29%)
KARNATAKA 6207.0 5803 (93%) 196 (3%) 170 (87%) 89 (52%) 86 (97%) 6118.0 3561 (58%)
KERALA 1400.0 1114 (80%) 68 (6%) 60 (88%) 29 (48%) 25 (86%) 1371.0 553 (40%)
LADAKH 67.0 65 (97%) 0 (0%) #DIV/0! #DIV/0! #DIV/0! 67.0 59 (88%)
LAKSHADWEEP 1.0 1 (100%) 0 (0%) #DIV/0! #DIV/0! #DIV/0! 1.0 1 (100%)
MADHYA PRADESH 13821.0 10877 (79%) 240 (2%) 166 (69%) 106 (64%) 101 (95%) 13715.0 6649 (48%)
MAHARASHTRA 7145.0 6320 (88%) 212 (3%) 170 (80%) 56 (33%) 48 (86%) 7089.0 3912 (55%)
MANIPUR 221.0 190 (86%) 2 (1%) 0 (0%) #DIV/0! #DIV/0! 221.0 101 (46%)
MEGHALAYA 813.0 782 (96%) 3 (0%) 3 (100%) 2 (67%) 2 (100%) 811.0 562 (69%)
MIZORAM 260.0 188 (72%) 1 (1%) 1 (100%) 1 (100%) 1 (100%) 259.0 89 (34%)
NAGALAND 211.0 177 (84%) 4 (2%) 1 (25%) 1 (100%) 1 (100%) 210.0 102 (49%)
ODISHA 4167.0 3949 (95%) 70 (2%) 62 (89%) 59 (95%) 60 (102%) 4108.0 2408 (59%)
PUDUCHERRY 83.0 83 (100%) 6 (7%) 6 (100%) 3 (50%) 3 (100%) 80.0 74 (93%)
PUNJAB 3393.0 2678 (79%) 44 (2%) 37 (84%) 12 (32%) 11 (92%) 3381.0 1403 (41%)
RAJASTHAN 8202.0 7470 (91%) 100 (1%) 78 (78%) 27 (35%) 24 (89%) 8175.0 3188 (39%)
SIKKIM 64.0 43 (67%) 2 (5%) 2 (100%) 1 (50%) 1 (100%) 63.0 50 (79%)
TAMIL NADU 3721.0 3440 (92%) 195 (6%) 182 (93%) 33 (18%) 26 (79%) 3688.0 2328 (63%)
TELANGANA 2369.0 2228 (94%) 136 (6%) 117 (86%) 33 (28%) 15 (45%) 2336.0 1230 (53%)
TRIPURA 182.0 173 (95%) 3 (2%) 3 (100%) 1 (33%) 0 (0%) 181.0 110 (61%)
UTTAR PRADESH 32669.0 28987 (89%) 357 (1%) 223 (62%) 199 (89%) 146 (73%) 32470.0 12862 (40%)
UTTARAKHAND 1716.0 1480 (86%) 35 (2%) 9 (26%) 7 (78%) 6 (86%) 1709.0 551 (32%)
WEST BENGAL 9920.0 9333 (94%) 123 (1%) 89 (72%) 35 (39%) 21 (60%) 9885.0 5567 (56%)
INDIA 138415.0 121846 (88%) 2735 (2%) 2190 (80%) 1026 (47%) 880 (86%) 137389.0 66465 (48%)

241 INDIA TB REPORT 2022 INDIA TB REPORT 2022 242

7.3 TB Preventive Treatment (TPT) in eligible children (HHC) of Pulmonary Bacteriologically Confirmed TB
>/=5years, adolescent and adult household contact (PBCT) [Jul to Dec 2021]
Screening, diagnosis and tratment of TB Ruling out active TB, TBI testing and TPT initiation
No. of HHC of PBCT
No. of HHC No. of HHC No. of HHC No. of HHC No. of HHC No. of HHC No. of HHC No. of HHC No. of HHC ≥5years of
put on TB tNo. of No. of HHC
States/UTs ≥5years of ≥5years of PBCT ≥5years of PBCT ≥5years of PBCT ≥5years of PBCT ≥5years of PBCT ≥5years ≥5years PBCT eligible for TPT
≥5years of
HHC ≥5years of of PBCT of PBCT (TBI positives + testing
PBCT screened for TB symptomatic evaluated for diagnosed with and TB not PBCT initiated
PBCT put on TB tested for TB postives for not done among TB not
(%) for TB (%) TB (%) TB (%) diagnosed (B-F) TPT (%)
infection TB infection diagnosed {J+[H-I]})
treatment (%)
ANDAMAN & NICOBAR
410 403 (98%) 9 (2%) 8 (89%) 2 (25%) 2 (100%) 408 (100%) 0 (0%) --- 408 1 (0%)
ISLANDS
ANDHRA PRADESH 27921 26816 (96%) 182 (1%) 63 (35%) 47 (75%) 24 (51%) 27874 (100%) 0 (0%) --- 27874 2582 (9%)
ARUNACHAL PRADESH 1100 1035 (94%) 87 (8%) 81 (93%) 81 (100%) 81 (100%) 1019 (93%) 0 (0%) --- 1019 11 (1%)
ASSAM 10073 8519 (85%) 135 (2%) 95 (70%) 61 (64%) 49 (80%) 10012 (99%) 0 (0%) --- 10012 238 (2%)
BIHAR 22948 20165 (88%) 165 (1%) 92 (56%) 38 (41%) 36 (95%) 22910 (100%) 0 (0%) --- 22910 360 (2%)
CHANDIGARH 1997 1962 (98%) 14 (1%) 13 (93%) 5 (38%) 5 (100%) 1992 (100%) 0 (0%) --- 1992 155 (8%)
CHHATTISGARH 14467 12698 (88%) 462 (4%) 376 (81%) 249 (66%) 157 (63%) 14218 (98%) 0 (0%) --- 14218 652 (5%)
DADRA AND NAGAR HAVELI
519 519 (100%) 37 (7%) 37 (100%) 1 (3%) 1 (100%) 518 (100%) 426 (82%) 131 (31%) 223 120 (54%)
AND DAMAN AND DIU
DELHI 18691 14361 (77%) 278 (2%) 162 (58%) 104 (64%) 37 (36%) 18587 (99%) 24 (0%) 1 (4%) 18564 858 (5%)
GOA 934 934 (100%) 3 (0%) 3 (100%) 0 (0%) --- 934 (100%) 0 (0%) --- 934 2 (0%)
GUJARAT 84448 83601 (99%) 2722 (3%) 2531 (93%) 234 (9%) 134 (57%) 84214 (100%) 2588 (3%) 1197 (46%) 82823 501 (1%)
HARYANA 35838 33470 (93%) 212 (1%) 111 (52%) 72 (65%) 64 (89%) 35766 (100%) 1017 (3%) 500 (49%) 35249 652 (2%)
HIMACHAL PRADESH 15240 15184 (100%) 57 (0%) 46 (81%) 15 (33%) 11 (73%) 15225 (100%) 0 (0%) --- 15225 515 (3%)
JAMMU & KASHMIR 6014 5341 (89%) 153 (3%) 134 (88%) 102 (76%) 96 (94%) 5912 (98%) 0 (0%) --- 5912 783 (13%)
JHARKHAND 15419 12623 (82%) 396 (3%) 361 (91%) 321 (89%) 265 (83%) 15098 (98%) 0 (0%) --- 15098 2161 (14%)
KARNATAKA 52300 50057 (96%) 918 (2%) 705 (77%) 183 (26%) 120 (66%) 52117 (100%) 1543 (3%) 477 (31%) 51051 1522 (3%)
KERALA 10033 9252 (92%) 282 (3%) 209 (74%) 28 (13%) 21 (75%) 10005 (100%) 2264 (23%) 574 (25%) 8315 171 (2%)
LADAKH 204 183 (90%) 2 (1%) 1 (50%) 2 (200%) 1 (50%) 202 (99%) 0 (0%) --- 202 21 (10%)
LAKSHADWEEP 0 --- --- --- --- --- --- --- --- 0 ---
MADHYA PRADESH 58212 53594 (92%) 1308 (2%) 963 (74%) 314 (33%) 262 (83%) 57898 (99%) 1207 (2%) 398 (33%) 57089 17051 (30%)
MAHARASHTRA 63783 58499 (92%) 1513 (3%) 1227 (81%) 226 (18%) 169 (75%) 63557 (100%) 3646 (6%) 639 (18%) 60550 4770 (8%)
MANIPUR 1268 1130 (89%) 3 (0%) 3 (100%) 0 (0%) --- 1268 (100%) 0 (0%) --- 1268 6 (0%)
MEGHALAYA 3028 2948 (97%) 18 (1%) 10 (56%) 9 (90%) 9 (100%) 3019 (100%) 0 (0%) --- 3019 16 (1%)
MIZORAM 639 606 (95%) 3 (0%) 2 (67%) 2 (100%) 1 (50%) 637 (100%) 0 (0%) --- 637 26 (4%)
NAGALAND 1057 997 (94%) 3 (0%) 3 (100%) 2 (67%) 2 (100%) 1055 (100%) 0 (0%) --- 1055 152 (14%)
ODISHA 28406 27292 (96%) 385 (1%) 313 (81%) 140 (45%) 131 (94%) 28266 (100%) 0 (0%) --- 28266 2030 (7%)
PUDUCHERRY 1071 1071 (100%) 115 (11%) 115 (100%) 2 (2%) 2 (100%) 1069 (100%) 0 (0%) --- 1069 2 (0%)
PUNJAB 16866 15014 (89%) 95 (1%) 65 (68%) 53 (82%) 51 (96%) 16813 (100%) 0 (0%) --- 16813 2561 (15%)
RAJASTHAN 57355 54897 (96%) 823 (1%) 735 (89%) 91 (12%) 54 (59%) 57264 (100%) 0 (0%) --- 57264 1036 (2%)
SIKKIM 557 335 (60%) 21 (6%) 19 (90%) 9 (47%) 9 (100%) 548 (98%) 0 (0%) --- 548 38 (7%)
TAMIL NADU 45363 43997 (97%) 1006 (2%) 864 (86%) 60 (7%) 44 (73%) 45303 (100%) 765 (2%) 207 (27%) 44745 1313 (3%)
TELANGANA 26760 25694 (96%) 1233 (5%) 1178 (96%) 171 (15%) 135 (79%) 26589 (99%) 0 (0%) --- 26589 1546 (6%)
TRIPURA 2776 2594 (93%) 66 (3%) 61 (92%) 1 (2%) 0 (0%) 2775 (100%) 0 (0%) --- 2775 2 (0%)
UTTAR PRADESH 157164 151725 (97%) 1280 (1%) 652 (51%) 452 (69%) 384 (85%) 156712 (100%) 0 (0%) --- 156712 1276 (1%)
UTTARAKHAND 8604 7958 (92%) 272 (3%) 108 (40%) 67 (62%) 61 (91%) 8537 (99%) 0 (0%) --- 8537 372 (4%)
WEST BENGAL 59089 56887 (96%) 2375 (4%) 2171 (91%) 207 (10%) 152 (73%) 58882 (100%) 0 (0%) --- 58882 10201 (17%)
INDIA 850554 802361 (94%) 16633 (2%) 13517 (81%) 3351 (25%) 2570 (77%) 847203 (100%) 13480 (2%) 4124 (31%) 837847 53703 (6%)

243 INDIA TB REPORT 2022 INDIA TB REPORT 2022 244

7.4 T
 B Preventive Treatment (TPT) in eligible household TPT among eligible HHC children <5year [2021 Nikshay]
contact (HHC) of PBCT plus eligible HHC >/=5year [Jul to Dec 2021 Nikshay]
Screening, diagnosis and tratment of TB Ruling out active TB, TBI testing and TPT initiation
No. of HHC
No. of HHC No. of HHC of No. of HHC of No. of HHC of No. of HHC of No. of HHC ≥5years No. of HHC ≥5years
State of PBCT No. of HHC of PBCT No. of HHC of PBCT
of PBCT PBCT screened PBCT evaluated PBCT diagnosed PBCT put on TB of PBCT tested for of PBCT postives
symptomatic eligible* for TPT provided TPT (%)
for TB (%) for TB (%) with TB (%) treatment (%) TB infection for TB infection
for TB (%)
ANDAMAN & NICOBAR
459.0 452 (98%) 10 (2%) 9 (90%) 3 (33%) 3 (100%) 0.0 0.0 456.0 42 (9%)
ISLANDS
ANDHRA PRADESH 30008.0 28787 (96%) 204 (1%) 76 (37%) 57 (75%) 33 (58%) 0.0 0.0 29951.0 3840 (13%)
ARUNACHAL PRADESH 1460.0 1346 (92%) 114 (8%) 108 (95%) 108 (100%) 108 (100%) 0.0 0.0 1352.0 91 (7%)
ASSAM 11629.0 9730 (84%) 156 (2%) 108 (69%) 69 (64%) 56 (81%) 0.0 0.0 11560.0 735 (6%)
BIHAR 30494.0 26299 (86%) 229 (1%) 129 (56%) 61 (47%) 53 (87%) 0.0 0.0 30433.0 2242 (7%)
CHANDIGARH 2242.0 2205 (98%) 15 (1%) 14 (93%) 5 (36%) 5 (100%) 0.0 0.0 2237.0 365 (16%)
CHHATTISGARH 17118.0 14849 (87%) 516 (3%) 418 (81%) 282 (67%) 183 (65%) 0.0 0.0 16836.0 1555 (9%)
DADRA AND NAGAR HAVELI
596.0 596 (100%) 37 (6%) 37 (100%) 1 (3%) 1 (100%) 426.0 131.0 300.0 196 (65%)
AND DAMAN AND DIU
DELHI 21353.0 16081 (75%) 324 (2%) 200 (62%) 134 (67%) 58 (43%) 24.0 1.0 21196.0 1941 (9%)
GOA 981.0 981 (100%) 4 (0%) 3 (75%) 0 (0%) #DIV/0! 0.0 0.0 981.0 40 (4%)
GUJARAT 95001.0 94065 (99%) 3126 (3%) 2906 (93%) 258 (9%) 157 (61%) 2588.0 1197.0 93352.0 9007 (10%)
HARYANA 42867.0 39822 (93%) 275 (1%) 160 (58%) 107 (67%) 100 (93%) 1017.0 500.0 42243.0 3957 (9%)
HIMACHAL PRADESH 16848.0 16780 (100%) 155 (1%) 137 (88%) 45 (33%) 41 (91%) 0.0 0.0 16803.0 1862 (11%)
JAMMU & KASHMIR 7044.0 6257 (89%) 177 (3%) 155 (88%) 115 (74%) 107 (93%) 0.0 0.0 6929.0 1449 (21%)
JHARKHAND 19702.0 15846 (80%) 508 (3%) 464 (91%) 419 (90%) 360 (86%) 0.0 0.0 19283.0 3374 (17%)
KARNATAKA 58507.0 55860 (95%) 1114 (2%) 875 (79%) 272 (31%) 206 (76%) 1543.0 477.0 57169.0 5083 (9%)
KERALA 11433.0 10366 (91%) 350 (3%) 269 (77%) 57 (21%) 46 (81%) 2264.0 574.0 9686.0 724 (7%)
LADAKH 271.0 248 (92%) 2 (1%) 1 (50%) 2 (200%) 1 (50%) 0.0 0.0 269.0 80 (30%)
LAKSHADWEEP 1.0 1 (100%) 0 (0%) #DIV/0! #DIV/0! #DIV/0! 0.0 0.0 1.0 1 (100%)
MADHYA PRADESH 72033.0 64471 (90%) 1548 (2%) 1129 (73%) 420 (37%) 363 (86%) 1207.0 398.0 70804.0 23700 (33%)
MAHARASHTRA 70928.0 64819 (91%) 1725 (3%) 1397 (81%) 282 (20%) 217 (77%) 3646.0 639.0 67639.0 8682 (13%)
MANIPUR 1489.0 1320 (89%) 5 (0%) 3 (60%) 0 (0%) #DIV/0! 0.0 0.0 1489.0 107 (7%)
MEGHALAYA 3841.0 3730 (97%) 21 (1%) 13 (62%) 11 (85%) 11 (100%) 0.0 0.0 3830.0 578 (15%)
MIZORAM 899.0 794 (88%) 4 (1%) 3 (75%) 3 (100%) 2 (67%) 0.0 0.0 896.0 115 (13%)
NAGALAND 1268.0 1174 (93%) 7 (1%) 4 (57%) 3 (75%) 3 (100%) 0.0 0.0 1265.0 254 (20%)
ODISHA 32573.0 31241 (96%) 455 (1%) 375 (82%) 199 (53%) 191 (96%) 0.0 0.0 32374.0 4438 (14%)
PUDUCHERRY 1154.0 1154 (100%) 121 (10%) 121 (100%) 5 (4%) 5 (100%) 0.0 0.0 1149.0 76 (7%)
PUNJAB 20259.0 17692 (87%) 139 (1%) 102 (73%) 65 (64%) 62 (95%) 0.0 0.0 20194.0 3964 (20%)
RAJASTHAN 65557.0 62367 (95%) 923 (1%) 813 (88%) 118 (15%) 78 (66%) 0.0 0.0 65439.0 4224 (6%)
SIKKIM 621.0 378 (61%) 23 (6%) 21 (91%) 10 (48%) 10 (100%) 0.0 0.0 611.0 88 (14%)
TAMIL NADU 49084.0 47437 (97%) 1201 (3%) 1046 (87%) 93 (9%) 70 (75%) 765.0 207.0 48433.0 3641 (8%)
TELANGANA 29129.0 27922 (96%) 1369 (5%) 1295 (95%) 204 (16%) 150 (74%) 0.0 0.0 28925.0 2776 (10%)
TRIPURA 2958.0 2767 (94%) 69 (2%) 64 (93%) 2 (3%) 0 (0%) 0.0 0.0 2956.0 112 (4%)
UTTAR PRADESH 189833.0 180712 (95%) 1637 (1%) 875 (53%) 651 (74%) 530 (81%) 0.0 0.0 189182.0 14138 (7%)
UTTARAKHAND 10320.0 9438 (91%) 307 (3%) 117 (38%) 74 (63%) 67 (91%) 0.0 0.0 10246.0 923 (9%)
WEST BENGAL 69009.0 66220 (96%) 2498 (4%) 2260 (90%) 242 (11%) 173 (71%) 0.0 0.0 68767.0 15768 (23%)
INDIA 988969.0 924207 (93%) 19368 (2%) 15707 (81%) 4377 (28%) 3450 (79%) 13480.0 4124.0 975236.0 120168 (12%)

245 INDIA TB REPORT 2022 INDIA TB REPORT 2022 246

 8.1 State Level - Programme Staffing Status in 2021
Technical Technical
State MO – Store Store
State TB Epidemiologist Epidemiologist MO – State TB-HIV TB-HIV PPM PPM DR TB DR TB State IEC State IEC State State Officer- Officer- Data Data DEO- Pharmacist Pharmacist Secretarial Secretarial
TB State TB DEO-STC Assistant Assistant
Officer (APO) (APO) TB Cell Coordinator Coordinator Coordinator Coordinator Coordinator Coordinator Officer Officer Accountant Accountant Proc. and Proc. and Analyst Analyst STC - SDS - SDS asst. asst.
Officer Cell - SDS - SDS
State Logistics Logistics

In In
Sanctioned Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned Sanctioned In Place Sanctioned In Place Sanctioned In Place
Place Place

Andaman &
1 1 0 0 1 0 1 0 0 0 0 0 1 1 1 1 0 0 1 0 1 1 1 1 1 1 1 1
Nicobar

Andhra
1 1 1 1 1 0 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 0 1 1
Pradesh

Arunachal
1 1 1 1 1 0 0 0 0 0 0 0 1 1 1 1 1 0 0 0 1 1 1 0 1 1 1 1
Pradesh

Assam 1 1 1 0 1 0 1 1 0 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1

Bihar 1 1 1 1 1 0 1 0 1 0 1 1 1 1 1 0 1 1 0 0 1 1 2 0 1 0 2 1

Chandigarh 1 1 0 0 1 0 1 1 0 0 0 0 1 1 1 1 0 0 0 0 1 1 1 1 1 1 1 1

Chattisgarh 1 1 1 0 1 1 0 0 1 1 0 0 1 1 1 1 0 0 0 0 1 1 1 1 1 0 1 1

Dadra Nagar &

Haveli Daman 1 1 2 2 2 2 1 1 0 0 0 0 2 1 2 2 0 0 0 0 2 2 2 2 1 1 1 0
& Diu

Delhi 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 0 1 1 1 1 2 0 1 1 2 0

Goa 1 1 1 0 1 1 1 0 0 0 0 0 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1

Gujarat 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 0 0 0 1 1 1 0 1 1 1 1

Haryana 1 1 1 0 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1

Himachal
1 1 1 1 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 1 1 1 0 1 0 1 1
Pradesh

Jammu 0 0 1 0 1 1 1 1 1 1 1 0 1 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1

Kashmir 0 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1

Ladakh 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0

Jharkhand 1 1 1 1 1 1 1 0 1 1 1 0 1 1 2 1 1 1 1 0 1 1 2 1 1 0 2 1

Karnataka 1 1 1 0 1 0 1 0 1 0 1 0 1 0 2 2 1 1 1 0 2 2 1 0 1 0 1 0

Kerala 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 1 1 1 1 1 1

Lakshdweep 1 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 1 1 0 0 0 0 0 0

Maharashtra 1 1 2 2 1 0 1 1 1 1 1 0 1 1 3 3 1 0 2 2 2 2 50 42 2 2 8 8

Manipur 1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 1 0 0 0 0 1 1 1 1 1 1 1 1

Mizoram 1 1 0 0 1 1 1 1 1 1 0 0 1 1 1 1 0 0 0 0 1 1 1 1 1 1 1 1

Meghalaya 1 1 0 1 1 0 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1

Madhya
1 1 1 0 1 1 1 0 1 0 1 0 0 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1
Pradesh

Nagaland 1 1 1 1 1 1 0 0 1 1 0 0 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1

Odisha 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 0 0 0 1 1 1 0 1 1 1 0

Puducherry 1 1 0 0 1 1 1 1 0 0 0 0 1 1 1 1 0 0 0 0 1 1 1 1 1 1 1 1

Punjab 1 1 1 0 1 0 1 1 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0

Rajasthan 1 1 1 0 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 1 2 1 3 2 1 1 4 0

Sikkim 1 1 1 1 1 0 1 0 1 1 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1

Telangana 0 1 1 0 1 0 1 0 1 0 1 0 1 1 1 1 1 0 1 1 1 0 1 1 0 0 1 1

Tamil Nadu 1 1 0 0 1 1 1 0 1 1 1 0 1 1 2 1 1 1 1 0 2 0 1 2 2 0 3 2

Tripura 1 1 1 1 1 1 0 0 1 0 0 0 1 1 1 1 1 0 1 1 1 0 1 1 1 1 1 0

Uttar Pradesh 1 1 2 1 2 0 2 1 2 1 2 0 2 2 2 2 2 2 2 1 2 2 4 4 1 1 8 5

Uttarakhand 1 1 1 1 1 1 (PMC) 0 0 0 0 1 0 1 1 1 1 0 0 0 0 1 1 2 2 1 0 2 1

West Bengal 1 1 2 1 1 0 2 0 2 2 2 1 2 1 2 2 1 0 2 2 2 1 2 1 1 1 4 2

247 INDIA TB REPORT 2022 INDIA TB REPORT 2022 248

8.2 STDC - Programme Staffing Status in 2021

Secretarial
Director (STDC) Director (STDC) MO - STDC MO - STDC Epidemiologist Epidemiologist NIKSHAY Operator NIKSHAY Operator Secretarial assistant-STDC
assistant-STDC
State
Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place

Andaman & Nicobar 0 0 0 0 0 0 0 0 0 0

Andhra Pradesh 0 0 0 0 1 1 0 0
Arunachal Pradesh 0 0 0 0
Assam 0 0 0 0
Bihar 2 2 14 8 1 0 0 0 0 0
Chandigarh 0 0 0 0 0 0 0 0 0 0
Chattisgarh 0 0 2 0 1 0 1 0 0 0
Dadra Nagar & Haveli
0 0 0 0 0 0 0 0 0 0
Daman & Diu
Delhi 1 1 1 1 1 1
Goa 0 0 0 0 0 0 0 0 0 0
Gujarat 2 2 4 4 0 0 1 1 0 0
Infrastructure
Infrastructure ready, Infrastructure Infrastructure
ready, HR
Haryana 0 HR Projected in supp 0 ready, HR Projected 0 ready, HR Projected 0
Projected in supp
PIP 2021-22 in supp PIP 2021-22 in supp PIP 2021-22
PIP 2021-22
Himachal Pradesh 1 1 1 1 1 1 1 1 1 1
Jammu 0 0 0 0
Kashmir 1 1
Ladakh 0 0 0 0 0 0 0 0 0
Jharkhand 1 1 1 1 1 0 1 0 0 0
Karnataka 1 1 0 0 0 0 0 0 0 0
Kerala 1 1 2 2 0 0 0 0 0 0
Lakshdweep 0 0 0 0 0
Maharashtra 3 2 2 2 2 2 0 0 0 0
Manipur 1 1 0 0 0 0 0 0 0 0
Mizoram 0 0 0 0 0 0 0 0 0 0
Meghalaya 0 0 0 0 0 0 7 7 0 0
Madhya Pradesh 1 1 1 1 0 0 0 0 0 0
Nagaland NA NA NA NA 0 0 0 0 0 0
Odisha 1 1 1 1 1 1 1 1 1 1
Puducherry 1 1 5 5 0 0 0 0 0 0
Punjab 1 1 1 1 1 1 0 0 0 0
Rajasthan 1 1 3 3 1 0 1 1 1 1
Sikkim 1 1 1 0 1 0 1 0 1 0
Telangana 1 1 1 2 2 1 1 0 0 0
Tamil Nadu 1 1 0 0 1 0 0 0 0 0
Tripura NA NA NA NA NA NA NA NA NA NA
Uttar Pradesh 1 1 3 1 0 0 0 0 0 0
Uttarakhand 0 0 1 0
West Bengal 1 1 3 2 1 1 1 1 0 0

249 INDIA TB REPORT 2022 INDIA TB REPORT 2022 250

8.3 IRL- Programme Staffing Status in 2021

Microbiologist Microbiologist Technical Technical Senior Lab. Data Entry Data Entry Lab Lab
Senior Lab. Tech. Lab Attendant Lab Attendant
(C-DST) (C-DST) Officer Officer Tech. Operator Operator technicians technicians
State
Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place

Andaman & Nicobar 0 0 0 0 0 0 0 0 0 0 0 0

Andhra Pradesh 2 2 0 0 10 7 2 2 6 4 2 2
Arunachal Pradesh 1 1 0 0 1 1 0 0 0 0 4 4
Assam 1 0 0 0 0 0 0 0 0 0 0 0
Bihar 4 0 0 0 15 0 4 0 0 0 0 0
Chandigarh 1 1 0 0 0 0 1 1 3 3 2 2
Chattisgarh 1 1 0 0 0 0 1 0 2 0 0 0
Dadra Nagar & Haveli Daman & Diu 0 0 0 0 0 0 0 0 0 0 0 0
Delhi 1 1 0 0 5 0 1 0 0 0 0 0
Goa 0 0 0 0 0 0 0 0 0 0 0 0
Gujarat 2 2 0 0 0 0 1 1 10 10 8 8
Infrastructure Infrastructure Infrastructure
Infrastructure
almost ready, ready, HR ready , HR 1 (Sr. Lab
ready, HR
Haryana HR Projected 0 Projected in 0 0 Projected in 0 Technician- 0 1 0
Projected in supp
in supp PIP supp PIP 2021- supp PIP 2021- EQA) approved
PIP 2021-22
2021-22 22 22
Himachal Pradesh 2 2 0 0 5 3 0 0 4 2 0 0
Jammu
Kashmir
Ladakh 0 0 0 0 0 0 0 0 0 0 0
Jharkhand 1 1 1 0 2 0 1 0 2 0 1 0
Karnataka 3 3 0 0 0 0 2 2 1 0 4 4
Kerala 1 1 0 0 0 0 1 1 2 2 2 2
Lakshdweep 0 0 0 0 0 0 0 0 0 0 0 0
Maharashtra 11 5 0 0 30 15 6 8 8 2 0 0
Manipur 0 0 0 0 0 0 0 0 0 0 0 0
Mizoram 1 0 0 0 2 2 1 1 2 2 0 0
Meghalaya 0 0 0 0 0 0 0 0 0 0 0 0
Madhya Pradesh 4 3 1 1 1 1 3 3 14 9 4 4
Nagaland NA NA NA NA NA NA NA NA NA NA NA NA
Odisha 1 1 0 0 0 0 0 0 0 0 0 0
Puducherry 1 1 0 0 0 0 1 1 4 4 1 1
Punjab 0 0 0 0 0 0 0 0 0 0 0 0
Rajasthan 4 4 2 2 3 3 3 2 19 16 2 (FIND) 2 (FIND)
Sikkim 1 1 0 0 0 0 0 0 0 0 0 0
Telangana 1 0 0 0 0 0 1 0 2 0 1 0
Tamil Nadu 1 1 0 0 1 1 1 0 0 0 0 0
Tripura 1 1 0 0 1 1 1 1 0 1 (FIND) 0 2 (FIND)
Uttar Pradesh 8 3 0 0 24 1 6 3 4 2 6 3
Uttarakhand 0 0 0 0 0 0 0 0 0 0 0 0
West Bengal 5 1 0 0 16 4 1 0 4 3 0 0

251 INDIA TB REPORT 2022 INDIA TB REPORT 2022 252

8.4 CDST - Programme Staffing Status in 2021

Microbiologist Microbiologist Technical Technical Senior Lab. Data Entry Data Entry Lab Lab
Senior Lab. Tech. Lab Attendant Lab Attendant
(C-DST) (C-DST) Officer Officer Tech. Operator Operator technicians technicians
State
Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place

Andaman & Nicobar 0 0 0 0 0 0 0 0 0 0 0 0

Andhra Pradesh 2 2 0 0 10 7 2 2 6 4 2 2
Arunachal Pradesh 1 1 0 0 1 1 0 0 0 0 4 4
Assam 1 0 0 0 0 0 0 0 0 0 0 0
Bihar 4 0 0 0 15 0 4 0 0 0 0 0
Chandigarh 1 1 0 0 0 0 1 1 3 3 2 2
Chattisgarh 1 1 0 0 0 0 1 0 2 0 0 0
Dadra Nagar & Haveli Daman & Diu 0 0 0 0 0 0 0 0 0 0 0 0
Delhi 1 1 0 0 5 0 1 0 0 0 0 0
Goa 0 0 0 0 0 0 0 0 0 0 0 0
Gujarat 2 2 0 0 0 0 1 1 10 10 8 8
Infrastructure Infrastructure Infrastructure
Infrastructure
almost ready, ready, HR ready , HR 1 (Sr. Lab
ready, HR
Haryana HR Projected 0 Projected in 0 0 Projected in 0 Technician- 0 1 0
Projected in supp
in supp PIP supp PIP 2021- supp PIP 2021- EQA) approved
PIP 2021-22
2021-22 22 22
Himachal Pradesh 2 2 0 0 5 3 0 0 4 2 0 0
Jammu
Kashmir
Ladakh 0 0 0 0 0 0 0 0 0 0 0
Jharkhand 1 1 1 0 2 0 1 0 2 0 1 0
Karnataka 3 3 0 0 0 0 2 2 1 0 4 4
Kerala 1 1 0 0 0 0 1 1 2 2 2 2
Lakshdweep 0 0 0 0 0 0 0 0 0 0 0 0
Maharashtra 11 5 0 0 30 15 6 8 8 2 0 0
Manipur 0 0 0 0 0 0 0 0 0 0 0 0
Mizoram 1 0 0 0 2 2 1 1 2 2 0 0
Meghalaya 0 0 0 0 0 0 0 0 0 0 0 0
Madhya Pradesh 4 3 1 1 1 1 3 3 14 9 4 4
Nagaland NA NA NA NA NA NA NA NA NA NA NA NA
Odisha 1 1 0 0 0 0 0 0 0 0 0 0
Puducherry 1 1 0 0 0 0 1 1 4 4 1 1
Punjab 0 0 0 0 0 0 0 0 0 0 0 0
Rajasthan 4 4 2 2 3 3 3 2 19 16 2 (FIND) 2 (FIND)
Sikkim 1 1 0 0 0 0 0 0 0 0 0 0
Telangana 1 0 0 0 0 0 1 0 2 0 1 0
Tamil Nadu 1 1 0 0 1 1 1 0 0 0 0 0
Tripura 1 1 0 0 1 1 1 1 0 1 (FIND) 0 2 (FIND)
Uttar Pradesh 8 3 0 0 24 1 6 3 4 2 6 3
Uttarakhand 0 0 0 0 0 0 0 0 0 0 0 0
West Bengal 5 1 0 0 16 4 1 0 4 3 0 0

253 INDIA TB REPORT 2022 INDIA TB REPORT 2022 254

8.5 DRTB Centre level – Programme Staffing Status 2021

Counselor – DR TB
Senior MO – DR TB Centre Senior MO – DR TB Centre Counselor – DR TB Centre SA – DR TB Centre SA – DR TB Centre
Centre
State
Sanctioned In Place Sanctioned In Place Sanctioned In Place

Andaman & Nicobar 1 0 1 0 1 1

Andhra Pradesh 9 4 13 11 13 12
Arunachal Pradesh 2 1 0 0 2 2
Assam 5 3 5 2 5 3
Bihar 9 1 46 0 9 6
Chandigarh 1 0 0 0 1 1
Chattisgarh 4 2 4 3 4 4
Dadra Nagar & Haveli Daman & Diu 0 0 0 0 0 0
Delhi 4 2 14 0 4 4
Goa 1 1 1 1 1 1
Gujarat 5 4 5 5 5 5
Haryana 2 1 3 2 3 1
Himachal Pradesh 3 1 3 2 2 1
Jammu 1 1 1 1 1 1
Kashmir 1 1 1 1
Ladakh 1 1 0 0 1 1
Jharkhand 5 2 5 2 5 4
Karnataka 7 6 6 5 6 6
Kerala 2 2 0 0 2 2
Lakshdweep 0 0 0 0 0 0
Maharashtra 19 15 20 15 22 20
Manipur 1 0 1 1 2 2
Mizoram 1 1 1 1 1 1
Meghalaya 2 1 2 2 2 2
Madhya Pradesh 12 6 13 3 13 0
Nagaland 2 2 2 2 2 2
Odisha 4 2 4 3 4 2
Puducherry 1 0 0 0 1 1
Punjab 3 1 0 0 2 1
Rajasthan 7 2 7 6 7 6
Sikkim 1 0 1 0 1 1
Telangana 2 2 4 1 7 6
Tamil Nadu 8 6 13 8 8 8
Tripura 1 1 (On Duputation) 1 1 1 1
Uttar Pradesh 23 13 23 17 23 18
Uttarakhand 2 1 2 2 2 2
West Bengal 9 5 9 9 9 8

255 INDIA TB REPORT 2022 INDIA TB REPORT 2022 256

 8.6 District level - Programme Staffing Status in 2021

Senior Senior Senior Senior

District District Senior DR Senior DR Lab. Techs. Lab. Techs.
District TB District TB District PPM District PPM Treatment Treatment TB Lab TB Lab
Program Program MO – DTC MO – DTC MO-TC MO-TC TB – TBHIV TB – TBHIV Accountant Accountant (LT) – RNTCP (LT) – RNTCP MO – PHI MO – PHI TBHV TBHV
Officers Officers Coordinator Coordinator Supervisor Supervisor Supervisor Supervisor
Coordinator Coordinator supervisor supervisor Contractual Contractual
State (STS) (STS) (STLS) (STLS)

Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place

Andaman & Nicobar 3 3 3 3 3 2 6 6 3 3 0 0 3 3 9 9 4 4 4 4 146 113 4 4

Andhra Pradesh 13 10 13 12 5 2 225 225 13 11 13 12 13 12 239 228 134 108 209 193 1600 1589 161 135

Arunachal Pradesh 15 15 0 0 14 6 14 6 17 15 0 0 15 15 20 20 18 18 12 12 830 800 11 11

Assam 27 27 0 0 16 0 350 156 27 26 27 22 27 23 153 139 78 75 88 82 4283 1816 30 30

Bihar 38 38 38 24 38 20 544 480 38 24 0 0 0 0 534 311 223 158 436 355 2686 860 110 29

Chandigarh 1 1 0 0 1 0 4 4 1 1 0 0 0 0 4 3 5 5 17 11 54 54 14 7

Chattisgarh 28 28 27 25 13 11 155 155 27 24 27 23 27 25 155 151 69 65 146 101 3672 1312 46 40

Dadra Nagar &

0 0 1 1 1 1 0 0 2 2 0 0 1 1 6 3 3 3 5 4 0 0 3 2
Haveli Daman & Diu

Delhi 25 25 25 0 12 11 38 20 27 23 25 0 25 0 72 31 38 31 186 168 286 286 189 172

Goa 2 2 2 0 0 0 6 6 2 2 2 2 1 1 6 4 5 5 8 7 225 210 9 8

Gujarat 41 41 35 33 24 22 306 306 38 38 35 33 36 35 321 298 168 148 189 175 4816 4180 243 239

Haryana 22 22 21 17 0 0 0 0 21 18 21 16 21 20 119 114 52 48 72 71 0 0 99 86

Himachal Pradesh 12 12 10 9 5 1 75 75 12 11 0 0 14 11 95 82 53 47 106 91 547 498 22 10

Jammu 6 6 6 4 9 5 41 40 6 6 6 3 6 4 47 39 18 18 0 0 831 346 10 7

Kashmir 6 6 6 6 57 57 6 6 3 3 6 6 57 57 21 21

Ladakh 2 2 2 2 2 2 0 0 2 2 0 0 2 1 5 5 5 4 2 2 1 1

Jharkhand 24 24 24 18 8 1 202 202 24 20 24 19 24 16 207 150 101 75 168 135 1920 1297 74 52

Karnataka 31 31 34 32 6 4 0 0 33 33 33 33 30 28 284 269 149 142 224 211 0 0 298 264

Kerala 14 14 0 0 14 14 73 72 14 13 6 4 14 14 85 72 74 74 79 65 55 54

Lakshdweep 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 3 0 0 0 0 0

Maharashtra 80 80 34 27 86 66 384 381 84 80 79 75 79 77 617 506 318 304 344 278 5340 4363 520 470

Manipur 16 13 0 0 1 1 13 13 9 9 9 8 9 8 27 19 19 16 23 19 0 0 8 8

Mizoram 8 8 0 0 0 0 1 0 8 8 8 6 8 8 14 12 9 9 7 7 0 0 4 4

Meghalaya 7 7 7 7 1 1 24 21 7 7 4 2 7 7 24 24 15 14 20 19 620 613 7 6

Madhya Pradesh 51 51 50 19 51 28 303 191 50 36 0 0 0 0 367 143 315 249 433 243 1799 1416 275 205

Nagaland 11 10 0 0 2 2 0 0 11 11 2 2 2 2 22 22 13 13 13 13 0 0 7 7

Odisha 31 31 31 27 9 4 245 244 31 30 31 28 31 30 318 300 109 85 156 90 1459 1260 64 61

Puducherry 1 1 1 1 7 6 1 1 0 0 1 0 7 5 5 5 4 4 123 121 9 8

Punjab 22 22 0 0 3 3 134 134 22 20 0 0 0 0 134 105 59 46 149 87 3169 3135 102 62

Rajasthan 34 34 34 23 36 32 283 263 34 28 34 29 34 24 338 242 152 118 67 22 4908 3950 90 43

Sikkim 5 5 5 4 0 0 5 5 5 4 5 4 5 5 5 5 5 5 5 5 43 43 1 1

Telangana 11 8 8 8 0 0 171 135 11 11 19 19 3 3 171 157 96 90 150 150 750 100 100 100

Tamil Nadu 31 31 36 27 22 14 461 461 38 35 38 33 36 32 462 434 146 114 491 267 2977 1860 375 343

Tripura 8 8 0 0 1 1 0 0 0 0 0 0 8 6 20 19 13 10 9 9 0 0 3 3

Uttar Pradesh 75 75 75 66 10 8 1168 1152 89 80 89 76 76 67 1197 814 584 368 1045 874 4448 2693 562 438

Uttarakhand 13 13 13 12 13 13 95 95 13 13 0 0 13 10 110 104 31 30 72 64 450 450 34 28

West Bengal 37 37 28 27 28 28 464 464 48 41 35 26 28 27 484 431 204 164 386 350 3950 2780 373 232

257 INDIA TB REPORT 2022 INDIA TB REPORT 2022 258

8.7 Medical College - Programme Staffing Status in 2021

TBHV-Medical TBHV-Medical LT – DMC (All LT – DMC (All MO – Medical MO – Medical LT – Medical LT – Medical Data Entry Data Entry
College College sources) sources) College College College College Opertaor Opertaor
State
Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place Sanctioned In Place

Andaman & Nicobar 1 1 26 26 0 0 0 0 0 0

Andhra Pradesh 23 21 610 512 22 6 25 18 13 13
Arunachal Pradesh 0 0 35 35 0 0 1 0 15 15
Assam 6 6 350 253 6 3 6 6 1 1
Bihar 11 5 858 585 11 2 11 2 38 33
Chandigarh 2 1 17 11 2 2 2 1 0 0
Chattisgarh 9 7 9 6 9 6 9 6 27 23
Dadra Nagar & Haveli Daman & Diu 0 0 11 11 0 0 0 0 0 0
Delhi 14 8 215 189 14 7 14 6 26 25
Goa 1 1 24 24 1 1 1 1 2 2
Gujarat 26 20 2097 2043 17 13 26 25 38 36
Haryana 9 8 9 4 5 5 21 21
Himachal Pradesh 7 7 218 198 567 490 120 85 12 12
Jammu 4 2 151 146 26 7 9 9 6 5
Kashmir 6 6
Ladakh 0 0 2 2 0 0 0 0 2 2
Jharkhand 3 3 415 365 3 3 3 3 24 24
Karnataka 0 0 0 0 37 34 0 0 31 31
Kerala 24 24 19 16 25 25 14 14
Lakshdweep 0 0 4 3 0 0 0 0
Maharashtra 39 35 68 53 41 30 58 39 90 71
Manipur 2 2 23 19 2 1 2 2 9 9
Mizoram 0 0 0 0 0 0 0 0 8 8
Meghalaya 1 1 70 70 1 1 1 1 7 7
Madhya Pradesh 22 13 1177 944 27 8 50 43 51 51
Nagaland 0 0 NA NA NA NA 11 11
Odisha 7 7 584 551 6 4 7 4 31 17
Puducherry 10 5 28 28 4 3 9 8 0 0
Punjab 9 8 268 208 9 8 9 8 22 18
Rajasthan 18 5 1415 1310 6 2 8 4 42 32
Sikkim 1 1 43 43 1 1 (Manipal) 1 1 1 0
Telangana 0 0 750 618 8 5 16 13
Tamil Nadu 53 36 738 376 41 27 50 32 0 0
Tripura 2 2 59 2 1 2 1 8 7
Uttar Pradesh 36 26 2604 1869 36 16 40 23 89 81
Uttarakhand 4 4 153 138 0 0 4 4 13 12
West Bengal 27 14 945 896 15 9 27 13 38 34

259 INDIA TB REPORT 2022 INDIA TB REPORT 2022 260

9 NIKSHAY POSHAN YOJANA

BANK DETAILS AVAILABLE OF BENEFICIARIES PAID AT LEAST ONE BENEFIT OF

STATES TOTAL NOTIFICATION TOTAL NOTIFIED TOTAL NOTIFIED
Andaman & Nicobar Islands 516 510 (98.8%) 472 (91.5%)
Andhra Pradesh 87761 85701 (97.7%) 76593 (87.3%)
Arunachal Pradesh 2872 2635 (91.7%) 1032 (35.9%)
Assam 37732 32299 (85.6%) 26808 (71.0%)
Bihar 135485 107493 (79.3%) 62115 (45.8%)
CHANDIGARH 3243 3014 (92.9%) 202 (6.2%)
Chhattisgarh 32616 29066 (89.1%) 25120 (77.0%)
Dadra and Nagar Haveli and Daman
763 774 (101.4%) 729 (95.5%)
and Diu
Delhi 84367 56734 (67.2%) 25504 (30.2%)
Goa 2038 1521 (74.6%) 1307 (64.1%)
Gujarat 141290 126315 (89.4%) 112156 (79.4%)
Haryana 71251 60107 (84.4%) 46094 (64.7%)
Himachal Pradesh 14797 15075 (101.9%) 14468 (97.8%)
Jammu & Kashmir 11005 9896 (89.9%) 6217 (56.5%)
Jharkhand 53177 43907 (82.6%) 21319 (40.1%)
Karnataka 71443 64503 (90.3%) 37542 (52.5%)
Kerala 22023 19591 (89.0%) 16075 (73.0%)
Ladakh 319 257 (80.6%) 211 (66.1%)
Lakshadweep 20 19 (95.0%) 18 (90.0%)
Madhya Pradesh 168247 158020 (93.9%) 144753 (86.0%)
Maharashtra 196620 155147 (78.9%) 91694 (46.6%)
Manipur 1873 1441 (76.9%) 79 (4.2%)
Meghalaya 4193 3096 (73.8%) 995 (23.7%)
Mizoram 1781 1738 (97.6%) 1052 (59.1%)
Nagaland 3687 2879 (78.1%) 1532 (41.6%)
Odisha 52148 50423 (96.7%) 47170 (90.5%)
Puducherry 1408 1214 (86.2%) 95 (6.7%)
Punjab 52077 41655 (80.0%) 16564 (31.8%)
Rajasthan 151034 126228 (83.6%) 84368 (55.9%)
Sikkim 1438 1273 (88.5%) 865 (60.2%)
Tamil Nadu 84933 77662 (91.4%) 70833 (83.4%)
Telangana 60929 52938 (86.9%) 42531 (69.8%)
Tripura 2776 2483 (89.4%) 1234 (44.5%)
Uttar Pradesh 464894 365561 (78.6%) 272837 (58.7%)
Uttarakhand 23574 20825 (88.3%) 13272 (56.3%)
West Bengal 91500 82668 (90.3%) 62450 (68.3%)
INDIA 2135830 1804668 (84.5%) 1326306 (62.1%)

261 INDIA TB REPORT 2022 INDIA TB REPORT 2022 262

10 Key Program Reviews done from the National level in
the year 2021

Activity Page

State Review under the Chair of AS(H) 02-10-2021

IDDS Project Review 02-12-2021

03/02/2021, 24/02/2021,
Review for Jan Andolan Activities under Hon'ble HFM
24/06/2021

TB Mukt Bharat Review under AS(H) 09/04/2021, 07/09/2021

Monthly progress review meeting of research projects under

28/05/2021
GFATM
Review meeting to assess preparedness regarding
25/06/2021
implementation of Shorter oral BDQ-containing regimen
08/07/2021,
World Bank Virtual Review Mission
09/07/2021,12/07/2021
06/07/2021,11/08/2021,03/09/202
Review of the States Performance
1,14/10/2021,28/12/2021
Review meeting on setting of Milestones for SDG Indicators
under Chairpersonship of AS&MD on 23rd July 2021-DDG & 23/07/2021
JD(RR)

Review on Partnerships & PIP-MP 08-06-2021

NTEP performance Review under the Chairmanship of

09-02-2021
Hon'ble HFM
Joint Supportive Supervision Mission Sensitization Meeting
13/09/2021, 21/09/2021
followed by State Visits

Review & Orientation of STSU 16/09/2021, 17/09/2021

NTEP Review under the Chairpersonship of AS(H) 10-07-2021

Monthly Review of STSU 10-08-2021

NTEP Review under Hon'ble Minister of State for Health 13/10/2021

Hybrid Meeting - Review of Nikshay Aushadhi under the

28/12/2021
chairpersonship of DDG (TB)

263 INDIA TB REPORT 2022

 Central TB Division
3, Sansad Marg, Janpath, New Delhi – 110001
www.tbcindia.gov.in

TB Mukt Bharat NTEPEndsTB @Tbdivision